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ZUSAMMENFASSUNG I 
ZUSAMMENFASSUNG 
Die molekularbiologische Untersuchung der Wechselwirkungen zwischen Pathogenen und 
ihren Wirtszellen ist ein wertvoller Ansatz zur Erschließung bakterieller  
Pathogenitätsmechnismen und trägt darüber hinaus dazu bei, unser ständig wachsendes 
Wissen über fundamentale Prozesse in eukaryotischen Zellen zu erweitern. Das Gram-
negative, fakultativ intrazelluläre Bakterium Salmonella Typhimurium ist ein gängiger 
Modellorganismus, um den intrazellulären Lebensstil bakterieller Pathogene und deren 
Einfluss auf Wirtszellprozesse zu erforschen. In der vorliegenden Arbeit wurde ein 
Durchflusszytometrie-basierter Hochdurchsatz RNA Interferenz (RNAi) Screen einer 
humanen Kinase-Bibliothek etabliert und durchgeführt, um die Wirtszellfaktoren zu 
entschlüsseln, welche in die intrazelluläre Replikation von Salmonella Typhimurium 
involviert sind. Ein Salmonellen-Stamm, der zwei fluoreszierende Reporterproteine 
exprimiert, wurde konstruiert, um die bakterielle Replikation und die metabolische Aktivität 
in infizierten Wirtstzellen zu detektieren. Dies ermöglichte es, die Auswirkungen fehlender 
Wirtszellfaktoren auf das intrazelluläre Wachstum von Salmonellen zu untersuchen. In 
Vorversuchen wurde die humane Epithelzelllinie HeLa als adäquate Zelllinie für die 
Durchführung der Hochdurchsatzexperimente (Screen) bestimmt sowie geeignete 
Infektionsbedingungen festgelegt. Als inhibitorische Kontrolle für den Screen diente die 
Depletierung der GTPase Rab7A, welche einen essentiellen Faktor während der 
Salmonelleninfektion darstellt. Nachdem die technische Stabilität der 
Untersuchungsmethode und die Genauigkeit der ermittelten Daten überprüft wurden, 
konnte die Anwendbarkeit des Systems im Hochdurchsatz anhand ausgewählter chemischer 
Inhibitoren sowie einer innerhalb der Abteilung zusammengestellten siRNA-Bibliothek  
gezeigt werden. Der Einsatz der humanen Kinase-Bibliothek lieferte 48 potentielle 
Kandidatengene, von denen 15 in einer anschließenden Validierung als die Infektion 
beeinflussende Faktoren identifiziert werden konnten. Die Mitogen-aktivierte Protein Kinase 
(MAPK) MKK7, deren Herrunterregulation eine verminderte bakterielle Replikation zur Folge 
hatte, wurde für eine weitergehende funktionelle Charakterisierung ausgewählt. Es konnte 
gezeigt werden, dass reduzierte MKK7 Proteinmengen eine Verringerung des Proteins 
zytosolische Phospholipase A2 (cPLA2) zur Folge hatten. Dieser Einfluss auf die Menge von 
cPLA2 beruhte nicht auf einer direkten Interaktion der beiden Proteine, sondern auf der 
transkriptionellen Regulation von cPLA2 durch MKK7, wie die Herunterregulation der mRNA  
nach MKK7 Depletion zeigte. Die Bedeutung von cPLA2 für die bakterielle Infektion wurde 
durch die Salmonellen-induzierte, dauerhafte Phosphorylierung des Faktors deutlich und 
konnte darüber hinaus durch Replikationsvergleiche in cPLA2-depletierten und nicht-
depletierten Zellen bestätigt werden. Weitergehende mikroskopische Experimente deuteten 
darauf hin, dass die Phospholipase A2 für den fehlerfreien Aufbau von Salmonellen-
induzierten Filamenten notwendig ist, welche unerlässlich für die Salmonellenreplikation in 
Epithelzellen sind. 
 
 
 
 
 
 
 
ABSTRACT II 
ABSTRACT 
The study of pathogen-host cell interactions on the molecular level is a valuable tool to 
reveal bacterial pathogenicity mechanisms and, moreover, contributes to our increasing 
knowledge of fundamental cellular processes of eukaryotic cells. The Gram negative, 
facultative intracellular bacterium Salmonella Typhimurium is a well established model 
organism to investigate the intracellular lifestyle of bacterial pathogens and their modulation 
of host cell processes. In this work, a flow cytometry (FACS) based high-throughput RNA 
interference (RNAi) human kinome screen was established and performed in order to 
elucidate host cell factors involved in the intracellular replication of Salmonella 
Typhimurium. An elaborate Salmonella strain expressing two fluorescent reporter constructs 
was generated which allowed for monitoring the bacterial replication and metabolic activity 
within infected cells. This made it possible to robustly assess the impact of host cell gene 
knock down on Salmonella intracellular growth. The human epithelial cell line HeLa was 
evaluated as the suitable cell line for the screening experiments and proper infection 
conditions were determined. The knock down of the host cell small GTPase Rab7A was 
selected as the inhibitory control for the screen due to the essential role of this factor during 
the infection process of the pathogen. The technical stability of the FACS assay and the 
accuracy of the acquired data were verified before successfully testing the applicability of 
the system with a small screen employing chemical inhibitors and with an in-house RNAi 
library, serving as a proof-of-principle. The human kinome-wide siRNA library was screened 
and 48 candidates were chosen for further validation. Among these, 15 host cell genes were 
identified to influence Salmonella intracellular replication. The mitogen activated protein 
kinase (MAPK) MKK7, whose depletion caused a decrease in bacterial replication, was 
selected for a more profound functional characterization to reveal its role during Salmonella 
infection. It could be demonstrated that the knock down of MKK7 caused a decrease in 
phospholipase A2 (cPLA2) protein levels. This control of cPLA2 levels through MKK7 did not 
occur via a direct interaction but rather by a transcriptional regulation of cPLA2 which was 
demonstrated by reduced cPLA2 mRNA levels upon knock down of MKK7. A role for cPLA2 
during bacterial intracellular lifestyle was implicated by the finding that Salmonella induced 
a permanent phosphorylation of the phospholipase. The necessity of cPLA2 was confirmed 
with replication assays in cPLA2 depleted cells using siRNA and shRNA mediated knock down 
strategies. Microscopic experiments indicated that the phospholipase A2 is involved in the 
accurate generation of Salmonella-induced filaments, structures that were reported to be 
indispensable for replication.  
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I Introduction 
I.1 RNA interference 
I.1.1 A short chronology 
RNA interference (RNAi) describes a molecular pathway in which different RNA species are 
involved in the silencing of target genes either by inducing the cleavage of target mRNA 
(dsRNA and siRNA) or by inhibiting the translation of the mRNA (microRNA). During the last 
years a major research focus has been put on regulatory RNAs unravelling an increasing 
number of complex regulation mechanisms. 
The first unintended indication for a mechanism of RNAi, also termed posttranscriptional 
gene silencing (PTGS), came from a study in plants performed by Napoli et al. (1990). The 
group introduced a chalcone synthase (chsA) transgene, responsible for the purple colour of 
the leaves, into petunia flowers. Unexpectedly, some of the transgenic plants produced pure 
white or variegated colours. Moreover, the level of chsA mRNA in these plants was 
decreased which was not due to lower transcription activity as could be shown later with 
transcription tests in isolated nuclei (van Blokland et al., 1994). The observation was named 
“co-supression” but the underlying mechanism remained unknown. In 1997, Metzlaff and 
colleagues pointed to a role of double-stranded RNA in the initiation of PTGS as they found 
that the expression of the chsA transgene resulted in the formation of double-stranded RNA 
which initiates PTGS (Metzlaff et al., 1997). Although the first observations were made in 
plants, the phenomenon of PTGS is not limited to this evolutionary group. Shortly after the 
discovery in petunia plants, reversible gene silencing in the fungal species Neurospora crassa 
was demonstrated and termed “quelling”. It was achieved by introducing plasmids 
containing different constructs of the albino-3 gene (al-3) or the al-1 gene which are 
involved in the biosynthesis of carotenoids and subsequent screening for an albino 
phenotype (Romano et al., 1992). When cultivating the resulting primary transformants for 
longer times a phenotypic reversion could be observed indicating that the gene silencing was 
only transient and not heritable in this model.  
Although the biochemical nature of PTGS inducers was assumed to be double-stranded RNA, 
it was the group of Craig Mello and Andrew Fire who finally proofed this. In 1998, they 
injected different RNA molecules targeting the non-essential unc gene into Caenorhabditis 
elegans and examined the resulting phenotypes (Fire et al., 1998). It could be shown 
conclusively that double-stranded RNA rather than single-stranded RNA (either sense or 
anti-sense strand) is a potent inducer of RNAi. This effect was evident in both the injected 
animals and their progeny arguing for a heritable mechanism in C. elegans. Moreover, they 
demonstrated that even a few molecules of dsRNA were enough to evoke the RNAi 
phenotype, thereby disproving the model of stochiometric gene silencing and indicating an 
amplification mechanism within the worms. This amplification of RNAi leading to systemic 
silencing was also detected in plants. When grafting a scion of a non-silenced tobacco plant 
on a beheaded stock plant which was silenced in the nia2 gene causing chlorosis of the 
plant, the grafted scion also developed chlorosis (Palauqui et al., 1997). With this 
experiment, a systemic spreading of the PTGS signals could be shown. Systemic RNAi was 
also shown for other organisms but not for flies or mammals and it involves a RNA-
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dependent RNA polymerase (RdRP) and most likely membrane transport proteins to 
facilitate whole organism spread (Himber et al., 2003). 
First attempts to specifically silence genes in vertebrates and mammalian cell lines using 
dsRNAs failed (Oates et al., 2000). This was mainly due to the fact that long dsRNA, 
consisting of more than 30 base pairs activates the mammalian protein kinase PKR (Manche 
et al., 1992) which leads to a non-specific translation inhibition and eventually to apoptotic 
cell death (Gil et al., 2000). In a cell-free system of Drosophila embryo lysates (Tuschl et al., 
1999) it could be demonstrated that long dsRNA is cleaved by an ATP dependent mechanism 
to RNA fragments of 21-23 nt which act as guiding strands for mRNA cleavage (Zamore et al., 
2000). Using the same Drosphila in-vitro system, the group of Thomas Tuschl could show 
that chemically synthesized small inhibitory RNA (siRNA) duplexes targeting specific mRNA 
sequences are potent inducers of RNAi in these lysates (Elbashir et al., 2001b). This finding 
highlighted that long dsRNA was not necessarily required for gene silencing. The same group 
was then able to show that synthesized siRNA molecules of 21 nt length are competent to 
mediate RNAi in different mammalian cell lines without eliciting non-specific cellular 
responses as detected with longer dsRNA molecules (Elbashir et al., 2001a). This observation 
made possible the employment of RNAi in virtually all commonly used laboratory cell lines. 
Since then significant improvement with respect to delivery of siRNAs, sequence specificity, 
and large-scale applications of RNAi has been made to answer important scientific questions. 
 
I.1.2 The molecular mechanism of RNAi 
Evolutionary, the RNAi pathway induced by dsRNA can be seen as a protective mechanism 
against viral attacks and to maintain genome integrity, possibly threatened by transposon 
elements. Indeed, the minimum components necessary for cleavage of long dsRNA into 
siRNA fragments and subsequent degradation of target RNAs are present in essentially all 
eukaryotic groups, suggesting a development that took place very early in the evolution of 
eukaryotic species (for overview see (Shabalina et al., 2008). 
The RNAi pathway can be divided into two stages: the initiation and the effector stage. 
During the initiation phase small interfering siRNAs are generated from long dsRNA 
molecules mediated by the enzyme Dicer. In a next step, these siRNA molecules are 
introduced into the RNA induced silencing complex (RISC), a high molecular weight protein 
complex, where the dsRNA fragments are unwound and subsequently bind to their target 
mRNA in a sequence specific manner to finally facilitate the degradation of the mRNA. 
Dicer was identified as a dsRNA-specific RNase-III-type endonuclease with two RNaseIII 
domains and a dsRNA binding motif (Bernstein et al., 2001). It is conserved structurally and 
functionally among eukaryotic species. Whereas humans possess only one Dicer protein 
(Provost et al., 2002), the fruit fly Drosophila melanogaster encodes two paralogues, DCR-1 
and DCR-2, which are involved in processing miRNAs and dsRNAs, respectively (Lee et al., 
2004). For the plant Arabidopsis thaliana as much as four Dicer-like proteins (DCL) have been 
identified so far, with each of them fulfilling different RNA-processing functions (Xie et al., 
2004). Dicer produces siRNA fragments of about 21 nt length with 5’ phosphates and 2-
nucleotide 3’ overhangs, a process shown to be ATP-dependent for DCR-2 of 
D. melanogaster (Nykanen et al., 2001), but not for human Dicer (Zhang et al., 2002). 
Several proteins have been reported to interact with Dicer at different stages of RNAi. One 
major group of proteins is the family of PPD (PAZ Piwi domain) proteins. These are highly 
conserved proteins that can be found in diverse organisms ranging from archae to humans. 
They possess two characteristic protein domains: a central PAZ domain (named after three 
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members of this group: Piwi, Ago, and Zwille) and a C-terminal PIWI domain (Cerutti et al., 
2000). The PAZ domain was reported to bind to the 2 nt 3’ overhangs of the siRNA molecule, 
thereby enabling the introduction of the guide siRNA into the RISC (Song et al., 2003, Ma et 
al., 2004), whereas the PIWI domain is responsible for binding of the PPD proteins to Dicer 
(Tahbaz et al., 2004). Most research has been performed on the group of PPD proteins 
named Ago. Ago1 and Ago2 of humans (Martinez et al., 2002) and Ago2 of Drosophila 
(Hammond et al., 2001) were among the first protein components of RISC to be identified 
during experiments to isolate the ribonucleoprotein structures. The crystal structure of an 
Ago protein from the archae Pyrococcus furiosus was resolved in 2004 and showed 
similarities to members of the RNase H family (Song et al., 2004). Since RNase H enzymes are 
responsible for cleaving RNA in a RNA/DNA duplex it was proposed that Ago proteins are 
responsible for cleaving the target mRNA in the RISC during the stage of guide siRNA/target 
mRNA duplex formation. The proposed enzymatic activity was named Slicer and in humans 
this is performed by Ago2 (Meister et al., 2004). 
Several other non-PDD proteins were identified to be part of the RISC, many of them with so 
far unknown functions and the list is still expanding. The role of the Drosophila protein R2D2 
in RNAi initiation and effector stage has been examined in more detail. It was identified as a 
dsRNA-binding protein co-fractionating in S2 cell extracts that displayed dsRNA-processing 
activity (Liu et al., 2003). R2D2 forms a stable complex with Dcr2 and this complex is needed 
for efficient RISC stimulation. Furthermore, the Dcr2-R2D2 association is fundamental for 
binding and transfer of siRNA single strands to Ago2 in RISC (Liu et al., 2003). The decision 
which single strand enters RISC is dependent on thermodynamic differences between the 
two siRNA strands, with the one whose 5’ end is less tightly bound serving as guide strand 
which is transferred to Ago2 (Schwarz et al., 2003). From this data and accumulating other 
observations a stepwise model was proposed for long dsRNA-mediated post transcriptional 
gene silencing in Drosophila which is probably also relevant for other species and their 
respective homologous RNAi proteins (see figure I.1). 
In a first step, Dcr2 forms a complex with R2D2 and maybe additional proteins to bind to 
long dsRNA. Dicer then cleaves the molecule into siRNA fragments of about 21 nt with 
characteristic 2 nt 3’ overhangs. Both the 3’ end of the guide siRNA strand which enters RISC 
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Figure I.1: Schematic overview of the RNAi pathway in Drosophila melanogaster. 
This model has been proposed based on several experimental observations. See text for details. 
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as well as the 5’ end of the non-incorporated strand bind to R2D2. In an ATP-dependent 
enzymatic step the double-stranded siRNA is unwound by helicase activity and the guide 
siRNA single strand is transferred from the Dcr2-R2D2 complex to Ago2 to facilitate target 
mRNA cleavage after complementary base pairing. This cleavage takes place between nt 10 
and 11 relative to the 5’ end of the guide siRNA (Elbashir et al., 2001b). The cleaved mRNA is 
then targeted and degraded by cellular nucleases (Orban et al., 2005) resulting in the 
silencing of gene expression. Subsequently, the RISC can undergo a new enzymatic RNAi 
cycle (Hutvagner et al., 2002). 
 
I.1.3 Applications of siRNA mediated gene knock down 
I.1.3.1 RNAi screens 
Although the precise molecular mechanisms of siRNA-mediated gene silencing as well as 
other post-transcriptional gene silencing pathways are still matter of intensive research, 
soon after the first discoveries the enormous potential of specifically knocking down gene 
expression was recognized. Especially the large scale application of RNAi developed very 
rapidly and enabled scientists to examine biological events and underlying genetic traits in 
high-throughput experiments, ending up finally with genome-wide siRNA screens. 
Since the beginning of large-scale screening approaches respective scientific publications 
have been expanded in number and cover virtually every aspect of cellular biology. For 
example, a genome-wide screen for Drosophila cell morphology was performed by Kiger et 
al. (2003). The group constructed a library of long dsRNAs targeting about 1,000 different 
genes from various functional backgrounds to screen in a 384 well plate format. Using 
automated microscopy and differential staining they could identify several genes that 
altered the morphology of either round-shaped S2R+ cells or flat-shaped Kc167 cells or both 
cell types with respect to actin organisation, cell size, and other features (Kiger et al., 2003). 
A screen conducted by Kamath et al. (2003) aimed to functionally analyse the genome of 
Caenorhabditis elegans. Since it is possible to induce RNAi in C. elegans by feeding the 
worms with bacteria expressing long dsRNA molecules (Timmons et al., 1998), they 
constructed a respective library targeting about 87% of the predicted genome. Gene knock 
down mediated phenotypes such as sterility or larval lethality were assigned and the 
responsible genes were grouped to functionally cluster the assayed C. elegans genes 
(Kamath et al., 2003). 
To identify genes that are involved in cell division of the human cancer cell line HeLa, a plate-
reader based screen was performed (Kittler et al., 2007). The scientists used esiRNAs 
targeting about 18,000 genes and following knock down cellular DNA content was measured 
by propidium iodide staining using an Acumen plate reader device. EsiRNAs are 
enzymatically generated pools of siRNA-like molecules which mediate efficient gene knock 
down (Yang et al., 2002). Hundreds of genes were identified to influence HeLa cell division 
although these results have to be judged carefully since HeLa cells, as nearly all laboratory 
tissue culture cell lines, are already transformed. Thus, it is very likely that genes important 
for non-transformed cells were not identified within this work. 
Also in the field of infection biology large scale RNAi screens have been applied to examine 
pathogen-host cell interactions by studying the impact of host cell gene knock down on the 
infection process. One of the first of such screens was a genome-wide RNAi screen 
performed in Drosophila cells to elucidate host cell factors required for Listeria 
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monocytogenes intracellular replication (Agaisse et al., 2005). Using automated microscopy 
and distinct bacterial intracellular phenotypes as read-out, about 200 targets that influenced 
Listeria replication were identified. In a comparable screen, Philips et al. (2005) identified 
CD36 family members as being involved in mycobacterial infection of Drosophila cells. 
Several screens have been published dealing with viral entry and/or intracellular replication, 
e.g. for hepatitis C virus (Randall et al., 2007), West Nile virus (Krishnan et al., 2008) or 
Influenza virus (Hao et al., 2008). 
In 2007, a kinome siRNA screen for intracellular growth of Salmonella Typhimurium was 
published in which the serine/threonine kinase PKB/Akt1 was reported to be essential for 
bacterial replication (Kuijl et al., 2007). The screen was performed in MCF-7 cancer cells and 
analyzed using automated microscopy in 384 well format. The basic idea was to identify host 
cell targets that could be chemically inhibited to prevent intracellular bacterial replication 
and the group could show that H-89, a well-known protein kinase A (PKA) inhibitor, was able 
to decrease Salmonella replication. The group claimed that PKA is not the real target of H-89 
and in order to identify it they performed a kinase library screen. Although the published 
primary data did not necessarily point to Akt1 as being a fundamental host cell factor for 
Salmonella infection, it was chosen for further analysis. In subsequent experiments, the Akt1 
substrate AS160 was identified to be involved in Salmonella growth by repressing the activity 
of Rab 14 resulting in phagosomal fusion with lysosomes. When AS160 gets inactivated by 
Akt1 mediated phosphorylation this fusion is inhibited by the activity of Rab 14. 
Interestingly, during the screen peformed in this work neither Akt1 nor any other kinase or 
kinase-related protein reported by this group could be identified as affecting Salmonella 
intracellular growth. This will be discussed in detail in the discussion section. 
 
I.1.3.2 Therapeutic applications 
The possibility to specifically degrade RNA by the means of siRNA molecules encouraged 
scientists to develop therapeutic applications, especially anti-viral and anti-cancer 
approaches. By using synthetic siRNAs targeting the human immunodeficiency virus (HIV) 
envelope gene env, Park and colleagues (2003) could inhibit viral replication in tissue culture 
cell lines as well as in activated peripheral blood mononuclear cells (PBMC). Also, inhibition 
of hepatitis B virus using small hairpin (sh) RNA constructs that targeted different viral 
components was successful in cell culture and in immunocompetent and –compromised 
mice (McCaffrey et al., 2003). ShRNAs are retrovirally encoded RNAs that form a siRNA-like 
duplex by hairpin formation. These shRNAs are then recognized by the RNAi apparatus, 
thereby inducing target mRNA degradation. Since the retroviral construct is normally 
integrated into the host genome, a permanent inhibition of a specific gene expression can be 
achieved. 
Several other reports on viral inhibition using RNAi were published, indicating a potential 
therapeutic strategy (Zhou et al., 2008, Vigne et al., 2009). Nevertheless, the rapid viral 
mutation rate limits these approaches since strict sequence complementarities are a 
prerequisite for efficient siRNA mediated gene silencing. 
Another potential field of applied RNAi is the therapeutic treatment of cancer diseases. Since 
it is known that the overexpression of specific genes (oncogenes) favors the development of 
different forms of cancer, and indeed may serve as tumour markers, it was proposed to use 
RNAi as a gene therapeutic tool by inhibiting the expression of such oncogenes. It could, for 
example, be demonstrated that the stable gene silencing of the oncogenic allele K-RasV12 
leads to a loss of tumorigenic properties of a mammalian cell line (Brummelkamp et al., 
INTRODUCTION 15 
2002). It is thus tempting to hope for the development of cancer-type specific gene 
therapies based on RNAi. 
 
I.1.4 Summary 
Since the first experimental discoveries of the siRNA mediated gene silencing strong effort 
has been made in order to elucidate the molecular mechanism and to develop suitable 
applications to use RNAi as a cell biological tool. Although the advances in this field are 
strikingly and have been achieved in comparatively short time, major drawbacks still exist 
and might remain. These are for example: off-target effects, i.e. the down-regulation of 
other transcripts than the targeted one, cell toxicity due to transfection reagents, non-
specific cellular responses following transfection treatment, and hard-to-transfect cell lines 
such as immune cells. Nevertheless, the siRNA mediated gene silencing displays a precious 
tool to study gene function, possibly to combat diseases, and surely to examine host-
pathogen interactions from the host cell side. 
 
I.2 The biology of Salmonella 
I.2.1 Overview 
Salmonella are Gram negative, rod-shaped, facultative anaerob bacteria belonging to the 
genus Enterobacteriacea. They are mostly motile with peritricheous flagella and express 
different types of adhesins. Salmonella are very relevant pathogens of humans and livestock. 
Especially in under-developed countries with poor sanitary conditions infections with 
Salmonella display a significant health problem. The genus consists of only two species: 
Salmonella bongori and Salmonella enterica, the former one being a pathogen of cold-
blooded animals such as reptiles. The latter one can be further divided into a large number 
of different sub-species and serovars as defined by the antigenic composition of their 
somatic and flagella antigens (see table I.1) (Tindall et al., 2005). 
 
Table I.1 
Salmonella species Subspecies Important serovars 
Salmonella enterica S. enterica subsp. enterica  Typhi, Typhimurium 
 S. enterica subsp. salamae   
 S. enterica subsp. arizonae   
 S. enterica subsp. diarizonae   
 S. enterica subsp. houtenae   
 S. enterica subsp. indica  
   
Salmonella bongori none  
 
 
Nearly all reported cases of Salmonellosis in humans and livestock are caused by isolates 
from the S. enterica subsp. enterica subgroup. In humans, members of this subgroup are the 
causative agent of different diseases that range from mild, self-limiting gastro-intestinal 
disorders to severe systemic diseases with significant fatality. Although the systemic, life-
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threatening typhoid fever, caused by the S. enterica subsp. enterica serovars Typhi and 
Paratyphi, does not play a significant role in industrialized countries, gastro-intestinal 
Salmonellosis infections are among the most frequently reported infectious diseases in many 
developed countries. In Germany, non-typhoid Salmonellosis showed an incidence of 67 
cases per 100,000 inhabitants in 2007 and was therefore the second most prevalent 
bacterial infection (RKI: Epidemiologisches Bulletin 2008/16). Salmonella infections also 
constitute a major problem in animal husbandry, mainly by transmitting bacteria with 
contaminated food or water, while normally the animals are clinically silent. 
 
I.2.2 Salmonella Typhimurium 
Salmonella Typhimurium is the causative agent of mild to severe gastro-intestinal disorders 
and one of the major causes of food-poisoning. In contrats to humans, where Salmonella 
Typhimurium mainly remains extracellular in the gut’s lumen, in mice it is capable of 
breaching the intestinal barrier and eliciting a systemic disease where it primarily targets 
macrophages. Owing to the strict human specificity of Salmonella Typhi, the causative agent 
of typhoid fever, Salmonella Typhimurium serves as a model organism to elucidate general 
mechanisms of pathogen-host interactions. Utilized in infection models with tissue culture 
cell lines and in mouse experiments, Salmonella Typhimurium is a very important tool for 
studying the intracellular lifestyle of a pathogen. 
 
I.2.2.1 Attachment and invasion 
The initial attachment of Salmonella Typhimurium (Stm) to host cells is mediated by a 
number of different fimbrial adhesins, especially type I fimbriae which have been shown to 
be important for binding to epithelial cell lines (Boddicker et al., 2002, Althouse et al., 2003). 
In contrast to S. Typhi, where the cystic fibrosis transmembrane conductance regulator 
(CFTR) was identified to be responsible for binding (Pier et al., 1998), no specific host cell 
receptor has been determined for Stm yet. It was suggested that cellular membrane 
components sensitive to trypsin and neuraminidase are involved in bacterial invasion (Finlay 
et al., 1989), thus arguing for a receptor-like structure. In another report the cholesterol-
dependency of invasion was described, indicating that cholesterol-enriched membrane 
domains, such as lipid rafts, might be necessary for bacterial invasion, probably by serving as 
a docking station for the translocon component of the bacterial translocation system 
(Hayward et al., 2005). This would explain the rather unspecific ability of Stm to infect a wide 
range of different cell lines and host species. 
The expression of genes important for the invasion process is mainly regulated by the hyper-
invasive-locus A (hilA), a transcriptional regulator encoded on a cluster of virulence genes 
named Salmonella pathogenicity island 1 (SPI-1) (Lee et al., 1992, Bajaj et al., 1995). HilA 
expression itself is controlled by environmental signals such as oxygen levels, osmolarity, 
bacterial growth phase or pH (Bajaj et al., 1996). HilA activates the transcription of two 
important genes, invF and sicA, which then initiate the expression of several other invasion 
genes located inside and outside of SPI-1. Therefore, HilA constitutes a central regulator in 
bacterial invasion. As a response to environmental stimuli and controlled by HilA a 
specialized secretion apparatus encoded on SPI-1, the SPI-1 type-III secretion system (SPI-1 
T3SS), is formed (Kubori et al., 1998). This T3SS induces the uptake into non-phagocytic cells 
through the delivery of different effector proteins. It consists of more than 20 proteins and is 
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evolutionary related to the flagellar export system (see figure I.2). One set of proteins forms 
a supramolecular structure, referred to as the needle complex, consisting of two rings 
embedded into the inner and the outer membrane of the bacterium, a rod-like structure 
connecting the two rings and a filamentous needle connected to the outer ring (Marlovits et 
al., 2004). At the tip of the needle a translocon complex is formed by the proteins SipB, 
SipC and SipD which is integrated into the host cell membrane to facilitate the translocation 
of bacterial proteins (Collazo et al., 1997, Scherer et al., 2000). In the absence of any of these 
components, effector proteins are unable to cross the host cell membrane and, instead, are 
secreted into the medium. The secretion of effector proteins is mediated by a consensus 
sequence within the N-terminus of these proteins (Miao et al., 2000). Most of these 
effectors are stabilized by chaperones which direct them to the secretion apparatus 
(Bronstein et al., 2000, Tucker et al., 2000). InvC, an ATPase located at the base of the needle 
complex, then drives the chaperone release and transport of proteins through the T3SS 
(Eichelberg et al., 1994, Akeda et al., 2005). Ten different effector proteins have been 
identified so far to be delivered via the SPI-1 encoded T3SS. Several of them (SipA, SipC, 
SopB, SopE, SopE2, and SptP) are either directly or indirectly involved in the sophisticated 
manipulation of the host cell actin cytoskeleton to facilitate entry into the cell. SopE and the 
highly similar SopE2, for instance, are guanine nucleotide exchange factors (GEF) for Rac1, 
Cdc42, and RhoG, thus activating these proteins which are critical for actin physiology (Hardt 
et al., 1998, Stender et al., 2000, Patel et al., 2006). The precise function of SopB, a versatile 
protein with phosphatase activity on different phosphatidyl-inositol phosphate (PIP) species, 
is not yet understood in every detail but it contributes to Salmonella invasion by altering the 
PIP(4,5)2 levels at the plasma membrane (Terebiznik et al., 2002) and by indirectly activating 
RhoG through the stimulation of the exchange factor SGEF (Patel et al., 2006). The activation 
of the host’s small GTPases leads to the recruitment of the Arp2/3 complex via the WAVE 
and the WASP signaling pathways resulting in the induction of membrane ruffles (Criss et al., 
2003, Shi et al., 2005). Although the recruitment of the Arp2/3 complex seems to be 
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Figure I.2: Schematic illustration of the SPI-1 T3SS. 
For clarity reasons only the main components are depicted. See 
text for details. IM: inner bacterial membrane, OM: outer 
bacterial membrane. 
Adopted from Kimbrough and Miller, 2002 
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essential for Salmonella invasion, its role in actin assembly during invasion is contradictory 
(Unsworth et al., 2004). 
Two other SPI-1 T3SS translocated effector proteins contribute to the induction of actin 
rearrangements, namely SipA and SipC. SipA directly binds to actin, induces its 
polymerisation and subsequently stabilizes actin filaments (Zhou et al., 1999, Lilic et al., 
2003). SipC has been demonstrated to bundle actin in-vitro which was also confirmed in cell 
culture experiments with microinjected purified SipC (Hayward et al., 1999). However, since 
it possesses a central hydrophobic region it was speculated that SipC acts from host cell 
membranes rather than from the cytosol. Additionally, it was shown that SipC also interacts 
with host cell keratins, components of the intermediate filament structure (Carlson et al., 
2002). Thus, SipC probably connects membrane-located keratins with actin filaments to 
promote the stability of the induced membrane protrusions. In another report it was 
described that SipA can enhance the activity of SipC, which indicates a cooperative action 
between these two proteins (McGhie et al., 2001). The induced actin rearrangements 
leading to engulfment and uptake of adhesive Salmonella are counteracted by the effector 
protein SptP to ensure recovery of the cytoskeleton after invasion. SptP was shown to be 
able to reverse the GEF function of SopE on Rac1 and Cdc42 by preferentially binding to 
Rac1-GTP and Cdc42-GTP and exerting a GTPase activity, which downmodulates Rac1 and 
Cdc42 (Fu et al., 1999). In a subsequent study, the fine-tuning between SopE and SptP 
activities was shown to be dependent on the different half-life of these proteins. Although 
both proteins are translocated in equal amounts, SopE is rapidly degraded by the host cell 
proteasome whereas SptP remains inside the cytosol for longer times. This enables SptP to 
reverse the SopE induced actin rearrangements (Kubori et al., 2003). 
 
I.2.2.2 Phagosome formation and intracellular replication 
Once Salmonella entered the host cell it resides in a phagosome-like compartment called the 
Salmonella-containing vacuole (SCV), that was first described by Finlay and Falkow (1988), 
where the bacteria start to replicate after a lag period of about 3-4 hours (see figure I.3). The 
formation of the SCV and its subsequent development along the phagosome-maturation 
pathway has been the object of intensive studies, yet with partially conflicting data. This 
often attributed to the different pathogen-cell culture models used. It has been shown that 
the SCV transiently interacts with the early endocytic and the recycling pathway and rapidly 
acquires and loses respective markers such as early endosome antigen-1 (EEA1) and the 
transferrin receptor (TfR) (Steele-Mortimer et al., 1999) or Rab11 (Smith et al., 2005), 
respectively. Scott et al. (2002) could show that the recruitment of EEA1 is dependent on 
PI3P at the vacuole, and probably EEA1 is involved in the homotypic fusion of early SCVs to 
generate larger vacuoles (Mills et al., 1998). Shortly after invasion, early endosomal markers 
are replaced by those of late endosomes like Rab7 and lysosomes such as LAMP-1 and 
vATPase (Steele-Mortimer et al., 1999). The GTPase Rab7 replaces Rab5 to promote early to 
late endosome transition along the endocytic traffic of phagosomes (Rink et al., 2005) and 
initiates the fusion with lysosomal compartments by recruiting the effector protein RILP. 
RILP interacts with the dynein-dynactin motor complex to facilitate transport of endosomes 
towards the minus-end of microtubules to lysosomes (Cantalupo et al., 2001, Jordens et al., 
2001). It has been reported that the recruitment of Rab7 to SCV membranes is essential for a 
proper maturation of the SCV (Meresse et al., 1999) and, indeed, in this work further 
evidence is presented on the essential role of Rab7 on Salmonella intracellular growth. There 
is contradictory data whether or not the SCV fuses with lysosomes. Although some 
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lysosomal markers are acquired during the maturation of the SCV, such as LAMP-1 (Garcia-
del Portillo et al., 1995) and the vacuolar ATPase (Steele-Mortimer et al., 1999), others such 
as cathepsin D and mannose-6-phosphate-receptors could not be detected (Hashim et al., 
2000). Salmonella senses the intracellular milieu by different two-component systems with 
the PhoP/Q system being the best studied one. The SCV is poor in ions like Fe2+ and Mg2+ and 
slightly acidic as determined by respective reporter constructs and microarray studies 
(Garcia-del Portillo et al., 1992, Rathman et al., 1996, Martin-Orozco et al., 2006, Hautefort 
et al., 2008). The low magnesium concentration and probably also the low pH is sensed by 
the global regulator system PhoP/Q (Groisman, 2001, Garcia Vescovi et al., 1996, 
Chamnongpol et al., 2003) which then activates the transcription regulator PhoP. PhoP is 
responsible for the expression of a large number of virulence genes to promote intracellular 
survival and respective Salmonella mutants are strongly impaired in their virulence (Galan et 
al., 1989, Miller et al., 1989). Under the control of the PhoP/Q regulon and another 
transcriptional activator, OmpR, genes are expressed encoding a second T3SS located on SPI-
2 which translocates effector proteins across the vacuolar membrane into the host cell 
cytosol (Shea et al., 1996). The SPI-2 T3SS has been shown to be essential for virulence and 
the secreted effector proteins contribute to the intracellular survival of Salmonella by 
altering host cell processes. So far, about twenty different proteins have been described as 
being delivered by the SPI-2 T3SS, although the precise function and possible host cell 
targets are largely unknown (see figure I.4). Additionally, it is not clear whether all of these 
proteins play an essential role in survival since single gene knock out mutations do not 
impair growth in-vivo to the same extent as when deleting the entire SPI-2 T3SS, thus 
arguing for non-essential proteins and/or a functional redundancy among effector proteins. 
One of the best characterized SPI-2 effector is SifA, a protein that gets modified at the C-
terminus by host cell enzymes after translocation to facilitate SCV membrane anchorage 
(Reinicke et al., 2005, Boucrot et al., 2003). SifA has been identified as being responsible for 
Figure I.3: Maturation of the Salmonella-containing vacuole (SCV). 
Following entry into the host cell, the newly formed SCV interacts 
with the endocytic pathway and acquires certain specific endosomal  
markers whereas others, especially lysosomal proteins, are avoided 
from the vacuole. This suggests an inhibition of lysosomal fusion with 
the SCV, controlled by the bacterium. See text for further details. 
Taken and modified from Bakowski et al. (2008). 
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the generation of filamentous, LAMP-1 enriched membrane structures that protrude from 
the SCV along microtubules and were termed Salmonella induced filaments (Sif) (Garcia-del 
Portillo et al., 1993, Stein et al., 1996, Brumell et al., 2002). SifA mutants are impaired in 
replication inside macrophages due to the disruption of the vacuolar membrane and release 
of bacteria into the cytosol, indicating that SifA ensures the integrity of the SCV membrane 
(Beuzon et al., 2000, Brumell et al., 2001a). Using a yeast-two-hybrid approach Boucrot et al. 
(2005) could identify a human protein of unknown function as an interacting partner which 
was named SKIP (SifA and kinesin-interacting protein) due to the fact that SifA controls the 
activity of the plus-end microtubule motor kinesin via this protein. This process is supposed 
to prevent uncontrolled elongation of Sifs which is partly induced by the action of another 
SPI-2 effector, PipB2, which has been shown to redistribute endosomal vesicles to the cell 
periphery in overexpression experiments (Knodler et al., 2005b). Henry et al. (2006) 
identified PipB2 as a linker for kinesin to the SCV membrane, thus having a function 
oppositional to SifA. This was also speculated for the effector SseJ since the deletion of the 
respective gene was able to rescue the inhibitory effects on Sif formation in a ΔsifA 
background (Ruiz-Albert et al., 2002) and cells infected with a ssej mutant strain exhibit 
increased numbers of Sifs (Birmingham et al., 2005). SseJ is an effector protein sharing 
similarity to the family of GDSL lipases (Akoh et al., 2004) and deacylase and cholesterol 
acyltransferase activity has been described for this protein (Ohlson et al., 2005, Nawabi et 
al., 2008, Lossi et al., 2008). Therefore it was speculated that SseJ contributes to the lipid 
modification of the vacuolar membrane which might enable Sif curvatures or the generation 
of membrane microdomains involved in vesicle docking. So far the roles of the effector 
proteins SseF and SseG have not been clarified completely, since they have been allocated to 
endosome aggregation, microtubule bundling, recruitment of exocytic vesicles, and 
intracellular positioning of the SCV (Guy et al., 2000, Kuhle et al., 2004, Kuhle et al., 2006, 
Salcedo et al., 2003). Taken together it becomes clear that intracellular Salmonella heavily 
modify the SCV in order to promote survival and replication. Through a concerted action of 
several translocated effector proteins with so far only incompletely understood functions, 
Salmonella builds up membranous Sifs which may have different functions, for example 
recruitment and fusion of endocytic and/or exocytic vesicles for nutrient supply and 
Figure I.4: Modulation of the SCV and 
involved SPI2 effectors. 
The SPI2 encoded T3SS delivers several 
effector proteins across the SCV 
membrane into the host cell cytosol 
where they fulfil different functions to 
enable intracellular replication. 
(Haraga et al., 2008) 
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modification of the SCV membrane to form microdomains involved in docking of vesicles or 
as platforms to influence host cell signaling. Moreover, a stable vacuolar boundary is 
important for Salmonella to avoid the harmful cytosolic environment of the host cell, 
especially the one of phagocytes which efficiently kills pathogens. 
 
I.2.2.3 Impact on host cell signaling 
Infections with Salmonella Typhimurium elicit pronounced enteric inflammation reactions 
accompanied by diarrhoea. The molecular mechanisms underlying this are not fully 
understood yet, but they are doubtlessly multi-factor events with both pathogen and host 
properties contributing. Additionally, signaling events connected to inflammation observed 
in tissue culture cell models may not reflect the in-vivo situation which is examined in animal 
models of enteritis. 
The SPI-1 effector dependent stimulation of Rac1 and Cdc42 also activates mitogen activated 
protein kinases (MAPK) that leads to nuclear responses of the host cell, such as the 
activation of the transcription factors c-Jun (Hobbie et al., 1997, Chen et al., 1996a) and 
nuclear factor kappa B (NFκB) as determined by IL-8 secretion of epithelial cells (Eckmann et 
al., 1993, Hobert et al., 2002). Also other SPI-1 effector proteins have been identified to 
induce inflammatory reactions in different infection models (Jones et al., 1998, Chang et al., 
2007). In a polarized epithelial cell culture model SopB, SopE and SipA dependent disruption 
of tight junctions was reported (Boyle et al., 2006). Additionally, bacterial flagellin, the main 
component of flagella, recognized by host cell toll-like-receptor 5 (TLR5) can induce 
inflammatory responses (Tallant et al., 2004). In-vivo, secretion of IL-8 leads to the attraction 
of polymorphonuclear leukocytes (PMN) and inflammation whereas SopB and SopA 
mediated tight junction disruption causes ion effluxes and diarrhoea. 
Infections with Salmonella Typhimurium often result in profound gastro-intestinal disorders, 
at least partly due to the induction of inflammatory responses described. In order to turn 
back potentially harmful host responses and to avoid rapid clearance from the gut owing to 
massive diarrhoea, Salmonella Typhimurium has evolved strategies to downmodulate pro-
inflammatory signaling cascades. A major aspect is the inhibition of NFκB dependent gene 
expression. SspH1 is an effector protein which has been described to interact with the host 
cell kinase PKN1 (Haraga et al., 2003, Haraga et al., 2006), a kinase involved in the NFκB and 
JNK (c-Jun N-terminal kinase) signaling pathway (Kato et al., 2008) and this is proposed to 
inhibit NFκB activity, although the authors failed to conclusively proof this. NFκB inhibition 
was also shown for the secreted effector SseL (Le Negrate et al., 2008). Additionally, SpvC, a 
factor encoded on a virulence plasmid present in some Salmonella serovars (Jones et al., 
1982), has been reported to inhibit the MAPKs ERK (extracellular signal-regulated kinase) 
and JNK. This is achieved via its phosphothreonine lyase activity, an enzymatic property 
similar to that seen for the Shigella effector protein OspF (Mazurkiewicz et al., 2008, Li et al., 
2007). JNK is also targeted to downmodulate host immune responses by another effector, 
AvrA, translocated via the SPI-1 T3SS (Jones et al., 2008). In contrast to the Yersinia effector 
YopJ which was reported to inhibit different MAPKs (Orth et al., 1999), AvrA seems to 
specifically block JNK signaling. 
Thus, taking into account the numerous effector proteins that were described as being able 
to downregulate pro-inflammatory pathways it emerges that Salmonella Typhimurium 
aspires to control the innate immune response of the host in order to prevent excessive 
tissue inflammation. This might help the bacteria to colonize the gut epithelium for 
prolonged times. 
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I.2.2.4 Salmonella and cell death 
Apoptosis, one form of programmed cell death, is a complex, tightly regulated process of 
self-elimination which is essential for normal development, tissue homeostasis and also for 
repelling infections. It was first described by Kerr et al. (1972) and since then ever increasing 
knowledge of different apoptosis pathways and their regulation has been accumulated. 
Apoptosis, as a controlled, non-inflammatory cell death, can be distinguished from necrosis, 
which leads to the burst of cells and the release of highly inflammatory cytosolic contents 
into the tissue, although this strict classification has been weakened and several mixed-
classes of cell death have been defined (Kroemer et al., 2009). In order to combat 
intracellular infections, apoptosis constitutes a major strategy to prevent spread of infection. 
Therefore, the inhibition of host cell apoptosis is crucial for several intracellular pathogens in 
order to endure the replication niche. On the other hand, induction of apoptosis at the right 
time of the infection cycle might promote the systemic dissemination and thereby exhibits 
an attractive route for many pathogens. 
The interactions of intracellular Salmonella with the host cell’s death machinery had long 
been poorly understood. However, recent studies more and more reveal the complex 
signaling underlying this process. Initially, Salmonella induced apoptotic cell death was 
described for the macrophage-like cell lines J774A.1 (Chen et al., 1996b) and RAW264.7 
(Monack et al., 1996). In the study with J774 cells, the majority of infected macrophages 
showed the characteristic apoptotic morphology very early during infection. It could be 
demonstrated that this process was dependent on active invasion since stationary phase 
bacterial cultures displayed only minor cytotoxic activity. Later, it could be shown that the 
rapid macrophage killing is dependent on the bacterial protein SipB which is a component of 
the SPI1-T3SS and that SipB binds to Caspase-1 which causes release of pro-inflammatory IL-
1β and IL-18 (Hersh et al., 1999, Monack et al., 2001). Due to the fact that this form of cell 
death displays characteristics of both apoptosis and necrosis, it has recently been termed 
pyroptosis (Fink et al., 2007). Most recently, the inflammasome protein Ipaf was identified to 
play an important role in Salmonella-induced pyroptosis (Fink et al., 2008). Although the 
impact of SipB on host cell death has been emphasized by several other reports, the precise 
cellular mechanism is still under discussion since it was also described to induce 
mitochondria-dependent autophagy (Hernandez et al., 2003). Moreover, SipB independent 
killing during the course of infection has been described (Santos et al., 2001). Additionally, 
the route of entry into macrophages seems to be important for the cytotoxic effects 
(Forsberg et al., 2003), which might resemble different stages of the in-vivo infection, 
namely the disseminating infection with actively invading bacteria, accompanied by clinical 
symptoms, and the silent, persistent stage of mainly phagocytosed bacteria. 
Remarkably little is known about apoptosis pathways in Salmonella infected epithelial cells. 
Lundberg et al. (1999) reported that different epithelial cell lines infected with Salmonella 
Typhimurium did not undergo cell death at an early time point as compared to 
macrophages. Since most epithelial cell lines are derived from carcinoma tissues they often 
do not go into apoptosis easily, thus, this result has to be assessed carefully. Apoptosis of the 
colon cancer cell line HT-29 was shown after longer infection with Salmonella (Kim et al., 
1998), although a significant proportion of the cells also showed features of necrosis. 
Recently, the Salmonella effector SopB, translocated via the SPI1-T3SS, was shown to protect 
epithelial cells from apoptosis by activating the pro-survival kinase PKB/Akt1 (Knodler et al., 
2005a). Owing to the few reports a concluding determination whether Salmonella induces or 
inhibits epithelial apoptosis can not be made. Most likely this depends on the stage of 
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infection, the tissue type or host responses and Salmonella is potentially capable of 
controlling both directions. 
 
I.2.3 Summary 
Salmonella Typhimurium is a Gram negative, facultative intracellular pathogen which has the 
capacity to infect a wide range of host species and has become an object of intensive 
scientific studies with regard to pathogen-host cell interactions. It induces its uptake into 
non-phagocytic cells by the delivery of effector proteins via a sophisticated T3SS. After 
uptake, the bacteria reside in a phagosome-like compartment which undergoes maturation 
resembling the endocytic pathway to a certain extent. Throughout the whole infection cycle 
the bacteria remain inside the vacuolar compartment, termed the Salmonella-containing 
vacuole, which is actively remodelled by the pathogen and where replication is taking place. 
A second T3SS is expressed intracellularly and a plethora of effector proteins is delivered 
across the vacuolar membrane into the host cell’s cytosol. Although the precise function of 
the majority of these effector proteins is unknown it is tempting to speculate that they serve 
to interact with host cell factors in order to control their functions during the establishment 
of the intracellular replication niche. Thus, Salmonella is interacting at several stages of the 
infection with its host cell in order to facilitate entry, to replicate inside a modified 
phagosome, and to manipulate host cell signaling pathways to prevent degradation. The 
whole spectrum of these interactions is still far away from being deciphered. 
 
I.3 Goals of this study 
Intracellular pathogens are in close contact to their host cells and rely on their cellular 
machinery to assure a successful infection. During the evolution of host-pathogen 
interactions, a complex network has developed with both the host and the pathogen 
contributing. The identification of host cell functions which are essential for these 
interactions is crucial for the understanding of the mechanisms underlying pathogenicity and 
moreover serves to gain deeper insights into important host cell pathways.  
The aim of this work was to elucidate host cell factors that affect the intracellular growth of 
the Gram negative pathogenic bacterium Salmonella Typhimurium. For this purpose, a large 
scale high-throughput RNAi screen should be established and performed using a commercial 
human kinome-wide siRNA library. Kinases display central regulators of a plethora of cellular 
processes and are therefore likely targeted by intracellular pathogens to subvert host cell 
functions. In order to screen a large set of siRNAs a high-throughput system had to be 
established to automate critical steps such as the transfection of the cells or the plate 
measurement. Therefore, a flow cytometry based screening assay should be developed 
using a bacterial reporter strain to monitor Salmonella intracellular replication and 
metabolic activity upon host cell gene knock down. The set-up of a semi-automatic screening 
assay was intended to be achieved with the help of the flow cytometry device FACS Calibur. 
The primary data from the screening experiments should be validated with additional siRNA 
sequences to omit false positive candidate genes from further analysis. The final goal was to 
functionally characterize host cell genes for their role in Salmonella Typhimurium infection. 
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II Materials and methods 
II.1 Chemicals 
All chemicals were purchased from Roth (Karlsruhe), Sigma-Aldrich (Steinheim) or Merck (Darmstadt) if not 
stated otherwise. 
 
II.2 Buffers, solutions, and media 
10x PCN buffer 
 
0.8 M  MOPS-KOH (pH 7.4) 
0.04 M  tricine 
0.5 M  NaCl 
2.76 mM  K2SO4 
 
PCN medium 
 
1 x  PCN buffer 
0.01 mM  FeSO4 
15 mM  NH4Cl 
0.5 µM  CaCl2 
0.4 % or 0.2 %  glucose or arabinose [w/v] 
10 mM  MgSO4 
1.25 mM  potassium phosphate buffer pH7.4 
0.01 %  casein [w/v] 
 
10x TBS 
 
200 mM  Tris base 
1.4 M  NaCl 
 
adjusted to pH 7.4 
 
1x TBS-T 
 
0.1 % [v/v] Tween 20 in 1x TBS 
 
10x SDS running buffer 
 
247 mM  Tris base 
1.9 M  glycin 
35 mM  sodiumdodecyl sulphate (SDS) 
 
TBE 
 
890 mM  Tris base 
890 mM  boric acid 
20 mM  EDTA-NA2 
 
adjusted to pH 7.4 
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Transfer buffer 
 
25 mM  Tris-HCl pH 8.5 
190 mM  glycine 
10%  methanol [v/v] 
0.1%  SDS [w/v] 
 
RIPA buffer 
 
20 mM  Tris-HCl, pH 7.5 
150 mM  NaCl 
0.5%  NP-40 [v/v] 
0.5%  Triton X-100 [v/v] 
 
Stripping buffer 
 
68 mM  Tris-HCl, pH 7.5 
2%  SDS [w/v] 
0.8%  β-mercaptoethanol [v/v] 
 
LB medium 
 
10 g  Bacto tryptone (BD, Franklin Lakes, NJ, USA) 
5 g  Bacto yeast extract (BD, Franklin Lakes, NJ, USA) 
5 g  NaCl 
 
ad 1 L with ddH2O 
adjusted to pH 7.4 
 
for plates 1.5% (w/v) agar was added 
 
LB high salt medium 
 
LB medium with 17.5 g/L NaCl (i.e. 0.3 M) 
 
4% paraformaldehyde (PFA) 
 
for 1 L 
 
solve 40 g PFA in 600 mL ddH2O and heat at 60-70°C 
add conc. NaOH dropwise until solution becomes clear 
add 100 mL 10x PBS and add ddH2O ad 1L 
adjust pH 7.4 with HCl and sterilize the solution by filtering through 0.22 µm filters 
store aliquots at -20°C  
 
10x PBS 
 
1.36 M  NaCl 
27 mM  KCl 
14 mM  KH2PO4 
81 mM  Na2HPO4 x 2 H2O 
 
adjusted to pH 7.4 
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antibiotics 
 
antibiotic supplier stock concentration working concentration 
ampicillin Sigma 100 mg/mL 100 µg/mL 
kanamycin Fluka 50 mg/mL 50 µg/mL 
gentamicin Sigma 10 mg/mL 100 or 20 µg/mL 
 
10x PCR buffer 
 
100 mM  Tris 
500 mM  KCl 
adjusted to pH 8.3 
 
5x DNA loading dye 
 
50 %  glycerol (85%) [v/v] 
0.5 x  TBE 
0.2%  SDS [w/v] 
dash  bromophenol blue 
 
store at 4°C 
 
2x Lämmli buffer 
 
100 mM  Tris-HCl, pH 6.8 
4%  SDS [w/v] 
20%  glycerol [v/v] 
1.5%  β-mercaptoethanol [v/v] 
dash  bromophenol blue 
in ddH2O 
 
 
II.3 Technical equipment 
For this work, facilities equipped with state-of-the-art laboratory devices were used. 
 
 
II.4 Plasmids 
The following plasmids were used in this study. They were maintained in E. coli DH5α -80°C glycerol stocks or as 
midi prep samples at -20°C. 
 
Table II.1: Plasmids used in this study 
plasmid description source strain collection Nº 
pACYC177 cloning vector / AmpR / KanR Chang and Cohen, 
1978 / in-house 
H2678 
pBAD18 arabinose inducible expression vector / AmpR Guzman et al., 1995 / 
in-house 
H3125 
pFPV25.1 constitutive expression of GFPmut3 / AmpR Valdivia and Falkow, 
1996 / kindly 
provided by M. 
H3892 
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Hensel, Erlangen 
pFPVmCherry constitutive expression of mCherry / AmpR kindly provided by O. 
Steele-Mortimer 
H3893 
pRSET-B 
mCherry 
T7 promoter driven expression of mCherry / 
template for mCherry PCR / AmpR 
Shaner et al. 2004, 
kindly provided by 
Tsien Labs, USA 
H3894 
pOR25 constitutive expression of GFPmut3 / KanR this study H3895 
pOR26 arabinose inducible expression of mCherry / 
AmpR 
this study H3812 
    
    
 
II.5 Oligonucleotides, small inhibitory RNAs (siRNAs), and antibodies 
All oligonucleotides (“primers”) used in this study were synthesized by Invitrogen (Karlsruhe). 
 
Table II.2: Oligonucleotides used in this study 
oligonucleotide sequence (5’→ 3’) function 
FP_new-F GCTCTAGATTTAAGAAGGAG 
ATATACATATGGTGAGCAAG 
GGCGAGGAG 
5’ PCR primer for mCherry amplification (5’ 
XbaI restriction site) 
FP_new-R CTCTCAAGCTTATTACTTGTA 
CAGCTCGTCCA 
3’ PCR primer for mCherry amplification (3’ 
HindIII restriction site) 
pACYC BamHI 5’ GGAAGGTGATGTCATTCTGG 5’ sequencing primer for pOR25 quality check 
pACYC BamHI 3’ GGCAATACTGAGCTGATGAG 3’ sequencing primer for pOR25 quality check 
pBAD18 5’ MCS AGATTAGCGGATCCTACCTG 5’ sequencing primer for pOR26 quality check 
pBAD18 3’ MCS CACTTCTGAGTTCGGCATGG 3’ sequencing primer for pOR26 quality check 
 
 
All siRNA oligonucleotides were synthesized by Qiagen (Hilden), except the Rab7A sequences which were 
synthesized by Dharmacon (Lafayette, CO, USA). After testing the Rab7A sequences, the Rab7A_2 siRNA was 
synthesized by Qiagen according to the sequence information provided by Dharmacon. 
 
Table II.3: Small inhibitory RNA (siRNA) oligonucleotides used in this study  
siRNA target gene siRNA target sequence remarks 
Allstars none not available (property of Qiagen) neutral control 
PLK1 polo-like kinase 1 (Drosophila) CCGGATCAAGAAGAATGAATA toxic control 
Rab7A_1 RAB7A, member RAS oncogene family AACTAGATAGCTGGAGAGATG inhibitory control 
Rab7A_2 RAB7A, member RAS oncogene family AAGTACAAAGCCACAATAGGA inhibitory control 
Rab7A_3 RAB7A, member RAS oncogene family AAAAACGGAGGTGGAGCTGTA inhibitory control 
Rab7A_4 RAB7A, member RAS oncogene family AACGAATTTCCTGAACCTATC inhibitory control 
MKK7_10 mitogen-activated protein kinase kinase 7 CCCTTAGACGCTTGAGAATAA  
MKK7_13 mitogen-activated protein kinase kinase 7 CTGCGCTGAGAAGCTCAAGAA  
PLA2_1 phospholipase A2, group IVA AACAAGGAGTTTCTAAGTAAA  
PLA2_2 phospholipase A2, group IVA TCCCATGACAACTGGATTTAA  
 
 
Primary antibodies for immunoblotting were diluted in TBS-T buffer containing 3% [w/v] bovine serum 
albumine (BSA), fraction V, and stored at -20°C for multiple uses. Primary antibodies for immunofluorescence 
were diluted antibody-specific in 0.1 % [w/v] BSA/PBS for single use. Secondary antibodies for immunoblotting 
were diluted 1:2000 (anti-rabbit) or 1:3000 (anti-mouse) in 1x TBS-T, 5% [w/v] dry milk powder. Secondary 
antibodies for immunofluorescence were diluted 1:150 in 0.1 % [w/v] BSA/PBS. 
 
Table II.4: Antibodies used in this study 
antibody supplier and cat. Nº species application 
β-actin Sigma, A5441 monoclonal mouse immunoblotting 
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Rab7A Sigma, R8779 monoclonal mouse immunoblotting 
MKK7 Cell Signaling, 4172 polyclonal rabbit immunoblotting 
cPLA2 Cell Signaling, 2832 polyclonal rabbit immunoblotting 
P-cPLA2 (Ser505) Cell Signaling, 2831 polyclonal rabbit immunoblotting 
LAMP-1 BD Biosciences, 555798 monoclonal mouse immunofluorescence 
bacterial Hsp60 Alexis, ALX-804-071 monoclonal mouse immunoblotting 
anti-mouse GE Healthcare, NXA931 sheep secondary Ab immunoblotting 
anti-rabbit GE Healthcare, NA934 donkey secondary Ab immunoblotting 
 
II.6 Cell biological methods 
II.6.1 Cell lines and cultivation 
 
Cell lines used in this study are described in table II.5. The cells were routinely maintained in RPMI 1640 
(Gibco/Invitrogen, Karlsruhe), supplemented with 10% heat-inactivated fetal calf serum,  L-glutamine and  25 
mM HEPES buffer (i.e. RPMI full medium) at 37°C with 5% CO2 in a humidified temperature-stable cell culture 
incubator. For longer maintenance, medium was replaced every two to three days and the cells were passaged 
if appropriate using trypsin detachment. 
 
Table II.5: Mammalian tissue culture cell lines used in this study 
cell line origin source or reference 
HeLa cervical DSMZ Nº ACC57, obtained from ATCC CCL-2 
HT-29 colonic DSMZ Nº ACC299 
HEp-2 HeLa contaminant ATCC CCL-23 
Hec1b endometric HTB-113 
HepG2 hepatic DSMZ Nº ACC180 
 
II.6.2 Bacterial strains 
The Salmonella enterica subsp. enterica serovar Typhimurium (Salmonella Typhimurium) wildtype strain 12023 
was utilized for infection experiments. Expression of different fluorescent proteins was facilitated by plasmid 
transformation (see table II.1). Cloning experiments were performed with the Escherichia coli laboratory strain 
DH5α. 
 
Table II.6: Bacterial strains used in this study 
strain genotype source or reference strain collection Nº 
S. Typhimurium 12023 wildtype NCTC 12023 (ATCC 14028) X102 
E. coli DH5α F
-
, φ80dlacZΔM15, Δ(lacZYA-
argF)U169, deoR, recA1, endA1, 
hsdR17(rk
-
, mk
+
), phoA, supE44, 
λ
-
, thi-1, gyrA96, relA1 
in-house E248 
  
II.6.3 Preparation of bacterial glycerol stocks 
For long-term storage of bacteria, glycerol stocks were prepared by mixing 600 µL of an overnight LB culture of 
the strain with 300 µL of sterile glycerol in cryotubes. The stocks were stored at – 80°C. 
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II.6.4 Preparation and transformation of electro-competent bacteria 
In order to transform bacteria with DNA, electro-competent bacteria were prepared freshly before use. An 
overnight LB culture was diluted 1:100 in fresh, pre-warmed medium and grown until OD600 of 0.5. The 
bacterial culture was cooled down on ice for 30 min and all subsequent steps were performed at 4°C. The 
bacteria were pelleted and washed three times in a small volume of pre-chilled ddH2O to achieve a thick, dense 
solution of bacteria. 50 µL of electro-competent cells were mixed with the DNA and transferred to a pre-chilled 
Eppendorf tube. The mixture was incubated on ice for 30 min and then transferred to a pre-chilled 
electroporation cuvette (peqlab, Erlangen). Electroporation was performed under conditions indicated below 
(see table II.7) in a Gene Pulser electroporator (BioRad, Hercules, CA, USA). 1 mL of warm (37°C) LB medium 
was added to the cuvette, the mixture was transferred to an Eppendorf tube and incubated at 37 °C, 200 rpm 
for 60 min to allow recovery of the bacteria and expression of resistance genes. Bacteria were plated at 
different concentrations on selective agar plates to screen for positive clones. 
 
Table II.7: Electroporation conditions 
species voltage [kV] resistance [Ohm] capacity (µF] 
Salmonella Typhimurium 12023 2.5 600 25 
Escherichia coli DH5α 1.6 200 25 
 
II.6.5 Bacterial infection of mammalian cell lines 
The infection of mammalian cells with Salmonella Typhimurium was performed based on the infection protocol 
described by Steele-Mortimer et al. (1999) with minor changes. 
Two days before infection a bacterial culture was streaked from the frozen stock on a selective LB agar plate. 
The next day, an overnight bacterial culture was prepared by inoculating 5 mL of selective LB high-salt medium 
with one colony from the agar plate. The overnight culture was incubated at 37°C and 200 rpm for 16-20 hours 
and then diluted 1:33 in fresh, pre-warmed (37°C) selective LB hig-salt medium for a further incubation of 3,5 h. 
A part of the culture was transferred to 1.5 mL Eppendorf tubes and pelleted in an Eppendorf table top 
centrifuge at 20,000 x g for 1 min. The pellet was washed once with PBS (RT) and resuspended in RPMI full 
medium (37°C). In order to infect the cells with the aspired MOI, the bacterial culture was diluted according to 
the following assumption: 
 
OD600 of 1 ≈ 1.5 x 10
9
 cfu/mL 
 
Additionally, the volume of infection solution of the respective plate format was taken into account (see table 
II.8). To infect cells with the bacterial infection solution, the cell culture medium was aspirated and a plate 
format specific volume of infection solution was added to the wells. Plates were centrifuged in a Heraeus 
multifuge 3 S-R (DJB Labcare, Newport Pagnell, UK) at 700 rpm and RT for 5 min to ensure a synchronized 
infection and incubated at 37 °C with 5% CO2 in a humidified cell culture incubator to allow invasion. The cells 
were washed twice with PBS (RT) 60 min p.i. and remaining extracellular bacteria were killed by addition of 
killing medium (RPMI full medium with 100 µg/mL gentamicin) for 60 min. For the remaining infection period, 
the antibiotic concentration was lowered to 20 µg/mL. 
For arabinose-induced expression of mCherry, cells were washed twice with PBS (RT) and induction-medium 
was added to the samples (RPMI full medium + 20 µg/mL gentamicin + 0.2% [w/v] L-arabinose) for the desired 
period of time. 
 
Table II.8: Cell plate formats and volume of infection solution 
cell plate format (well) volume of infection solution [µL] type of pipette used 
96 50 automatic 8 channel 
24 500 manual 
12 1000 manual 
6 1000 manual 
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II.6.6 Gentamicin protection assay 
For the enumeration of intracellular bacterial replication, the gentamicin protection assay (gentamicin assay) 
was performed. Cells were infected as described and extracellular bacteria were killed with gentamicin. At the 
desired time-points, cells were washed twice with PBS (RT) and then lysed by adding 0.5% [v/v] triton X-100 in 
PBS to the wells. The lysates were transferred to 1.5 mL Eppendorf tubes. Serial dilutions of the lysates were 
prepared by diluting 1:10 in PBS and 100 µL of the appropriate dilution were plated on agar plates (with 
antibiotics, if needed). The plates were incubated at 37°C until bacterial colonies were visible and the colonies 
were counted to calculate intracellular bacteria. The replication rate was determined by forming the ratio of 
two different time points. 
 
II.6.7 Measurement of cPLA2 enzymatic activity 
In order to detect the enzymatic activity of cPLA2 in HeLa cells a specific substrate (PED6, Molecular Probes) 
was used which is taken up by the cells and is cleaved predominantly by activated cPLA2. Thereby turns into a 
fluorescent compound that can be monitored with the FACS Calibur.  HeLa cells were either infected as 
described or left uninfected. At the respective time-point cells were washed and PED6 (5 µM) was added in 
complete medium to the cells for 60 min. Cells were washed thoroughly with PBS, trypsinized and resuspended 
in PBS for FACS analysis. Excitation = 488 nm; Emission = 530 nm (FL-1). 
 
II.6.8 Transfection of mammalian cells with small inhibitory RNA (siRNA) 
The RNA interference technique was applied to specifically inhibit the translation of eukaryotic genes. Different 
experimental procedures were used for 12 well format transfections for single knock-down experiments or for 
96 well format large scale RNAi experiments (screening). 
 
II.6.8.1 Transfection in 12 well format 
Cells were trypsinized, counted in a Neubauer chamber and seeded at a density of 1 x 10
5
 cells/well the day 
before transfection. For each siRNA to transfect a mixture was prepared and the supernatant was aspirated 
from the wells. 600 µL of fresh, pre-warmed (37°C) RPMI full medium was added before the dropwise 
apposition of the transfection mixture. The cells were incubated at 37°C with 5% CO2 in a humidified cell 
culture incubator and split the next day as necessary. Three days post transfection the cells were employed for 
the respective experiments. 
 
siRNA transfection mixture 
 96 µL serum-free RPMI 
+ 4 µL siRNA (20 µM stock) 
 mix 
+ 6 µL Hiperfect 
 incubate at RT for 15-20 min, apply on cells 
 
II.6.8.2 Transfection in 96 well format 
96 well format transfections for large scale experiments were either performed automatically with the help of a 
pipetting robot or manually for smaller amounts of plates. Optimized transfection protocols using Hiperfect as 
transfection reagent were employed. 
 
II.6.8.2.1 Automatic transfection 
One day before transfection cells were seeded with a density of 2.5 x 10
3
 cells/well using the automatic 8-
channel pipette (Biohit, Rosbach v. d. Höhe). A Qiagen pipetting robot (Biorobot 8000) was used for automatic 
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transfection of 96 well plates under semi-sterile working conditions. The respective program that controlled 
the pipetting steps of the robot was written and functionally tested by the RNAi group of Nikolaus Machuy and 
further adjusted to fulfil the specific needs. With the program “Doppelter 2.1.1 für Salmonellen”, the 
transfection of two cell plates with two different transfection plates per run was achieved. Prior to every run, 
the transfection reagent was prepared freshly (Hiperfect 1:20 in RPMI medium without FCS), pipette tips as 
well as the cell culture media were refilled and fresh aliquots of control siRNAs (Allstars, PLK and Rab7A; 1:100 
in RPMI without FCS) were used. Cells were incubated at 37°C with 5% CO2 in a humidified cell culture 
incubator. 24 h post transfection the medium was replaced by fresh, pre-warmed (37°C) RPMI full medium and 
the cells were incubated for two more days to allow gene knock down. 
 
II.6.8.2.2 Manual transfection 
Cells were seeded as described above and the transfection complexes were mixed in sterile deep-well plates 
(Cole-Parmer, Vernon Hills, IL, USA) according to the table below using a manual 12 channel pipette, an 
automatic 12 channel pipette and an automatic 8 channel pipette (Biohit, Rosbach v. d. Höhe). 
 
Table II.9: Manual transfection protocol 
component volume per well [µL] 
RPMI Ø FCS 30 
Hiperfect (1:40 in RPMI Ø FCS) 30 
siRNA (1:100 in RPMI Ø FCS) 15 
mix  
incubate at RT for 10 min  
RPMI full medium 150 
aspirate 90 µL medium from the cells  
add 20 µL RPMI full medium to the cells  
add 75 µL of transfection complex/well  
 
Following transfection, cells were incubated and treated as described above (see II.6.7.2.1).  
 
II.6.9 Construction of stable shRNA transduced cell lines 
The gene silencing mediated by siRNA molecules is a transient one. In order to achieve a permanent gene 
knock down, lentiviral encoded small hairpin (sh) RNA expression vectors were constructed and these were 
integrated into the target cell’s genome. This ensures a constitutive expression of shRNA molecules and 
thereby a permanent gene knock down. By using a GFP reporter gene on the lentiviral plasmid, the transfection 
efficiency could be determined. Respective shRNA sequences (designed with the help of the RNAi designer 
from Invitrogen, Karlsruhe: https://rnaidesigner.invitrogen.com/rnaiexpress) were cloned into the vector 
pLVTHM and virus particles were produced by transfecting 293T cells with 20 µg of vector in combination with 
the packaging vectors psPAX2 (15 µg) and pMD2G (6 µg) using calcium phosphate transfection (DNA in 0.5 M 
CaCl2 added 1:1 to 2xHBS; DNA-calciumphosphate precipitates are then added to the cells). 48 h post 
transfection, the filtered virus particles in the supernatant were transferred to HeLa cells with the help of 
polybrene (final concentration 1 mg/mL). The next day, the medium was replaced by fresh medium and five 
days later the knock down efficiency was tested by immunoblotting. 
 
Table II.10: Sequences of shRNA constructs used in this study 
shRNA target gene sequence strain collection Nº of  
HeLa cell line 
remarks 
Luciferase firefly luciferase AACTTACGCTGAGTACTTCGA 
 
HeLa05 Luci neutral control 
MKK7.1 mitogen-activated 
protein kinase 
kinase 7 
GCATTGAGATTGACCAGAAGC HeLa05 OR01  
PLA2.1 phospholipase A2, 
group IVA 
GGAGATTACGTTAATGGATGC HeLa05 OR02  
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II.7 Molecular biological methods 
II.7.1 Preparation of plasmid DNA 
Plasmid DNA was used for transformation of bacteria or as template for cloning experiments. For isolation of 
plasmid DNA from bacteria a mini or midi prep kit from Qiagen (Hilden) was used according to the 
manufacturer’s instructions. The DNA concentration was measured spectrometrically using a Nanodrop ND-
1000 device (peqlab, Erlangen). 
 
II.7.2 Polymerase chain reaction (PCR) 
PCR was utilized for 1) the amplification of specific DNA fragments with explicit 5´and 3´restriction sites for 
cloning and 2) for amplification of DNA fragments for analytical purposes (e.g. colony PCR). 
In table II.10 the composition of the reaction mixture as well as the standard protocol for PCR is depicted. For 
larger PCR approaches a master mix was prepared and distributed to the PCR reaction tubes (ABgene, 
Hamburg). 100-500 ng of purified DNA was used routinely, for colony PCR, some bacterial material was 
resuspended in 100 µL ASC-H2O and 1 µL of this mixture was employed for PCR. All reactions were performed 
in a GeneAmp thermocycler (Applied Biosystems, Carlsbad, CA, USA). Pfx50 DNA polymerase (Invitrogen, 
Karlsruhe) and “in-house” Taq DNA polymerase were applied for cloning PCR applications and simple analytical 
purposes, respectively. The PCR products were further analyzed by gel electrophoresis (see II.7.3). 
 
Table II.11: PCR reaction mixture and PCR protocol 
standard reaction mixture (30 µL)  standard PCR protocol 
component volume [µL]  condition time 
10 x reaction buffer 3 1. 95°C 5 min 
dNTP’s (10 mM each) 0.6 2. 95°C 30 sec 
5’ primer 0.6 3. 55°C 30-60 sec 
3’ primer 0.6 4. 68°C or 72°C dependent on fragment size 
DNA template different 5. repeat steps 2-4 
20-30 times 
 
100 mM MgCl2 (if not part 
of reaction buffer) 
0.9 6. 68°C or 72°C 5 min 
enzyme 1   
H2O ad 30 µL   
 
II.7.3 Quantitative Real Time-PCR (RT-PCR) 
RT-PCR was used to quantify the amount of specific mRNA populations, e.g. after siRNA or shRNA mediated 
knock down experiments. For this, total RNA was isolated using the RNeasy RNA purification kit (Qiagen, 
Hilden). The reverse transcription of mRNA and the subsequent RT-PCR were performed in a ABI Prism 7900 HT 
system (Applied Biosystems, Carlsbad, CA, USA) using the QuantiTect SYBR Green Kit (Qiagen, Hilden). 
 
II.7.4 Gel electrophoresis 
For the preparative analysis of DNA fragments or the excision of specific DNA fragments after restriction 
reactions, gel electrophoresis was performed. Here, DNA fragments are separated inside an agarose gel 
according to their migration speed along an electrical field. 
Separation and detection of DNA fragments was performed in gels with 0.4-1.2 % [w/v] of agarose in 0.5x TBE 
and 1 µg/mL ethidiumbromide. The samples were mixed with DNA loading buffer, loaded into the pockets of 
the gel and separated using 80-140 V for the aspired time. To visualize the DNA, the gel was inspected with a 
Gene Genius device (Syngene, Cambridge, UK) detecting the fluorescence of the DNA-intercalating dye 
ethidiumbromide. Fragment sizes were calculated by employing DNA standards (DNA ladder 1kb or 500 bp, 
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Fermentas, St. Leon-Rot). For excision of fragments from a gel a sharp, clean scalpel was used and the DNA was 
eluted from the agarose using a gel extraction kit (Qiagen, Hilden). 
 
II.7.5 Endonuclease reaction 
In order to open plasmid DNA, to cut out DNA fragments from plasmids or to prepare PCR products for ligation 
reactions different restriction enzymes (all from NEB, Ipswich, MA, USA) were used. DNA was purified before 
restriction enzyme reactions using a PCR purification kit (Qiagen, Hilden) and multiple restriction reactions 
were performed sequentially with purification steps. If appropriate, BSA (NEB, Ipswich, MA, USA) was added to 
the digestion reaction. All experiments were performed in PCR tubes for two hours in a 37 °C incubator and the 
reaction products were purified again or separated with gel electrophoresis. 
 
II.7.6 Filling of DNA overhangs 
To fill up DNA overhangs produced by enzymatic restriction T4 DNA polymerase (NEB, Ipswich, MA, USA) 
according to the manufacturer’s advice was used. The reaction was incubated in a waterbath at 30°C for 60 
min. The enzyme was heat-inactivated at 65°C for 10 min and the DNA was purified using a PCR purification kit 
(Qiagen, Hilden). 
 
II.7.7 Dephosphorylation of DNA 
For dephosphorylation of DNA, Antarctic Phosphatase (NEB, Ipswich, MA, USA) was added to the purified DNA 
according to the manufacturer’s advice and incubated at 37°C for 60 min. The enzyme was heat-inactivated at 
65 °C for 10 min and purified using a PCR purification kit (Qiagen, Hilden). 
 
II.7.8 Ligation 
Ligations of DNA fragments were carried out with the help of the Rapid DNA Ligation Kit (Roche, Hague Road, 
IN, USA). For each mixture 10 µL of pre-aliquoted ligation buffer containing ATP was used. A molecular ratio 
fragment:plasmid of 3:1 was employed and the ligation reaction was incubated for 15-30 min at RT, transferred 
on ice and then purified using the PCR purification kit (Qiagen, Hilden). 
 
 
II.8 Biochemical methods 
II.8.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were separated according to their migration speed using the SDS PAGE. Samples were 
resuspended in 1x Laemmli buffer and boiled at 95 °C for 10 min for denaturation of proteins. Acrylamide 
concentrations from 10-15% were used and the samples were first loaded on a stacking gel before separation 
over a running gel to ensure similar running conditions. Voltages applied were 60 V and 140 V for stacking and 
running gel, respectively. A pre-stained protein marker (Fermentas, St. Leon-Rot) was loaded on every gel to 
inspect SDS PAGE progression and to estimate the size of the desired protein band. 
 
II.8.2. Immunoblotting 
To detect specific antigens in a protein sample, the SDS PAGE separated proteins were blotted onto a 
Polyscreen PVDF membrane (Perkin-Elmer, Waltham, MA, USA). This was done using the semi-dry method and 
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a semi-dry blotting chamber (Biometra, Göttingen) with 1 mA of current per cm
2
 of membrane for 60 min. The 
membrane was activated prior to use with 100% methanol and washed once in transfer buffer. After protein 
transfer the membrane was washed once with 1x TBS-T and blocked with 5% dry milk powder in 1x TBS-T at RT 
for 60 min followed by washing three times for 5 min with 1x TBS-T. In order to visualize specific protein bands, 
the membrane was incubated with the respective primary antibody, in an antibody specific dilution in 3% 
BSA/TBS-T, at 4 °C overnight with shaking. The membrane was washed 60 min with TBS-T and then the 
secondary antibody, coupled to HRP, was added 1:2000-3000 in 5% milk powder/ 1xTBS-T for 60 min at RT. The 
membrane was washed thoroughly and the antibody signals were detected by applying HRP substrate solution 
(GE Helathcare, Little Chalfont, UK) to the membrane and exposition to X-ray films (GE Healthcare, Little 
Chalfont, UK). For sequential detection of different proteins on the same membrane, the PVDF membrane was 
stripped in stripping buffer (50 °C, 20 min), washed once with isopropanol and thoroughly with distilled H2O. 
Subsequently, the membrane was blocked again and treated as described above. 
 
II.8.3 Immunoprecipitation (IP) 
For the identification of protein-protein complexes immunoprecipitation was performed. Cells were seeded in 
10 cm dishes (Corning, Lowell, MA, USA) to gain approx. 70 % confluency and the respective experiment was 
conducted. Afterwards, the dishes were put on ice and all subsequent steps were performed on ice and with 
pre-cooled (4°C) centrifuges. Cells were washed once with cold PBS and then 2 mL of cold PBS + PhosStop 
(Roche) (broad-range phosphatase inhibitor cocktail; one pellet in 10 mL) was added to the dish. Cells were 
gently scraped with a rubber policeman and the cell suspension was transferred to 2 mL Eppendorf tubes. The 
cells were pelleted at 1800 rpm, 4°C for 5 min and the supernatant was discarded. Cells were resuspended in 
500 µL RIPA buffer + PhosStop (one pellet in 10 mL), incubated for 5 min on ice and then passaged ten times 
thorugh a pre-cooled 0,25 mm needle to break up the cells. From this suspension 40 µL was removed and 
mixed with 40 µL 2x Lämmli buffer to yield the input control. The remaining lysate was centrifuged at 10,000 
rpm for 10 min to pellet cell debris and the supernatant was transferred to new 1,5 mL Eppendorf tubes. The 
lysate was pre-incubated with 20 µL Dynabeads Protein G beads (Invitrogen, Karlsruhe; washed two times with 
PBS before use) for 30 min on a rotator in the cold room and then the antibody for pull-down was added 1:50. 
The lysates were incubated on a rotator overnight at 4°C. For recovery of protein complexes 100 µL Dynabeads 
Protein G beads were added and the lysates were incubated on a rotator at 4°C for 2 h. The samples were then 
washed two times with cold RIPA buffer by using the Dynal MPC -E concentrator (Invitrogen, Karlsruhe) for 
pelleting the beads. Afterwards the samples were washed two times with PBS and then 40 µL 2x Lämmli buffer 
was added and the samples were heated at 95°C for 10 min. The supernatant was transferred to new tubes and 
the beades were resuspended in 30 µL 2x Lämmli buffer and heated again and the supernatant was added to 
the previous one. Samples were stored at -20°C until SDS-PAGE and Immunoblotting was performed. 
In order to avoid masking of proteins with an approximate molecular weight of around 50 kDa by the 
predominant denatured heavy chains of the IP antibody, a light-chain specific antibody was used for the 
immunoblots. A second, HRP-coupled antibody was then employed to detect the light-chain specific antibody. 
 
 
II.9 Microscopical methods 
II.9.1 Immunofluorescence staining 
Immunofluorescence staining for confocal microscopy was performed in 24 well format on 12 mm acetone-
washed, autoclaved coverslips. Cells were seeded with the desired density and treated as appropriate (e.g. 
infected with Salmonella Typhimurium). 
The cells were fixed by adding 2% paraformaldehyde/PBS and incubating at 37°C for 10 min and then washed 
three times with PBS. For intracellular staining the cells were permeabilized with triton X-100 (0.2 % [v/v] in 
PBS at RT for 15 min). Following permeabilization the cells were washed extensively with PBS (RT) and treated 
as described in table II.12. All staining steps were performed at RT. The incubation with primary or secondary 
antibody was performed in a humidified chamber to prevent drying of the samples. 
 
Table II.12: Immunofluorescence staining procedure 
staining step component time 
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blocking 1% [w/v] BSA/PBS 30 min 
primary antibody antibody 1:50-1:200 in 0.1% BSA/PBS 60 min 
washing five times with PBS  
blocking 1% [w/v] BSA/PBS 15 min 
secondary antibody 1:300 in 0.1% BSA/PBS 45 min 
washing five times with PBS  
washing once with ddH2O  
 
The coverslips were mounted on glass-slides with mowiol and subjected to microscopic analysis. 
 
II.9.2 Confocal microscopy 
A Leica TCS SP-1 (Wetzlar) was employed for confocal microscopy analysis. The samples were first inspected 
manually with the 63x objective, then images were acquired using the software Leica LCS. Images were further 
processed with the software Adobe Photoshop, e.g. to overlay different fluorescence channels. 
 
 
 
II.10 Fluorescence activated cell sorting (FACS), Flow Cytometry 
During flow cytometric measurements a continuous stream of sample fluid, hydro-dynamically focused by a 
sheath fluid, passes a laser. Particles inside the sample scatter the laser light in a characteristic manner. 
Additionally, fluorescent compounds within the particle (such as fluorescent dyes) are excited and emit light of 
a specific wavelength. Both the scattered light and the emitted light are picked up by detectors, eventually are 
amplified for dim fluorescence, and thereby the measured particle can be analyzed multiparametrically (see 
supplementary figure S.4). This gives information about several physical and chemical properties on a single cell 
level. Historically, flow cytometry was used to phenotypically characterize eukaryotic cells, mainly human blood 
cells, but it is now also established for the measurement of bacteria. 
For all flow cytometry experiments a FACS Calibur (BD, BD, Franklin Lakes, NJ, USA), equipped with a HTS 
loader device (BD, BD, Franklin Lakes, NJ, USA) for high-throughput applications was employed. The software 
controlled needle unit of the HTS supply is able to remove a specific sample volume from 96 well or 384 well 
plates and to apply it to the FACS device for parametric analysis.  The software CellQuest Pro V5.2.1 or Plate 
Manager V1.0.1 (both: BD, BD, Franklin Lakes, NJ, USA) was used for single tube experiments or 96 well plate 
measurements, respectively. Before conducting 96 well plate experiments single tube measurements were 
performed to produce the required template and setting files. 
 
II.10.1 Single tube experiments 
Samples (e.g. infected cells) were prepared as described elsewhere and then processed for flow cytometry. 
Cells were trypsinized, resuspended in PBS and fixed with 2% [w/v] PFA, bacterial solutions were fixed 1:1,000 – 
1:10,000 in 2% [w/v] PFA and measured directly. It was observed that cells that were FACS-measured directly in 
the fixative solution displayed differing auto-fluorescence when compared to non-fixed cells. Additionally, the 
fluorescence of infected cells could not be analyzed adequately, most likely because the PFA altered the 
properties of the respective fluorescent proteins. Therefore, the fixative had to be removed to obtain proper 
FACS results which was carried out by transferring the cell samples to 1.5 mL Eppendorf tubes and pelleting 
them in an Eppendorf tabletop centrifuge at 520 x g at RT for 4 min. The supernatant was discarded and the 
cell pellet was resuspended in 400 µL PBS, transferred to FACS tubes and subjected to FACS analysis. 
 
II.10.2 High-throughput experiments 
For 96 well plate FACS analysis the samples were prepared as described elsewhere. Prior to flow cytometry 
measurements, the cells were trypsinized inside the wells with 30 µL/well trypsin (RT) and incubated at 37°C 
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for 5 min until cells detached. The cells were resuspended with 70 µL PBS (RT) and fixed with 2% [w/v] PFA (RT) 
at 37°C for 10 min. To remove the fixative the plates were centrifuged in a Heraeus multifuge 3 S-R (DJB 
Labcare, Newport Pagnell, UK) centrifuge at 1200 rpm and RT for 5 min to sediment cells and the supernatant 
was aspirated carefully from the wells. The cells were resuspended in 100 µL/ well PBS and analyzed by FACS. 
Before high-throughput FACS acquisition, the system was primed 2-3 times. 
 
II.10.3 General FACS settings and data analysis 
The fluorescence channels FL-1 and FL-3 were used to detect GFP or mCherry fluorescence, respectively. Both 
fluorescence signals were compensated against all other channels by performing single fluorescence 
experiments. Mammalian cells or bacteria were identified according to their light scattering properties using a 
forward scatter (FSC) and side scatter (SSC) dot plot. Autofluorescence of eukaryotic cells in the GFP channel 
was calculated by analysing non-infected cells and was used to define the population of infected cells. 
During 96 well plate measurements 40 µL of each well was analysed to allow well-to-well comparison of cell 
concentrations. The raw data was further analysed with the software FlowJo 7.2.1 (Treestar, Ashland, OR, USA) 
or FCS Express (DeNovo software, Los Angeles, CA, USA) for high-throughput data and single tube experiment 
data, respectively. Processed high-throughput data was applied to prefabricated Excel forms for initial 
statistical analysis. 
 
 
II.11 Statistical analysis and bioinformatics  
The FACS high-throughput raw data was analyzed with regard to the parameters described in table II.13 using 
the software FlowJo 7.2.1 (Treestar, Ashland, OR, USA). The data was applied to Excel analysis, the analytical 
parameter were normalized to the Allstars mean values and the mean inhibition of test siRNAs was calculated 
in relation to the control siRNAs Allstars (neutral) and Rab7A (inhibitory) using the following equation: 
 
 
Mean GFP value of Allstars controls – GFP value of test sample 
Mean GFP value of Allstars control – Mean GFP value of Rab7A_2 controls 
 
 
The toxic control siRNA PLK was used to inspect the knock down efficiency.  
 
Table II.13: FACS parameters used for statistical analysis 
analytical parameter derived from FACS data 
number of cells number of cells in cell gate (FSC/SSC) 
percentage of infected cells ratio of eGFP-positive cells (FL-1) 
eGFP fluorescence of infected cells median eGFP fluorescence of eGFP-positive cells (FL-1) 
percentage of mCherry positive cells ratio of mCherry-positive cells (FL-3) 
mCherry fluorescence of infected cells median mCherry fluorescence of mCherry-positive cells (FL-3) 
 
Further analysis involved the calculation of mean and standard deviation values from different experiments 
and the verification of statistical significance using Student’s two-tailed t-test. 
In general, only siRNAs that fulfilled the following criteria were regarded as possible “hits”: 
 
1.) non-toxic (cell count ≥ 0.4) 
2.) impact on GFP fluorescence (mean inhibition ≥ 0.5 for inhibitory and ≤ -0.5 for activating siRNAs 
3.) statistical significance (p-value ≤ 0.05) 
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III Results 
III.1 Assay development 
The interaction between a pathogen and its host cell is a fascinating and highly complex 
subject that is intensively studied in many different fields of scientific research. A plethora of 
pathogen-host models is investigated with the aim to unravel important molecular pathways 
that underlie the elaborate interactions of pathogens and their host cells. Host signaling 
pathways that are activated in response to the infection or manipulated by the pathogen 
just like the virulence factors involved in pathogenesis are of strong interest to basic 
research. Transferring the increasing knowledge of these interactions to the applied sciences 
might allow developing new strategies to combat infections and control infectious diseases. 
With the advent of the RNA interference technique to specifically knock down the 
expression of eukaryotic genes, it became possible to examine the importance of certain 
host cell proteins for the establishment of a successful infection on a large scale. Recently, 
several RNAi based screens have been performed with diverse infection models of 
intracellular pathogens: Listeria (Agaisse et al., 2005), Chlamydia (Derre et al., 2007, Elwell et 
al., 2008) or Plasmodium (Prudencio et al., 2008). Without exception, all of these screens 
were conducted using microscopy as the principal read-out technique. 
In this work, a FACS based assay was developed to evaluate the impact of RNAi mediated 
host cell gene knock down on intracellular growth of Salmonella Typhimurium. A Salmonella 
strain was constructed carrying two reporter plasmids which made it possible to monitor 
bacterial replication and metabolic fitness in one experimental run. Each reporter plasmid 
was responsible for the expression of a different fluorescent protein that could be detected 
and distinguished using FACS. This reporter strain satisfied the need and the wish to 
generate data of high content to cover as many parameters of the infection process as 
possible. After the construction and validation of the reporter strain, described in III.1.1 and 
III.1.2, respectively, the high-throughput FACS assay was set up and different conditions (e.g. 
cell seeding or infection parameters) were tested to ascertain the optimal experimental 
design (see III.1.3). Pre-screening experiments were performed to test the functionality of 
the assay and its applicability for large scale experiments (see III.1.4 and III.1.5) before the 
actual screening of large siRNA libraries was accomplished (see III.2). 
 
III.1.1 Construction of a Salmonella Typhimurium reporter strain 
Two reporter plasmids were constructed and electroporated into the Salmonella 
Typhimurium wildtype strain 12023 to obtain the sensor strain for monitoring both 
intracellular bacterial replication and fitness (see figure III.1). This sensor strain was thought 
to enable the acquisition of very detailed data regarding the impact of host cell gene knock 
down on the infection process of Salmonella in one experimental run. 
The plasmid pOR25 drives the constitutive expression of the green fluorescent protein (GFP) 
from the bacterial promoter φrpsM. GFP can be easily excited with the FACS laser line of 
488 nm and is detected at 530 nm (fluorescence channel FL-1). The vector pACYC177 (Chang 
et al., 1978) was used as the back bone for cloning pOR25. It harbours two antibiotic 
resistance genes: bla for ampicillin resistance and kan for kanamycin resistance. Since it was 
intended to apply a second reporter construct also carrying an ampicillin resistance gene, 
RESULTS 38 
the bla gene of pACYC177 had to be interrupted to ensure an equal propagation of both 
plasmids inside Salmonella under selective conditions. For this, the plasmid pACYC177 was 
digested with the enzyme BsaHI to cut the vector 5’ of the bla gene and inside the gene. 
Subsequently, the plasmid was re-ligated, electroporated into E. coli DH5α, and tested on 
ampicillin and kanamycin agar plates. No growth on ampicillin plates could be observed 
indicating that the disruption of the bla gene was successful. In order to clone the φrpsM-
GFP fusion into the modified pACYC177 vector (pACYC177 ‘ampR), the respective fragment 
was digested from the plasmid pFPV25.1 (Valdivia et al., 1996) using the enzymes XbaI and 
SphI and was treated with T4 DNA polymerase to produce blunt ends. The pACYC177 ‘ampR 
vector was digested with BamHI, was T4 DNA polymerase-treated and then de-
phosphorylated. The rpsM-GFP fragment was ligated into the modified vector pACYC177 to 
gain the reporter plasmid pOR25 (see figure III.1).  
The second reporter plasmid, pOR26, was constructed using the vector pBAD18 (Guzman et 
al., 1995) which constitutes an arabinose inducible expression system. It has been widely 
used in heterologous protein expression (Ghigo et al., 2000, Low et al., 2006) and also for 
the controlled expression of GFP, luciferase, and lysis gene E in a Salmonella infection model 
(Loessner et al., 2007). A DNA fragment of mCherry, flanked by a 5’ XbaI and a 3’ HindIII 
restriction site was synthesized from the plasmid pRSET mCherry (Shaner et al., 2004) by PCR 
with primers FP_new-F and FP_new-R and digested with the enzymes XbaI and HindIII to 
produce cohesive DNA ends. The vector pBAD18 was digested with XbaI/HindIII, de-
phosphorylated and the PCR fragment was ligated to produce the plasmid pOR26 (see figure 
III.1). 
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Figure III.1: Schematic diagrams of the cloning strategies for pOR25 and 
pOR26. 
The cloning schemes for the construction of the reporter plasmids pOR25 and 
pOR26 are shown in [A] and [B], respectively. See text for details. 
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Both plasmids were propagated in E. coli DH5α and sequenced with primers flanking the 
ligated insert. The DNA sequencing was performed by SMB DNA Sequencing Service Martin 
Meixner (Berlin) and showed a correct DNA sequence for both constructs. 
The plasmids were electroporated sequentially into the Salmonella Typhimurium 12023 wild 
type strain and the resulting strain 12023 pOR25/26 was grown on ampicillin/kanamycin 
selective agar plates to ensure propagation of both plasmids. 
 
III.1.2 Validation of the reporter strain 
III.1.2.1 The viability of the reporter strain is not altered 
In order to test the viability of the double-transformed strain 12023 pOR25/26, the growth 
in LB medium was compared to the growth of the wild type 12023 strain. Both strains were 
grown overnight at 37°C, 200 rpm. They were diluted 1:100 in fresh medium and the OD600 
was measured at different time points. Figure III.2 depicts the growth curves of both the wild 
type strain and the strain 12023 pOR25/26. It becomes obvious that there was no significant 
difference between both strains. This indicates that the viability of the reporter strain was 
not impaired by the propagation of the two plasmids (see figure III.1). 
 
 
 
 
 
 
Figure III.2: The reporter strain is not impaired in growth. 
The Salmonella Typhimurium 12023 wildtype strain and the reporter strain 
12023 pOR25/26 were cultivated overnight in LB medium. At the indicated 
time points after subcultivation, samples were taken and the OD600 was 
measured to control bacterial growth. The plot shows the data of three 
independent experiments as means with standard deviations for the 
wildtype strain (open triangles) and the reporter strain (filled triangles). 
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III.1.2.2 Expression of both fluorescent proteins can be detected and discerned by FACS 
III.1.2.2.1 FACS analysis of the reporter strain in-vitro 
The functionality of the plasmids pOR25 and pOR26 was first tested in-vitro. The strain 
12023 pOR25/26 was grown in defined PCN culture medium overnight with glucose and then 
subcultured 1:50 in fresh PCN medium with glucose for 2h. Since the availability of glucose 
completely represses the arabinose expression system (Guzman et al., 1995), the bacteria 
were pelleted, washed two times with ddH2O and resuspended in PCN medium without 
glucose, supplemented with 0.2 % [w/v] arabinose to induce the expression of mCherry. 
Figure III.3: The expression of both fluorescent proteins can be monitored using FACS. 
In order to test the functionality of the reporter strain the fluorescence of GFP and mCherry was 
monitored using flow cytometry. Bacterial cultures of 12023 pOR25/26 were grown in PCN medium with 
glucose overnight, subcultured 1:50 in fresh medium for 2 hours and then washed with dH2O. Pellets 
were resuspended in PCN medium without glucose, supplemented with 0.2 % [w/v] L-arabinose and 
grown for the indicated time. Samples were fixed with 2% PFA and then measured with a FACS Calibur. 
The spectral overlap of GFP and mCherry was compensated during measurements. 
[A] Non-induced (grey) and induced (black) cultures were analyzed for their fluorescent characteristics, 
showing clearly distinguishable populations. [B] The mCherry fluorescence intensity increases with 
induction time, indicated by the shift of the histograms. Time points were 0 (grey filled), 15 (dashed), 30 
(dotted), 60 (dash-dotted) and 120 (black filled) minutes, respectively. [C] The triplicate data of one 
representative experiment with means and standard deviations for GFP fluorescence (open triangles) and 
OD600 (filled triangles) is shown. 
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Samples were taken at different time points and analyzed by FACS as described in II.10.1. 
Figure III.3.A illustrates the respective dot plot for GFP and mCherry fluorescence with 
spectral compensation. A clearly distinguishable population showing GFP as well as mCherry 
fluorescence originated 2 h post induction whereas the non-induced bacterial culture only 
exhibited GFP fluorescence. In figure III.3.B, the mCherry fluorescence at different time 
points after arabinose addition is depicted. It becomes obvious that a significant shift in 
fluorescence intensity occurred 2 h post induction that could be easily discerned from the 
background fluorescence (figure III.3.B; grey shaded curve). 
Figure III.3.C displays the GFP fluorescence as well as the OD600 of the bacteria over time 
after subcultivation in glucose-free PCN medium. Characteristic curves showing a growth 
phase dependent GFP expression driven by the ribosomal protein promoter φrpsM can be 
seen. 
 
III.1.2.2.2 FACS analysis of the reporter strain in cell culture infections 
In order to test the reporter plasmids in-vivo and, moreover, to find the adequate cell line 
for the performance of the high-throughput screen, several human tissue culture lines were 
infected with the reporter strain for FACS analysis. 14 h p.i. the samples were treated with 
induction medium for 2 h, were processed as described in II.10.1 and were analyzed for GFP 
and mCherry fluorescence. Samples were taken at 2 h p.i. and 16 h p.i. for the analysis of the 
initial bacterial invasion and the long-term infection process, respectively. 
Figure III.4 reveals that the infection efficiency strongly varied among the different cell lines 
investigated. Using the dot plot view (figure III.4.A) it is possible to discern and quantify 
different cell populations: 1.) non-infected cells in quadrant three (Q3), 2.) infected cells 
displaying only GFP-expressing bacteria (Q4) and 3.) infected cells showing both GFP and 
mCherry fluorescence (Q2). The visual inspection of the dot plots further displays 
remarkable differences in the infection efficiency of the different human cell lines with 
Salmonella under the conditions used. For instance, GFP intensity as well as the infection 
rate was much lower in infected HT-29 cells than in infected HeLa cells. 
The quantification of important infection parameters within the different cell lines is 
depicted in figure III.4.B. Samples were analyzed 16 hours p.i. for replication (upper and 
middle panel) and 2 hours p.i. for invasion (lower panel). The analysis implied the rate of 
cells showing the correspondent fluorescence signal and the intensity of GFP or mCherry 
fluorescence. Distinct differences between the cell lines could be observed with regard to 
the initial bacterial invasion rate, the replication efficiency in these cells or the ability of the 
bacteria to express the mCherry protein. The invasion rate was comparable among all cell 
lines tested except HepG2 cells which showed a significantly lower bacterial invasion (see 
figure III.4.B, lower panel). The amount of GFP fluorescence was equal in HeLa and Hec1b 
cells but lower in the other cell lines used, indicating that fewer bacteria per cell had 
entered. 16 h p.i. the percentage of infected cells was in the same range as 2 h p.i. for HeLa, 
Hec1b, HepG2, and HEp-2 cells but had dropped dramatically for HT-29 cells (see figure 
III.4.B, upper panel). Additionally, the bacteria in HT-29 and HepG2 cells only showed a weak 
mCherry induction after overnight infection (see figure III.4.B, middle panel), indicating that 
the bacterial metabolic activity was weak under these conditions. For HEp-2 cells two 
distinct populations of infected cells could be observed (see figure III.4.A), one showing a 
GFP/mCherry fluorescence pattern similar to HeLa cells and one that displayed lower 
mCherry expression levels which resulted in relatively lower values for mCherry intensity in 
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the quantification. This suggested that HEp-2 displays a heterogeneous cell line with regard 
to Salmonella infection and was therefore not considered to be used within the screen. 
Thus, based on the results gained from infection experiments with different human cell lines, 
the HeLa cell line proved to be an adequate tool to investigate intracellular replication and 
fitness of Salmonella Typhimurium and it was therefore used for all subsequent experiments 
if not stated otherwise. 
 
III.1.2.2.3 Microscopic analysis of the reporter strain in cell culture infection 
For microscopic analysis of the reporter strain, HeLa cells were seeded on coverslips, 
infected with the reporter strain and treated with induction medium to induce mCherry 
expression or were left untreated. 
Figure III.5 depicts the confocal microscopic analysis for sequentially aquired GFP and 
mCherry fluorescence as well as the image overlay. In the non-induced sample only GFP 
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Figure III.4: FACS analysis of different cell lines infected with the reporter strain. 
Using the reporter strain in a FACS assay, fundamental infection parameters can be quantified showing 
significant differences between the cell lines tested. Human cell lines (1: HeLa, 2: Hec1b, 3: HepG2, 4: HEp-2 
and 5: HT-29) were seeded in 24 well plates, infected with a MOI of 200 and processed for FACS analysis as 
described in II.10. Dot plots were generated and then further analyzed for quantification using FlowJo 7.2.1. 
[A] Two-parametric dot plots of infected human cell lines with the log GFP fluorescence intensity on the x-
axis and the log mCherry fluorescence intensity on the y-axis. [B] Quantification of different infection 
parameters as indicated. Upper and middle panel: 16 hours p.i. Lower panel: 2 hours p.i. 
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fluorescence is detectable, whereas in arabinose stimulated cells most of the bacteria show 
GFP as well as mCherry fluorescence, as reflected by the overlay image. This is a further 
proof that the reporter constructs are working reliably and that Salmonella bacteria inside 
their host cell can be induced to express the mCherry protein by the external addition of 
arabinose. 
III.1.3 Development of a high-throughput FACS application 
After having evaluated the sensor strain intensively in-vitro and in-vivo, the assay was 
transferred to a large scale application to perform high-throughput screening experiments 
in a 96 well plate format. As mentioned above, it was chosen to use the human epithelial cell 
line HeLa for the experiments for the following reasons: 1. the cell line is the predominantly 
used epithelial cell infection model in Salmonella research, 2. it gave the best results with 
respect to the infection parameters measured in the FACS analysis (see III.1.2.2.2 and figure 
III.4) and 3. there had already been good expertise in successfully transfecting HeLa cells 
with siRNAs inside the department. For the establishment of the high-throughput assay 
several details had to be evaluated, such as the overall robustness of the FACS 
measurements performed with the HTS supply and the proper infection conditions. 
 
Figure III.5: Intracellular replicating Salmonella can be induced to express mCherry. 
HeLa cells were seeded on coverslips and infected with the reporter strain as described in II. 14 h p.i., 
samples were either treated with induction medium for 2 hours or left untreated and were processed 
for confocal analysis. Images are shown for the GFP fluorescence (left images), the mCherry 
fluorescence (middle images), and the overlay of both channels (right images). In the upper panel and 
the lower panel representative intracellular bacteria are shown for non-treated and treated cells, 
respectively. Scale bar = 2 µm 
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III.1.3.1 Stability of measurements 
The FACS Calibur HTS supply is equipped with a mobile needle that removes a specified 
sample volume from a 96 well or 384 well plate and injects it into the flow system which 
transports the sample to the flow chamber for parametric analysis (see figure S.4 in the 
supplements). 
Since the processing of one 96 well plate with this supply takes about 30 min to 1 h (in 
normal working mode and dependent on sample volume and sample speed), it was 
necessary to assure a stable measurement of sample over the time and for the whole plate.  
To test the technical variation of measurements over time, HeLa cells fixed with 2 % [w/v] 
PFA were pipetted into a 96 well plate at a density of 4x104 cells/well and were measured 
with the help of the HTS supply and the conditions specified below. Only the inner 60 wells 
were acquired since in the planned RNAi experiments the outer wells would be omitted due 
to already observed irregular growth behaviours of cells in the outer wells. During the whole 
time of acquisition, the amount of cells remained stable as in all 60 wells an equal number of 
cells could be detected (figure III.6). Thus, the high-throughput FACS analysis ensures a high 
technical reproducibility under the conditions used. 
 
III.1.3.2 Infection conditions and assay accuracy 
III.1.3.2.1 Determination of appropriate infection conditions 
After having secured that the general technical variation of the measurements was in a 
range that could be tolerated, the adequate infection conditions had to be determined. In 
order to evaluate the proper infection dose to avoid cell toxicity, a multiplicity of infection 
(MOI) titration experiment was performed. The impact of different MOIs on cell survival and 
infection parameters in a 96 well plate format HeLa cell infection, analyzed by high-
throughput FACS acquisition, is shown in figure III.7. The amount of measured cells 
normalized to non-infected cells exhibited a MOI dependent decrease, indicating 
Figure III.6: The HTS FACS aquisition is stable over time. 
In order to evaluate the variability of the FACS HTS measurement over time, PFA-fixed cells 
were pipetted at equal density into the wells of a 96 well plate. Afterwards the inner 60 
wells of the plate were measured with identical conditions: 40 μL/well at a speed of 2 
μL/sec. Each bar represents a well and the wells are depicted in the order of measurement. 
The number of acquired cells is presented on the y-axis. 
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a tremendous cell toxicity of 84% for HeLa cells infected with a MOI of 200 compared to a 
relatively low toxicity caused by MOIs of 10 and 20 (figure III.7.A).  
The infection efficiency (i.e. the percentage of GFP-positive cells that were detected) was 
also MOI dependent displaying an infection rate of about 80 % for MOI 200 and about 40 % 
for cells infected with a MOI of 10 (figure III.7.B). For the median GFP fluorescence intensity 
of infected cells no MOI dependence could be observed. For all MOI conditions employed, a 
similar value of GFP fluorescence intensity per cell was measured (figure III.7.C). 
These results suggested the use of MOI 20 for the infection of HeLa cells with Salmonella 
Typhimurium as the cell toxicity was negligible and at the same time the infection 
parameters proved to be adequate. 
 
III.1.3.2.2 Accuracy of the FACS assay 
The toxicity of certain siRNAs might lead to variable cell numbers in the wells. The impact of 
lower or higher cell numbers on the infection was tested in a 96 well format experiment  by 
seeding different cell numbers and infecting at MOI of 20 (see figure III.8). The respective 
amount of bacteria to reach MOI 20 was adjusted with respect to the samples with 1x104 
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Figure III.7: MOI titration for evaluating the appropriate infection conditions. 
HeLa cells were seeded in 96 well format, infected and processed for FACS analysis 16 h p.i. Ten wells for 
each MOI were analyzed. The data of one representative experiment with means and standard 
deviations is shown. [A] Number of detected cell particles, normalized to non-infected cells (MOI 0). [B] 
Percentage of infected cells (i.e. infection rate). [C] Median GFP fluorescence of infected cells. 
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cells seeded. The FACS analysis showed that the detected cell numbers within a constant 
volume of 40 µL decreased with diminishing seeding quantities (figure III.8.A). Concerning 
the invasion rate of the bacteria, a significant difference to the reference value (white bar in 
figure III.8) could only be detected for extreme high or low cell numbers (4x104 and 
1.25x103), whereas in the range from 2.5x103 to 2x104 cells, the invasion rate was 
comparable (figure III.8.B). No significant difference could be observed with respect to the 
GFP fluorescence intensity (figure III.8.C). Thus, the infection with the reporter strain runs 
similar over a certain range of host cell densities providing certain stability against eventual 
differences in cell numbers due to toxic siRNAs. Next, it was of interest to figure out whether 
the detected cell number had an influence on the statistical robustness of measurements. In 
order to determine the range of cell numbers that gave comparable analysis data, an 
Figure III.8: Salmonella reporter strain infections run stable with varying cell densities. 
To test the impact of differing cell numbers on the infection parameters, HeLa cells were seeded in 96 well 
format at a density of 1: 4x10
4
, 2: 2x10
4
, 3: 1x10
4
, 4: 5x10
3
, 5: 2.5x10
3
 and 6: 1.25x10
3
. Cells were infected the 
next day with a MOI of 20 as adjusted for the cell density of samples with 1x10
4
 cells seeded. 16 h p.i. cells 
were processed for FACS analysis and ten wells for each condition were measured. The data of one 
experiment with triplicates, normalized to 1x10
4
 cells seeded (white bar), with means and standard 
deviations is shown for [A] number of cells detected, [B] invasion rate and [C] median GFP fluorescence of 
infected cells. P-values *<0.05 and **<0.01 with 1x10
4
 cells as reference. 
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Figure III.9: FACS assay shows high accuracy of measurements over a wide range of particle numbers.  
Different volumes of infected cells were loaded from each well and analyzed by flow cytometry. The 
volume in µL that was analyzed is displayed on the x-axis. The y-axis shows GFP fluorescence [A] or 
invasion rate [B]on the left and the number of detected cells on the right. 
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accuracy assay experiment was performed. An equal number of HeLa cells was seeded into 
the wells of a 96 well plate, infected the next day as described (II.6.5) and the plate was 
processed for flow cytometry. For FACS acquisition, different volumes were taken out of 
different wells by the HTS supply and analyzed. The quantification of the FACS data is 
depicted in figure III.9. As expected, the number of detected cell particles increased with 
rising volumes measured. However, the values for the rate of infected cells and for the GFP 
fluorescence were comparable within the whole range of analyzed volumes. This shows that 
even with very low cell numbers, which might occur during the screen as a consequence of 
toxic siRNAs, a statistical robustness is assured using the FACS technique. 
 
III.1.4 Functionality test: small antibiotic screen 
In order to demonstrate that inhibition of bacterial replication inside epithelial cells can be 
monitored with the bichromatic FASC assay, a small antibiotic screen in 96 well plate format 
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Figure III.10: Small antibiotic screen as a functionality test. 
The applicability of the reporter strain FACS assay was finally validated in 96 well format testing several 
antibiotics in different concentrations for their impact on bacterial replication and host cell toxicity. HeLa 
cells were infected with the reporter strain and 1 hour p.i. the medium was aspirated and 100 µL/well 
RPMI full medium, supplemented with 20 µg/mL gentamicin and the indicated concentration of drug 
was added for the rest of the infection. 14 hours p.i. the medium was aspirated, mCherry expression was 
induced and 2 hours later the samples were processed for FACS analysis. The plots shows the number of 
cells detected (right y-axis and open squares) and median GFP fluorescence of infected cells (left y-axis 
and open triangles) one of experiment. Applied concentrations are displayed on the x-axis. Drugs used 
were: 1 chloramphenicol, 2 irgasan, 3 streptomycin, 4 erythromycin, 5 tetracyclin, 6 cefixim, 7 
rifampicin, 8 trimethoprim, 9 brefeldin A, 10 H-89 and 11 DMSO (as control). Concentration units are as 
follows: µg/mL (1-9), µM (10), % [v/v] (11). 
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was performed. Various antibiotics and chemical inhibitors were applied at different 
concentrations on cells infected with the reporter strain 1 hour post infection for the rest of 
the infection process and the plate was processed for FACS acquisition.  
Figure III.10 shows the impact of different antibiotics on host cell survival and GFP 
fluorescence of the bacteria. For most of the inhibitors that were used in this small screen a 
decrease in GFP intensity was observed at higher concentrations. In the case of Irgasan, a 
phenol compound widely used as disinfectant and preservative, the cell toxicity was also 
very pronounced at the highest concentration of 100 µg/mL. 
 
III.1.5 Rab7A as the siRNA control for conducting the RNAi screens 
After intensive functional evaluation of the bichromatic FACS assay, the set-up of the RNAi 
screen had to be further approached. Most importantly, it was necessary to find and 
establish siRNAs that could operate as control siRNAs throughout the whole screen. The 
siRNA controls are of great importance as they allow for monitoring the transfection 
efficiency itself and as they serve as markers for the statistical analysis of the siRNAs to test. 
The following siRNA controls had to be concerned: 1. a neutral control to assess the overall 
impact of the siRNA transfection process on the host cell as well as on the infection, 2. 
a toxic siRNA that kills the host cells in a reliable way to directly control the transfection 
efficiency, and 3. a siRNA that leads to a host cell gene knock down which stably inhibits the 
bacterial infection process leading to a decrease of fluorescence. 
A commercially available scrambled siRNA sequence named Allstars (Qiagen, Hilden) served 
as the neutral control. This sequence should not lead to a specific gene knock down and, 
moreover, was designed by the company in a way to cause only minimal off-target effects. A 
siRNA against the host cell protein PLK1, the polo-like kinase 1 which is involved in mitosis, 
was used as a toxic control due to already existing profound experiences with this sequence 
in our laboratory. Upon transfection with this sequence, the majority of cells was killed 
within three days. 
In order to find a control siRNA which would reliably inhibit Salmonella replication, the 
respective literature was screened. Some reports describe a role for Rab7 in the infection 
process of Salmonella. For instance, Meresse et al. (1999) showed that Rab7 is involved in 
the biogenesis of the Salmonella containing vacuole (SCV) by mediating the acquisition of 
lysosomal glycoproteins (lgp) which are evident on mature vacuoles. In another publication a 
role of Rab7 for the formation of Salmonella induced filaments (Sifs), which is essential for 
the replication, was reported (Brumell et al., 2001b). Thus, Rab7 seems to play an important 
role in the accurate maturation of the SCV and thereby ensures the successful bacterial 
replication inside the vacuole. Based on these observations it was decided to test the impact 
of Rab7 gene knock down on Salmonella intracellular growth by flow cytometry (III.1.5.1), by 
confocal microscopy (III.1.5.2), and with a gentamicin protection assay (III.1.5.3) to evaluate 
its employment as the inhibitory siRNA control. For this, Dharmacon Rab7A smart pool 
siRNAs were purchased and initially tested with the FACS assay. 
 
III.1.5.1 FACS based evaluation of Rab7A knock down on infection 
To test the impact of the Dharmacon smart pool mediated Rab7A gene knock down on 
Salmonella intracellular growth, Hela cells were transfected with the respective siRNA in 96 
well format, infected three days post transfection, and analyzed by FACS. 
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As illustrated in figure III.11.A, the mean GFP fluorescence of infected Rab7A knock down 
cells was reduced to about 50% compared to Allstars control treated cells. This indicates a 
strong replication defect in the absence of Rab7A. The dot plot analysis of Rab7A treated 
cells showed a significant shift of the infected cell population compared to Allstars treated 
cells (figure III.11.C). Additionally, the mCherry signal dropped into the range of the non-
infected background intensity, implicating that the bacteria responded only very weakly to 
the arabinose trigger. This indicates that the Rab7A knock down caused to a strong inhibition 
of bacterial replication and metabolic activity and, thus, exhibits an excellent control 
to monitor the inhibition of Salmonella infection during the screening conductance. 
However, it has to be noted that the transfection with the smart pool had significant 
cytotoxic effects as the normalized cell number decreased to about 50% (figure III.11.B). It 
was therefore resolved to test all four siRNAs that are combined in the smart pool 
separately. Although the knock down was comparably efficient for all sequences and the 
smart pool on protein level (figure III.12.C; lower band in Rab7A panel), their influence on 
cell survival differed significantly (figure III.12.A). Whereas the siRNA sequences 1 and 3 as 
well as the pool had a negative impact on the number of detected cell particles (16, 18, and 
27%, respectively, compared to Allstars), the inhibition of bacterial replication (i.e. the GFP 
expression) was comparable for all Rab7A siRNAs tested (77.9 ± 15.6 for sequence 1, 65.4 ± 
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Figure III.11: Impact of Dharmacon smart pool mediated Rab7A knock down on 
Salmonella infection of HeLa cells. 
HeLa cells were seeded in 96 well format and transfected with Allstars control siRNA or 
the Dharmacon Rab7A smart pool siRNAs. Three days later cells were infected with MOI 
20 and processed for FACS analysis. Six wells were measured for each condition and the 
data from one representative experiment with means and standard deviations is shown. 
[A] Median GFP fluorescence of infected cells normalized to Allstars. [B] Mean number 
of cells detected, normalized to Allstars. [C] FACS two-parametric dot plots for Allstars 
(upper plot) and Rab7A (lower plot) treated samples. 
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7.4 for sequence 2, 61 ± 14.9 for sequence 3, 78.4 ± 5.8 for sequence 4 and 62.4 ± 10.2 for 
the pool; Mean ± SD, n=6). Based on these results it was decided to use the Dharmacon 
Rab7A siRNA sequence 2 because it had a good knock down efficiency, showed no host cell 
toxicity, and was effective in inhibiting bacterial replication. The FACS analysis of Allstars and 
Rab7A_2 treated cells is depicted in figure III.12.D (Allstars: left; Rab7A_2: right) 
demonstrating a strong inhibition of both GFP and mCherry fluorescence after Rab7A_2 
transfection. 
 
III.1.5.2 Microscopic evaluation of Rab7A knock down on infection 
In order to further phenotypically characterize the impact of Rab7A knock down on the 
bacterial infection process, Rab7A_2 transfected cells were analyzed using a confocal 
microscope. HeLa cells were seeded and infected as described in II.6.5 and processed for 
confocal microscopy analysis. The GFP and the mCherry fluorescence channel were aquired 
sequentially and the editing of the confocal images was performed with Adobe Photoshop. 
As can be seen in figure III.13, the knock down of Rab7A caused a dramatic inhibition of the 
bacterial infection process. No mCherry expression could be detected in the representative 
infected cell and the GFP-positive vesicle-like structures differed significantly from the usual 
appearance of the Salmonella containing vacuole as shown in the Allstars control images, 
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Figure III.12: Individual Rab7A siRNAs differ in their biological properties. 
The siRNAs sequences that were part of the Dharmacon Rab7A smart pool were purchased 
separately and tested for their knock down efficiency and their influence on host cell survival 
and Salmonella infection. HeLa cells were seeded in 96 well format and transfected with the 
individual siRNAs and the pool. Three days later the cells were infected with MOI 20 and 
processed for FACS. The mean cell number [A] and median GFP fluorescence [B] of one 
representative experiment with means and standard deviations is depicted (n=6). [C] Western 
blot analysis of cell samples three days post transfection with the respective siRNA. [D] 
Representative two-parametric dot plots for Allstars (left) and Rab7A_2 (right) treated cells. 
A: Allstars   M: mock   Nº: different Rab7A sequences   1-4: Rab7A siRNA pool 
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namely, significantly less bacteria and a more scattered distribution of the small vesicles. 
These observations suggest that the absence of Rab7A in the host cell provoked incomplete 
fusion events between different bacteria-containing phagosomal structures. This would be in 
accordance to the publications cited above. 
 
III.1.5.3 Quantification of bacterial replication 
The quantification of bacterial replication in Rab7A_2 treated cells compared to Allstars 
transfected control cells was carried out with the help of the gentamicin protection assay 
(see II.6.6). Allstars or Rab7A_2 transfected cells were infected and 2 h p.i. and 16 h p.i. 
samples were lysed, serial diluted and plated on selective agar plates for counting colony 
forming units (cfu). The replication rate was calculated by the ratio of cfu at 16 h p.i. and cfu 
at 2 h p.i. 
Figure III.14 presents the bacterial replication rates for Allstars or Rab7A_2 treated cells. It 
could be observed that the replication rate of Salmonella inside Rab7A_2 transfected cells is 
significantly lower than in Allstars control cells (30 ± 7.9 for Allstars and 12.8 ± 2.4 for 
Rab7A_2; Mean ± SD, n=3). This finding again allocates that the knock down of Rab7A 
inhibited bacterial replication inside HeLa cells. 
 
Figure III.13: Confocal analysis of Rab7A knock down cells displays inhibition of bacterial 
replication and metabolic activitiy. 
HeLa cells were seeded on coverslips in 24 well format and transfected either with the 
Allstars siRNA or the Rab7A siRNA.  Three days post transfection the cells were infected 
and treated with induction medium for two hours. The fluorescence channels for GFP and 
mCherry were acquired sequentially to avoid spectral overlap and images were edited 
using Adobe Photoshop. Representative images of Allstars (upper panel) and Rab7A 
(lower panel) treated cells and the fluorescence channels for GFP (left) and mCherry 
(middle) as well as the overlay of both channels (right) are depicted. Scale bar = 10 µm. 
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In summary, the data gained with the FACS assay, confocal microscopy, and gentamicin 
protection assay demonstrate that the depletion of Rab7A has a significant adverse 
biological effect on the Salmonella infection process. The stability of FACS measurements 
made after Rab7A knock down using the sequence Rab7A_2 additionally legitimates the 
employment of this siRNA as the inhibitory control for the screening experiments. 
 
III.2 Large scale RNAi screening and statistical analysis 
III.2.1 Primary screen 
Two siRNA libraries were employed for large scale RNAi screening experiments using the 
high-throughput bi-chromatic FACS assay, namely, 1. the SOS library, containing varied siRNA 
sequences used in our laboratory, and 2. the validated kinase library (SKV). The composition 
and the properties of the libraries are summarized in table III.1. 
Both libraries were already distributed into the 48 inner wells of 96 well plates, solved in 
RPMI medium without FCS with a concentration of 200 nM and stored at -80°C. These plates 
are from now on called the transfection plates. Each plate could be used for two transfection 
experiments using the pipetting robot. The automatic transfections were carried out as 
described in II.6.8.2.1 using the plate scheme depicted in figure S.1. 
The SOS library was screened first with testing every transfection plate at least three times, 
followed by the SKV screen. The acquired raw data from the siRNA libraries was further 
processed with the respective software (see II.11) and analyzed statistically. 
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Figure III.14: Gentamicin protection assay demonstrates a significant bacterial 
replication defect in Rab7A knock down cells. 
In order to calculate the bacterial replication rate, a gentamicin protection assay was 
performed. Transfected HeLa cells were infected and at 2 hours p.i. and 16 h p.i. 
infected cells were lysed with triton, the lysates were serial diluted and plated on 
selective agar plates to count bacterial colonies. The replication rate was calculated 
by the ratio of recovered bacteria at 16 h p.i. and 2 h p.i. The data shows a 
representative experiment with means and standard deviations (n=3) for Allstars 
treated and Rab7A_2 treated cells. P-value <0.05. 
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Table III.1: siRNA library composition and properties 
library Nº of genes Nº of siRNAs per gene Nº of plates composition source 
SOS 480 1 10 non-related in-house 
SKV 588 2 26 kinase genes Qiagen 
 
Initially, it was important to validate the quality and robustness of the screening data. In a 
first analysis step, the mean inhibition values for Rab7A of all plates and runs were 
calculated and plotted to control the stability of the down-regulating control siRNA 
throughout the whole screening procedure (see figure III.15). As holds true for both libraries, 
the GFP fluorescence in the Rab7A samples normalized to Allstars was comparable within 
the whole amount of plates and runs with a total mean of about 0.68 and 0.65 for the SKV 
and the SOS library, respectively. Based on these results, the inhibition data of the siRNAs to 
test that was calculated on the basis of the Allstars and Rab7A values could be considered as 
reliable and was therefore analyzed further. 
To obtain an overview of the distribution of critical screening parameters, the entire data 
sets for the SKV and the SOS library were further analyzed for mean plate inhibition and cell 
toxicity as well as inhibition on the single siRNA level. The respective diagrams are shown in 
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Figure III.15: Statistical robustness of the Rab7A siRNA control. 
The reliability and quality of the screening data was validated in a first step by analyzing 
the stability of the Rab7A inhibitory control for all plates screened. The median values of 
all Rab7A replicates for each plate were used to calculate the respective decrease in GFP 
intensity normalized to Allstars. The box-plots show the median (line in box), the upper an 
lower quartile (box), the 2.5% percentile (lower whisker) and the 97.5% percentile (upper 
whisker). Plates are shown in their order for the SKV library [A] and the SOS library [B]. 
The means and standard deviations for the medians of all plates are shown in [C].  
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figure III.16. In order to guarantee an unbiased plate allocation of the transfection plates, the 
mean inhibition of the collectivity of siRNAs in one plate should be in the range of zero. This, 
indeed, was the case for both library plates as indicated by the box plot characteristics 
(figure III.16.A). Thus, the quality of the plates with regard to the unbiased distribution of the 
test siRNAs was proven. The cell number of each siRNA sequence, normalized to Allstars, 
revealed a difference in cell toxicity between the SKV and the SOS library (figure III.16.B). 
Whereas the overall toxicity of siRNAs of the SKV library was relatively moderate, a higher 
number of siRNA sequences of the SOS library showed significant cell toxicity. This is also 
demonstrated by the quantification diagram (figure III.17.A). Additionally, the mean 
inhibition values of the individual siRNAs of the SOS library showed a slight bias to a down-
regulating phenotype (figure III.16.C). This becomes also obvious from the quantification 
shown in figure III.17.B. The observed bias is probably founded in the more pronounced 
toxicity of the SOS siRNAs leading to inadequate infection conditions. 
The relatively high number of toxic siRNAs in both libraries made it necessary to carefully 
check the tested siRNAs for their impact on cell number before evaluating their importance 
for the bacterial infection process, namely the GFP and mCherry fluorescence. Therefore, a 
three step selection procedure was performed as described in II.11. First, the normalized cell 
counts were examined and all siRNAs that showed a significant cell loss (cell counts < 0.4) 
were excluded from further analysis. Next, the mean inhibition was queried to specify 
siRNAs as up-regulating (≤ -0.5) or down-regulating (≥ 0.5). As the last criterion, the 
Figure III.16: Analysis of whole screening data. 
The entire screening data set that was acquired for the SKV library (left side) and the SOS 
library (right side) was statistically validated. [A] Mean inhibition of all test siRNAs for each 
plate reveals no phenotypic bias (mean values approximately zero) in neither the SKV or the 
SOS library produced by the allocation of the plates. Plates are shown in their order. [B] 
Overall cell toxicity of every sample siRNA sequence, normalized to Allstars, in quantitative 
order. [C] Mean inhibition values for every siRNA sequence in quantitative order. 
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statistical significance for the mean inhibition with Allstars as reference was calculated using 
the Student’s t-test and a value of < 0.05 was defined as implying significant differences. This 
procedure is allegorized in figure III.18 which shows “volcano plots” for the data from the 
SKV and the SOS library. In this two dimensional graphical analysis method the statistical 
significance of the inhibition values (p-value) was plotted against the values for the mean 
inhibition. Characteristic volcano shaped distribution patterns occurred and simplified the 
selection of promising siRNAs for further validation. Only siRNAs located in the shaded areas, 
i.e. siRNAs that fulfilled the criteria for significance (p-value < 0.05) and inhibition (≤ -0.5 or 
≥ 0.5, see above), were considered as being relevant. They were finally evaluated with 
respect to their cell toxicity. A complete list with the toxicity and phenotypic results for all 
siRNA sequences from the SKV library can be found in the supplement (see table S.1). The 
solid analysis with regard to the criteria mentioned above gave a list of candidate genes that 
Figure III.17: Higher toxicity and a biased phenotype in the SOS library. 
The entire screening data from the SKV and the SOS library was quantified with regard to 
the cell toxicity [A] and the impact on Salmonella growth [B]. > 0.5: relevant inhibition of 
Salmonella replication; < -0.5: relevant up-regulation of Salmonella replication. 
white bars: SKV library     grey bars: SOS library 
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Figure III.18: Volcano plots of SKV and SOS data. 
The mean data of all siRNA sequences for mean inhibition (x-axis) and p-value (y-axis) was 
plotted as is shown for the SKV library [A] and the SOS library [B]. Samples that fulfill the criteria 
for mean inhibition and significance are located in the grey shaded areas. They were further 
analyzed by applying the cell count threshold to serve as validation candidates. 
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were considered as possible screening hits. Due to technical restrictions only a limited 
number of siRNAs could be integrated into the validation process with the main focus on SKV 
siRNA targets. The 48 chosen candidate genes of the SKV library with their mean inhibition 
and p values are listed in figure III.19 and in the supplementary table S.3. 20 of these showed 
a down-regulating phenotype, whereas 28 caused an upregulation of the infection. It has to 
be mentioned that for all of the candidate genes that were chosen for the subsequent 
validation only one out of two siRNAs from the SKV library showed the effect. Although, the 
library was validated for knock down efficiency, this result might have resulted from 
inadequate knock down rates. 
This first selection of siRNA sequences that caused a decrease in GFP fluorescence was 
further analyzed implying the second fluorescence read-out. For this, the ratio of the 
mCherry fluorescence and the GFP fluorescence was calculated to test for shifts in the 
fluorescence intensity (figure III.20.A). The Allstars treated sample was used as a neutral 
control and as the reference for calculating the statistical significance. Cells depleted of 
Rab7A displayed a significantly lower ratio, normalized to Allstars (69 ± 5, mean and SD, n= 
4, p-value < 0.001). This was also the case for MKNK2 and EIF2AK3 (84 ± 10 and 72 ± 19, p-
values < 0.05,), MAP2K7, AKT2, MAP3K7, CDC2L1 and MAP3K7IP1 (75 ± 10, 81 ± 8, 64 ± 17, 
79 ± 10 and 63 ± 15, p-values < 0.01) and BEGAIN (66 ± 11, p-value < 0.001). 
The difference in the mCherry/GFP ratio gave a first indication that the bacterial metabolic 
activity could have been impaired after siRNA mediated knock down of the respective genes 
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Figure III.19: Selected candidate genes of the primary SKV screen. 
After statistical analysis of the data from the primary SKV screen, 48 candidate genes were chosen for 
validation. Their impact on Salmonella growth is illustrated on the left, the mean values of at least three 
independent experiments with SD for each candidate. The statistical signifance of the mean inhibition of 
all candidates with Allstars as reference is shown on the right. 
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since the ratio normally shows a linear course and a lower value would be a sign of 
differentially distributed cell populations (see figure III.4; dot plots with different cell lines 
and figure III.12; dot plot of Rab7A depleted cells). To further evaluate this, the quadrants 
two and four containing GFP/mCherry and GFP-only cells (harboring presumably metabolic 
inactive bacteria), respectively, were determined and the ratio of the according percentages 
was calculated. In figure III.20, the diagrams for the ratio normalized to Allstars (figure 
II.20.B) as well as the respective dot plots (figure II.20.C) are depicted. Rab7A knock down 
cells displayed a much lower ratio, indicating only small numbers of GFP/mCherry positive 
cells which was in accordance to the microscopic analysis and bacterial quantification 
described in III.1.5.2 and III.1.5.3, respectively. A similar phenotype could be seen for 
MAP3K7IP1 and EIF2AK3, whereas the other samples showed no significant differences to 
the Allstars control value. The mathematically derived rating could be underlined by the 
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Figure III.20: Bichromatic FACS read-out allows further phenotypically validation of 
primary hits. 
All primary hits that showed a down-regulation of infection were further evaluated using 
the different fluorescence properties of both fluorescence reporters. [A] Ratio of mCherry 
and GFP fluorescence of infected cells with the respective siRNAs. The value of Allstars 
treated cells was taken as reference for the calculation of the statistical significance. Values 
below the Allstars reference indicate proportionally lower mCherry fluorescence. The data 
shown are means from at least three independent experiments with SD. P-values are 
<0.05, <0.01, and <0.001, respectively. [B] The ratio of particles detected in quadrants two 
(GFP and mCherry) and four (GFP only) for targets that were identified as being significant 
in [A], normalized to Allstars. [C] Respective dot plots for the targets from [B] with GFP and 
mCherry fluorescence on the x-axis and y-axis, respectively. 
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corresponding dot plots. For Rab7A, MAP3K7IP1 and EIF2AK3 a strong shift of the infected 
population could be observed (see figure III.20.C) 
 
III.2.2 Validation of screening results 
The primary screen resulted in 48 possible hits for the SKV library. In order to increase the 
reliability of the acquired phenotypes the primary hits had to be further validated. This was 
achieved by ordering siRNA oligonucleotides targeting the genes of interest with sequences 
different from those already examined within the screen. Due to technical reasons, the 
validation was focused on the kinase library (SKV). All genes that were part of the validation 
process are listed in table S.2 (supplement). For each gene, four individual siRNA sequences 
were ordered from Qiagen according to their availability. They were delivered in 96 well 
plates and resuspended to gain the transfection plates for the SKV validation. The 
transfection and infection experiments were performed manually as described in II.6.8.2.2 
and the statistical analysis was carried out similarly to the one described before. 
Table III.2 shows the results of the validation experiments for those siRNAs that showed a 
phenotype in the validation experiments. The mean inhibition values of the primary screen 
are included, to allow direct comparison of the results for the different siRNAs. For the 
validation data the strongest inhibition value is given along with the number of siRNA 
sequences that yielded the respective phenotype. 
 
Table III.2: Validated kinases constituting possible candidates for functional characterization 
siRNA 
target  
function Gene 
ID 
% inhibition phenotype 
   screen  validation screen  validation 
CSNK1D casein kinase 1453 0.72  - 0.52 (1/4) down  up 
EIF2AK3 translation initiation 
factor kinase 3 
9451 0.83  - 1.25 (2/4) down  up 
ACVR2 activin receptor 92 - 0.71  - 0.52 (2/4) up  up 
CERK ceramide kinase 64781 - 1.0  - 0.3 (1/4) up  (up) 
AK1 adenylate kinase  - 0.81  - 0.57 (2/4) up  up 
SNF1LK2 salt-inducible kinase 
2 
23235 - 1.13  - 0.67 (2/4) up  up 
MAPK3 mitogen-activated 
kinase 3 
5595 - 0.77  - 0.47 (2/4) up  (up) 
PGK1 phosphoglycerate 
kinase 1 
5230 - 0.96  - 0.65 (4/4) up  up 
MAP2K7 mitgen-activated 
kinase kinase 7 
5609 0.94  0.71 (3/4) down  down 
MAP3K7IP1 TAK1-binding 
protein 1 
10454 0.73  - 0.73 (2/4) down  up 
CSNK1G3 casein kinase 1456 - 1.0  0.89 (2/4) up  down 
NEK7 NIMA-related kinase 
7 
140609 - 0.72  - 0.45 (2/4) up  (up) 
MERTK c-mer proto-
oncogene 
10461 - 1.13  - 0.72 (2/4) up  up 
MKNK2 MAPK interacting 
kinase 2 
2872 1.10  - 0.65 (3/4) down  up 
MAP3K7 TGF activated kinase 6885 0.83  - 0.41 (3/4) down  (up) 
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III.3 Functional characterization to reveal the role of the mitogen-activated protein kinase 
kinase 7 (MKK7) during Salmonella infection of epithelial cells 
After the validation of the primary screening data with additional independent siRNA 
sequences, a set of host cell genes that play a role during Salmonella growth in HeLa cells 
was compiled (see table III.2). A major challenge was then to decide on the factor that would 
be integrated into follow-up experiments to derive functional data. First, the comparison 
between primary screening data and validation results was taken into account, especially the 
phenotype of Salmonella growth (up/down). Interestingly, for a lot of targets oppositional 
phenotypes were observed (see table III.2) which characterized these targets as less 
interesting for further studies. Additionally, the robustness of the validation, i.e. the number 
of siRNA sequences showing the same trend of phenotype, was considered. Finally, it was 
surveyed whether helpful scientific publications regarding a host cell factor and Salmonella 
infection had already been published. Therefore, the considerations of possible follow-up 
targets led to the decision to functionally characterize the mitogen-activated protein kinase 
kinase 7 (MAP2K7 or MKK7) during Salmonella infection for the following reasons: 
 
1. The knock down of MKK7 resulted in the inhibition of Salmonella growth both in the 
primary screen and the validation (same phenotype), 
2. Within the validation, three out of four siRNA sequences showed the same phenotypic 
trend, and 
3. MAP kinases are known to play a role during Salmonella invasion and replication.k 
 
Several MAPKs have been reported to be activated by Salmonella, mainly in the context of 
pro-inflammatory host responses (see Introduction part for details). Therefore, they play a 
significant role in infections with this pathogen. MKK7 is involved in mediating the response 
to pro-inflammatory cytokines such as TNFα and other environmental stress stimuli, 
predominantly by activating the effector MAPK c-jun N-terminal kinase (JNK)(Tournier et al., 
1997). One important pathway of cellular stress is the release of the second messenger 
arachidonic acid (AA) from cell membrane phospholipids, catalyzed by the ubiquitously 
expressed enzyme cytosolic phospholipase A2 alpha (cPLA2) (Chakraborti, 2003) which can 
also be phosphorylated by MAPKs (Lin et al., 1993, Borsch-Haubold et al., 1998, Hefner et al., 
2000). AA then stimulates the synthesis of prostaglandins. Interestingly, Galan and 
colleagues demonstrated that an inhibitor of cPLA2 is able to decrease the invasion rate of 
Salmonella Typhimurium into cultured epithelial cells, arguing that cPLA2 activity is involved 
in this process (Pace et al., 1993). They also observed an increase in intracellular calcium, 
which stimulates the localization of cPLA2 from the cytosol to membranes and thereby leads 
to its activation. In the same report phosphorylation of the MAPK Erk was shown upon 
Salmonella attachment and invasion resembling signaling through the epidermal growth 
factor receptor (EGFR). Taken together one could speculate that cPLA2 is activated through 
the MAPK pathway and active cPLA2 is necessary for Salmonella invasion and probably also 
subsequent replication which could be demonstrated for the intracellular bacterium 
Chlamydia trachomatis (Su et al., 2004). In this context, the knock down of MKK7 might lead 
to a decrease of cPLA2 activity. This could cause an inhibition of bacterial invasion and/or 
replication. Therefore the role of MKK7 and cPLA2 in Salmonella infection was further 
characterized. 
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III.3.1 MKK7 knock down reduces Salmonella intracellular growth 
MKK7 was identified within the kinome screen as being important for Salmonella 
intracellular growth. Infected HeLa cells showed less GFP fluorescence after MKK7 knock 
down compared to Allstars treated cells. A representative FACS histogram is depicted in 
figure III.21.A. The grey shaded curve and the black line resembles Allstars treated cells and 
MKK7 treated cells, respectively. A shift in GFP fluorescence could be observed for MKK7 
treated cells resulting in approximately 30 % reduction of GFP intensity (figure III.21.B). In 
order to evaluate the FACS derived inhibitory phenotype for MKK7 knock down, gentamicin 
protection assays were performed as described in II.6.6. This allowed quantification of 
intracellular bacterial replication in Mock, Allstars and MKK7 treated HeLa cells. As a 
confirmation for the FACS results, the gentamicin protection assay using siRNA-treated HeLa 
Figure III.21: MKK7 knock down inhibits Salmonella intracellular growth. 
The impact of MKK7 kd on Salmonella intracellular growth was evaluated with the FACS 
assay and with gentamicin protection assays. [A] A representative FACS histogram 
showing the GFP fluorescence of Allstars transfected cells (grey shaded curve) and 
MKK7 transfected cells (black line). [B] Quantification of the GFP fluorescence from 
infected cells after Allstars or MKK7 transfection as mean with SD from triplicates. [C] 
Gentamicin assay of Allstars treated cells (white) or MKK7 treated cells (grey) showing 
the replication rate normalized to Allstars as the mean with SD from three individual 
experiments. [D] Gentamicin assay of Luciferase (white) or MKK7 (grey) shRNA 
transfected cells showing the replication rate normalized to Allstars as mean with SD 
from two individual experiments. 
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cells revealed a significant decrease of replicating bacteria in MKK7-depleted host cells 
(figure III.21.C). This was further validated with a shRNA-mediated MKK7 stable knock down 
HeLa cell line (figure III.21.D). 
Taken together, these experimental data verified that the depletion of MKK7 inhibits 
Salmonella intracellular replication. 
 
III.3.2 cPLA2 is activated in Salmonella infected cells 
MAPK have been reported to be involved in the activation of cPLA2, a molecule that was 
described to be involved in Salmonella invasion. In order to find out whether the knock 
down of the MAPK MKK7 had an influence on cPLA2 activation directly or indirectly and 
thereby caused an inhibition of bacterial infection, initially, a possible activation of cPLA2 
during Salmonella infection was investigated. 
HeLa cells were seeded in 24 well plate format and were either infected with a MOI of 50 or 
left uninfected. Uninfected cells were either left untreated or stimulated with 100 nM 
phorbol-12-myristate-13-acetate (PMA), a non-specific inducer of several pro-inflammatory 
pathways serving as a positive control. One infected sample was treated with 10 µg/mL 
chloramphenicol (CAM) 2 h p.i. to prevent bacterial replication. Cells were lysed with 1x 
Lämmli buffer at different time-points and the cell lysates were tested for cPLA2 
phosphorylation by SDS-PAGE and immunoblotting using an antibody specific for 
Figure III.22: cPLA2 is phosphorylated and activated upon Salmonella infection. 
[A] Infected or non-infected HeLa cells were prepared for immunoblotting at different time-points. Cell 
lysates were probed for Ser505 phosphorylated cPLA2 (p-cPLA2), total cPLA2, bacterial Hsp60 and actin as 
loading control. [upper part] Immunoblots showing the respective samples. [lower part] Quantification of 
the relative amount of phosphorylated cPLA2 in the respective samples, normalized to the non-infected 
control at 0 min (black bar). PMA: phorbol-12-myristate-13-acetate; CAM: chloramphenicol [B] The 
enzymatic activity of cPLA2 was quantified in non-infected (white bar) and infected (grey bar) cells at the 
respective time-points using a specific fluorescent dye and FACS analysis. 
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phosphorylated cPLA2. Additionally, bacterial Hsp60 was detected to monitor bacterial 
replication and total cPLA2 and actin detection were used to assess relative cPLA2 
phosphorylation or equal sample loading, respectively. For quantification of the relative 
amount of phosphorylated cPLA2, immunoblots were processed with ImageJ 
(http://rsbweb.nih.gov/ij/index.html). First, all actin signals were normalized to the intensity 
of the non-infected sample from time-point zero. Then, total cPLA2 was normalized to this 
value and finally the intensity of phosphorylated cPLA2 was set into relation to total cPLA2. 
Additionally, cPLA2 enzymatic activity was monitored in non-infected and infected cells at 
different time-points using a specific substrate and resulting fluorescence was measured 
with a FACS Calibur. 
Figure III.22.A reveals that cPLA2 became phosphorylated very early in infection. Already five 
minutes p.i. a significantly stronger band of expected size compared to the non-infected 
background level could be observed which could also be quantified using ImageJ (III.22.A, 
lower part). The phosphorylation of cPLA2 remained equal during the infection time tested 
with a slight decrease 20 hours p.i. (see quantification in figure III.22). The chloramphenicol-
treated sample showed less phosphorylation which, nevertheless, was stronger than in the 
control sample. This observation was further verified with the quantification of cPLA2 
enzymatic activity (figure III.22.B). Here, a higher activity was measured for infected cells 2 h 
p.i. compared to non-infected which was in comparison to the phosphorylation levels 
detected. This activity was less at 20 h p.i. but still higher than in control cells, indicating a 
sustained enzymatic activity of cPLA2 in infected cells. The demonstrated phosphorylation 
and induction of enzymatic activity by Salmonella Typhimuirum might be a hint for the 
requirement of cPLA2 enzymatic activity for the efficient replication of the pathogen. 
 
III.3.3 cPLA2 is necessary for Salmonella intracellular replication 
The infection time course revealed an activation of PLA2 during Salmonella infection (figure 
III.22), indicating that cPLA2 might be important for Salmonella growth in epithelial cells. To 
test this, the expression of cPLA2 was silenced using specific siRNAs (PLA2_1 and PLA2_2 as a 
Figure III.23: cPLA is necessary for Salmonella intracellular replication. 
The intracellular replication rate was quantified with the help of the gentamicin assay for siRNA-treated cells 
[A] or shRNA treated cells [B]. Intracellular replication was normalized to the controls Allstars [A] or 
Luciferase [B]. Mean data from two experiments with SD is shown. P-values: **<0.01; ***<0.001. 
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pool) or by constructing a stable cPLA2 knock down cell line and gentamicin protection 
assays were performed as described in II.6.6. The results of these experiments are presented 
in figure III.23. It becomes obvious that the knock down of cPLA2 reduced the intracellular 
replication of bacteria to about sixty percent of the control level. 
 
III.3.4 MKK7 knock down provokes reduced cPLA2 protein levels 
In contrast to the results described above, Galan and colleagues reported on the 
requirement of cPLA2 for the Salmonella invasion process (Pace et al., 1993). In their study, 
the authors argued that MAPKs are likely to be involved in this process. However,  the role of 
MKK7 in cPLA2 activation was not evaluated. To do so in this work, cPLA2 phosphorylation 
during infection in the absence of MKK7 was ascertained. 
HeLa cells were seeded in 12 well plates and 24 hours later they were either mock 
transfected or transfected with Allstars siRNA or MKK7 siRNAs. Three days post transfection 
cells were infected with Salmonella Typhimurium 12023 wt with a MOI of 50. 2 h p.i. cells 
were lysed and tested for cPLA2 phosphorylation by SDS-PAGE and immunoblotting using a 
phosphorylation-specific antibody. Total cPLA2 and MKK7 levels were detected with 
respective antibodies and actin detection was used to assess equal sample loading. The 
knock down of MKK7 using a pool of two siRNAs was successful demonstrated by a 
significantly weaker band of expected size (see third row for MKK7 siRNA in figure III.24.A 
and white bar in III.24.B). In the MKK7 knock down sample also the levels of phosphorylated 
cPLA2 (first row) as well as total cPLA2 (second row) were considerably lower than in control 
transfected cells (Allstars and Mock), indicating that the knock down of MKK7 caused 
changes in the protein level of cPLA2 during infection. Although the total levels of cPLA2 
were considerably lower in MKK7 depleted cells, the relative phosphorylation level of cPLA2 
(i.e. ratio of phosphorylated to total cPLA2) was the same under all conditions applied (see 
Figure III.24: MKK7 knock down provokes reduced cPLA2 protein levels. 
HeLa cells were either mock transfected or transfected with Allstars siRNA or a pool of two siRNAs targeting 
MKK7. Three days post transfection cells were infected and 2 h p.i. cells were lysed and subjected to SDS-
PAGE and immunoblotting. [A] Immunoblot showing respective lysates analyzed for phospho-cPLA2 (first 
row), total cPLA2 (second row), MKK7 (third row), and actin as loading control (fourth row). [B] 
Quantification of the immunoblot displayed in [A]. Shown are the values for MKK7 (white bar), cPLA2 (light 
grey bar), and the ratio of phosphorylated to total cPLA2 (dark grey bar), normalized to mock transfected 
cells. 
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dark grey bar in III.24.B). Therefore, a MKK7 dependent control of cPLA2 levels seems likely 
which could account for the observed downregulation of Salmonella infection upon MKK7 
knock down. 
 
III.3.5 MKK7 and cPLA2 do not form a stable protein complex 
Both MKK7 and cPLA2 are involved in the intracellular replication of Salmonella in epithelial 
cells which was demonstrated by siRNA or shRNA mediated knock down experiments. 
Additionally, it was observed that upon MKK7 depletion the protein levels of cPLA2 decline 
which could explain the inhibitory phenotype of MKK7 knock down. Although to date, there 
are no reports on a physical interaction between MKK7 and cPLA2 it could be possible that 
MKK7 forms a complex with cPLA2, thereby stabilizing this protein. Similar observations have 
been reported for inhibitor of apoptosis protein (IAP) complexes (Rajalingam et al., 2006). 
In order to find out whether MKK7 and cPLA2 form a stable complex, co-
immunoprecipitation (Co-IP) experiments were performed as described in II.8.3. 2.4x106 
HeLa cells were seeded in 10 cm dishes. The next day the cells were differentially treated as 
described in the legend of figure III.25 and 2 hours later they were processed for Co-IP using 
either an antibody against MKK7 or against cPLA2 for pull-down. Pre-clear lysates as input 
control and immunoprecipitated lysates were applied to SDS-PAGE and immunoblotting to 
detect MKK7 and cPLA2. In order to avoid masking of the MKK7 signal by the denatured 
heavy chain of the IP antibody, a light chain specific secondary antibody was used (see 
II.8.3). The Co-IP studies revealed that there is no direct interaction of the MAP kinase and 
PLA2 (figure III.25). Within all input samples (left part) distinct bands for cPLA2 and MKK7 
Figure III.25: MKK7 and cPLA2 do not form a stable complex. 
HeLa cells were seeded in 10 cm dishes and 24 h later treated for 2 h as follows: Ø, no treatment; 
P, 100 nM PMA; L, 10 ng/µL E. coli LPS; S, Salmonella Typhimurium 12023 wt (MOI 50). Samples 
were prepared for Co-IP as described in II.8.3 and proteins were detected using specific 
antibodies. [A] Input and IP samples from a Co-IP using a MKK7 antibody that were analyzed for 
cPLA2 (upper panel) and MKK7 (lower panel). [B] Input and IP samples from a Co-IP using a cPLA2 
antibody that were analyzed for cPLA2 (upper panel) and MKK7 (lower panel). 
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could be observed. However, after pull down of MKK7 no cPLA2 signal was detected (figure 
III.25.A, upper panel in right part) and vice versa (figure III.25.B, lower panel in right part), 
indicating that under the conditions used cPLA2 could not be co-immunoprecipitated with 
MKK7. This suggests that MKK7 and cPLA2 do not form a stable complex. 
 
III.3.6 MKK7 regulates the expression of cPLA2 
Given the fact that the Co-IP for MKK7 and cPLA was negative, a control of cPLA on protein 
level exerted by MKK7 seemed unlikely. In order to test whether MKK7 regulates the 
expression of cPLA2, HeLa cells were either transfected with Allstars control siRNA or with 
different siRNAs targeting MKK7 or cPLA2 and the relative cPLA2 mRNA amounts were 
detected by quantitative RT-PCR (figure III.26). Indeed, following MKK7 knockdown with two 
different siRNA sequences, the mRNA levels of cPLA2 also decreased significantly (figure 
III.26). This implicates that MKK7 is involved in the transcriptional regulation of cPLA2. 
III.3.7 cPLA2 knock down leads to an increased formation of filiform Sifs 
In order to further functionally characterize the impact of cPLA2 knock down on intracellular 
bacteria, HeLa cells were either transfected with Allstars or cPLA2 siRNAs, infected with 
Salmonella Typhimurium constantly expressing the mCherry protein and 16 h p.i. the 
samples were stained for the lysosomal marker protein LAMP-1. This lysosomal marker helps 
to visualize the strcuture and form of the Salmonella induced filaments (Sifs) which are an 
indication for the accomodation of Salmonella Typhimurium inside epithelial cells. Figure 
III.27.A displays exemplary confocal images of Allstars or cPLA2 transfected cells. Bacteria 
Figure III.26: MKK7 regulates cPLA2 expression. 
HeLa cells were transfected with Allstars control siRNA or with different siRNA sequences 
targeting MKK7 and cPLA2. Three days post transfection cells were lysed and RNA was 
isolated. The relative cPLA2 mRNA amount was detected using RT-PCR. 
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are false colour stained in red and LAMP-1 is false colour stained in grey. Interestingly, it was 
observed that in a significant proportion of infected cPLA2 kd cells, Sifs appeared very thin 
and filamentous (see arrowheads in figure III.27.A) as compared to the more robust and 
Figure III.27: Knock down of cPLA2 induces the formation of filiform Sifs. 
HeLa cells were treated either with Allstars or cPLA2 siRNAs and infected with Salmonella Typhimurium, 
constitutively expressing the mCherry protein (red colour in [A]). 16 h p.i. samples were stained for LAMP-1 
(grey colour in [A]) and images were acquired using a confocal microscope. [A] Exemplary images of infected 
cells treated with Allstars (upper panel) or cPLA2 (lower panel) siRNAs. Thick, mature Sifs are indicated by 
arrows, filiform Sifs by arrowheads. Scale bar: 10 µm. [B] Quantification of infected cells showing the filiform 
Sif structure. Data shown is from one experiment and at least twenty infected cells were analyzed. 
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thick structure of Sifs in Allstars transfected cells (see arrows in figure III.27.A). The initial 
observation was quantified by counting at least twenty infected cells for both conditions. 
Stacks of three confocal planes were merged and the percentage of infected cells showing 
filiform Sifs was calculated (see figure III.27.B). In cPLA2 depleted cells, about 50 % of 
infected cells show filiform Sifs, compared to 16 % of infected cells in Allstars-treated 
samples. This indicates that cPLA2 plays a role in the formation of regular Sifs, probably by 
its enzymatic activity which enables the lipid modification of Sif membranes.
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IV Discussion 
 
Intracellular pathogens rely on cellular functions of their host cells to establish a niche 
suitable for growth and replication. Key aspects of successfully concluding an infection are 
the invasion of the host cell, intracellular accommodation and replication, and subsequent 
release from infected cells to initiate a new infectious cycle. During all of these stages, 
components of the host cell machinery must be exploited to arrange conditions favourable 
for the pathogen. In this context it is conceivable that different pathogens use common host 
cell pathways but also distinct ones which reflect specific needs and evolutionary 
adaptations. The study of molecular pathways used by intracellular pathogens contains the 
capacity to gain a deeper insight into basic cellular processes of the host cell. Salmonella 
Typhimurium constitutes an ideal model organism to study bacterial interactions with host 
cells. It is a Gram negative facultative intracellular bacterium which induces its uptake into a 
variety of different eukaryotic cell types by the delivery of effector proteins via a type three 
secretion system (T3SS). It can be cultivated on solid agar plates as well as in liquid medium 
and it is readily accessible to genetic manipulations, making it comparatively easy to deploy 
under normal laboratory conditions. Since Salmonella are also very relevant pathogens for 
humans and livestock, research on the intracellular lifestyle of this organism shall contribute 
to further development of antimicrobial therapies. Intensive genetic studies on the bacterial 
side have identified a number of important virulence factors, which mostly became obvious 
using Salmonella Typhimurium mutants in cell culture or mouse infections. This led to a 
comparatively good knowledge of bacterial factors and their regulation that play a role in 
Salmonella interplay with host cells. On the other side, only a few host cell factors have been 
identified so far that are targeted by Salmonella to establish a successful infection. This was 
mainly due to the lack of techniques to routinely generate cell lines exhibiting a specific 
genetic deletion. Therefore, scientific research was mainly restricted to cells isolated from 
knock out mice or to overexpression of dominant-negative forms of proteins of interest. 
With the discovery of the RNAi pathway in eukaryotes, a powerful tool to study eukaryotic 
gene function emerged which also showed to be auxiliary in disclosing pathogen-host cell 
interactions on a molecular level. Despite drawbacks of the RNAi technique, the possibility to 
evaluate the impact of a specific host cell gene knock down on the course of infection will 
certainly contribute significantly to the understanding of the many ways pathogens have 
evolved to exploit host cell processes. 
In this work, a technical system was set up to precisely monitor the intracellular growth of 
Salmonella Typhimurium inside eukaryotic host cells. This was achieved by using the green 
fluorescent protein (GFP) together with a derivative of the Discosoma sp. Red fluorescent 
protein (DsRed), named mCherry, as reporter genes for bacterial replication and metabolic 
activity. The principal readout system for this assay was flow cytometry but it also proofed to 
be applicable to microscopy. With this robust assay RNAi screens were performed employing 
two different siRNA libraries and the impact of host cell gene knock down on Salmonella 
intracellular growth was verified. The screening was followed by statistical analysis and 
intensive validation to distil host cell factors that are involved in Salmonella Typhimurium 
infection of the human epithelial cell line HeLa. 
The Salmonella Typhimurium reporter strain was generated by constructing two plasmids 
that were introduced into the wild type strain 12023. The first plasmid, pOR25, expresses 
the GFP variant GFPmut3 (Cormack et al., 1996) under a constitutively active promoter, 
DISCUSSION 69 
φrpsM. This reporter allows to monitor the bacterial replication both in-vitro and in-vivo. 
The FACS analysis of single bacteria in-vitro showed a characteristic GFP fluorescence 
intensity curve over time. This was set in correlation to the growth phase at the respective 
time-point (see figure III.3.C). Since the promoter φrpsM drives the expression of a gene 
encoding a ribosomal protein which is especially necessary in rapidly dividing bacteria with 
high protein turnover, the GFP intensity of single bacteria increases when the bacteria are in 
the logarithmic growth phase. When entering the late-logarithmic and later the stationary 
phase, the activity of the rpsM promoter declines and the GFP intensity decreases due to 
dilution during cell divisions. However, this scenario can be seen only under ideal growth 
conditions, especially in a nutrient rich environment. The conditions of the nutrient poor 
Salmonella containing vacuole (SCV) inside the host cell do not allow a dilution of GFP 
molecules among dividing bacteria when the φrpsM activity is reduced, resulting in less GFP 
intensity, since the replication rates in-vitro and in-vivo are not comparable. Rather, the 
relatively long half-life of the GFP molecule, which was estimated to be more than 24 h 
(Andersen et al., 1998), leads to an accumulation of GFP inside the bacteria and therefore 
the GFP fluorescence intensity will increase in relation to the number of bacteria inside the 
vacuole (Thone et al., 2007). This allows for monitoring intracellular bacterial replication 
using the GFP intensity as a general fluorescence reporter. Nevertheless, when not following 
the growth of intracellular bacteria in a time-course experiment but rather only determining 
one time-point, as during the performance of a high-throughput screen, the stability of the 
GFPmut3 molecule brings about the problem to distinguish between slowly replicating 
bacteria and those that are unable to replicate at a certain time-point of the infectious cycle. 
Both bacterial populations will probably display a comparable GFP intensity but with 
dramatically different underlying phenotypes. Thus, in order to query the vitality of 
intracellular bacteria shortly before performing the FACS analysis, an inducible reporter 
system was developed, the plasmid pOR26. Here, the fluorescent protein mCherry is 
expressed under the control of the promoter φaraBAD which is induced by arabinose 
(Guzman et al., 1995). Since the bacteria have to be in a metabolic active state to react to 
the arabinose trigger, the mCherry fluorescence intensity can serve as an additional indicator 
for the impact of host cell gene depletion on the fitness of intracellular bacteria. In FACS and 
confocal microscopy experiments within this work, it could be demonstrated that the 
external addition of arabinose was able to stimulate intracellular Salmonella to express the 
mCherry protein (see figure III.4 and III.5). Interestingly, these experiments also showed that 
the compound arabinose was taken up into the SCV, indicating that a respective sugar 
transporter could be located at the SCV membrane. Additionally, because the presence of 
glucose totally represses the φaraBAD (Guzman et al., 1995), the induction of mCherry 
expression from the plasmid pOR26 suggests that the SCV environment is avoid of glucose. 
In summary, the combination of two functionally distinct bacterial reporter systems in one 
Salmonella reporter strain made it possible to monitor both bacterial replication and 
metabolic activity in one experimental run. The applicability of the reporter strain could be 
demonstrated conclusively in HeLa cells that had been depleted of Rab7A by siRNA 
transfection. The GFP intensity of infected cells after Rab7A siRNA treatment was about 30 % 
lower than in Allstars treated control cells at 16 h p.i. (see figure III.12.B). This indicated a 
moderate replication inhibition upon Rab7A depletion. However, the induction of mCherry 
after arabinose addition nearly completely failed in Rab7A treated cells as can be seen in 
figure III.12.D, suggesting that the majority of intracellular bacteria resided in a metabolic 
inactive state, most likely because the Rab7A knock down had a significantly deleterious 
effect on Salmonella survival. Alternatively, it is possible that the transport of arabinose to 
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the SCV was inhibited in the absence of the small GTPase Rab7A which is a central regulator 
of endosomal vesicle trafficking. This possibility can be excluded when taking into account 
the results from the gentamicin protection assay (see figure III.14). The quantification of 
bacterial replication using this method further demonstrated that the intracellular 
replication of Salmonella Typhimurium is significantly inhibited upon Rab7A knock down. 
This phenotype could be persuasively verified using the bichromatic reporter strain 12023 
pOR25/26, making it an adequate tool for the global RNAi analysis approach. 
In order to perform high-throughput RNAi screenings the Salmonella reporter strain assay 
had to be established in an appropriate experimental format. It was chosen to use the 96 
well plate format which allows to conduct the screens with a considerable low amount of 
plates and in an acceptable time frame. The robustness of the 96 well plate assay had to be 
assured since it was crucial to generate primary data of high quality to minimize the amount 
of false positive or false negative host cell targets. In this context, especially the reliability of 
the semi-automatic FACS acquisition using the FACS Calibur with HTS supply was verified 
intensively. To do so, an adequate human tissue culture cell line had to be found. The FACS 
analysis of different cell lines that had been infected with the Salmonella Typhimurium 
reporter strain revealed remarkable differences with respect to the permissiveness to the 
bacterial infection. Although different epithelial cell lines are exerted for in-vivo Salmonella 
infection experiments, an integrated comparison with respect to invasion efficiency and 
replication capacity has not been reported yet. Therefore, the results from the respective 
studies conducted in this work should be able to give recommendations for the proper cell 
culture model for Salmonella infection. Hec1b is a cancer cell line derived from an 
endometrial adenocarcinoma (Kuramoto et al., 1972). So far, no reports have been 
published concerning Salmonella infections with the cell line Hec1b. Also for HepG2, a liver 
carcinoma cell line (Aden et al., 1979), no reports for the permissiveness to Salmonella 
infections are available. On the other hand, the colon cancer cell line HT-29 has been used 
casually as a model for polarized epithelial cells in Salmonella infection (Raffatellu et al., 
2005, Mellor et al., 2009) and the cervix adenocarcinoma cell line HeLa is the standard 
epithelial cell culture model for Salmonella infections. Although these cell lines are all from 
the epithelial lineage they differed significantly in their permissiveness to Salmonella 
infection which became obvious from the visual analysis and the respective quantification of 
FACS experiments (see figure III.4). The initial invasion rate (i.e. the percentage of infected 
cells) was comparable for all cell lines except for HepG2, although the amount of entered 
bacteria was dramatically different, as could be shown with the GFP fluorescence. Since 
HepG2 cells tend to grow in colonies, thereby building up clumps of cells, if not seeded on 
plastic coated with extracellular matrix components, the access to these cells might have 
been aggravated, explaining the lower invasion rates. Additionally, the responsiveness to 
Salmonella triggered uptake mechanisms might have been variable in the different cell lines, 
explaining the varying amount of bacteria that entered the cells at an early time-point. With 
respect to bacterial replication, the observed differences between the cell lines were even 
more dramatic. The number of infected cells as well as the fluorescence intensities for both 
GFP and mCherry was significantly lower in HT-29 cells than in any other cell line tested. As 
the ability of the reporter strain to grow in these cells was very weak, HT-29 cells proofed to 
be an unsuitable cell line for further experiments. The same was true for HepG2 cells, where 
only weak infection parameters could be observed. The cell lines Hec1b and HEp-2 instead 
showed to be very permissive to Salmonella infections, because the invasion and replication 
parameters were comparable to those of HeLa cells. Nevertheless, the dot plot analysis of 
the mCherry fluorescence showed that two populations of infected cells had emerged, one 
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showing a good response to the arabinose trigger and another one that exhibited lower 
mCherry fluorescence intensities. This could argue for a heterogeneous infection process in 
these cells, probably also for an inherent heterogeneity among the cell lines, which also 
made these cell lines no proper infection models for the screening experiments. Therefore, 
the cell line HeLa was chosen for the subsequent experimental work, as it showed to be the 
best cell line for infections with the reporter strain. 
Suitable infection conditions in the 96 well plate format using the HeLa cell line were 
determined employing different multiplicities of infection (MOI), i.e. the number of bacteria 
per host cell. It became obvious that high numbers of bacteria, while producing very good 
infection rates also provoked significantly high cell toxicity, most likely by triggering 
apoptotic and/or necrotic pathways of the host cell. A MOI of 20 was chosen for the 
screening experiments since the cell toxicity was tolerable and the invasion rate was about 
50 %. Due to the fact that only every second host cell was infected, it had to be assured that 
the siRNA transfection prior to infection yielded a very high transfection rate to rule out the 
possibility that a considerable amount of non-transfected cells could be infected. This might 
lead to unstable phenotypes during the screen and probably also to more false-negative 
results. Therefore, the transfection conditions were adjusted to gain a very high transfection 
rate, which was estimated to be nearly 100 %, using the Qiagen Biorobot 8000 and a small 
amount of cells (approximately 3000) in 96 well format plates (Nikolaus Machuy, personal 
communication). The toxic siRNA control targeting the human polo-like kinase 1 (PLK1) 
served as a direct transfection control and the threshold was set to < 5 % cells detected 
compared to Allstars treated cells. This threshold was achieved in every experimental run, 
demonstrating adequate and reliable transfection conditions. Interestingly, the median GFP 
fluorescence intensity of infected cells was independent of the MOI that was applied for 
infection (see figure III.7.C). This was an unexpected finding as the number of infected cells 
was significantly dependent on the amount of bacteria used. The equal GFP intensity might 
have different reasons: The initial amount of bacteria that was taken up by the cells could be 
identical for every MOI, which would suggest that only a limited number of cellular “invasion 
platforms” do exist, resulting in an equal number of entering bacteria. However, the 
observed differing GFP intensities at early time-points for cells infected with varying MOIs 
would argue against this. Another possibility is that for every Salmonella-infected cell a 
critical number of intracellular bacteria is acceptable, a phenomenon likely to be controlled 
by the bacteria through a quorum-sensing like process, to prevent killing of the cell. This 
would then lead to an equal mean GFP fluorescence of infected cells with different MOIs. 
Before performing the high-throughput RNAi screening experiments, a small inhibitor screen 
was conducted. Several antibiotics as well as inhibitors of host cell pathways were applied 
and the FACS assay was used in 96 well plate format to evaluate their impact on Salmonella 
replication. For most of the antibiotics and for some of the inhibitors a decrease in GFP as 
well as mCherry fluorescence could be observed with rising concentrations. Another 
important aspect of the assay is its capability to give information on cell toxicity, reflected by 
the number of detected cells. Therefore, this assay is also useful in screening experiments 
with small compound libraries to identify new compounds with antibacterial properties. 
These compounds could either directly target bacterial metabolism or indirectly inhibit 
bacterial growth by influencing important host cell pathways. The impact on host cell 
survival could also be evaluated which would give a first hint on the tolerance of new 
compounds. 
After having evaluated the proper infection conditions and the overall stability of the assay, 
the RNAi screening was performed. Two siRNA libraries were employed, the SOS library and 
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the SKV library. The SOS library consisted of ten 96 well plates and the plates were allocated 
“in-house” with siRNAs of different biological functions, resulting in an only moderately 
functionally biased library. The SKV library was a commercially available library 
(Qiagen, Hilden;http://www1.qiagen.com/products/genesilencing/librarysirna/sirnasets/hu
manvalidatedkinase.aspx) covering the whole human kinome. The genes targeted by this 
library had been derived from experimental data or from theoretical predictions based on 
sequence similarities to known kinases. The SKV library was declared to be knock down 
proven, thus, the knock down efficiciency of all siRNAs of this set had been checked on 
mRNA levels by the company, although this was performed in different cell lines and no 
complete list  of the results is available. Additionally, for every gene target two siRNA 
sequences were distributed on different plates to enable an easier pre-selection of “hits”. 
Kinases are central regulators of many cellular processes, such as cell division, apoptosis, cell 
development, or signaling and are therefore attractive targets for pathogens to reprogram 
the host cell. Hence, the main focus of the screening, the data analysis, the validation, and 
the follow-up work was put on the kinome-wide library. The accumulated primary data from 
both libraries was carefully analyzed statistically to be able to decide on candidates for 
validation. The comparison of the results from both libraries gave interesting indications for 
the quality of the libraries. First, the overall toxicity of all siRNA sequences from both 
libraries was evaluated. For this, data for the number of detected cells from at least triplicate 
values was normalized to Allstars and plotted in quantitative order (see figure III.16.B). It was 
observed that the SOS library had a significantly higher toxicity compared to the SKV library. 
Here, about 60 % of all test siRNAs resulted in a considerable cell loss (i.e. cell count < 0.4 
compared to Allstars). In contrast, the SKV library contained only about 30 % of toxic siRNAs. 
Thus, in the case of the SOS library two thirds of all siRNAs were already excluded from 
further analysis because of their toxicity. This probably also removed potentially interesting 
host cell genes and therefore the quality of the SOS library could be reviewed as inadequate, 
at least under the conditions applied in this setting. The higher amount of toxic siRNAs in the 
SOS library compared to the SKV library could be founded in the fact that the siRNAs of the 
SOS set were designed a couple of years before the SKV sequences and at that time the 
experimental knowledge of the best possible siRNA sequence design to avoid toxicity and 
off-target effects was less than today. Additionally, the SOS library contains a lot of apoptosis 
related target genes or target genes involved in transcription and translation which are likely 
to have a dramatic negative survival effect when depleted. Nevertheless, the SOS screening 
had its relevance as a proof-of-principle screen to test all experimental steps of the assay 
under high-throughput conditions, even though the usefulness with respect to the 
identification of critical host cell factors has to be assessed as marginal. 
Within the primary screen of the SKV more than 70 target sequences resulted in a 
phenotypic shift that was regarded as significant. Due to technical limitations, only 48 of 
them (the strongest candidates) were selected for further validation. Interestingly, for all of 
these candidates only one out of the two sequences yielded the phenotype, whereas the 
other either showed a significant cytotoxicity or generated no phenotypic change. Such a 
result was not expected since the supplier of the library had claimed that all siRNA 
sequences were knock down validated and therefore a phenotype, if specific to the gene 
knock down, was anticipated for both siRNAs. The rationale behind this result could be that 
the observed phenotypes were not specific to the gene knock down but were rather based 
on unspecific effects of the respective siRNA treatments (e.g. off-target effects), and 
therefore, most likely, would not be strong enough to remain during the validation rounds. 
Furthermore, the knock down efficiency of the siRNA sequences could have had a high 
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variation, although validated sequences were proposed for the library. Most likely, an 
interplay of both matters was responsible for the outcome of the primary SKV screening 
data. The primary, unvalidated SKV hit list contained kinases of several different functions, 
making it hard to speculate whether distinct host cell pathways were enriched (see figure 
III.19). Interestingly, the number of targets that resulted in an upregulation of the infection 
exceeded the inhibitory siRNAs. If one assumes an equal statistical detection accuracy for 
both phenotypes (up and down), this implies that the majority of host cell kinases rather 
have an inhibitory function towards Salmonella intracellular replication than a stimulatory 
one. Although enriched kinase pathways were not obvious among the primary SKV data, 
three targets that resulted in a down-regulation of the infection could be identified that are 
located in one functional pathway, namely MAP3K7, MAP3K7IP1, and MAP2K7. All of them 
are involved in the cellular response to pro-inflammatory cytokines and environmental 
stresses and lead to the activation of the effector kinase c-Jun N-terminal kinase (JNK) (Wang 
et al., 2001, Tournier et al., 1999). Although JNK itself did not emerge as a primary hit, these 
results could point to a role of the JNK pathway during Salmonella infection. JNK exists in 
three forms, JNK1, JNK2, and the neuronal-specific JNK3 (Bode et al., 2007). JNK1 and JNK2 
have distinct as well as overlapping functions and therefore, it might be possible that the 
function of one JNK isoform was substituted by another JNK species after the respective 
knock down. A closer look with regard to JNK1 revealed that both sequences caused no 
significant change of the infection phenotype. This would argue against a role of JNK1 itself 
but, nevertheless, JNK1 was considered to be an interesting candidate for later follow-up 
studies for which other siRNA sequences should be tested.  
Surprisingly, the primary SKV candidate list did not contain any of the kinases or kinase 
related genes that were identified within a kinome-wide screen performed by Kuijl et al. 
(2007), published during the accomplishment of this work. This was probably due to 
different infection models since in the publication the breast cancer cell line MCF-7 and the 
Salmonella Typhimurium strain SL1344 were used. It was described that the histidine 
auxotroph strain SL1344 has a cell division defect in cell culture infections (Henry et al., 
2005) and therefore it might not be a suitable strain for these experiments. The pro-survival 
serine/threonine kinase Akt1 (Song et al., 2005), also known as PKB was identified by Kuijl et 
al. as a central regulator of Salmonella replication inside epithelial cells. It was described that 
Akt1 is transiently phosphorylated at an early infection time and thereby inhibits apoptosis 
of infected epithelial cells (Knodler et al., 2005a). It has to be noted, that the primary data 
that was provided by Kuijl and colleagues was not very well structured. Additionally, only the 
data from one out of three experimental runs can be inspected, and thereby it is difficult to 
comprehend why Akt1 was considered an important target for Salmonella infection because 
the inhibitory effect of Akt1 knockdown was only in a moderate range as compiled from the 
primary data list. In addition, it was reported that the data from the siRNA screening 
experiments could be confirmed with shRNA constructs targeting the human kinome. 
However, there was hardly any phenotypic change using any of these constructs, as provided 
within the supplementary information. Within the screen of my work, both sequences 
targeting Akt1 did not lead to a relevant phenotypic alteration of the infection. Moreover, 
one of the sequences caused significant cytotoxicity. This seems very plausible keeping in 
mind that Akt1 is a crucial anti-apoptotic factor and, indeed, the activity of Akt1 is increased 
in many forms of cancer (Altomare et al., 2005). In order to verify the candidates presented 
by Kuijl et al., four siRNA sequences against all of the 14 published targets were purchased 
and tested with the FACS assay again (see table S.3). Using four different sequences for 
every target, there was no significant overlap between both data sets. Summing up, the 
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work of Kuijl et al. did not appear very convincing and thereby a comparison with the data 
generated within my kinome screen seemed to be very difficult. 
48 candidate genes were nominated for further validation, among them 20 down-regulating 
targets and 28 which caused an increasing infection phenotype upon knock down. For each 
gene target four separate siRNA sequences were ordered and tested in 96 well plate format. 
During the validation 32 possible hits could not be confirmed (i.e. 75%) which was in 
accordance to experiences of others, showing that commonly only about 20% of primary hit 
candidates can be verified with solid validation experiments (Nikolaus Machuy, personal 
communication). The complete list of the remaining 16 targets together with their validation 
results can be seen in table III.2. Surprisingly, most of the factors showed an opposing 
phenotype in the primary screen and the validation round, which suggested that either the 
primary data or the data derived from the validation experiments was based on non-specific, 
but reproducible knock down effects. Only four of the validation targets (PGK1, MAP2K7, 
MKNK2, and MAP3K7) gave comparable results with more than two out of four siRNA 
sequences, which classified these factors as more interesting than the others. PGK1 showed 
the same phenotype in the primary screen and the validation during which all sequences 
gave comparable results. However, since PGK1 is a kinase involved in sugar breakdown it 
was suggested that this factor fulfils a housekeeping gene function and would therefore 
have an indirect influence on Salmonella growth. Hence, PGK1 was excluded from further 
analysis. MKNK2 and MAP3K7 showed opposing phenotypes in the primary screen and the 
validation and were therefore also not considered for follow-up experiments, leaving, at this 
stage, MAP2K7 as the most interesting factor. The depletion of MAP2K7 had an inhibitory 
impact on Salmonella intracellular replication in both the primary screen and the validation. 
Within the validation, three out of four siRNA sequences showed the same phenotype. 
Therefore, the role of MAP2K7 (also named MKK7) during Salmonella Typhimurium infection 
of epithelial cells was further investigated. 
MKK7 belongs to the group of mitogen-activated protein kinases (MAPK) which are central 
regulators of diverse cellular processes like apoptosis, growth, differentiation, or 
inflammation. MAPKs transmit extracellular signals, e.g. from growth factors or apoptotic 
stimuli, in the form of a signaling cascades into the cell and shape a cellular response either 
by directly activating other regulatory proteins or by inducing specific transcriptional 
activities (Zhang et al., 2007). MKK7 is mainly involved in the cellular response to pro-
inflammatory cytokines and other environmental stresses. MKK7 can be activated by 
different upstream kinases, LZK (Ikeda et al., 2001), MAP3K1 (Wu et al., 1997), MAP3K4 
(Abell et al., 2007), DLK (Merritt et al., 1999), and TAK1 (Hammaker et al., 2007). 
Extracellular signals leading to MKK7 activation are mainly the pro-inflammatory cytokines 
IL-1 and TNF-α, transmitted via DLK and TAK1. Additionally, signals from growth factor 
receptors, forwarded via the Ras-Rac protein signaling pathway, are able to stimulate MKK7 
(Foltz et al., 1998). Once in an active state, MKK7 specifically induces JNK activity whereas 
the functionally related MAPK MKK4 is able to stimulate both JNK and p38, leading to a 
diversity of physiological outcomes that still have to be deciphered (Wang et al., 2007). JNK, 
also named stress-activated protein kinase 1 (SAPK1) is able to activate several transcription 
factors. Among these are c-JUN, a component of the activator protein-1 (AP-1) complex 
which binds to specific promoter sites leading to transcription of several genes (Shaulian et 
al., 2002) and ATF-2, a transcription factor binding both to AP-1 and cAMP response element 
promoter elements (Gupta et al., 1995). In summary, JNK activation mainly leads to pro-
inflammatory and apoptotic cell responses, but dependent on cell type and way of activation 
it is also important for cell differentiation and growth. 
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Salmonella Typhimurium activates JNK in infected cells which leads to the expression of the 
chemokine IL-8 (Hobbie et al., 1997). It was reported that JNK together with the 
extracellular-regulated kinase (ERK), another member of the MAPK group, can stimulate the 
expression of cytosolic phospholipase A2 α (cPLA2) (Van Putten et al., 2001). Moreover, 
MAPKs are able to phosphorylate cPLA2, thereby enhancing its activity (Lin et al., 1993, 
Borsch-Haubold et al., 1998, Hefner et al., 2000). PLA2 catalyzes the release of arachidonic 
acid (AA) from host cell membrane phospholipids which serves as an important second 
messenger for cellular stress pathways (Chakraborti, 2003). Interestingly, it was reported 
that the activation of cPLA2 is necessary for Salmonella invasion into epithelial cells (Pace et 
al., 1993). This indicates that the activation of the MKK7-JNK-cPLA2 pathway might be 
involved in bacterial invasion. For another intracellular pathogen, Chlamydia trachomatis, it 
could be shown that the activity of cPLA2 is important for intracellular growth by providing 
free fatty acids metabolized by the intracellular bacteria (Su et al., 2004). Intriguingly, 
Salmonella Typhimurium encodes an effector protein, SseJ, which is secreted into the host 
cell harbouring an enzymatic activity similar to cPLA2 (Lossi et al., 2008) and a sseJ mutant is 
slightly attenuated in a mouse infection model (Ohlson et al., 2005), implying that the 
deacylase activity is important for intracellular survival, probably by modulating the SCV 
membrane or by delivering fatty acids to the bacteria. Therefore, the role of cPLA2 and its 
possible regulation via the MKK7-JNK pathway during Salmonella infection was investigated 
in more detail in this work. 
The inhibitory effect of MKK7 depletion on Salmonella replication was studied in more detail 
using both siRNA and shRNA mediated silencing strategies. With both knock down methods 
decreased replication rates could be observed, demonstrating that MKK7 is involved in the 
intracellular growth of Salmonella (figure III.21). The relatively mild level of about 40 % 
inhibition was maybe due to a subordinated importance of MKK7 for Salmonella growth. 
Most likely, the pronounced redundancy among kinases, and especially members of the 
MAP kinase pathways, could account for this. For example, MKK4 is also able to 
phosphorylate JNK (Lin et al., 1995); thereby it could substitute MKK7 to some extent in 
MKK7 depleted cells. Interestingly, the mCherry expression of bacteria in MKK7 depleted 
cells was in a normal range, indicating that MKK7, unlike Rab7, does not play an essential 
role during Salmonella infection but rather contributes, among other factors, to bacterial 
replication.  
The activation of cPLA2 during Salmonella infection of HeLa cells was determined by 
measuring the phosphorylation of cPLA2 and the enzymatic activity using a specific 
substrate. A very early phosphorylation of cPLA2 upon infection with Salmonella was 
observed. This phosphorylation was sustained over the whole infection period, indicating 
that cPLA2 was constantly active (figure III.22). Interestingly, this was also the case in the 
chloramphenicol treated sample, although on a lower level, which suggests that the cPLA2 
activity was induced in a robust way during the first two hours of infection. This could have 
been mediated by a secreted bacterial factor which either targets cPLA2 itself, thereby 
keeping it in an activate state or by inhibiting a host cell factor which de-phosphorylates 
cPLA2. The chloramphenicol experiment also shows that bacterial replication is probably not 
absolutely necessary for the cPLA2 activation, again arguing for an early event. The early and 
sustained activation implies that the enzymatic activity of cPLA2 is necessary for the 
intracellular lifestyle of Salmonella. This assumption was further supported by the results 
from gentamicin protection assays in cPLA2 depleted cells. Here, a significant reduction of 
intracellular replication could be observed compared to infected control cells (figure III.23). 
When investigating the impact of MKK7 depletion on cPLA2 phosphorylation, it was 
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observed that total protein levels of cPLA2 but not the relative phosphorylation levels were 
reduced (figure III.24). This suggests that MKK7 is not a kinase for cPLA2 but does play a role 
in controlling cPLA2 protein turnover. A possible underlying mechanism could have been 
that MKK7 directly or indirectly influenced the protein stability of cPLA2, probably through a 
protein complex formation after stimulation. In this case, the depletion of MKK7 would de-
stabilize cPLA2 and therefore target it for degradation pathways. A similar process has been 
described for inhibitor of apoptosis protein (IAP)-complexes (Rajalingam et al., 2006). 
Alternatively, MKK7 could control cPLA2 levels at the transcriptional level by regulating the 
JNK-dependent expression of the cPLA2 gene (Van Putten et al., 2001). A non-specific RNAi 
mediated degradation of cPLA2 mRNA after transfection with MKK7 siRNA seems unlikely 
since the effect was observed with two distinct MKK7 sequences. Moreover, sequence 
alignments revealed that there are only marginal matches of the MKK7 siRNA sequences 
inside the cPLA2 mRNA. Nevertheless, off-target mediated cPLA2 degradation cannot be 
ruled out totally. In order to test whether MKK7 and cPLA2 form a complex, co-
immunoprecipitation experiments were performed using antibodies against both MKK7 and 
cPLA2 for pull-down. When the lysates were probed for cPLA2 and MKK7, no stable complex 
formation could be identified after infection with Salmonella (see figure III.25). The fact that 
an interaction could not be induced with either PMA or LPS, two distinct pro-inflammatory 
stimuli, argues against a possible MKK7 mediated stabilization of cPLA2 upon environmental 
stresses. Therefore, it was tested whether MKK7 controls cPLA2 at the level of transcription. 
HeLa cells were treated with different siRNAs against MKK7 or cPLA2 and three days later 
the relative amount of cPLA2 mRNA was quantified by RT-PCR. Interestingly, the MKK7-
treated samples displayed lower cPLA2 mRNA levels (figure III.26). This was the case for both 
MKK7 sequences and the MKK7 sequence pool, making off-target effects of the MKK7 
siRNAs unlikely. This result indicates that the knock down of MKK7 down-regulates the 
expression of cPLA2 (likely due to weaker JNK signaling activity), implying that the inhibitory 
impact of MKK7 depletion on Salmonella growth is rather an indirect than a direct one: The 
knock down of MKK7 negatively regulates the basal cPLA2 protein levels in the cells which 
negatively influences the bacterial intracellular growth. 
The functional role of cPLA2 for Salmonella intracellular growth was ascertained further by 
comparing the structure and appearance of Salmonella-induced filaments (Sifs) in Allstars 
and cPLA2 siRNA treated cells. Sifs are formed along microtubules and are enriched in the 
lysosomal marker protein LAMP-1 (Garcia-del Portillo et al., 1993, Brumell et al., 2002). It 
has been reported that the formation of Sifs at early time-points of infection is a highly 
dynamic process with Sifs branching, extending, or contracting. At later time-points of 
infection Sifs seem to stabilize and form a regular network displaying a less dynamic 
behaviour which certainly indicates a form of final maturation step (Rajashekar et al., 2008, 
Drecktrah et al., 2008). Therefore, the structure of Sifs might give an indication about the 
successful accommodation of Salmonella inside its host cell. Interestingly, a large proportion 
of cPLA2 depleted cells infected with Salmonella Typhimurium showed needle-like, filiform 
Sif structures which could be immature, non-stable Sif elongations. These structures were 
only marginally seen in Allstars-treated cells. Here, robust Sifs with a thicker appearance 
dominated (figure III.27). This observation suggests that cPLA2 is involved in the correct 
maturation of Sifs. As mentioned earlier, Salmonella encodes an effector protein (SseJ) with 
similar function to cPLA2, and maybe these two proteins complement one another in their 
enzymatic properties to allow different lipid modifications of the Sif membrane which are 
crucial for the structural maturation of Sifs. Although it was not successful to immunostain 
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cPLA2 using two different antibodies, it could be possible that cPLA2 is recruited to the SCV 
membrane and to Sifs. 
In summary, in this work it could be established that MKK7 controls cPLA2 at the 
transcriptional level and that cPLA2 is involved in Salmonella intracellular growth. This is 
likely mediated by its enzymatic activity towards membrane phospholipids which contributes 
to the correct formation of mature Sifs, a prerequisite of successful Salmonella replication. 
Outlook 
Within a kinome RNAi screen, the MAPK MKK7 was identified as an important factor in the 
replication of Salmonella Typhimurium inside human epithelial cells. The depletion of MKK7 
from cells led not only to a reduction of bacterial replication but, moreover, to a significant 
decrease in cPLA2 mRNA levels and thereby to reduced protein levels. This pointed to a role 
of cPLA2 during Salmonella infection which, indeed, could be demonstrated with cPLA2 
depleted cells. The precise role of cPLA2 during Salmonella infection could not be clarified 
but initial observations made during this work point to a role of cPLA2 in Sif formation.  
Hence, a cPLA2 mediated modification of the SCV and Sifs could be important for the 
integrity of the membrane or the elongation of Sifs and should be further investigated. In 
this context, the localisation cPLA2 in Salmonella infected HeLa cells would be of great 
interest and therefore ectopically expressed fluorescence-tagged cPLA2 would be useful. 
Additional studies with Salmonella mutant strains which are depleted of SseJ, an effector 
protein that possesses functions similar to that of cPLA2, might give further important 
insights into the process of Sif formation during Salmonella infection. 
Also, the signaling pathways leading to a downregulation of cPLA2 expression upon MKK7 
knock down have to be analyzed in more detail. It seems likely that cellular homeostasis 
pathways are altered upon MKK7 depletion. For example, the response to growth factors 
mediated by the Rac1-MEKK4/12-MKK7-JNK pathway could be affected. To evaluate this, 
specific knock down experiments should be helpful. 
Since the bichromatic FACS assay proved to be a powerful tool for quantifying intracellular 
replication and metabolic fitness of Salmonella Typhimurium in different human cell lines, it 
is valuable for further investigations of cellular factors, such as small GTPases. Many of them 
(Rab proteins) are involved in endosomal trafficking processes which have been described to 
be important for Salmonella infection (Kuhle et al., 2006, Drecktrah et al., 2007). In order to 
gain a complete picture of essential host cell factors for Salmonella infection, a screening 
approach using a human whole genome siRNA library would be the best strategy. However, 
this brings about new experimental challenges. The large amount of siRNAs makes it 
necessary to work with a 384 well plate format which premises totally automated working 
processes. Additionally, the amount of data acquired during genome-wide screens 
dramatically exceeds the data sets of limited RNAi libraries. Therefore, a reliable way of 
automated analysis would have to be installed. Thus, whole-genome wide screens have to 
be established very robustly as there is nearly no possibility to manually evaluate the 
primary screening results. 
It would also be very interesting to compare different intracellular pathogens with regard to 
the specific infection pathways that have evolved. In principal, a similar FACS assay should 
be feasible for other bacteria suppositional that plasmid-based reporter systems are 
accepted in respective pathogens.  
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Apart from the employment for RNAi screens, the assay established in this work can also be 
used for high-throughput compound screens to identify new antibacterial drugs. This has 
been performed on a small scale but should also be practicable on a larger dimension. 
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Figure S.1: 96 well plate scheme for automatic transfections. 
The scheme shows the general allocation of 96 well plates for the automatic siRNA 
transfections. The outer wells (white) were left untreated due to observed unsual cell 
growth behaviour but filled with medium as well. The controls were pipetted into the 
outer columns (B2-G2 and B11-G11) of the 60 analysis wells and the siRNAs to test 
were transferred into the 48 wells coloured in grey (B3-G10) according to the order 
they were allocated in the transfection plates. Controls were: Allstars (yellow), PLK1 
(blue) and Rab7A_2 (red). 
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VII.2 Publications 
Riede, O., Heuer, D., Machuy, N., Meyer, T.F. „Kinome-wide RNAi screen identifies MKK7 
dependent regulation of Salmonella replication by controlling cPLA2 levels” (in preparation) 
 
VII.3 Talks and posters 
2009 1st Joint Congress of the Swiss and German Societies of Cell Biology, Konstanz. 
“Global analysis of host cell functions affecting Salmonella intracellular growth.” 
(Poster) 
  
2008 Symposium „Fachgruppe Mikrobielle Pathogenität“, Bad Urach. 
„Global analysis of host cell factors essential for intracellular growth of Salmonella 
Typhimurium.” (Oral presentation) 
  
2007 Fourth Annual EIMID Meeting, Norton Park, UK. 
“Bichromatic flow cytometry high-throughput assay for quantifying bacterial 
intracellular survival.” (Poster) 
 
VII.4 Supplementary data 
Figure S.1: 96 well plate scheme 
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Table S.1: Complete list of kinase library screening results in quantitative order 
Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
AK1 203 SKV_08 E07 Hs_AK1_5 CCGGGATGCCATGGTGGCCAA 0,47 0,41 OK 2,27 2,00 DOWN 0,121098 
PSKH1 5681 SKV_06 D07 Hs_PSKH1_5 CCCGATTAGGGTCGAGTGTCA 0,08 0,05 TOXIC 2,03 0,67 DOWN 0,006342 
ADRBK1 156 SKV_01 B03 Hs_ADRBK1_1 CCGGGAGATCTTCGACTCATA 0,15 0,05 TOXIC 1,79 0,27 DOWN 0,000336 
GRK4 2868 SKV_02 F08 Hs_GRK4_5 CAGGATGTTACTCACCAAGAA 0,05 0,05 TOXIC 1,72 1,18 DOWN 0,065402 
ATM 472 SKV_03 G06 Hs_ATM_9 TTGGCTTATACGCGCAGTGTA 0,27 0,08 TOXIC 1,64 0,13 DOWN 0,000028 
AKT2 208 SKV_01 B06 Hs_AKT2_7 ACGGGCTAAAGTGACCATGAA 0,15 0,08 TOXIC 1,64 0,47 DOWN 0,003877 
ROCK2 9475 SKV_01 G03 Hs_ROCK2_6 ATGCACTTGTATAAAGCCATA 0,45 0,21 OK 1,59 0,45 DOWN 0,003730 
PDK4 5166 SKV_04 B03 Hs_PDK4_6 CAGATGCTATCATCTACTTAA 0,08 0,03 TOXIC 1,57 0,34 DOWN 0,001343 
TSSK1B 83942 SKV_05 D07 Hs_STK22D_4 CCAGCTTTCCTTGGCCATCAA 0,17 0,02 TOXIC 1,47 0,15 DOWN 0,000067 
TNIK 23043 SKV_18 G09 Hs_TNIK_5 AAGGACCATATTGATAGAACA 0,42 0,55 OK 1,44 1,39 DOWN 0,085831 
DMPK 1760 SKV_01 B07 Hs_DMPK_5 AACCAGAACTTCGCCAGTCAA 0,09 0,12 TOXIC 1,30 1,63 DOWN 0,237810 
RPS6KA6 27330 SKV_02 B07 Hs_RPS6KA6_5 CAGCGGTATACTGCTGAACAA 0,08 0,05 TOXIC 1,29 0,39 DOWN 0,004491 
PRKAB1 5564 SKV_01 C05 Hs_PRKAB1_5 CACGTCTAGAAGTCACATGAA 0,10 0,11 TOXIC 1,28 0,86 DOWN 0,061159 
GRK4 2868 SKV_01 B08 Hs_GRK4_6 CCGGGTGTTTCAAAGACATCA 0,26 0,23 TOXIC 1,27 0,39 DOWN 0,005045 
FLT4 2324 SKV_21 D07 Hs_FLT4_9 CACGCTCTTGGTCAACAGGAA 0,15 0,09 TOXIC 1,26 0,32 DOWN 0,000204 
PIK3CD 5293 SKV_15 E10 Hs_PIK3CD_5 CCGGTCACGCATGAAGGCAAA 0,14 0,08 TOXIC 1,26 0,66 DOWN 0,002669 
LATS2 26524 SKV_03 F05 Hs_LATS2_8 AAGGATGTCCTGAACCGGAAT 0,61 0,06 OK 1,26 0,13 DOWN 0,000080 
PDPK1 5170 SKV_01 C04 Hs_PDPK1_8 AAGCGGTTAGGCTGTGAGGAA 0,15 0,19 TOXIC 1,23 0,35 DOWN 0,003798 
CDK2 1017 SKV_07 E04 Hs_CDK2_8 CAGGTTATATCCAATAGTAGA 0,80 0,69 OK 1,23 2,63 DOWN 0,463503 
AKT1 207 SKV_02 F05 Hs_AKT1_8 ACGCTACTTCCTCCTCAAGAA 0,37 0,19 TOXIC 1,23 0,21 DOWN 0,000495 
STK32C 282974 SKV_02 C05 Hs_STK32C_5 CCGGGCTTCGTGCCCAACAAA 0,05 0,03 TOXIC 1,21 1,22 DOWN 0,162570 
CDC42BPA 8476 SKV_01 F07 Hs_CDC42BPA_6 CAGACTTTCCGTAGCAGCTTA 0,16 0,15 TOXIC 1,17 1,30 DOWN 0,195497 
PKN1 5585 SKV_03 B10 Hs_PKN1_6 CCGCAAGGAGCTGAAGCTGAA 0,17 0,27 TOXIC 1,16 1,47 DOWN 0,242949 
PRKACA 5566 SKV_01 C07 Hs_PRKACA_5 CAAGGACAACTCAAACTTATA 0,26 0,31 TOXIC 1,16 1,98 DOWN 0,367669 
FGFR4 2264 SKV_24 B05 Hs_FGFR4_5 CCGCCTGACCTTCGGACCCTA 0,13 0,03 TOXIC 1,16 0,75 DOWN 0,055711 
AKAP3 10566 SKV_16 B06 Hs_AKAP3_6 CCCATTGTAGGTGACCAAGAA 0,05 0,01 TOXIC 1,15 0,57 DOWN 0,002087 
GAK 2580 SKV_17 B07 Hs_GAK_6 CCCGTGGTTGTCTGTACAGAA 0,03 0,01 TOXIC 1,13 0,86 DOWN 0,038491 
HIPK3 10114 SKV_10 B04 Hs_HIPK3_6 CTCATTCTGGTTGGAGATTAA 0,21 0,11 TOXIC 1,10 0,35 DOWN 0,005471 
MKNK2 2872 SKV_06 C04 Hs_MKNK2_15 CAGCCAGGAGTACGCCGTCAA 0,54 0,49 OK 1,10 0,21 DOWN 0,000854 
PRKACB 5567 SKV_02 G08 Hs_PRKACB_10 CTGACCAATCAAGTACACTAA 0,19 0,13 TOXIC 1,10 0,38 DOWN 0,007571 
PNCK 139728 SKV_07 C03 Hs_PNCK_2 CACGCCCTTTGAGGACTCGAA 0,29 0,12 TOXIC 1,09 0,42 DOWN 0,010639 
IKBKG 8517 SKV_15 G05 Hs_IKBKG_5 CTCCTCTAGTTCAGAGACATA 0,06 0,04 TOXIC 1,08 0,97 DOWN 0,038911 
TSKS 60385 SKV_16 E05 Hs_TSKS_6 CACCAACGTGTCACTGCTCAA 0,25 0,11 TOXIC 1,08 0,17 DOWN 0,000001 
LATS2 26524 SKV_02 B05 Hs_LATS2_7 CTCCGCAAAGGGTACACTCAA 0,13 0,04 TOXIC 1,07 0,12 DOWN 0,000104 
CAMK1 8536 SKV_06 D10 Hs_CAMK1_6 CTGCATGACCTGGGCATTGTA 0,35 0,12 TOXIC 1,06 0,13 DOWN 0,000130 
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Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
PLK3 1263 SKV_15 C10 Hs_PLK3_5 CAGAAAGACTGTGCACTACAA 0,12 0,05 TOXIC 1,06 0,52 DOWN 0,003056 
ADCK2 90956 SKV_04 C10 Hs_ADCK2_5 CCGGAATGTGAAAGCCGTCAA 0,62 0,15 OK 1,05 0,15 DOWN 0,000237 
MAPKAPK2 9261 SKV_04 G07 Hs_MAPKAPK2_6 CGCCATCATCGATGACTACAA 0,27 0,08 TOXIC 1,05 0,40 DOWN 0,010413 
ALS2CR7 65061 SKV_08 E03 Hs_ALS2CR7_6 CTGGCGTACATCCACCACCAA 0,26 0,18 TOXIC 1,05 0,46 DOWN 0,016700 
DGKB 1607 SKV_08 G03 Hs_DGKB_9 CCCGAACTACTTCTCCTGCAA 0,07 0,01 TOXIC 1,04 0,26 DOWN 0,002407 
CDK2 1017 SKV_05 G04 Hs_CDK2_7 CACGTACGGAGTTGTGTACAA 0,07 0,03 TOXIC 1,03 0,62 DOWN 0,043652 
PRKCH 5583 SKV_01 D08 Hs_PRKCH_5 CGCCGTGTGCTCATCACTGAA 0,54 0,30 OK 1,02 0,25 DOWN 0,002166 
ATM 472 SKV_02 C06 Hs_ATM_8 AACCATGAGTCTAGTACTTAA 0,13 0,12 TOXIC 1,01 0,45 DOWN 0,017578 
MAST1 22983 SKV_01 G09 Hs_MAST1_6 CAGTATGTTCCGCCGCACCAA 0,17 0,08 TOXIC 1,00 0,63 DOWN 0,050761 
KHK 3795 SKV_09 B09 Hs_KHK_6 TAGCCGCACCATCCTATACTA 0,16 0,14 TOXIC 0,99 1,45 DOWN 0,301977 
IRAK2 3656 SKV_24 B08 Hs_IRAK2_6 CCAGATCATCCTGAACTGGAA 0,45 0,02 OK 0,98 0,58 DOWN 0,043250 
RIOK3 8780 SKV_04 B06 Hs_RIOK3_6 CTGGCTGTATTAGTACAGGAA 0,05 0,02 TOXIC 0,98 0,26 DOWN 0,002798 
ULK2 9706 SKV_19 D03 Hs_ULK2_4 TAGGATAATCGGTACAGTTAT 0,19 0,11 TOXIC 0,95 0,34 DOWN 0,001284 
SGK2 10110 SKV_01 G06 Hs_SGK2_10 TGGGTACGTGACTATCCCTAA 0,03 0,03 TOXIC 0,95 1,05 DOWN 0,190905 
PI4KA 5297 SKV_25 D05 Hs_PIK4CA_10 TCCGGACGCCATCCTCTTCTA 0,30 0,02 TOXIC 0,95 0,43 DOWN 0,019613 
MAP2K7 5609 SKV_20 C07 Hs_MAP2K7_13 CTGCGCTGAGAAGCTCAAGAA 0,40 0,06 OK 0,94 0,04 DOWN 0,000000 
AATK 9625 SKV_22 B09 Hs_AATK_5 TCCGCTGAGATCAGAAGGCAA 0,07 0,02 TOXIC 0,91 0,75 DOWN 0,104372 
FGFR3 2261 SKV_23 B03 Hs_FGFR3_5 ACCCTACGTTACCGTGCTCAA 0,44 0,04 OK 0,91 0,05 DOWN 0,000007 
WNK4 65266 SKV_19 F05 Hs_WNK4_10 CTGCCAAGAGTCAACCACTAA 0,16 0,06 TOXIC 0,90 0,18 DOWN 0,000136 
PDXK 8566 SKV_18 B09 Hs_PDXK_5 GAGGCTGAACAACATGAATAA 0,21 0,10 TOXIC 0,89 0,19 DOWN 0,000076 
PKMYT1 9088 SKV_15 G07 Hs_PKMYT1_3 CTGGGAGGAACTTACCGTCTA 0,25 0,18 TOXIC 0,89 0,21 DOWN 0,000026 
TAOK3 51347 SKV_20 F03 Hs_TAOK3_6 CAGCTCCTCCGTCGTGCATAA 0,05 0,02 TOXIC 0,89 0,10 DOWN 0,000002 
FES 2242 SKV_21 C09 Hs_FES_5 AAGGCCAAGTTTCTACAGGAA 0,14 0,08 TOXIC 0,88 0,35 DOWN 0,002333 
CIT 11113 SKV_01 G07 Hs_CIT_9 ATGGAAGGCACTATTTCTCAA 0,17 0,26 TOXIC 0,87 2,24 DOWN 0,537125 
MARK4 57787 SKV_05 D03 Hs_MARK4_5 CCGCATCATGAAGGGCCTAAA 0,57 0,19 OK 0,87 0,07 DOWN 0,000027 
CDK9 1025 SKV_05 G10 Hs_CDK9_5 TAGGGACATGAAGGCTGCTAA 0,15 0,10 TOXIC 0,85 0,56 DOWN 0,058206 
AKT3 10000 SKV_01 G05 Hs_AKT3_8 CAGCAGGCACGTTAACTCGAA 0,32 0,29 TOXIC 0,85 0,77 DOWN 0,131749 
CDK5R2 8941 SKV_13 B07 Hs_CDK5R2_6 CCGCGAGAACCTTCTCCGCAA 0,38 0,21 TOXIC 0,84 0,53 DOWN 0,007465 
AKT2 208 SKV_02 F06 Hs_AKT2_8 CAAGCGTGGTGAATACATCAA 0,55 0,28 OK 0,83 0,15 DOWN 0,000699 
MAP3K7IP2 23118 SKV_14 E06 Hs_MAP3K7IP2_5 CAGTCAATAGCCAGACCTTAA 0,26 0,03 TOXIC 0,83 0,45 DOWN 0,003179 
MAP3K7 6885 SKV_20 D05 Hs_MAP3K7_8 AAGACTTGACTGTAACTGGAA 0,66 0,11 OK 0,83 0,25 DOWN 0,000582 
CDC2L1 984 SKV_07 E03 Hs_CDC2L1_9 CACGTCGCTGAGGGAGATCAA 0,40 0,21 OK 0,83 0,18 DOWN 0,001436 
EIF2AK3 9451 SKV_17 E09 Hs_EIF2AK3_6 CGGCAGGTCATTAGTAATTAT 0,49 0,17 OK 0,83 0,32 DOWN 0,001943 
HIPK1 204851 SKV_08 E04 Hs_HIPK1_9 AGGGAAGCTGTACACCACTAA 0,27 0,15 TOXIC 0,83 0,30 DOWN 0,008615 
PTK2 5747 SKV_21 G04 Hs_PTK2_10 CCGGTCGAATGATAAGGTGTA 0,22 0,06 TOXIC 0,81 0,22 DOWN 0,000352 
FLT4 2324 SKV_23 B07 Hs_FLT4_8 CACCGTGTGGGCTGAGTTTAA 0,19 0,05 TOXIC 0,80 0,29 DOWN 0,008402 
CNKSR1 10256 SKV_17 F05 Hs_CNKSR1_7 CAGGGTGGCGTGTCCCTCCTA 0,12 0,09 TOXIC 0,80 0,30 DOWN 0,001763 
CDC2L1 984 SKV_05 G03 Hs_CDC2L1_1 CAAGATCTACATCGTGATGAA 0,06 0,01 TOXIC 0,80 0,53 DOWN 0,061041 
ROR2 4920 SKV_23 D08 Hs_ROR2_5 CCGGTTTGGGAAAGTCTACAA 0,28 0,05 TOXIC 0,79 0,14 DOWN 0,000588 
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Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
EPHA2 1969 SKV_20 G08 Hs_EPHA2_7 CAGCGCCAAGTAAACAGGGTA 0,42 0,12 OK 0,79 0,05 DOWN 0,000000 
AKAP8L 26993 SKV_14 E09 Hs_AKAP8L_7 CCGCGTGGCCGAAGCTGGAAA 0,42 0,48 OK 0,79 0,86 DOWN 0,075065 
LIMK1 3984 SKV_24 B09 Hs_LIMK1_6 CTGCCTGGTCCGCGAGAACAA 0,37 0,03 TOXIC 0,78 0,28 DOWN 0,008669 
DDR2 4921 SKV_23 D09 Hs_DDR2_2 CCGGTTCATTCCAGTCACCGA 0,28 0,07 TOXIC 0,78 0,05 DOWN 0,000011 
STK38 11329 SKV_03 E08 Hs_STK38_5 AACCTTATCGCTCAACATGAA 0,48 0,07 OK 0,78 0,31 DOWN 0,011501 
PIP4K2C 79837 SKV_13 F05 Hs_PIP5K2C_6 TTGATGTGTGATAATCTCATA 0,86 0,25 OK 0,78 0,12 DOWN 0,000001 
PRKCE 5581 SKV_03 B07 Hs_PRKCE_5 CCCGACCATGGTAGTGTTCAA 0,18 0,18 TOXIC 0,77 0,60 DOWN 0,089533 
FYN 2534 SKV_23 B09 Hs_FYN_8 AAGAAGCAGGATGCTGATCTA 0,16 0,07 TOXIC 0,77 0,05 DOWN 0,000012 
BEGAIN 57596 SKV_16 E04 Hs_KIAA1446_5 CGGGCGGACCATGTCACCGTA 0,55 0,15 OK 0,76 0,10 DOWN 0,000000 
BMPR1B 658 SKV_22 D03 Hs_BMPR1B_5 AACGAATGTAATAAAGACCTA 0,09 0,02 TOXIC 0,75 0,30 DOWN 0,012253 
BUB1B 701 SKV_15 B08 Hs_BUB1B_6 CAGATTTAGCACATTTACTAT 0,18 0,11 TOXIC 0,75 0,15 DOWN 0,000011 
MAP3K5 4217 SKV_18 D06 Hs_MAP3K5_6 CCGGGAATCTATACTCAATGA 0,19 0,02 TOXIC 0,75 0,20 DOWN 0,000328 
FER 2241 SKV_22 G08 Hs_FER_5 CAGATAGATCCTAGTACAGAA 0,16 0,04 TOXIC 0,73 0,16 DOWN 0,001255 
MAP3K7IP1 10454 SKV_14 D04 Hs_MAP3K7IP1_7 AACGGCTATGATGGCAACCGA 0,48 0,12 OK 0,73 0,19 DOWN 0,000029 
NRGN 4900 SKV_12 C10 Hs_NRGN_6 CACCCAAGCACACTCACTTAA 0,83 0,08 OK 0,72 0,31 DOWN 0,016160 
PAK4 10298 SKV_20 E04 Hs_PAK4_3 CAAGGTGTCGCCATCCCTGAA 0,32 0,09 TOXIC 0,72 0,17 DOWN 0,000130 
TWF2 11344 SKV_02 D10 Hs_PTK9L_5 AAGACAGAGATCAGTGTGGAA 0,53 0,25 OK 0,72 0,46 DOWN 0,054300 
CSNK1D 1453 SKV_07 C06 Hs_CSNK1D_6 CTCCCTGACGATTCCACTGTA 0,62 0,15 OK 0,72 0,22 DOWN 0,005080 
WNK1 65125 SKV_19 F04 Hs_WNK1_5 CTAGAGGATCTTGATGCTCAA 0,15 0,08 TOXIC 0,72 0,15 DOWN 0,000070 
MAPK14 1432 SKV_09 D05 Hs_MAPK14_7 CTCAGTGATACGTACAGCCAA 0,24 0,08 TOXIC 0,71 0,23 DOWN 0,005684 
PDPK1 5170 SKV_02 G04 Hs_PDPK1_9 CACGCCTAACAGGACGTATTA 0,79 0,29 OK 0,71 0,42 DOWN 0,041453 
ACVR1B 91 SKV_23 G06 Hs_ACVR1B_6 CCGTTCTTACGTCGCCATAAA 0,26 0,07 TOXIC 0,71 0,11 DOWN 0,000366 
CMPK 51727 SKV_25 F07 Hs_UMP-CMPK_6 AAGGCTAATTCTAAACCTGAA 0,23 0,11 TOXIC 0,71 0,49 DOWN 0,065432 
AKAP8 10270 SKV_16 B03 Hs_AKAP8_5 CAAGGTTAGCACGCAACAGAA 0,36 0,07 TOXIC 0,71 0,12 DOWN 0,000001 
CIB3 117286 SKV_15 B04 Hs_CIB3_3 CTGGAGCAGACGGTGACCAAA 0,17 0,06 TOXIC 0,71 0,20 DOWN 0,000044 
ANKK1 255239 SKV_24 G05 Hs_ANKK1_6 GCGGACGGAGTACGCCATCAA 0,38 0,06 TOXIC 0,70 0,19 DOWN 0,003046 
DAPK2 23604 SKV_05 B10 Hs_DAPK2_5 CGGAATTTGTTGCTCCAGAAA 0,81 0,16 OK 0,70 0,27 DOWN 0,011613 
STK11 6794 SKV_26 C03 Hs_STK11_7 GAGGATGACCTAGCACTGAAA 0,52 0,14 OK 0,70 0,04 DOWN 0,000005 
NME3 4832 SKV_09 C05 Hs_NME3_3 CTGCATCGAGGTTGGCAAGAA 0,08 0,04 TOXIC 0,70 0,60 DOWN 0,114606 
TYRO3 7301 SKV_22 B06 Hs_TYRO3_6 CGGACTGACCAAATCACCCAA 0,07 0,01 TOXIC 0,70 0,32 DOWN 0,019091 
TWF1 5756 SKV_04 B05 Hs_PTK9_5 TCCAAGCAAGTGAAGATGTTA 0,27 0,07 TOXIC 0,69 0,04 DOWN 0,000005 
ITPKB 3707 SKV_10 F08 Hs_ITPKB_5 AAGGCCATTCGAACCACTCTA 0,40 0,15 TOXIC 0,68 0,17 DOWN 0,002275 
PIK3R1 5295 SKV_15 F04 Hs_PIK3R1_5 CAGCATTAAACCAGACCTTAT 0,27 0,11 TOXIC 0,68 0,26 DOWN 0,000425 
HK2 3099 SKV_09 B04 Hs_HK2_5 CCGGCCGTGCTACAATAGGTA 0,59 0,35 OK 0,68 0,11 DOWN 0,000407 
PI4KA 5297 SKV_25 E05 Hs_PIK4CA_10 TCCGGACGCCATCCTCTTCTA 0,27 0,05 TOXIC 0,67 0,33 DOWN 0,023665 
CAMK2D 817 SKV_04 D06 Hs_CAMK2D_9 CCGCCTGCATAGCATATATTA 0,46 0,16 OK 0,67 0,22 DOWN 0,006517 
TNNI3K 51086 SKV_24 F08 Hs_TNNI3K_6 CAGCATTCGGCGTATACCTAA 0,24 0,01 TOXIC 0,67 0,83 DOWN 0,236967 
MAPK11 5600 SKV_08 B04 Hs_MAPK11_5 CAGGATGGAGCTGATCCAGTA 0,07 0,03 TOXIC 0,67 0,51 DOWN 0,084484 
MAP4K1 11184 SKV_20 E08 Hs_MAP4K1_6 TACGTGGGTGTACTCCATCAA 0,34 0,11 TOXIC 0,67 0,26 DOWN 0,002168 
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Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
ADRBK1 156 SKV_02 F03 Hs_ADRBK1_2 CGGCTGGAGGCTCGCAAGAAA 0,23 0,03 TOXIC 0,66 0,23 DOWN 0,007084 
SRC 6714 SKV_23 E09 Hs_SRC_6 AAGCAGTGCCTGCCTATGAAA 0,21 0,07 TOXIC 0,66 0,12 DOWN 0,000698 
ABL1 25 SKV_19 B09 Hs_ABL1_10 ACGCACGGACATCACCATGAA 0,28 0,14 TOXIC 0,66 0,19 DOWN 0,000452 
CHKA 1119 SKV_08 F06 Hs_CHKA_6 CCGGCCCTTACCAAACCTGAT 0,36 0,18 TOXIC 0,66 0,20 DOWN 0,005085 
CNKSR3 154043 SKV_16 F05 Hs_MAGI1_6 CGGAGTTGTGTTACTGCTTAA 0,12 0,03 TOXIC 0,65 0,42 DOWN 0,009028 
STK19 8859 SKV_04 B07 Hs_STK19_5 CCCGGAGACCTTTGGAGTTAA 0,22 0,12 TOXIC 0,65 0,41 DOWN 0,051278 
CDK5R2 8941 SKV_11 D07 Hs_CDK5R2_5 CAGCAAGAAGGTGACACCCAA 0,14 0,09 TOXIC 0,65 0,34 DOWN 0,024181 
CAMK1D 57118 SKV_06 G09 Hs_CAMK1D_6 ATGGAGAAGGACCCGAATAAA 0,92 0,40 OK 0,65 0,14 DOWN 0,001368 
STYXL1 51657 SKV_16 D07 Hs_DUSP24_5 CAAGATTCAGAAGGACTTGAA 0,31 0,08 TOXIC 0,64 0,26 DOWN 0,000496 
LTK 4058 SKV_23 C09 Hs_LTK_6 CCTGCAGATGCTTCTAATAAA 0,91 0,10 OK 0,63 0,06 DOWN 0,000060 
CDKL1 8814 SKV_09 G08 Hs_CDKL1_6 TCGGGAAATCCGAATGCTCAA 0,36 0,01 TOXIC 0,63 0,39 DOWN 0,048775 
STK36 27148 SKV_25 B08 Hs_STK36_5 ATCCCTGTTTATGTTGATTCA 0,89 0,09 OK 0,62 0,14 DOWN 0,001685 
PRKAA1 5562 SKV_06 D06 Hs_PRKAA1_6 TCGGGATCAGTTAGCAACTAT 0,29 0,16 TOXIC 0,62 0,30 DOWN 0,021557 
PRKCA 5578 SKV_01 D04 Hs_PRKCA_6 CGCAGTGGAATGAGTCCTTTA 0,17 0,07 TOXIC 0,62 0,19 DOWN 0,004862 
PIK3AP1 118788 SKV_12 C03 Hs_PIK3AP1_6 CAGCAGGGTATTTAAGTGCTA 0,24 0,16 TOXIC 0,61 0,21 DOWN 0,007115 
ADCK5 203054 SKV_06 B04 Hs_ADCK5_6 CCGCTACTTCCTTATGGCTAA 0,16 0,13 TOXIC 0,61 0,36 DOWN 0,041486 
SPEG 10290 SKV_05 B04 Hs_APEG1_6 CAGCTGGAATAACAAGCCCAA 0,10 0,06 TOXIC 0,61 0,65 DOWN 0,179593 
MAPK14 1432 SKV_07 F05 Hs_MAPK14_6 CAGAGAACTGCGGTTACTTAA 0,28 0,09 TOXIC 0,61 0,11 DOWN 0,000563 
ZC3HC1 51530 SKV_14 F05 Hs_ZC3HC1_5 AGGGAGAATGGTGGAACTGAA 0,13 0,03 TOXIC 0,61 0,24 DOWN 0,000473 
MAP2K6 5608 SKV_18 E06 Hs_MAP2K6_6 TAGACCTATGATAAATAACCA 0,49 0,21 OK 0,61 0,13 DOWN 0,000077 
MST1R 4486 SKV_21 F05 Hs_MST1R_7 CAGGTCTGCGTAGATGGTGAA 0,38 0,09 TOXIC 0,61 0,25 DOWN 0,002639 
SPHK1 8877 SKV_13 B06 Hs_SPHK1_10 TGGGCCCAGCTGCCTATGTAA 0,50 0,12 OK 0,61 0,17 DOWN 0,000055 
ITPKC 80271 SKV_12 B07 Hs_ITPKC_5 CAGAAGGAGCCTGTCCCTCAA 0,03 0,01 TOXIC 0,61 0,39 DOWN 0,055555 
TSKS 60385 SKV_14 G05 Hs_TSKS_5 AACCAACGTCTTGAAGCAGAA 0,21 0,03 TOXIC 0,60 0,49 DOWN 0,024122 
BEGAIN 57596 SKV_14 G04 Hs_KIAA1446_6 CTGCAGCTTCTCTGAACGCTA 0,54 0,11 OK 0,60 0,27 DOWN 0,001061 
PDIK1L 149420 SKV_19 G05 Hs_PDIK1L_5 AAGCTAGACTCTACCCTCTAA 0,11 0,03 TOXIC 0,60 0,16 DOWN 0,000485 
STK33 65975 SKV_05 D04 Hs_STK33_6 TCCATAAGTGACTGTGCTAAA 0,52 0,17 OK 0,60 0,06 DOWN 0,000065 
MAPK12 6300 SKV_08 B09 Hs_MAPK12_5 CTGGACGTATTCACTCCTGAT 0,17 0,06 TOXIC 0,60 0,11 DOWN 0,000714 
MKNK2 2872 SKV_26 B03 Hs_MKNK2_8 CAGAACCGTTACTGTGAATGA 0,92 0,10 OK 0,59 0,19 DOWN 0,006178 
BCKDK 10295 SKV_02 D08 Hs_BCKDK_5 AACGCCCACCATGATGCTCTA 0,15 0,11 TOXIC 0,58 0,32 DOWN 0,033917 
MAP4K3 8491 SKV_18 F07 Hs_MAP4K3_5 GAGGTGGTTCTTTACAGGATA 0,36 0,08 TOXIC 0,58 0,28 DOWN 0,006488 
TNK2 10188 SKV_23 F10 Hs_TNK2_6 CGGCAGTCAGATCCTGCATAA 0,08 0,01 TOXIC 0,58 0,16 DOWN 0,003022 
GKAP1 80318 SKV_14 G08 Hs_GKAP1_5 AACGCTCAACATGATCTTCCA 0,16 0,03 TOXIC 0,58 0,17 DOWN 0,000054 
NRBP1 29959 SKV_17 G07 Hs_NRBP_5 CCGGTTGACTTCTCTGCTAGA 0,46 0,25 OK 0,58 0,19 DOWN 0,001540 
PRKCD 5580 SKV_03 B06 Hs_PRKCD_8 CCGCTTCAAGGTTCACAACTA 0,19 0,18 TOXIC 0,58 0,70 DOWN 0,226437 
TPK1 27010 SKV_13 C09 Hs_TPK1_6 CAGGTTGTCTGTAGAGAATGA 0,25 0,13 TOXIC 0,57 0,74 DOWN 0,116217 
FLT1 2321 SKV_21 D05 Hs_FLT1_5 ACCGCATATGGTATCCCTCAA 0,34 0,08 TOXIC 0,57 0,23 DOWN 0,002563 
ILK 3611 SKV_22 D06 Hs_ILK_4 AAGGAAGAGCAGGGACTTCAA 0,14 0,02 TOXIC 0,57 0,34 DOWN 0,044696 
MLCK 91807 SKV_07 B10 Hs_LOC91807_6 ACGGAGGACAATGACCTTGCA 0,38 0,21 TOXIC 0,57 0,67 DOWN 0,214480 
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PIP4K2A 5305 SKV_11 B04 Hs_PIP5K2A_6 CTGCCCGATGGTCTTCCGTAA 0,40 0,09 TOXIC 0,56 0,41 DOWN 0,059980 
PRKACG 5568 SKV_02 G09 Hs_PRKACG_5 AACCAGCTGGATCGCCATCTA 0,11 0,04 TOXIC 0,56 0,67 DOWN 0,220165 
DAPK2 23604 SKV_06 F10 Hs_DAPK2_6 CTGGTTAAAGAGACCCGGAAA 0,38 0,25 TOXIC 0,56 0,29 DOWN 0,030273 
TSSK2 23617 SKV_06 G03 Hs_STK22B_5 CAAGTTCAATGTGGCTGTCAA 0,24 0,13 TOXIC 0,56 0,27 DOWN 0,022514 
TSSK6 83983 SKV_25 D09 Hs_TSSK6_1 GAAGGTGGCCACATCCAAGAA 0,20 0,10 TOXIC 0,56 0,15 DOWN 0,003149 
RPS6KB2 6199 SKV_01 F05 Hs_RPS6KB2_6 CGGGCTGAGCGGAACATTCTA 0,31 0,17 TOXIC 0,55 0,15 DOWN 0,002736 
ULK1 8408 SKV_15 G03 Hs_ULK1_5 CGCGCGGTACCTCCAGAGCAA 0,20 0,08 TOXIC 0,55 0,32 DOWN 0,004963 
IHPK3 117283 SKV_13 F10 Hs_IHPK3_6 CTGAGATACGTTACCCAATTA 0,62 0,33 OK 0,55 0,43 DOWN 0,020463 
TEC 7006 SKV_23 F03 Hs_TEC_6 CCGCAGCTAATCAGAATCAGA 0,42 0,04 OK 0,55 0,12 DOWN 0,001493 
PTK7 5754 SKV_23 E05 Hs_PTK7_7 CGGGATGATGTCACTGGAGAA 0,20 0,05 TOXIC 0,55 0,12 DOWN 0,001270 
ULK1 8408 SKV_17 E03 Hs_ULK1_6 TGCCCTTTGCGTTATATTGTA 1,02 0,30 OK 0,55 0,67 DOWN 0,150703 
MAP3K10 4294 SKV_24 C04 Hs_MAP3K10_12 GTCGTCCGTGTCCGACTGCAA 0,25 0,12 TOXIC 0,55 0,32 DOWN 0,041783 
NME7 29922 SKV_13 C10 Hs_NME7_6 TTCATGTAGATCACCAGTCAA 0,82 0,31 OK 0,55 0,29 DOWN 0,003964 
EPHB3 2049 SKV_22 F09 Hs_EPHB3_10 AGAGGTGTTTGTGGCCATCAA 0,59 0,12 OK 0,54 0,09 DOWN 0,000420 
PKN1 5585 SKV_01 D10 Hs_PKN1_5 CAGGACAGTAAGACCAAGATT 0,24 0,24 TOXIC 0,54 0,39 DOWN 0,073844 
STK24 8428 SKV_26 B08 Hs_STK24_8 CTCAGTGTTTATCTACAATTA 0,59 0,04 OK 0,54 0,87 DOWN 0,344315 
MERTK 10461 SKV_22 C03 Hs_MERTK_8 CACCAGAAACACAGCCTTCAA 0,17 0,01 TOXIC 0,53 0,23 DOWN 0,015345 
PIM2 11040 SKV_06 F05 Hs_PIM2_5 CCGGGATTGTCCAATTACTAA 0,70 0,16 OK 0,53 0,38 DOWN 0,075092 
ADCK1 57143 SKV_02 E07 Hs_ADCK1_3 TAACAAGTACTTGGACCCTAA 0,12 0,03 TOXIC 0,53 0,62 DOWN 0,211241 
STK24 8428 SKV_18 F06 Hs_STK24_5 CCCACCGACGTTGGAAGGAAA 0,33 0,10 TOXIC 0,52 0,21 DOWN 0,002660 
CDKN1B 1027 SKV_15 B09 Hs_CDKN1B_5 AAAGCGTTGGATGTAGCATTA 0,52 0,16 OK 0,52 0,25 DOWN 0,001734 
IHPK2 51447 SKV_13 D04 Hs_IHPK2_11 TAGGACGGAAACGCCGAGGAA 0,59 0,33 OK 0,52 0,09 DOWN 0,000001 
AKAP14 158798 SKV_16 F06 Hs_AKAP14_7 TACGAGGATGAATTGACTCAA 0,55 0,04 OK 0,52 0,19 DOWN 0,000406 
EEF2K 29904 SKV_02 E05 Hs_EEF2K_6 CGGGATGGCGCTCTTCTTCTA 0,86 0,21 OK 0,51 0,39 DOWN 0,086015 
SLK 9748 SKV_20 E03 Hs_SLK_6 TAGCATCTTGTGATCACCCAA 0,05 0,01 TOXIC 0,51 0,11 DOWN 0,000093 
CHEK1 1111 SKV_04 D08 Hs_CHEK1_9 AAGAAAGAGATCTGTATCAAT 0,36 0,21 TOXIC 0,51 0,26 DOWN 0,028296 
RYK 6259 SKV_25 F10 Hs_RYK_11 AAGGTGAAGGATATAGCAATA 0,39 0,05 TOXIC 0,51 0,46 DOWN 0,126387 
NTRK3 4916 SKV_23 D06 Hs_NTRK3_10 CTGGTTGGAGCGAATCTGCTA 0,21 0,06 TOXIC 0,51 0,19 DOWN 0,010855 
RIOK2 55781 SKV_04 C06 Hs_RIOK2_6 CGCGGTTGAAATGGGCATGAA 0,17 0,09 TOXIC 0,50 0,07 DOWN 0,000217 
PIP5K1A 8394 SKV_11 C07 Hs_PIP5K1A_5 CAGCCTCTTGATGTCAATCCA 0,55 0,14 OK 0,50 0,25 DOWN 0,102867 
EPHB6 2051 SKV_26 B10 Hs_EPHB6_6 CTCCTGGATTACATCTACTTA 0,75 0,11 OK 0,50 0,52 --- 0,169948 
PIP5K1C 23396 SKV_26 B06 Hs_PIP5K1C_6 CGCGCCCGCCACCGACATCTA 0,47 0,05 OK 0,50 0,55 --- 0,193341 
MAPK13 5603 SKV_09 F07 Hs_MAPK13_6 CGGGATGAGCCTCATCCGGAA 0,45 0,12 OK 0,50 0,28 --- 0,038715 
NAGK 55577 SKV_11 G05 Hs_NAGK_5 ACCTGAGTGAAAGCTACTTAA 0,55 0,24 OK 0,50 0,56 --- 0,110103 
FLT1 2321 SKV_23 B05 Hs_FLT1_6 CACTACAGTATTAGCAAGCAA 0,32 0,05 TOXIC 0,50 0,23 --- 0,020123 
CAMK1 8536 SKV_04 F10 Hs_CAMK1_5 CAGGTGCTGGATGCTGTGAAA 1,52 0,36 OK 0,50 0,26 --- 0,031449 
GRK5 2869 SKV_01 B09 Hs_GRK5_5 AGCGTCATAACTAGAACTGAA 0,19 0,09 TOXIC 0,49 0,35 --- 0,072246 
ACVRL1 94 SKV_22 C08 Hs_ACVRL1_5 CACCGAGTTCGTCAACCACTA 0,68 0,10 OK 0,49 0,17 --- 0,007360 
MAPK7 5598 SKV_07 G10 Hs_MAPK7_10 TACGAGATCATCGAGACCATA 1,00 0,24 OK 0,49 0,34 --- 0,068844 
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CAMK1G 57172 SKV_06 G10 Hs_CAMK1G_6 CAGGTCTTGTCGGCAGTGAAA 0,34 0,14 TOXIC 0,49 0,11 --- 0,001435 
LIMK2 3985 SKV_25 G09 Hs_LIMK2_8 CACGGGCAAAGTGATGGTCAT 0,48 0,11 OK 0,49 0,32 --- 0,060337 
TNK2 10188 SKV_22 B10 Hs_TNK2_5 ACGCAAGTCGTGGATGAGTAA 0,13 0,02 TOXIC 0,49 0,36 --- 0,077935 
PDLIM5 10611 SKV_16 B07 Hs_PDLIM5_6 TCCGATGTGCGCCCATTGTAA 0,63 0,13 OK 0,49 0,11 --- 0,000021 
AURKB 9212 SKV_15 G08 Hs_AURKB_5 AACGCGGCACTTCACAATTGA 0,14 0,10 TOXIC 0,48 0,47 --- 0,051425 
PHKG2 5261 SKV_06 D04 Hs_PHKG2_6 TACGGGCACTGGGTAAAGAAA 0,28 0,06 TOXIC 0,48 0,29 --- 0,045187 
TSSK1B 83942 SKV_07 B07 Hs_STK22D_5 TAGAAGCTGATTTAACACCAA 0,36 0,15 TOXIC 0,48 0,26 --- 0,032326 
UCK1 83549 SKV_12 B08 Hs_UCK1_7 TCCCTCTAGGTCACTGAGAAA 0,73 0,35 OK 0,48 0,03 --- 0,000018 
MAP3K1 4214 SKV_20 B03 Hs_MAP3K1_10 CACGCATGTCAAATTCTCATA 0,53 0,14 OK 0,48 0,12 --- 0,000229 
FRAP1 2475 SKV_25 E03 Hs_FRAP1_6 CAGGCCTATGGTCGAGATTTA 0,26 0,10 TOXIC 0,48 0,23 --- 0,022971 
MAP4K1 11184 SKV_18 G08 Hs_MAP4K1_5 CTGACTAAGAGTCCCAAGAAA 0,15 0,04 TOXIC 0,48 0,38 --- 0,047425 
MAP3K13 9175 SKV_24 D05 Hs_MAP3K13_5 CAGACTCAATATGCACGGACA 0,65 0,11 OK 0,47 0,40 --- 0,109383 
STK40 83931 SKV_05 D06 Hs_MGC4796_5 CAGCGCTACCTGCGGAAATAA 0,16 0,03 TOXIC 0,47 0,04 --- 0,000038 
ADCK4 79934 SKV_04 C08 Hs_ADCK4_6 CCGGGTCCCAGCCGTGGTTAA 0,89 0,20 OK 0,47 0,36 --- 0,088909 
BRSK2 9024 SKV_06 E05 Hs_STK29_5 CCCGACTGCCAGAGTCTGCTA 0,36 0,29 TOXIC 0,47 0,54 --- 0,205525 
MOS 4342 SKV_17 B08 Hs_MOS_5 CGCGAACATCTTGATCAGTGA 0,53 0,14 OK 0,47 0,17 --- 0,001445 
EPHB6 2051 SKV_22 G03 Hs_EPHB6_10 CGGGAAGTCGATCCTGCTTAT 0,27 0,09 TOXIC 0,47 0,45 --- 0,143520 
PMVK 10654 SKV_11 E04 Hs_PMVK_6 TTGGCTGTGCTTGAAGGCGAA 0,87 0,23 OK 0,47 0,22 --- 0,139852 
GSK3B 2932 SKV_07 F08 Hs_GSK3B_8 CTGCATTTATCGTTAACCTAA 0,79 0,50 OK 0,46 0,36 --- 0,089617 
NME2 4831 SKV_10 G04 Hs_NME2_2 ATAGAGCATATTTGCCAATAA 0,30 0,15 TOXIC 0,46 0,30 --- 0,056207 
MAP4K4 9448 SKV_20 D10 Hs_MAP4K4_5 AGGCAAGATCCTACCCGGAAA 0,56 0,11 OK 0,46 0,28 --- 0,018056 
MKNK1 8569 SKV_04 G03 Hs_MKNK1_6 TAGATAGTGCTCTGTGCCTAA 0,11 0,03 TOXIC 0,45 0,30 --- 0,056487 
DAPK3 1613 SKV_06 B10 Hs_DAPK3_8 CCAGTTTGCGATCGTGCGGAA 0,50 0,06 OK 0,44 0,02 --- 0,000003 
TYRO3 7301 SKV_23 F06 Hs_TYRO3_5 AACGGTGACCTTTAGTGCCAA 0,44 0,08 OK 0,44 0,02 --- 0,000002 
STK11IP 114790 SKV_15 B03 Hs_STK11IP_8 AAAGTTGTTTCCAACTCATAA 0,24 0,09 TOXIC 0,44 0,12 --- 0,000028 
MAP4K2 5871 SKV_18 E08 Hs_MAP4K2_5 CTGGCTCTACTGCGTGAACAA 0,08 0,04 TOXIC 0,44 0,36 --- 0,048933 
EPHA4 2043 SKV_22 F03 Hs_EPHA4_6 CCGCCAGGACATTTCCTATAA 0,13 0,04 TOXIC 0,44 0,22 --- 0,026036 
PIP5K3 200576 SKV_12 C06 Hs_PIP5K3_9 ACCCAGTAACATAATATTTCA 0,82 0,32 OK 0,44 0,19 --- 0,017476 
FLT3LG 2323 SKV_13 G08 Hs_FLT3LG_7 CTCCTCCGACTTCGCTGTCAA 0,49 0,46 OK 0,43 0,44 --- 0,057300 
MAP3K2 10746 SKV_20 E06 Hs_MAP3K2_3 CACAGTAATATGATTGTCCTA 0,57 0,10 OK 0,43 0,11 --- 0,000238 
AKAP7 9465 SKV_12 E04 Hs_AKAP7_6 CCCGATGACGCTGAACTAGTA 0,64 0,40 OK 0,43 0,26 --- 0,047306 
NEK11 79858 SKV_19 F07 Hs_NEK11_6 CTGCCTATGCTTGGAGTCATA 0,31 0,11 TOXIC 0,43 0,22 --- 0,010046 
PIK3CD 5293 SKV_17 C10 Hs_PIK3CD_6 CGCCGTGATCGAGAAAGCCAA 0,84 0,40 OK 0,43 1,12 --- 0,474469 
ERN1 2081 SKV_15 D06 Hs_ERN1_5 CAGCACGGACGTCAAGTTTGA 0,82 0,18 OK 0,43 0,09 --- 0,000008 
DYRK4 8798 SKV_09 G07 Hs_DYRK4_6 CTGCATCACGGCGGAGTTGTA 0,74 0,39 OK 0,42 0,15 --- 0,008742 
ITPKA 3706 SKV_10 F07 Hs_ITPKA_5 CACCAGCGGGCTGATCCTGAA 0,74 0,83 OK 0,42 0,25 --- 0,044029 
SGK 6446 SKV_01 F06 Hs_SGK_5 CACAGCTGAAATGTACGACAA 0,29 0,22 TOXIC 0,41 0,23 --- 0,034420 
PIP5K3 200576 SKV_13 G06 Hs_PIP5K3_10 TTGCCGTTACCCAGTAACATA 0,92 0,60 OK 0,41 1,02 --- 0,395200 
FLT3 2322 SKV_21 D06 Hs_FLT3_7 TACGTTGATTTCAGAGAATAT 0,14 0,06 TOXIC 0,41 0,32 --- 0,043007 
SUPPLEMENTARY INFORMATION                                                                                                                                                                                                                                                         106 
Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
SGK2 10110 SKV_03 E06 Hs_SGK2_9 CAGGGCCAATGGGAACATCAA 0,46 0,08 OK 0,40 0,28 --- 0,066954 
MAP2K6 5608 SKV_20 C06 Hs_MAP2K6_5 AAGGCTTGCATTTCTATTGGA 0,68 0,11 OK 0,40 0,16 --- 0,002373 
SYK 6850 SKV_23 E10 Hs_SYK_6 TCCGGAATGCATCAACTACTA 0,38 0,15 TOXIC 0,40 0,09 --- 0,001242 
PIK3R4 30849 SKV_17 G08 Hs_PIK3R4_8 CAAGCAATGCGTGGACTTTAA 0,13 0,08 TOXIC 0,40 0,34 --- 0,056424 
WNK3 65267 SKV_18 B06 Hs_WNK3_9 AAGATTGGTGATCTAGGATTA 0,37 0,10 TOXIC 0,40 0,17 --- 0,003342 
ADK 132 SKV_08 E06 Hs_ADK_6 CAAGGGAGAGATGACACTATA 0,69 0,20 OK 0,40 0,17 --- 0,015508 
PHKG1 5260 SKV_04 F03 Hs_PHKG1_5 CAAGAGCCTGCAAGCACTTAA 0,36 0,15 TOXIC 0,40 0,20 --- 0,025296 
GUK1 2987 SKV_08 G10 Hs_GUK1_5 CAGGGCTGACATCCTAATAAA 0,84 0,41 OK 0,40 0,58 --- 0,299943 
LYK5 92335 SKV_19 B07 Hs_LYK5_7 CACCCAGATGCTGCTAGAGAA 0,69 0,25 OK 0,40 0,27 --- 0,026923 
PKMYT1 9088 SKV_17 E07 Hs_PKMYT1_2 CCGGCCAGAGTCCTTCTTCCA 0,16 0,05 TOXIC 0,40 0,21 --- 0,012252 
AKAP11 11215 SKV_16 C03 Hs_AKAP11_5 ACCGGTTATCTAAATCTATTA 0,35 0,13 TOXIC 0,40 1,03 --- 0,411013 
MINK1 50488 SKV_25 E08 Hs_MINK1_1 CACGTACGGGCGCATCATTAA 0,32 0,01 TOXIC 0,39 0,28 --- 0,074332 
PKLR 5313 SKV_12 F05 Hs_PKLR_15 CACACACAAACCAAGAGCCAA 0,68 0,33 OK 0,39 0,32 --- 0,097881 
C17orf75 64149 SKV_13 E09 Hs_NJMU-R1_8 AAAGGCCATACAAGACACAAA 0,84 0,35 OK 0,39 0,24 --- 0,005784 
DGKD 8527 SKV_13 B03 Hs_DGKD_6 CCGCCTCGTGACCAAGTTTAA 0,94 0,26 OK 0,39 0,21 --- 0,003377 
TK2 7084 SKV_11 C03 Hs_TK2_5 ATGCCAGAAGTGGACTATGTA 0,44 0,41 OK 0,39 0,45 --- 0,249618 
MAP3K4 4216 SKV_18 D05 Hs_MAP3K4_5 CACCAATCCCTGAAAGATTAA 0,40 0,07 OK 0,39 0,09 --- 0,000139 
ITPKA 3706 SKV_09 B07 Hs_ITPKA_6 CCGGTCTAACGTCTCACACCA 0,19 0,08 TOXIC 0,39 0,39 --- 0,162401 
PRKD3 23683 SKV_05 C04 Hs_PRKD3_5 CACGATATGTCAGTACTGCAA 0,53 0,22 OK 0,39 0,16 --- 0,013047 
STK3 6788 SKV_20 C10 Hs_STK3_6 CGGCGCCTAAGAGTAAACTAA 0,74 0,11 OK 0,39 0,10 --- 0,000235 
EIF2AK4 440275 SKV_17 G05   CTGCAGGAATTTAGTAACATT 0,40 0,21 OK 0,39 0,41 --- 0,108686 
PRKCA 5578 SKV_03 B04 Hs_PRKCA_7 TACAAGTTGCTTAACCAAGAA 0,07 0,02 TOXIC 0,38 0,32 --- 0,109925 
HK1 3098 SKV_10 F03 Hs_HK1_9 CACGATGTAGTCACCTTACTA 0,19 0,16 TOXIC 0,38 0,08 --- 0,001306 
TPD52L3 89882 SKV_13 F09 Hs_NYD-SP25_9 ATCATATACTTCAGACATCAA 0,99 0,21 OK 0,38 0,27 --- 0,013522 
NEK9 91754 SKV_18 B10 Hs_NEK9_7 CAGGTGTCATGTGGTGATGAT 0,15 0,09 TOXIC 0,37 0,37 --- 0,090274 
STK3 6788 SKV_18 E10 Hs_STK3_5 CCGGCGCCTAAGAGTAAACTA 0,67 0,15 OK 0,37 0,05 --- 0,000005 
SKP2 6502 SKV_12 D05 Hs_SKP2_5 AAGTGATAGTGTCATGCTAAA 0,48 0,22 OK 0,37 0,27 --- 0,074403 
SGK 6446 SKV_03 D06 Hs_SGK_9 TCGCAGTGTTTCAGTTCTTTA 1,07 0,32 OK 0,37 0,20 --- 0,032493 
DYRK1A 1859 SKV_07 F06 Hs_DYRK1A_6 TACGGTCGCTGACTACTTGAA 0,79 0,08 OK 0,37 0,05 --- 0,000172 
FUK 197258 SKV_12 C05 Hs_FUK_6 TGGCTTAGAGTTGTAGACTTA 0,74 0,27 OK 0,37 0,21 --- 0,036307 
PXK 54899 SKV_18 C09 Hs_PXK_5 CTGGCAGATTGTTAGAAGATA 0,20 0,06 TOXIC 0,37 0,66 --- 0,305210 
STK31 56164 SKV_18 C10 Hs_STK31_5 CCCAGTGTGGATCACTTGCTA 0,19 0,08 TOXIC 0,37 0,10 --- 0,000286 
SPHK1 8877 SKV_11 D06 Hs_SPHK1_6 CTGCCTATGTAAGGCCTTCTA 0,44 0,03 OK 0,36 0,06 --- 0,297365 
PDK2 5164 SKV_03 G09 Hs_PDK2_6 TAGGTCTGTGATGGTCCCTAA 0,36 0,22 TOXIC 0,36 0,40 --- 0,196112 
CAMKK2 10645 SKV_19 D07 Hs_CAMKK2_7 CTAGCTGATTGTTGTGGTCAA 0,99 0,14 OK 0,36 0,05 --- 0,000004 
PDK3 5165 SKV_02 C10 Hs_PDK3_7 CTCGTTACTTTGGGTAAAGAA 0,60 0,01 OK 0,36 0,23 --- 0,055666 
PLK4 10733 SKV_19 D08 Hs_PLK4_7 AAGGACTTGGTCTTACAACTA 0,13 0,11 TOXIC 0,36 0,67 --- 0,323814 
MATK 4145 SKV_23 D03 Hs_MATK_9 ACGGATTCTAAGGACTCTAAA 0,62 0,04 OK 0,36 0,11 --- 0,005495 
PRKCDBP 112464 SKV_14 G10 Hs_PRKCDBP_4 CACGCCCTAATAAGGAGCGAA 0,49 0,48 OK 0,35 0,47 --- 0,130510 
SUPPLEMENTARY INFORMATION                                                                                                                                                                                                                                                         107 
Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
KSR1 8844 SKV_24 F04 Hs_KSR_10 CTGGAAGTCAGCTGACATTAA 0,47 0,11 OK 0,35 0,13 --- 0,008985 
ERBB4 2066 SKV_22 G06 Hs_ERBB4_6 TCGGGATTTGGCAGCCCGTAA 0,39 0,05 TOXIC 0,35 0,29 --- 0,102120 
STK11 6794 SKV_06 D08 Hs_STK11_12 TACAACGAAGAGAAGCAGAAA 0,56 0,59 OK 0,35 0,19 --- 0,032654 
CLK3 1198 SKV_07 F04 Hs_CLK3_5 CACGAAGATCTCGGTCCAGAA 0,23 0,08 TOXIC 0,35 0,23 --- 0,056671 
CDK5R1 8851 SKV_13 B05 Hs_CDK5R1_6 TGAGCTGGTTTGACTCATTAA 0,36 0,16 TOXIC 0,35 0,43 --- 0,105398 
STK19 8859 SKV_02 D07 Hs_STK19_6 CTGTTATTACTCTGTCTTGAA 0,34 0,21 TOXIC 0,35 0,32 --- 0,129378 
ROR2 4920 SKV_21 F08 Hs_ROR2_6 CTGGTGCTTTACGCAGAATAA 0,09 0,05 TOXIC 0,35 0,24 --- 0,033013 
CHEK2 11200 SKV_05 B07 Hs_CHEK2_10 AGGACTGTCTTATAAAGATTA 0,70 0,13 OK 0,35 0,34 --- 0,156698 
STK4 6789 SKV_18 F03 Hs_STK4_6 CACCATTTGCTGTGCGAATTA 0,56 0,06 OK 0,34 0,08 --- 0,000138 
PAK1 5058 SKV_20 B07 Hs_PAK1_9 TTGAAGAGAACTGCAACTGAA 0,36 0,11 TOXIC 0,34 0,11 --- 0,000717 
GK 2710 SKV_08 G09 Hs_GK_5 CCACCACTTAAGTGACATAAA 0,48 0,23 OK 0,34 0,34 --- 0,156913 
VRK3 51231 SKV_05 F04 Hs_VRK3_5 CTCACTCAAACTGGATGCCAA 0,18 0,10 TOXIC 0,34 0,43 --- 0,244409 
PLK3 1263 SKV_16 G10 Hs_PLK3_6 CTGCATCAAGCAGGTTCACTA 0,29 0,14 TOXIC 0,34 0,07 --- 0,000004 
SMG1 23049 SKV_02 E03 Hs_SMG1_5 CACCATGGTATTACAGGTTCA 0,19 0,10 TOXIC 0,34 0,17 --- 0,024525 
WEE1 7465 SKV_25 C05 Hs_WEE1_9 ACAATTACGAATAGAATTGAA 0,35 0,07 TOXIC 0,34 0,74 --- 0,467906 
PACSIN2 11252 SKV_14 E04 Hs_PACSIN2_5 CACCCTTAATGTCCCGAGCAA 0,07 0,01 TOXIC 0,34 0,71 --- 0,314487 
IKBKE 9641 SKV_15 G10 Hs_IKBKE_7 CCGCATCATCGAACGGCTAAA 0,24 0,17 TOXIC 0,34 0,17 --- 0,002777 
MAP2K2 5605 SKV_20 C03 Hs_MAP2K2_6 CCGGCCTGCCATGGCCATCTT 0,13 0,06 TOXIC 0,34 0,36 --- 0,108625 
SGK3 23678 SKV_02 B04 Hs_SGKL_6 CCACAGCGAGACCCTAGTTAA 0,79 0,21 OK 0,34 0,29 --- 0,112316 
NME7 29922 SKV_11 E10 Hs_NME7_5 CCCGGCATTTACGCCCTGGAA 0,40 0,24 TOXIC 0,33 0,04 --- 0,358990 
CNKSR3 154043 SKV_15 B05 Hs_MAGI1_5 CCGGAGTTGTGTTACTGCTTA 0,58 0,15 OK 0,33 0,19 --- 0,004524 
HUNK 30811 SKV_05 C06 Hs_HUNK_6 TCGGACCAAGATCAAACCAAA 1,12 0,27 OK 0,33 0,26 --- 0,090972 
PIK3CA 5290 SKV_26 B09 Hs_PIK3CA_8 CTCCGTGAGGCTACATTAATA 0,90 0,29 OK 0,33 0,09 --- 0,002953 
ALS2CR2 55437 SKV_19 B05 Hs_ALS2CR2_5 CAGGAACACTGGTAACTATAA 0,10 0,07 TOXIC 0,33 0,51 --- 0,243742 
BMPR2 659 SKV_22 D04 Hs_BMPR2_5 AAGCACCGAAGCGAAACTTAA 0,65 0,15 OK 0,33 0,47 --- 0,290367 
KSR2 283455 SKV_24 G06 Hs_KSR2_5 CAGGCTTACCGTGGACGCCTA 0,30 0,04 TOXIC 0,33 0,60 --- 0,397650 
ICK 22858 SKV_10 B05 Hs_ICK_11 AAGGACTATATACATCTAATA 1,03 0,11 OK 0,33 0,17 --- 0,028672 
NEK6 10783 SKV_19 D10 Hs_NEK6_5 ACCGGAGAGGATCCATGAGAA 0,60 0,29 OK 0,33 0,28 --- 0,058839 
STK38 11329 SKV_01 G08 Hs_STK38_6 TACGTCGGCCATAAACAGCTA 0,25 0,12 TOXIC 0,33 0,41 --- 0,239269 
PRKAG1 5571 SKV_02 G10 Hs_PRKAG1_5 CCCTAAGATAATAGCACAACA 0,27 0,15 TOXIC 0,33 0,96 --- 0,587656 
DYRK3 8444 SKV_09 G05 Hs_DYRK3_10 TCGACAGTACGTGGCCCTAAA 0,34 0,36 TOXIC 0,32 0,05 --- 0,000247 
MAP2K3 5606 SKV_20 C04 Hs_MAP2K3_5 ACGGATATCCTGCATGTCCAA 0,15 0,03 TOXIC 0,32 0,35 --- 0,112698 
TNK1 8711 SKV_23 F08 Hs_TNK1_5 AAGGATCTAGTCTGCCCACTA 0,07 0,03 TOXIC 0,32 0,30 --- 0,137662 
PACSIN3 29763 SKV_16 D03 Hs_PACSIN3_5 AAGGATATGCTGCTCACCTTA 0,70 0,09 OK 0,32 0,17 --- 0,002517 
NEK8 284086 SKV_19 G06 Hs_NEK8_5 ACGGACAGTTGGGCACCAATA 0,10 0,04 TOXIC 0,32 0,23 --- 0,034326 
HIPK1 204851 SKV_10 C04 Hs_HIPK1_10 CTGAGCTATGTTTGTAATGCA 0,47 0,30 OK 0,32 0,15 --- 0,020629 
WNK4 65266 SKV_25 G10 Hs_WNK4_1 CACTAGTGTCTCAGACCAGAA 0,17 0,03 TOXIC 0,31 0,63 --- 0,437770 
CDKN2C 1031 SKV_16 G05 Hs_CDKN2C_5 CAGGCTTATGAATATATTTAA 0,68 0,21 OK 0,31 0,34 --- 0,070261 
BCR 613 SKV_02 C08 Hs_BCR_7 ACGGCAGTCCATGACGGTGAA 0,39 0,23 TOXIC 0,31 0,22 --- 0,073182 
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CKM 1158 SKV_10 D08 Hs_CKM_10 CTCAGTATTTGACGTGTCCAA 0,33 0,13 TOXIC 0,31 0,18 --- 0,037679 
MAP2K3 5606 SKV_18 E04 Hs_MAP2K3_6 CCGGGCCACCGTGAACTCACA 0,14 0,08 TOXIC 0,31 0,48 --- 0,238090 
CDKN2D 1032 SKV_15 C06 Hs_CDKN2D_5 ACCCAAGGGCAGAGCATTTAA 0,06 0,02 TOXIC 0,31 0,38 --- 0,102497 
UHMK1 127933 SKV_19 G03 Hs_UHMK1_9 TAGGTTGTCTTTAAAGATATA 0,42 0,09 OK 0,31 0,16 --- 0,009144 
FRK 2444 SKV_21 D08 Hs_FRK_6 CTGGGAGTACCTAGAACCCTA 0,44 0,15 OK 0,31 0,38 --- 0,150042 
RPS6KA2 6196 SKV_03 D03 Hs_RPS6KA2_10 CCGGAGGTCCTGAAGCGTCAA 0,58 0,20 OK 0,31 0,22 --- 0,073006 
PTK2B 2185 SKV_22 G07 Hs_PTK2B_14 CAGGAGAACTTAAAGCCCAAA 0,50 0,08 OK 0,31 0,20 --- 0,052183 
PANK4 55229 SKV_13 D08 Hs_PANK4_6 TCGACATAGGCGGGTCGTTAA 1,40 0,36 OK 0,31 0,16 --- 0,002669 
PIM1 5292 SKV_06 D05 Hs_PIM1_10 TGGGATAGGACTAGCACCATT 0,27 0,14 TOXIC 0,31 0,45 --- 0,299947 
PIK3R4 30849 SKV_19 E08 Hs_PIK3R4_7 AAGATGTACTTGACTAGTTTA 0,77 0,11 OK 0,31 0,17 --- 0,010611 
HK1 3098 SKV_09 B03 Hs_HK1_10 CCGTGTCGTATGACCTAGTAA 0,10 0,05 TOXIC 0,31 0,26 --- 0,111977 
FRK 2444 SKV_23 B08 Hs_FRK_5 CAGGACAGTCAAGGTGATATA 0,67 0,08 OK 0,31 0,11 --- 0,007306 
WNK3 65267 SKV_19 F06 Hs_WNK3_10 CCGGGTGACGCCAATAAAGAA 0,70 0,15 OK 0,30 0,18 --- 0,015858 
RIOK1 83732 SKV_04 C09 Hs_RIOK1_6 TACCATGTCCAGAACCAATAA 0,36 0,09 TOXIC 0,30 0,12 --- 0,010897 
MARK1 4139 SKV_06 C05 Hs_MARK1_11 AAGCTGTGATAAATACTGTAA 0,86 0,53 OK 0,30 0,31 --- 0,173759 
ADCK1 57143 SKV_04 C07 Hs_ADCK1_5 TACGACGGCTGTCATCAGTTA 0,44 0,25 OK 0,30 0,24 --- 0,099242 
UHMK1 127933 SKV_18 C03 Hs_UHMK1_8 CAGAAACATCGTGACTTTGTA 0,65 0,15 OK 0,30 0,09 --- 0,000643 
MAPK9 5601 SKV_08 B05 Hs_MAPK9_7 ATCGTGAACTTGTCCTCTTAA 0,51 0,18 OK 0,30 0,17 --- 0,037471 
FGFR4 2264 SKV_22 D05 Hs_FGFR4_6 CAGGCTCTTCCGGCAAGTCAA 0,37 0,13 TOXIC 0,30 0,22 --- 0,078550 
FES 2242 SKV_22 G09 Hs_FES_6 CAGCCTGAGGCTGAGTACCAA 0,31 0,16 TOXIC 0,30 0,40 --- 0,267615 
PAK3 5063 SKV_18 D09 Hs_PAK3_5 TTCCAGTACTTTGTACAGGAA 0,47 0,15 OK 0,30 0,63 --- 0,380224 
PMVK 10654 SKV_13 C04 Hs_PMVK_5 CCCAGTGTGGATACTAATAAA 0,74 0,04 OK 0,29 0,15 --- 0,003450 
GAK 2580 SKV_15 D07 Hs_GAK_5 ACGCGTGTGACATTCAAGAAA 0,17 0,13 TOXIC 0,29 0,20 --- 0,012979 
MAP3K8 1326 SKV_25 E04 Rn_Map3k8_1 ATCCCTCCTACCTGTACATAA 0,61 0,23 OK 0,29 0,25 --- 0,115091 
PANK2 80025 SKV_12 B06 Hs_PANK2_5 CAGAGCGACTTTGATCACCAT 0,16 0,07 TOXIC 0,29 0,43 --- 0,314499 
GSK3A 2931 SKV_09 D07 Hs_GSK3A_12 AAGAAAGACGAGCTTTACCTA 0,93 0,20 OK 0,29 0,13 --- 0,018476 
STK35 140901 SKV_25 C10 Hs_STK35_6 TGCCGTTGTCGTGTTCTCACA 0,51 0,07 OK 0,28 0,17 --- 0,046445 
CDK7 1022 SKV_05 G09 Hs_CDK7_5 CCGGATGGCTCTGGACGTGAA 0,66 0,28 OK 0,28 0,26 --- 0,129143 
ADRBK2 157 SKV_02 F04 Hs_ADRBK2_6 CAAGTGTATGGGATTAACTAA 0,73 0,26 OK 0,28 0,13 --- 0,021717 
MYLK2 85366 SKV_07 B08 Hs_MYLK2_6 CGGGATCCTCTTCATGCACAA 0,56 0,40 OK 0,28 0,34 --- 0,230801 
PRKACA 5566 SKV_02 G07 Hs_PRKACA_6 CAGAAGGTGGTGAAACTGAAA 0,60 0,28 OK 0,28 0,36 --- 0,254908 
MAP3K11 4296 SKV_24 C05 Hs_MAP3K11_5 CCGGAGGAGAAACGTCTTCGA 0,38 0,19 TOXIC 0,27 0,21 --- 0,082399 
TNIK 23043 SKV_20 E09 Hs_TNIK_6 CTGGAATATAAGCGCAAACAA 0,11 0,07 TOXIC 0,27 0,29 --- 0,108627 
UGP2 7360 SKV_12 G04 Hs_UGP2_6 CCCAAAGTTAGTTACTCTTAA 0,81 0,30 OK 0,27 0,30 --- 0,192587 
CDC42BPG 55561 SKV_03 G03 Hs_CDC42BPG_5 CGCCGGTGGCTTTGCACTCTA 0,63 0,40 OK 0,27 0,37 --- 0,267818 
PI4K2A 55361 SKV_11 G03 Hs_PI4KII_6 CCGCATCGGGCTACCACCAAA 0,42 0,34 OK 0,27 0,14 --- 0,512684 
NEK3 4752 SKV_15 E03 Hs_NEK3_10 CAGAGATATCAAGTCCAAGAA 0,06 0,03 TOXIC 0,27 0,71 --- 0,413839 
PIP5K1B 8395 SKV_12 G08 Hs_PIP5K1B_10 CACCAGAATTATCCACAGCAA 0,71 0,20 OK 0,27 0,50 --- 0,400181 
GKAP1 80318 SKV_16 E08 Hs_GKAP1_6 CATGCTGTTTGTAACGCTCAA 0,40 0,09 OK 0,27 0,13 --- 0,002100 
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PDLIM5 10611 SKV_14 D07 Hs_PDLIM5_5 CAGCAGGGAAACGAACTCCGA 0,49 0,36 OK 0,27 0,59 --- 0,346279 
AAK1 22848 SKV_17 G03 Hs_AAK1_5 AACGTGAGTAGCGGTGATGTA 0,29 0,05 TOXIC 0,26 0,45 --- 0,281124 
PRKAR2A 5576 SKV_11 B07 Hs_PRKAR2A_6 AACTTGAAAGTCAGCACTAAA 0,86 0,06 OK 0,26 0,34 --- 0,544527 
PRKCQ 5588 SKV_03 C04 Hs_PRKCQ_7 CAGATTTAAAGTCTACAATTA 0,32 0,10 TOXIC 0,26 0,13 --- 0,026739 
WEE1 7465 SKV_25 B05 Hs_WEE1_8 CAAGACCTGCTAAGAGAATTA 0,09 0,06 TOXIC 0,26 0,84 --- 0,622222 
CDKN1B 1027 SKV_16 F09 Hs_CDKN1B_6 ACCGACGATTCTTCTACTCAA 0,16 0,09 TOXIC 0,25 0,07 --- 0,000027 
BCR 613 SKV_03 G08 Hs_BCR_8 CAGCATTCCGCTGACCATCAA 0,14 0,08 TOXIC 0,25 0,44 --- 0,375606 
MAP3K9 4293 SKV_25 G04 Hs_MAP3K9_6 ACCATAGAGAATGTTCGCCAA 0,99 0,20 OK 0,25 0,14 --- 0,036438 
ABL1 25 SKV_20 F09 Hs_ABL1_11 CCAGTGGAGATAACACTCTAA 0,53 0,03 OK 0,25 0,18 --- 0,035234 
ERN2 10595 SKV_17 F06 Hs_ERN2_5 AAGGATGAAACTGGCTTCTAT 0,55 0,13 OK 0,25 0,21 --- 0,054550 
SKP1A 6500 SKV_25 B04 Hs_SKP1A_9 TCGCAAGACCTTCAATATCAA 0,58 0,11 OK 0,25 0,30 --- 0,216041 
TSSK2 23617 SKV_05 C03 Hs_STK22B_6 GTCGGCCTTCACGTAAACTAA 0,47 0,28 OK 0,25 0,33 --- 0,263675 
PINK1 65018 SKV_19 F03 Hs_PINK1_3 CCGGACGCTGTTCCTCGTTAT 0,63 0,28 OK 0,25 0,16 --- 0,023272 
DYRK1B 9149 SKV_08 D03 Hs_DYRK1B_5 AAGGACGAAAGAACTCAGGAA 0,16 0,06 TOXIC 0,24 0,07 --- 0,003166 
FN3K 64122 SKV_11 G08 Hs_FN3K_6 CCCAGTGTTCGTCAAAGTCAA 0,58 0,23 OK 0,24 0,04 --- 0,599254 
NEK8 284086 SKV_18 C06 Hs_NEK8_6 CCAGAAGCTGGTGATCATCAA 0,56 0,13 OK 0,24 0,06 --- 0,000204 
AK3 50808 SKV_11 F03 Hs_AK3L1_5 CCCGTGGCACTATGTAAATAA 0,24 0,19 TOXIC 0,24 0,24 --- 0,612108 
LMTK2 22853 SKV_22 C04 Hs_LMTK2_5 CACCTCCGACTTAAATGTGAA 1,05 0,23 OK 0,24 0,04 --- 0,000786 
PBK 55872 SKV_17 G10 Hs_PBK_5 AAGTGTGGCTTGCGTAAATAA 0,16 0,10 TOXIC 0,24 0,37 --- 0,254437 
NADK 65220 SKV_13 F03 Hs_FLJ13052_5 AAAGAGCGTCCTTGTCATCAA 0,72 0,46 OK 0,23 0,29 --- 0,106305 
PCTK3 5129 SKV_07 G04 Hs_PCTK3_6 CAGGTTGGATACGGATGGCAT 0,22 0,15 TOXIC 0,23 0,77 --- 0,631319 
HUNK 30811 SKV_06 G06 Hs_HUNK_5 CACGGGCAAAGTGCCCTGTAA 0,10 0,11 TOXIC 0,23 0,62 --- 0,558040 
CAMKK2 10645 SKV_17 F07 Hs_CAMKK2_6 CCGCAAGATCTTCTCTGGGAA 0,78 0,11 OK 0,23 0,16 --- 0,029054 
CSNK2B 1460 SKV_15 D05 Hs_CSNK2B_5 CAGGTCCCTCACTACCGACAA 0,12 0,08 TOXIC 0,22 0,26 --- 0,094388 
PRKY 5616 SKV_03 C08 Hs_PRKY_1 CAGCAGTACAGTCCTTCCTAA 0,17 0,13 TOXIC 0,22 0,46 --- 0,442375 
UCK1 83549 SKV_13 F08 Hs_UCK1_6 AAGGCTGGTTGTGGCCTACAA 0,26 0,15 TOXIC 0,22 0,46 --- 0,303777 
PRKACG 5568 SKV_01 C09 Hs_PRKACG_6 CTGGATCGCCATCTATGAGAA 0,37 0,21 TOXIC 0,22 0,40 --- 0,382641 
MAPKAP1 79109 SKV_14 G07 Hs_MAPKAP1_6 CTAGGTATCTCTGGAGACAAA 0,37 0,16 TOXIC 0,22 0,59 --- 0,414829 
SRPK1 6732 SKV_08 B10 Hs_SRPK1_9 GAGGATCTACATAATGCTAAT 0,60 0,25 OK 0,22 0,38 --- 0,365639 
ERBB2 2064 SKV_21 C04 Hs_ERBB2_14 AACAAAGAAATCTTAGACGAA 0,61 0,23 OK 0,22 0,04 --- 0,000039 
MAPK8IP1 9479 SKV_12 E06 Hs_MAPK8IP1_3 CTGGAGGAGTTTGAGGATGAA 0,25 0,34 TOXIC 0,22 2,06 --- 0,861951 
HCK 3055 SKV_23 B10 Hs_HCK_8 CCGGGATAGCGAGACCACTAA 0,29 0,04 TOXIC 0,22 0,20 --- 0,127340 
MAPK9 5601 SKV_09 F05 Hs_MAPK9_6 AAAGTCGATTTATGTGTATTA 1,13 0,25 OK 0,22 0,37 --- 0,366188 
SNF1LK 150094 SKV_07 C04 Hs_SNF1LK_12 ATGCTTTACATCGTCACTGAA 0,71 0,20 OK 0,22 0,13 --- 0,039321 
MAP3K6 9064 SKV_20 D08 Hs_MAP3K6_5 CACCATCCAAATGCTGTTGAA 0,60 0,33 OK 0,22 0,26 --- 0,140575 
HIPK2 28996 SKV_10 B07 Hs_HIPK2_6 TCCCGAAGTCTCCATACTAAA 1,06 0,32 OK 0,22 0,04 --- 0,000837 
IKBKE 9641 SKV_17 E10 Hs_IKBKE_6 ACGGCGGAACAAGGAGATCAT 0,78 0,14 OK 0,21 0,10 --- 0,004869 
EPHA2 1969 SKV_19 C08 Hs_EPHA2_8 TCGGACAGACATATAGGATAT 0,21 0,07 TOXIC 0,21 0,15 --- 0,032355 
TPD52L3 89882 SKV_12 B09 Hs_NYD-SP25_10 CACGTTAAATCAAGGAAGGAA 0,12 0,03 TOXIC 0,21 0,47 --- 0,480091 
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FER 2241 SKV_21 C08 Hs_FER_6 CAGAACAACTTAGTAGGATAA 0,41 0,21 OK 0,21 0,36 --- 0,287518 
PFKFB2 5208 SKV_09 C07 Hs_PFKFB2_5 CCAGAGCAAGATAGTCTACTA 0,26 0,23 TOXIC 0,21 0,02 --- 0,000122 
MAP3K4 4216 SKV_20 B05 Hs_MAP3K4_6 CTCAAGCATCGCATAGTTTAA 0,40 0,12 TOXIC 0,21 0,25 --- 0,141805 
YES1 7525 SKV_22 B07 Hs_YES1_7 GAGGCTCCTGCTTATTTATAA 0,42 0,07 OK 0,21 0,19 --- 0,124969 
AURKA 6790 SKV_19 G07 Hs_AURKA_4 CAGGGCTGCCATATAACCTGA 0,20 0,06 TOXIC 0,21 0,32 --- 0,242519 
CSNK1G1 53944 SKV_05 F05 Hs_CSNK1G1_5 ATGGACCATCCTAGTAGGGAA 1,01 0,26 OK 0,21 0,46 --- 0,474350 
ROR1 4919 SKV_21 F07 Hs_ROR1_5 CCCAGTGAGTAATCTCAGTAA 0,39 0,41 TOXIC 0,20 0,35 --- 0,287087 
PLK2 10769 SKV_17 F09 Hs_PLK2_7 CACCTTTCAGGTGAATTTCTA 1,00 0,34 OK 0,20 1,00 --- 0,698757 
MELK 9833 SKV_04 G10 Hs_MELK_6 CTGGATCATGCAAGATTACAA 0,57 0,07 OK 0,20 0,36 --- 0,389282 
CAMKK1 84254 SKV_19 F08 Hs_CAMKK1_5 AGCGATGAGCAAACTCTATAA 0,44 0,15 OK 0,20 0,29 --- 0,217120 
PRKAG2 51422 SKV_02 B08 Hs_PRKAG2_5 TTCCAGTGATGTTGAAATTAA 0,60 0,15 OK 0,20 0,09 --- 0,020274 
PANK3 79646 SKV_12 B04 Hs_PANK3_1 AAGCGAGAATCTGTTAGTAAA 0,74 0,55 OK 0,20 0,29 --- 0,298098 
PNCK 139728 SKV_25 G03 Hs_PNCK_8 ACACTGGAAGCGAGCCTTCAA 0,33 0,22 TOXIC 0,20 0,19 --- 0,145521 
MAPK8 5599 SKV_08 B03 Hs_MAPK8_13 GCCCAGTAATATAGTAGTAAA 0,89 0,01 OK 0,20 0,10 --- 0,029693 
NRGN 4900 SKV_13 G10 Hs_NRGN_11 CTTGCTCTGACCGGAAGAGAA 0,80 0,13 OK 0,20 0,24 --- 0,100846 
DGKA 1606 SKV_08 F10 Hs_DGKA_5 ATCCATCTTCTCAACATGCAA 0,89 0,28 OK 0,20 0,72 --- 0,657778 
CSNK1D 1453 SKV_05 E06 Hs_CSNK1D_5 CCGGTCTAGGATCGAAATGTT 0,53 0,12 OK 0,20 0,11 --- 0,031686 
CDKN2A 1029 SKV_16 G03 Hs_CDKN2A_12 CACGCCCTAAGCGCACATTCA 0,08 0,05 TOXIC 0,20 0,26 --- 0,127627 
SMG1 23049 SKV_04 C03 Hs_SMG1_7 CAGAATCTGGTTGATAATATA 0,20 0,12 TOXIC 0,20 0,19 --- 0,139734 
MAPK11 5600 SKV_09 F04 Hs_MAPK11_6 CTGAGCGACGAGCACGTTCAA 0,91 0,27 OK 0,20 0,15 --- 0,092501 
NRGN 4900 SKV_25 F03 Hs_NRGN_7 AACAATAAAGAGGAATGTCCA 0,39 0,06 TOXIC 0,20 0,22 --- 0,202880 
MAP4K5 11183 SKV_18 G07 Hs_MAP4K5_5 CTTGCCTATTTGCATACTAAA 0,58 0,73 OK 0,20 0,26 --- 0,173139 
PRKCZ 5590 SKV_01 E05 Hs_PRKCZ_5 CGGAAGCATGACAGCATTAAA 0,78 0,13 OK 0,19 0,19 --- 0,154938 
TPK1 27010 SKV_11 E09 Hs_TPK1_5 AACCTGGTGCATCGAAATGTA 0,63 0,15 OK 0,19 0,12 --- 0,752444 
TGFBR2 7048 SKV_24 C09 Hs_TGFBR2_6 CTCCAATATCCTCGTGAAGAA 0,49 0,07 OK 0,19 0,07 --- 0,011080 
RPS6KA4 8986 SKV_01 F08 Hs_RPS6KA4_5 CAGGCTGTGCCTTTGACTTTA 0,48 0,10 OK 0,19 0,18 --- 0,145973 
KDR 3791 SKV_23 C07 Hs_KDR_6 AAGGCTAATACAACTCTTCAA 0,27 0,05 TOXIC 0,19 0,28 --- 0,291344 
BRSK2 9024 SKV_04 G05 Hs_STK29_6 GCGAGCTACTGTAAACTTTAA 0,16 0,05 TOXIC 0,19 0,28 --- 0,314431 
CMPK 51727 SKV_13 D05 Hs_CMPK_4 AACATGGTAATTACTAAATTA 0,93 0,23 OK 0,19 0,32 --- 0,227903 
PDXK 8566 SKV_19 F09 Hs_PDXK_10 ATGGCTGTTATGGCTGAATTA 0,26 0,05 TOXIC 0,19 0,29 --- 0,246674 
TTBK1 84630 SKV_07 D06 Hs_TTBK1_6 TGGCAGGAACGAGAAGTTTAA 1,06 0,40 OK 0,19 0,29 --- 0,323031 
RPS6KC1 26750 SKV_03 F06 Hs_RPS6KC1_11 CTGGTGAATTGGAGTCAACAA 0,05 0,02 TOXIC 0,19 0,78 --- 0,700959 
CAMK4 814 SKV_06 B05 Hs_CAMK4_5 CAGAAGCCTTATGCTCTCAAA 0,55 0,36 OK 0,19 0,10 --- 0,034896 
PIK3C3 5289 SKV_15 E07 Hs_PIK3C3_5 AACGCGAAAGTGGAAATCGTA 1,03 0,27 OK 0,19 0,12 --- 0,010472 
MVK 4598 SKV_09 B10 Hs_MVK_6 GCGGTGGGCCTGGTTAAATAA 0,56 0,20 OK 0,18 0,19 --- 0,167918 
DMPK 1760 SKV_02 F07 Hs_DMPK_2 GAGCCTGAGGGCTAAATTTAA 0,67 0,29 OK 0,18 0,44 --- 0,509032 
TESK2 10420 SKV_24 D06 Hs_TESK2_5 CCGGGAAGAATCGCTATCTGA 1,22 0,07 OK 0,18 0,28 --- 0,327756 
PRKCB1 5579 SKV_03 B05 Hs_PRKCB1_6 CCGGATGAAACTGACCGATTT 0,63 0,17 OK 0,18 0,16 --- 0,119392 
AURKC 6795 SKV_15 F09 Hs_AURKC_5 AAGATGTAAGATGCTAATTAA 0,84 0,13 OK 0,18 0,16 --- 0,033773 
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MARK2 2011 SKV_04 E03 Hs_MARK2_6 CACCTCTAATTCTTACTCTAA 0,57 0,30 OK 0,18 0,10 --- 0,038080 
TWF1 5756 SKV_02 D05 Hs_PTK9_6 ACCGGCATCCAAGCAAGTGAA 0,25 0,13 TOXIC 0,18 0,14 --- 0,098310 
ERN1 2081 SKV_17 B06 Hs_ERN1_6 CAGGACGTGAGCGACAGAATA 0,56 0,17 OK 0,18 0,05 --- 0,000307 
GRK5 2869 SKV_02 F09 Hs_GRK5_7 CCCGCCAGATCTGAACAGAAA 0,72 0,46 OK 0,18 0,23 --- 0,258376 
IHPK1 9807 SKV_13 B08 Hs_IHPK1_9 AAGGTGGATGTCCGCATGATT 0,72 0,12 OK 0,17 0,29 --- 0,216798 
STK38L 23012 SKV_03 E10 Hs_STK38L_6 TACAACCATGATAACCATTAT 0,39 0,06 TOXIC 0,17 0,26 --- 0,309120 
FN3K 64122 SKV_13 E08 Hs_FN3K_5 CCAGCTGTTTAACTACCTGAA 0,89 0,34 OK 0,17 0,31 --- 0,241085 
CDK6 1021 SKV_05 G08 Hs_CDK6_5 AAGACTCAAGGTGGTCAGTAA 0,30 0,16 TOXIC 0,17 0,25 --- 0,306823 
PNKP 11284 SKV_11 E05 Hs_PNKP_7 CTGGAGGATCTTGTACCCAGA 0,67 0,29 OK 0,17 0,23 --- 0,829764 
CALM2 805 SKV_08 F03 Hs_CALM2_8 GACCTTGTACAGAATGTGTTA 0,60 0,18 OK 0,17 0,38 --- 0,482254 
TLK2 11011 SKV_25 B07 Hs_TLK2_7 GTCGGATCCTTGAGTGATAAA 0,55 0,09 OK 0,17 0,20 --- 0,219322 
PRKD2 25865 SKV_05 C05 Hs_PRKD2_5 CACGACCAACAGATACTATAA 0,21 0,04 TOXIC 0,17 0,39 --- 0,504214 
PIM1 5292 SKV_04 F05 Hs_PIM1_6 CAACATTTACAACTCATTCCA 0,58 0,21 OK 0,17 0,13 --- 0,088289 
RAF1 5894 SKV_24 C06 Hs_RAF1_7 TGGGAAATAGAAGCCAGTGAA 0,52 0,22 OK 0,17 0,48 --- 0,584272 
CSK 1445 SKV_19 C06 Hs_CSK_2 CCGGTACAGAATGTATTGCCA 0,23 0,07 TOXIC 0,16 0,18 --- 0,119363 
NEK1 4750 SKV_15 D09 Hs_NEK1_5 ATGGCTCTCTCTACATAGTAA 0,63 0,28 OK 0,16 0,17 --- 0,070203 
MVK 4598 SKV_10 F10 Hs_MVK_5 CCGCTTGGCGATGCCAGCCAA 0,25 0,19 TOXIC 0,16 0,43 --- 0,548784 
MYLK2 85366 SKV_05 D08 Hs_MYLK2_5 AACGCTGTAACCGACGCCTTA 1,19 0,20 OK 0,16 0,13 --- 0,102828 
MAST4 375449 SKV_19 B08 Hs_LOC375449_5 GAGGAGCTTGACCACATATTA 0,85 0,20 OK 0,16 0,10 --- 0,019254 
ADCK5 203054 SKV_04 D04 Hs_ADCK5_5 AAGGCCTTTGCTGAGCAGATA 0,09 0,02 TOXIC 0,16 0,44 --- 0,568596 
DAPK3 1613 SKV_04 D10 Hs_DAPK3_3 CCCAGAGATTGTGAACTATGA 0,29 0,12 TOXIC 0,16 0,26 --- 0,361310 
PANK1 53354 SKV_11 F06 Hs_PANK1_6 CCGAAGGATATTACAGCCGAA 0,74 0,22 OK 0,15 0,27 --- 0,881513 
PDGFRA 5156 SKV_23 D10 Hs_PDGFRA_7 CGCAGGAAGCCTACTATTTAA 0,40 0,08 OK 0,15 0,01 --- 0,000035 
PI4KB 5298 SKV_12 F03 Hs_PIK4CB_6 CGACATGTTCAACTACTATAA 0,29 0,14 TOXIC 0,15 0,24 --- 0,320264 
ATR 545 SKV_03 G07 Hs_ATR_2 CCGCTAATCTTCTAACATTAA 0,35 0,21 TOXIC 0,15 0,59 --- 0,680256 
STK25 10494 SKV_18 G05 Hs_STK25_7 CCGGCCGAGTCCACACAGCAA 0,27 0,10 TOXIC 0,15 0,65 --- 0,656281 
DGKQ 1609 SKV_10 E05 Hs_DGKQ_6 CCGGAAGGTGACGCTCACCAA 0,37 0,18 TOXIC 0,15 0,74 --- 0,748356 
DBF4 10926 SKV_14 D08 Hs_ASK_9 CAGGTTAAACTAAGAATCCAA 0,62 0,42 OK 0,15 0,35 --- 0,380837 
MAP3K7IP2 23118 SKV_16 C06 Hs_MAP3K7IP2_6 TGGCTGGGTATCTCAGTTTAA 0,58 0,09 OK 0,15 0,05 --- 0,000512 
BMPR2 659 SKV_24 B04 Hs_BMPR2_6 CTCGTAAGTATGTAAAGGAAA 0,48 0,12 OK 0,14 0,52 --- 0,652501 
MAPK4 5596 SKV_07 G08 Hs_MAPK4_5 AAGGATCGTTGATCAGCATTA 0,54 0,25 OK 0,14 0,75 --- 0,759242 
AXL 558 SKV_20 G03 Hs_AXL_9 CCGGTGTTCTAAGATGTGATA 1,03 0,15 OK 0,14 0,13 --- 0,067777 
ACVRL1 94 SKV_23 G08 Hs_ACVRL1_11 CTGGGTAGAGGTAGTGTGAGT 0,88 0,01 OK 0,14 0,07 --- 0,026726 
PGK1 5230 SKV_09 C10 Hs_PGK1_6 GAGGAACGGATCAGATGTCTA 0,36 0,12 TOXIC 0,14 0,56 --- 0,689693 
AKT3 10000 SKV_03 E05 Hs_AKT3_7 AACTGTTGGCTTTGGATTAAA 0,78 0,12 OK 0,14 0,19 --- 0,266807 
DAPK1 1612 SKV_06 B09 Hs_DAPK1_6 CGGCTATTACTCTGTGGCCAA 0,56 0,28 OK 0,14 0,33 --- 0,514003 
LYN 4067 SKV_23 C10 Hs_LYN_12 CCCGGACGACTTGTCTTTCAA 0,93 0,06 OK 0,14 0,17 --- 0,230526 
ACVRL1 94 SKV_26 B04 Hs_ACVRL1_6 CAGCTTTGAGGACATGAAGAA 0,31 0,09 TOXIC 0,14 0,64 --- 0,729137 
CKB 1152 SKV_08 F07 Hs_CKB_2 CCAGATTGAAACTCTCTTCAA 0,70 0,25 OK 0,14 0,46 --- 0,635524 
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FUK 197258 SKV_13 G05 Hs_FUK_5 CCGAAGGGAGTTGATTGGACA 0,87 0,26 OK 0,14 0,56 --- 0,595159 
AK3L1 205 SKV_10 C09 Hs_AK3_9 CAGGAAGATGTGGTCATTCAT 0,32 0,18 TOXIC 0,14 0,26 --- 0,416570 
NEK7 140609 SKV_19 G04 Hs_NEK7_5 ACGACCGGATATGGGCTATAA 0,10 0,07 TOXIC 0,13 0,54 --- 0,637027 
WNK4 65266 SKV_18 B05 Hs_WNK4_5 CAGGAGGAGCCAGCACCATTA 0,21 0,08 TOXIC 0,13 0,16 --- 0,138415 
PIP4K2B 8396 SKV_11 C09 Hs_PIP5K2B_6 CAAGGACTTGCCAACATTCAA 0,38 0,01 TOXIC 0,13 0,09 --- 0,954650 
MKNK2 2872 SKV_04 E04 Hs_MKNK2_5 CCGCTTCTACCTGGTGTTTGA 0,95 0,30 OK 0,13 0,16 --- 0,227634 
STK25 10494 SKV_20 E05 Hs_STK25_5 CACCAAGCTATGGATCATCAT 0,67 0,12 OK 0,13 0,16 --- 0,144322 
PIK3R3 8503 SKV_17 E04 Hs_PIK3R3_13 CCAAATAACAATATAGAACAA 0,68 0,21 OK 0,13 0,10 --- 0,046769 
PDK2 5164 SKV_02 C09 Hs_PDK2_5 AAGAACCTTGTTAGACCGAGA 0,58 0,09 OK 0,13 0,04 --- 0,005007 
PRKCB1 5579 SKV_01 D05 Hs_PRKCB1_5 CAAGAGCTAAGTAGATGTGTA 0,64 0,23 OK 0,13 0,13 --- 0,165610 
ROCK2 9475 SKV_03 E03 Hs_ROCK2_5 AAGCTACATATGGAGCTTAAA 0,25 0,08 TOXIC 0,13 0,34 --- 0,550621 
ALPK2 115701 SKV_04 D03 Hs_ALPK2_7 CAGGGATGGGAAAGAAATAAA 0,50 0,26 OK 0,13 0,32 --- 0,522830 
OSR1 130497 SKV_25 C06 Hs_OXSR1_7 AAAGAGTAAATTGTCCTTAAA 0,71 0,13 OK 0,13 0,34 --- 0,554039 
SLK 9748 SKV_18 G03 Hs_SLK_5 CCAGATCAGGACCGTGATAAA 0,51 0,26 OK 0,12 0,31 --- 0,455171 
TESK2 10420 SKV_24 F06 Hs_TESK2_6 CGAGATGAGCCCTATAATGAA 0,55 0,09 OK 0,12 0,17 --- 0,283699 
VRK2 7444 SKV_05 F03 Hs_VRK2_5 CAGGTTTATCTTGCAGATTAT 0,12 0,08 TOXIC 0,12 0,66 --- 0,765294 
CDK4 1019 SKV_05 G06 Hs_CDK4_1 CCGAACTGACCGGGAGATCAA 0,96 0,36 OK 0,12 0,42 --- 0,650877 
ILKAP 80895 SKV_14 G09 Hs_ILKAP_5 TTCGGTGATCTTTGGTCTGAA 0,34 0,58 TOXIC 0,12 0,53 --- 0,638279 
PIP5K1A 8394 SKV_12 G07 Hs_PIP5K1A_6 CCCTGCCTTGATAATATGTTA 1,16 0,25 OK 0,12 0,11 --- 0,148734 
PRKAG1 5571 SKV_01 C10 Hs_PRKAG1_6 TTGGCCCTGATTCAACCCTAA 0,45 0,17 OK 0,12 0,62 --- 0,763179 
RPS6KC1 26750 SKV_02 B06 Hs_RPS6KC1_6 ATCAGTAAATTTCTAAACAGA 0,79 0,38 OK 0,11 0,15 --- 0,247555 
MST1R 4486 SKV_23 D05 Hs_MST1R_6 TCCCGGTGACACAGACACAAA 0,53 0,06 OK 0,11 0,04 --- 0,008089 
SKP1A 6500 SKV_25 C04 Hs_SKP1A_10 AAGATGATGAGAACAAAGAAA 0,79 0,10 OK 0,11 0,24 --- 0,466794 
AK3 50808 SKV_13 D03 Hs_AK3L1_6 CCGTGGCACTATGTAAATAAA 0,72 0,15 OK 0,11 0,23 --- 0,331235 
CDK3 1018 SKV_05 G05 Hs_CDK3_5 ATGGATATGTTCCAGAAGGTA 0,54 0,29 OK 0,11 0,16 --- 0,298444 
MAPKBP1 23005 SKV_14 E05 Hs_MAPKBP1_5 CAGGACCGAAATATTCGGATA 0,80 0,09 OK 0,11 0,17 --- 0,187492 
NAGK 55577 SKV_13 E05 Hs_NAGK_6 CCCGGTCTTGTTCCAGGGCAA 1,02 0,30 OK 0,11 0,21 --- 0,282916 
MAP3K8 1326 SKV_25 D04 Hs_MAP3K8_7 AAGGATAATAGAGTAGCCTAA 0,23 0,08 TOXIC 0,11 0,40 --- 0,667704 
PRKDC 5591 SKV_04 B04 Hs_PRKDC_5 CTCGTGTATTACAGAAGGAAA 0,48 0,25 OK 0,11 0,12 --- 0,209626 
NUAK2 81788 SKV_05 D05 Hs_SNARK_5 GACCATAAGATCCTAGTGAAA 0,74 0,37 OK 0,11 0,26 --- 0,527662 
PKM2 5315 SKV_12 F06 Hs_PKM2_6 CCCGATCAGTGGAGACGTTGA 1,38 0,50 OK 0,10 0,07 --- 0,071791 
DYRK4 8798 SKV_08 C07 Hs_DYRK4_5 CTCCATATGAACAAAGTGAAA 1,15 0,17 OK 0,10 0,33 --- 0,621259 
CKMT1B 1159 SKV_10 D09 Hs_CKMT1_6 CTGGACGTTACTATAGGCTCA 0,20 0,05 TOXIC 0,10 0,16 --- 0,344447 
FGFR3 2261 SKV_21 D03 Hs_FGFR3_6 CCGATGTTATTAGATGTTACA 0,68 0,33 OK 0,10 1,09 --- 0,860242 
MAPK10 5602 SKV_09 F06 Hs_MAPK10_6 TCCGAGCACAATAAACTCAAA 1,05 0,20 OK 0,10 0,32 --- 0,620960 
PICK1 9463 SKV_14 C03 Hs_PRKCABP_5 TCGCCTCACCATCAAGAAGTA 0,13 0,05 TOXIC 0,10 0,43 --- 0,618668 
PRKAA2 5563 SKV_25 C03 Hs_PRKAA2_7 ATGGAAGGTAGTGAATGCATA 0,72 0,18 OK 0,10 0,12 --- 0,235942 
STK10 6793 SKV_20 D04 Hs_STK10_6 CAGCTCAAACTGATGAAGAAA 0,27 0,06 TOXIC 0,10 0,30 --- 0,534260 
AKAP1 8165 SKV_12 D06 Hs_AKAP1_10 CACGCAGAGATGACAGTACAA 0,32 0,16 TOXIC 0,10 0,30 --- 0,605110 
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AXL 558 SKV_19 C03 Hs_AXL_10 TCCAAGATTCTAGATGATTAA 0,53 0,19 OK 0,10 0,31 --- 0,560632 
ITPKB 3707 SKV_09 B08 Hs_ITPKB_6 GACGTAAAGATTCTATGAATA 0,84 0,31 OK 0,09 0,16 --- 0,366612 
AK7 122481 SKV_12 C04 Hs_AK7_6 CAAGATTGTCTTGACCATTTA 0,88 0,31 OK 0,09 0,13 --- 0,280571 
KSR1 8844 SKV_24 D04 Hs_KSR_9 AAGGGCGAAGCTGGTCCGTTA 1,02 0,16 OK 0,09 0,28 --- 0,596891 
CDKL2 8999 SKV_09 G10 Hs_CDKL2_6 TTCTACGGACTTTAAATTAAA 1,09 0,15 OK 0,09 0,37 --- 0,708464 
AKT1 207 SKV_01 B05 Hs_AKT1_11 CACCATGAGCGACGTGGCTAT 0,42 0,28 OK 0,09 0,50 --- 0,783905 
PDIK1L 149420 SKV_18 C05 Hs_PDIK1L_6 CAGCCAAAGTACGATCTAATA 0,90 0,18 OK 0,09 0,12 --- 0,213162 
PIK3C2A 5286 SKV_15 E04 Hs_PIK3C2A_5 CAAGATGGTCGAATCAAGGAA 0,58 0,23 OK 0,08 0,27 --- 0,506014 
RP6-213H19.1 51765 SKV_19 B04 Hs_MST4_5 CCAAACCTACGTCAAGATTAA 0,34 0,09 TOXIC 0,08 0,29 --- 0,586738 
MAP2K4 6416 SKV_18 E09 Hs_MAP2K4_7 AGGGAGAATGGTGCTGTTTAA 0,49 0,12 OK 0,08 0,28 --- 0,575662 
C17orf75 64149 SKV_11 G09 Hs_NJMU-R1_9 CAGGCTTGAATTGGACAAGTA 0,62 0,43 OK 0,08 0,34 --- 0,869551 
PRKAR2B 5577 SKV_11 B08 Hs_PRKAR2B_5 ACGAACATGGATATTGTTGAA 0,80 0,12 OK 0,08 0,22 --- 0,867673 
BUB1 699 SKV_15 B07 Hs_BUB1_5 CAGCTTGTGATAAAGAGTCAA 0,37 0,10 TOXIC 0,08 0,22 --- 0,443854 
ILKAP 80895 SKV_16 E09 Hs_ILKAP_8 ATGGAGGAATTCGAGCCTCAA 0,73 0,12 OK 0,08 0,15 --- 0,292879 
SRPK1 6732 SKV_09 F10 Hs_SRPK1_7 ACGCTTATGGAACGTGATACA 0,28 0,09 TOXIC 0,08 0,23 --- 0,600986 
PANK2 80025 SKV_13 F06 Hs_PANK2_6 CTGTGTGTGAACTTACTGTAA 1,27 0,37 OK 0,08 0,29 --- 0,567167 
MAP3K5 4217 SKV_20 B06 Hs_MAP3K5_5 CAGCGAGTAGATAATATCGAA 0,83 0,07 OK 0,08 0,13 --- 0,289361 
RPS6KL1 83694 SKV_02 C04 Hs_RPS6KL1_5 CGCGATGTTAGTGAGGACTAT 0,74 0,56 OK 0,07 0,35 --- 0,732709 
UGP2 7360 SKV_11 C04 Hs_UGP2_5 CGAGTTCAAGTCTGTATCAAA 0,86 0,18 OK 0,07 0,16 --- 0,842387 
TLK2 11011 SKV_25 C07 Hs_TLK2_8 AACGTTAACGTTAGCAGAATA 0,57 0,07 OK 0,07 0,21 --- 0,573409 
NEK2 4751 SKV_15 D10 Hs_NEK2_6 TTACGAGGATGTTAAACTTAA 0,71 0,22 OK 0,07 0,08 --- 0,074268 
MAP3K2 10746 SKV_18 G06 Hs_MAP3K2_7 CAGAATGATGTCCGAGTCAAA 0,53 0,26 OK 0,07 0,07 --- 0,093104 
DYRK1A 1859 SKV_09 D06 Hs_DYRK1A_5 CAAGAATGGGTTGCCATTAAA 0,91 0,06 OK 0,07 0,11 --- 0,330905 
MAPK1 5594 SKV_09 E06 Hs_MAPK1_13 ATCATGGTAGTCACTAACATA 1,20 0,28 OK 0,07 0,36 --- 0,751707 
UCKL1 54963 SKV_13 D07 Hs_UCKL1_6 TACAATGAACACGGCACGCAA 0,44 0,19 OK 0,07 0,21 --- 0,477356 
NEK2 4751 SKV_17 B10 Hs_NEK2_5 TACGAGGATGTTAAACTTAAA 0,80 0,15 OK 0,07 0,34 --- 0,704017 
CAMK1G 57172 SKV_05 C10 Hs_CAMK1G_5 AACAGGCCGCCTGAAACTCAA 0,36 0,23 TOXIC 0,07 0,29 --- 0,709133 
BAIAP2L1 55971 SKV_16 D09 Hs_LOC55971_5 CACGGAGAGCACCTACCGGAA 0,45 0,12 OK 0,07 0,28 --- 0,616535 
NME6 10201 SKV_11 E03 Hs_NME6_5 CAGACTTCTCCTAGACATCTA 0,38 0,20 TOXIC 0,06 0,02 --- 0,810638 
PLK1 5347 SKV_15 F06 Hs_PLK1_6 CCGGATCAAGAAGAATGAATA 0,01 0,01 TOXIC 0,06 0,28 --- 0,626902 
IRAK1 3654 SKV_24 B07 Hs_IRAK1_6 TCCCATCGCCATGCAGATCTA 0,45 0,06 OK 0,06 0,16 --- 0,556118 
RBKS 64080 SKV_13 E07 Hs_RBKS_5 AACACAGTCATCTTACCCTTA 1,27 0,19 OK 0,06 0,17 --- 0,453965 
CLK3 1198 SKV_09 D04 Hs_CLK3_6 CTGCATTCTCTTTGAGTACTA 0,55 0,05 OK 0,06 0,30 --- 0,755227 
TGFBR1 7046 SKV_24 C08 Hs_TGFBR1_7 TGGGATTGTACTATACCAGTA 0,49 0,25 OK 0,06 0,27 --- 0,737692 
IRAK1 3654 SKV_22 D07 Hs_IRAK1_5 CCGGGCAATTCAGTTTCTACA 0,85 0,21 OK 0,06 0,05 --- 0,149611 
CARKL 23729 SKV_13 C07 Hs_CARKL_6 CAGGTAGTTTATTCAAAGAGA 0,71 0,33 OK 0,05 0,25 --- 0,632450 
NLK 51701 SKV_08 D09 Hs_NLK_5 TTGGTGTTGTCTGGTCAGTAA 0,51 0,15 OK 0,05 0,33 --- 0,793877 
CIB2 10518 SKV_14 D05 Hs_CIB2_5 CACCGAAGAGCAGCTAGACAA 0,27 0,06 TOXIC 0,05 0,36 --- 0,750457 
CHEK1 1111 SKV_06 B08 Hs_CHEK1_13 TTGGAATAACTCACAGGGATA 0,36 0,20 TOXIC 0,05 0,14 --- 0,549307 
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PRKRA 8575 SKV_11 D04 Hs_PRKRA_6 TAAGTATGATTGATTGTTAAA 1,03 0,31 OK 0,05 0,29 --- 0,767225 
PRKRIR 5612 SKV_25 G08 Hs_PRKRIR_8 CACATTATTCAGGAACTTAAA 0,72 0,22 OK 0,05 0,19 --- 0,665588 
RIOK2 55781 SKV_02 E06 Hs_RIOK2_5 AACGCGATTATCATAAACATA 0,70 0,32 OK 0,05 0,19 --- 0,679096 
BUB1B 701 SKV_16 F08 Hs_BUB1B_5 ACGAGAATACCTAATATGTGA 0,32 0,06 TOXIC 0,05 0,34 --- 0,747253 
CALM2 805 SKV_10 D03 Hs_CALM2_9 AAGCCCTTCTGCACATCTAAA 0,43 0,14 OK 0,05 0,02 --- 0,028848 
RPS6KA5 9252 SKV_01 F10 Hs_RPS6KA5_8 AAGCCAGTCATTCGAGATGAA 0,45 0,34 OK 0,05 0,33 --- 0,823529 
FASTK 10922 SKV_02 D09 Hs_FASTK_8 CAGCAGCAAGGTGGTACAGAA 0,11 0,03 TOXIC 0,04 0,49 --- 0,880952 
ATR 545 SKV_02 C07 Hs_ATR_11 AAGGACATGTGCATTACCTTA 1,10 0,27 OK 0,04 0,12 --- 0,555581 
HSPB8 26353 SKV_04 C04 Hs_HSPB8_6 CGCATGGTTTGGTTAATGAAA 0,76 0,36 OK 0,04 0,05 --- 0,215934 
NUAK1 9891 SKV_05 B03 Hs_ARK5_6 CTTGAGTTGATGATCAATTAA 0,65 0,15 OK 0,04 0,39 --- 0,854458 
CSNK1A1L 122011 SKV_05 F07 Hs_CSNK1A1L_5 CAGATTATCTTTAGAATTCCA 1,05 0,36 OK 0,04 0,42 --- 0,873283 
STK40 83931 SKV_07 B06 Hs_MGC4796_6 CCGGATGGTTAAGAAGATGAA 0,31 0,13 TOXIC 0,04 0,53 --- 0,899711 
PDK1 5163 SKV_01 C03 Hs_PDK1_5 CCCGAACTAGAACTTGAAGAA 0,29 0,23 TOXIC 0,04 0,61 --- 0,916904 
EEF2K 29904 SKV_04 C05 Hs_EEF2K_5 CAGACACTACATGAACACGAA 0,70 0,17 OK 0,04 0,19 --- 0,739110 
EPHA5 2044 SKV_22 F04 Hs_EPHA5_6 CCCGGCAGTATGTGTCTGTAA 0,08 0,05 TOXIC 0,04 0,20 --- 0,769048 
PLK2 10769 SKV_19 D09 Hs_PLK2_5 CAGATTGTGTCTGGACTGAAA 0,31 0,14 TOXIC 0,04 0,21 --- 0,733983 
MAPK8IP1 9479 SKV_14 C06 Hs_MAPK8IP1_4 TGGCATCAGCTTACAGTGCAA 0,64 0,17 OK 0,04 0,62 --- 0,899610 
CALM1 801 SKV_10 C10 Hs_CALM1_6 CTGGTTGTATCTTATTAGCAA 0,30 0,04 TOXIC 0,04 0,43 --- 0,893700 
MAP2K1IP1 8649 SKV_14 B08 Hs_MAP2K1IP1_5 ATGCCCAGGCTTGCAGAATAA 0,41 0,65 OK 0,03 0,39 --- 0,850211 
MAP2K2 5605 SKV_18 E03 Hs_MAP2K2_5 CAGCATTTGCATGGAACACAT 0,24 0,08 TOXIC 0,03 0,11 --- 0,576223 
PACSIN3 29763 SKV_14 F03 Hs_PACSIN3_6 CAGAGGACAATCAGCCGGAAA 0,33 0,04 TOXIC 0,03 0,12 --- 0,548202 
PSKH1 5681 SKV_04 F07 Hs_PSKH1_6 CCGCTCCACACGCTCCAATAA 0,50 0,10 OK 0,03 0,22 --- 0,807970 
PRKACB 5567 SKV_01 C08 Hs_PRKACB_9 CAGCCTGTGTAGTGTGACAAA 0,27 0,24 TOXIC 0,03 0,55 --- 0,926853 
CKM 1158 SKV_08 F08 Hs_CKM_5 GACCCTTGAACTCTACAAGAA 1,08 0,45 OK 0,03 0,07 --- 0,512635 
ANKK1 255239 SKV_24 E05 Hs_ANKK1_5 AGGAGCCGAGATGGAAATTTA 0,84 0,19 OK 0,03 0,35 --- 0,888955 
MAP2K1 5604 SKV_18 D10 Hs_MAP2K1_8 CTGGATCAAGTCCTGAAGAAA 0,21 0,07 TOXIC 0,03 0,27 --- 0,839969 
FLT3LG 2323 SKV_12 C08 Hs_FLT3LG_1 AGCCTGGAGCCCAACAACCTA 1,08 0,17 OK 0,03 0,23 --- 0,843669 
PRKAG3 53632 SKV_03 F09 Hs_PRKAG3_6 CAGATCTATGAGATTGAACAA 0,34 0,15 TOXIC 0,03 0,26 --- 0,874382 
TIE1 7075 SKV_25 E07 Hs_TIE1_2 CCCAGTGAGAACGTGACGTTA 0,82 0,21 OK 0,02 0,08 --- 0,621866 
IKBKB 3551 SKV_25 D10 Hs_IKBKB_9 CTGGAGAAGTACAGCGAGCAA 0,35 0,06 TOXIC 0,02 0,45 --- 0,932141 
CIB3 117286 SKV_16 F04 Hs_CIB3_2 CACGAGCAGCTGGAAGCGTAT 0,03 0,02 TOXIC 0,02 1,51 --- 0,974010 
LATS1 9113 SKV_01 F09 Hs_LATS1_6 CGCGATCTAGTATATGTTTAA 0,65 0,06 OK 0,02 0,31 --- 0,908845 
PTK2B 2185 SKV_21 C07 Hs_PTK2B_13 AAGCTGATCGGCATCATTGAA 0,64 0,11 OK 0,02 0,25 --- 0,868099 
MAPKAPK3 7867 SKV_04 F09 Hs_MAPKAPK3_5 CAGGCTTTCACTGAGAGAGAA 1,02 0,08 OK 0,02 0,09 --- 0,731348 
RIPK4 54101 SKV_24 E03 Hs_RIPK4_6 CACACGCAGTATGAAGATAAA 0,48 0,11 OK 0,02 0,80 --- 0,967816 
BCKDK 10295 SKV_04 B08 Hs_BCKDK_13 AACATGAGAAATGTATGCCAA 0,42 0,24 OK 0,02 0,18 --- 0,881207 
RPS6KA1 6195 SKV_03 C10 Hs_RPS6KA1_9 CCCAACATCATCACTCTGAAA 0,56 0,13 OK 0,02 0,55 --- 0,963144 
ITPK1 3705 SKV_10 F06 Hs_ITPK1_6 CCGATTAATGTCTGTACGTCA 0,67 0,32 OK 0,01 0,66 --- 0,971521 
TK1 7083 SKV_12 F10 Hs_TK1_6 TCGGCTCTGCTACTTCAAGAA 0,37 0,13 TOXIC 0,01 0,15 --- 0,903353 
SUPPLEMENTARY INFORMATION                                                                                                                                                                                                                                                         115 
Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
CDKL1 8814 SKV_08 C08 Hs_CDKL1_5 CTGGACCGAGTGACTACTATA 0,62 0,08 OK 0,01 0,23 --- 0,940318 
MKNK1 8569 SKV_06 E03 Hs_MKNK1_5 CCAGCAAAGATGATACCTTAA 0,41 0,31 OK 0,01 0,04 --- 0,659311 
IRAK2 3656 SKV_22 D08 Hs_IRAK2_5 CAGCAACGTCAAGAGCTCTAA 0,48 0,08 OK 0,01 0,09 --- 0,887276 
AKAP6 9472 SKV_12 E05 Hs_AKAP6_7 CAGAGATTGCTTTAATTATAA 0,57 0,52 OK 0,01 0,75 --- 0,987716 
PIM2 11040 SKV_05 B05 Hs_PIM2_6 CGGGATTGTCCAATTACTAAA 0,96 0,09 OK 0,01 0,47 --- 0,982669 
HSPB8 26353 SKV_02 E04 Hs_HSPB8_5 CCGCATGGTTTGGTTAATGAA 0,63 0,21 OK 0,01 0,43 --- 0,984444 
ERBB4 2066 SKV_21 C06 Hs_ERBB4_5 CTACGTGTTAGTGGCTCTTAA 0,47 0,12 OK 0,00 0,05 --- 0,856597 
PAK3 5063 SKV_20 B09 Hs_PAK3_2 CCGCTAAGACTGCAAGCCTTA 0,58 0,08 OK 0,00 0,15 --- 0,951984 
PRPF4B 8899 SKV_08 C09 Hs_PRPF4B_10 AAGGGTTTGAGTAAATACAAA 0,83 0,15 OK 0,00 0,35 --- 0,984702 
STK32C 282974 SKV_03 G05 Hs_STK32C_6 TCCGAGAATGACTATCTTCAA 0,41 0,26 OK 0,00 0,32 --- 0,984602 
RFK 55312 SKV_11 F10 Hs_RFK_8 AAGGTTGATAGTTTATCATAA 0,31 0,12 TOXIC 0,00 0,07 --- 0,614924 
CSNK1G1 53944 SKV_07 D05 Hs_CSNK1G1_11 CTGAGTATTCTCAGAGGTTAA 0,57 0,07 OK 0,00 0,46 --- 0,992025 
RAGE 5891 SKV_09 F08 Hs_RAGE_7 CAGGAATACCTCTACTAACAA 0,35 0,21 TOXIC 0,00 0,68 --- 0,998854 
MYLK 4638 SKV_04 E07 Hs_MYLK_9 AACCTGAAATCCGCTAGCAAA 1,15 0,50 OK 0,00 0,08 --- 0,999878 
YES1 7525 SKV_23 F07 Hs_YES1_6 CCAGCCTACATTCACTTCTAA 0,40 0,06 OK 0,00 0,44 --- 0,996253 
PHKB 5257 SKV_04 E10 Hs_PHKB_5 AGGGCTGTTCGTGGTCAGTTA 0,70 0,16 OK 0,00 0,29 --- 0,993018 
IHPK1 9807 SKV_11 D08 Hs_IHPK1_10 CCGGCAGATGCGGAAATGCGA 0,80 0,17 OK 0,00 0,14 --- 0,596082 
ROCK1 6093 SKV_01 E09 Hs_ROCK1_9 AACGGTTAGAACAAGAGGTAA 0,53 0,14 OK 0,00 0,28 --- 0,980902 
ITPKC 80271 SKV_13 F07 Hs_ITPKC_4 GACCATCTTGATACTTATTTA 1,22 0,31 OK 0,00 0,19 --- 0,961540 
PRPF4B 8899 SKV_09 G09 Hs_PRPF4B_9 AAGCATAAACACAGAAGTAAA 0,78 0,43 OK -0,01 0,56 --- 0,987789 
BUB1 699 SKV_16 F07 Hs_BUB1_6 TGGCACTTACATGAAAGTGAA 0,83 0,10 OK -0,01 0,13 --- 0,895955 
AKAP12 9590 SKV_12 E08 Hs_AKAP12_5 ACGGATGTAGTGTTGAAAGTA 0,75 0,37 OK -0,01 0,30 --- 0,965534 
TK2 7084 SKV_12 G03 Hs_TK2_6 CGGGATCGAATATTAACTCCA 1,19 0,33 OK -0,01 0,66 --- 0,979979 
MAPKAP1 79109 SKV_16 E07 Hs_MAPKAP1_5 GACCCTGTTACGAATCAGAAA 0,45 0,17 OK -0,01 0,27 --- 0,934564 
IRAK3 11213 SKV_24 D07 Hs_IRAK3_5 CACATTCGAATCGGTATATTA 0,89 0,16 OK -0,01 0,27 --- 0,946979 
FGFR2 2263 SKV_23 B04 Hs_FGFR2_12 CCCATCTGACAAGGGAAATTA 0,45 0,06 OK -0,01 0,27 --- 0,947100 
PRKAR2A 5576 SKV_12 F07 Hs_PRKAR2A_5 AACGGCATGTCTCTCCAACAA 0,45 0,32 OK -0,01 0,28 --- 0,949374 
CNKSR1 10256 SKV_19 D05 Hs_CNKSR1_5 ACCCATGACTTCCAGAGCATA 0,91 0,19 OK -0,01 0,16 --- 0,886526 
PRKAG3 53632 SKV_02 B09 Hs_PRKAG3_7 TAGCCTGTTTGAAGCTGTCTA 0,30 0,05 TOXIC -0,01 0,44 --- 0,965028 
MAP4K5 11183 SKV_20 E07 Hs_MAP4K5_8 TCCGCTTATTAGGATCAGACA 0,55 0,18 OK -0,01 0,12 --- 0,832387 
FASTK 10922 SKV_04 B09 Hs_FASTK_5 AAGGGTTGGAAGCTGCTCTAA 0,23 0,16 TOXIC -0,01 0,12 --- 0,847585 
TTBK1 84630 SKV_05 F06 Hs_TTBK1_5 CAGGAACGAGAAGTTTAACTA 0,69 0,13 OK -0,02 0,05 --- 0,581569 
CDC2L6 23097 SKV_08 D06 Hs_CDC2L6_5 CACTGTCGTCAGGAAGATATA 0,28 0,09 TOXIC -0,02 0,49 --- 0,957061 
EPHA4 2043 SKV_21 B03 Hs_EPHA4_5 CCCGCGAATGAAGTTACCTTA 0,93 0,20 OK -0,02 0,10 --- 0,746286 
PRKCQ 5588 SKV_01 E04 Hs_PRKCQ_12 CACAAGAAGTGTATTGATAAA 0,69 0,48 OK -0,02 0,91 --- 0,976140 
CASK 8573 SKV_06 E04 Hs_CASK_6 AAGGACGACAGATCTATGTAA 0,63 0,44 OK -0,02 0,59 --- 0,962950 
RPS6KL1 83694 SKV_03 G04 Hs_RPS6KL1_6 CTGAATTTGATTGGAAAGGAA 0,48 0,27 OK -0,02 0,44 --- 0,949692 
PFKM 5213 SKV_09 C09 Hs_PFKM_6 AAGGACTTTCGGGAACGAGAA 0,55 0,17 OK -0,02 0,12 --- 0,816336 
STK33 65975 SKV_07 B04 Hs_STK33_7 GAGCATAGGCGTCGTAATGTA 0,11 0,04 TOXIC -0,02 0,06 --- 0,612523 
SUPPLEMENTARY INFORMATION                                                                                                                                                                                                                                                         116 
Target gene Gene ID plate pos. sequence name siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
MAPK8IP2 23542 SKV_14 E07 Hs_MAPK8IP2_6 CCAGGACTCCCTAAACAACAA 0,44 0,50 OK -0,02 0,33 --- 0,905228 
MAPK6 5597 SKV_07 G09 Hs_MAPK6_6 CAGGCTTCCTGTTGAAATAAA 0,47 0,33 OK -0,02 0,24 --- 0,898566 
WNK1 65125 SKV_18 B04 Hs_WNK1_6 CTGCGACGACTACGAGATAAA 0,91 0,14 OK -0,02 0,07 --- 0,616762 
STK32B 55351 SKV_03 F10 Hs_STK32B_5 CTGGGACGCGGTGTTCAAGAA 0,57 0,06 OK -0,02 0,33 --- 0,920886 
MAP3K1 4214 SKV_18 D03 Hs_MAP3K1_11 CTCCGGGTGTTTCAACTAGAA 0,07 0,01 TOXIC -0,02 0,18 --- 0,806537 
CSNK1E 1454 SKV_05 E07 Hs_CSNK1E_5 GAGCTTTATCGTGGTTGTTAA 1,17 0,15 OK -0,02 0,09 --- 0,683259 
EPHA8 2046 SKV_22 F06 Hs_EPHA8_9 ACGGCCCACCAGGGTATGTAA 0,56 0,12 OK -0,02 0,22 --- 0,858042 
CDC2 983 SKV_07 D10 Hs_CDC2_1 TTGACTAACTATGGAAGATTA 0,25 0,09 TOXIC -0,03 0,13 --- 0,758263 
PCTK1 5127 SKV_09 D10 Hs_PCTK1_5 CACGCCAACATCGTTACGCTA 0,91 0,06 OK -0,03 0,20 --- 0,834052 
NUCKS1 64710 SKV_14 G06 Hs_NUCKS_1 AAGGTGTACCACGGTTGTAAA 0,86 0,18 OK -0,03 0,19 --- 0,764249 
EIF2AK4 440275 SKV_19 E05 Hs_EIF2AK4_4 TCCGATAATCTTGCAGTGCAA 0,38 0,09 TOXIC -0,03 0,46 --- 0,910416 
STK32B 55351 SKV_02 B10 Hs_STK32B_6 TTGGGCTGAGTTCACGAATTA 0,66 0,15 OK -0,03 0,30 --- 0,883618 
SPEG 10290 SKV_06 F04 Hs_APEG1_5 AACACCTATTTCTTAACTCAA 0,96 0,36 OK -0,03 0,39 --- 0,909989 
PHKA2 5256 SKV_06 C09 Hs_PHKA2_5 CCGCCTAACAAGGTAGATGAA 0,18 0,12 TOXIC -0,03 0,27 --- 0,864596 
DGKG 1608 SKV_08 G04 Hs_DGKG_6 TAGCCACTCACATAAAGTTTA 0,97 0,13 OK -0,03 0,07 --- 0,517642 
HGS 9146 SKV_14 B10 Hs_HGS_6 GCACGTCTTTCCAGAATTCAA 0,70 0,39 OK -0,03 0,65 --- 0,914114 
LIMK2 3985 SKV_22 D10 Hs_LIMK2_7 ATGAGCTTGCACCATATTTAA 0,85 0,16 OK -0,03 0,15 --- 0,708960 
PIP5K1B 8395 SKV_11 C08 Hs_PIP5K1B_5 TACACTCTATTCAAACAGCAA 0,54 0,18 OK -0,04 0,10 --- 0,503958 
CDC2L6 23097 SKV_10 B06 Hs_CDC2L6_6 GAGGATTTGTTTGAGTACGAA 0,90 0,13 OK -0,04 0,32 --- 0,840470 
TBK1 29110 SKV_19 E06 Hs_TBK1_7 CTGACTTGACACGTTTGTAAA 1,35 0,14 OK -0,04 0,12 --- 0,523937 
SNRK 54861 SKV_06 G07 Hs_SNRK_11 CCCTGTAGTGATAAATTACAA 0,96 0,37 OK -0,04 0,34 --- 0,841423 
CDKN1A 1026 SKV_08 F05 Hs_CDKN1A_7 CTGGCATTAGAATTATTTAAA 0,99 0,17 OK -0,04 0,06 --- 0,304991 
PI4K2B 55300 SKV_13 D09 Hs_PI4K2B_7 CAGAGTACTGGCCTTGTTCAA 0,76 0,14 OK -0,04 0,29 --- 0,741630 
MAPK13 5603 SKV_08 B07 Hs_MAPK13_5 CCGGAGTGGCATGAAGCTGTA 0,74 0,15 OK -0,04 0,19 --- 0,699035 
TTBK2 146057 SKV_07 D08 Hs_TTBK2_8 AGGCATCACCTCAAGATGAAA 0,78 0,50 OK -0,04 0,32 --- 0,820654 
DDR1 780 SKV_20 G05 Hs_DDR1_10 CAGGAATGATTTCCTGAAAGA 0,80 0,26 OK -0,05 0,23 --- 0,698216 
CDC42BPB 9578 SKV_03 E04 Hs_CDC42BPB_6 TAGGACCTTAAGAGAATAGTA 0,77 0,26 OK -0,05 0,25 --- 0,758026 
PRKCD 5580 SKV_01 D06 Hs_PRKCD_11 CAGCAGCAAGTGCAACATCAA 0,32 0,27 TOXIC -0,05 0,88 --- 0,925170 
CDKL5 6792 SKV_09 G04 Hs_CDKL5_6 AAGGCAATAATGCTAATTACA 0,93 0,24 OK -0,05 0,22 --- 0,687012 
GIT2 9815 SKV_12 E09 Hs_GIT2_5 CAGCGTTGAGAGTCAAGACAA 0,61 0,30 OK -0,05 0,16 --- 0,579694 
PAK4 10298 SKV_18 G04 Hs_PAK4_5 CGAGAATGTGGTGGAGATGTA 0,24 0,20 TOXIC -0,06 0,39 --- 0,779337 
IRAK3 11213 SKV_24 F07 Hs_IRAK3_6 CTGGATGTTCGTCATATTGAA 0,69 0,11 OK -0,06 0,25 --- 0,714868 
AURKB 9212 SKV_17 E08 Hs_AURKB_6 ACGCGGCACTTCACAATTGAT 0,09 0,01 TOXIC -0,06 0,51 --- 0,826121 
CHEK2 11200 SKV_06 F07 Hs_CHEK2_9 ACGCCGTCCTTTGAATAACAA 0,65 0,62 OK -0,06 0,07 --- 0,233793 
PDK3 5165 SKV_03 G10 Hs_PDK3_8 CCCGTCTGTATGCTAGATATT 0,40 0,15 OK -0,06 0,45 --- 0,834251 
AKAP8 10270 SKV_14 D03 Hs_AKAP8_6 GAGGCCGGTAGTGATCCTCAA 0,30 0,05 TOXIC -0,06 0,63 --- 0,841766 
PIK3AP1 118788 SKV_13 G03 Hs_PIK3AP1_7 CACCAAGTATATCGAACCATA 0,93 0,24 OK -0,06 0,42 --- 0,760523 
CDK5 1020 SKV_07 E07 Hs_CDK5_10 CCGGGAGATCTGCCTACTCAA 0,06 0,05 TOXIC -0,06 0,53 --- 0,854970 
CLK2 1196 SKV_09 D03 Hs_CLK2_6 TCGCCTGGATTGGGATGAGAA 0,54 0,15 OK -0,06 0,16 --- 0,549622 
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CAMK2G 818 SKV_06 B07 Hs_CAMK2G_11 CGCCATGAAGCCGATGAGAAA 1,01 0,39 OK -0,06 0,29 --- 0,722499 
MARK1 4139 SKV_26 C04 Hs_MARK1_6 TCGATACGTAGCATTGCAGAA 0,51 0,22 OK -0,06 0,22 --- 0,645818 
UCK2 7371 SKV_12 G05 Hs_UCK2_5 CCGGATGCCTTTGACAATGAA 0,45 0,34 OK -0,06 0,11 --- 0,366021 
PDK4 5166 SKV_02 D03 Hs_PDK4_7 AAGTTCGAAATAGACACCATA 0,33 0,17 TOXIC -0,06 0,36 --- 0,772597 
CAMK2N1 55450 SKV_06 G08 Hs_CaMKIINalpha_6 CGGGTTGTTATTGAAGATGAT 0,53 0,17 OK -0,06 0,48 --- 0,826634 
MAP4K4 9448 SKV_18 F10 Hs_MAP4K4_6 TCGGAGCTGCACCGAGGGCAA 0,34 0,09 TOXIC -0,07 0,21 --- 0,553082 
PRKX 5613 SKV_03 C07 Hs_PRKX_6 TTGGAATACTCTAAGAGAATA 0,75 0,34 OK -0,07 0,32 --- 0,733357 
AKAP9 10142 SKV_14 C10 Hs_AKAP9_5 CAGCCTATCAGTGAACATCAA 0,38 0,45 TOXIC -0,07 0,32 --- 0,643050 
IHPK2 51447 SKV_11 F04 Hs_IHPK2_6 CTGCTGAGATGCGCAAATTCA 0,58 0,25 OK -0,07 0,10 --- 0,416984 
CRKRS 51755 SKV_10 B10 Hs_CRK7_6 ATCGGGATATTAAGTGTTCTA 1,31 0,50 OK -0,07 0,65 --- 0,860750 
GIT1 28964 SKV_14 E10 Hs_GIT1_5 CAGCCTTGACTTATCCGAATT 0,83 0,11 OK -0,07 0,18 --- 0,396089 
MAP2K7 5609 SKV_18 E07 Hs_MAP2K7_9 CAGGAAGAGACCAAAGTATAA 0,29 0,12 TOXIC -0,07 0,34 --- 0,679989 
PAK7 57144 SKV_19 B06 Hs_PAK7_6 ATGGTGTGCACGTTTCATTAA 0,24 0,14 TOXIC -0,08 0,56 --- 0,797417 
EPHA5 2044 SKV_21 B04 Hs_EPHA5_5 ACCAGTTGGATCTCCAATGAA 0,97 0,18 OK -0,08 0,14 --- 0,319643 
MAPKAPK3 7867 SKV_06 D09 Hs_MAPKAPK3_6 CCAGATAGTAATAAACACCAT 0,53 0,48 OK -0,08 0,30 --- 0,680632 
CAMK2G 818 SKV_04 D07 Hs_CAMK2G_7 CTCGGATATGTCGACTTCTGA 0,84 0,24 OK -0,08 0,15 --- 0,416702 
MARK1 4139 SKV_04 E05 Hs_MARK1_5 TCCCTCGTTACTGTCCGCATA 1,13 0,67 OK -0,08 0,28 --- 0,657739 
IBTK 25998 SKV_19 E04 Hs_IBTK_6 TAGAAGAGTCATTACACCATA 0,42 0,13 OK -0,08 0,23 --- 0,518339 
KIDINS220 57498 SKV_14 G03 Hs_KIDINS220_5 CAGGCGAGACTCCTTATAATA 0,83 0,14 OK -0,08 0,20 --- 0,396813 
MAP3K13 9175 SKV_24 F05 Hs_MAP3K13_6 GCGAATAATTTATACATGGAA 0,74 0,16 OK -0,08 0,61 --- 0,834478 
NRBP1 29959 SKV_19 E07 Hs_NRBP_6 TCGGTGGAGGAGGGAGTCAAA 0,04 0,03 TOXIC -0,08 0,26 --- 0,559784 
CDKN2C 1031 SKV_15 C05 Hs_CDKN2C_6 TGCCTCTACTTTATCAATTAA 0,89 0,03 OK -0,08 0,09 --- 0,071612 
CKB 1152 SKV_10 D07 Hs_CKB_3 CCGGCCTCACCCAGATTGAAA 0,06 0,05 TOXIC -0,08 0,18 --- 0,460815 
PIK3C2G 5288 SKV_15 E06 Hs_PIK3C2G_5 CCAGATCAAGAAATTCGTAAA 1,44 0,15 OK -0,08 0,15 --- 0,233238 
MAPK15 225689 SKV_10 C05 Hs_MAPK15_2 TTGCTTGGAGGCTACTCCCAA 0,27 0,23 TOXIC -0,08 0,29 --- 0,635765 
PRKD2 25865 SKV_06 G05 Hs_PRKD2_6 TTGGGTGGTTCATTACAGCAA 1,01 0,39 OK -0,08 0,45 --- 0,760332 
PIK3CB 5291 SKV_15 E09 Hs_PIK3CB_5 CCCTTCGATAAGATTATTGAA 0,91 0,22 OK -0,09 0,21 --- 0,386126 
KSR2 283455 SKV_24 E06 Hs_KSR2_6 AAGGAAATCCATTACTTCAAA 0,89 0,19 OK -0,09 0,12 --- 0,290073 
BMX 660 SKV_20 G04 Hs_BMX_5 CCCAATATGACAACGAATCAA 0,45 0,08 OK -0,09 0,27 --- 0,544240 
STK24 8428 SKV_20 D06 Hs_STK24_14 TCCATATGTAACCAAATATTA 1,16 0,19 OK -0,09 0,27 --- 0,530322 
MAGI3 260425 SKV_13 G07 Hs_MAGI3_2 CCAGGCAAAGTCATTAATAAA 1,00 0,24 OK -0,09 0,28 --- 0,482646 
BMPR1A 657 SKV_23 G10 Hs_BMPR1A_6 GCGGCAGACATTAAAGGTACA 0,19 0,06 TOXIC -0,09 0,40 --- 0,711850 
PDGFRA 5156 SKV_21 F10 Hs_PDGFRA_6 ACGCAGGAAGCCTACTATTTA 0,73 0,07 OK -0,09 0,20 --- 0,380248 
MAPK8IP2 23542 SKV_16 C07 Hs_MAPK8IP2_9 GAGATGATCGATGACAATGAA 0,57 0,12 OK -0,09 0,04 --- 0,001742 
EPHA7 2045 SKV_21 B05 Hs_EPHA7_6 CAGGCTGCGAAGGAAGTACTA 0,96 0,19 OK -0,09 0,12 --- 0,177564 
NADK 65220 SKV_12 B03 Hs_FLJ13052_6 CCAGGAGAACATGATCGTGTA 0,92 0,16 OK -0,09 0,05 --- 0,038451 
PI4KB 5298 SKV_11 B03 Hs_PIK4CB_5 TCGGCTGATAGTGGCATGATT 0,64 0,15 OK -0,10 0,16 --- 0,355949 
CSNK1A1 1452 SKV_07 C05 Hs_CSNK1A1_5 AGGGCTAAAGGCTGCAACAAA 0,83 0,38 OK -0,10 0,41 --- 0,701168 
CINP 51550 SKV_14 F06 Hs_CINP_5 CGGCTGATTGGCACAATTTAA 0,74 0,23 OK -0,10 0,32 --- 0,513610 
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CERK 64781 SKV_11 G10 Hs_CERK_5 ATGGCATTATTTGATCTGAAA 0,91 0,32 OK -0,10 0,08 --- 0,348042 
BMX 660 SKV_19 C04 Hs_BMX_6 CGGAACAAAGTTTCCAGTCAA 0,51 0,12 OK -0,10 0,15 --- 0,242049 
CDC2L5 8621 SKV_08 C06 Hs_CDC2L5_5 AACGACGTAGTTTCATTGGAA 0,48 0,14 OK -0,10 0,14 --- 0,290255 
RYK 6259 SKV_23 E08 Hs_RYK_20 CTGGTCTGCCTTGTACAAGAA 0,18 0,05 TOXIC -0,10 0,21 --- 0,444072 
NME6 10201 SKV_13 C03 Hs_NME6_7 CAGGATCTAGCCTTCTATCTA 0,82 0,18 OK -0,10 0,33 --- 0,484937 
ITPK1 3705 SKV_09 B06 Hs_ITPK1_5 CACGCCGTCATTGACATCAAT 0,80 0,27 OK -0,11 0,43 --- 0,693605 
CAMKK1 84254 SKV_18 B08 Hs_CAMKK1_6 CGGCGTTATCTGGAAAGTGGA 0,65 0,12 OK -0,11 0,18 --- 0,284000 
MAP4K2 5871 SKV_20 C08 Hs_MAP4K2_6 TCGGTCAGCCTCAGAATTCCA 0,61 0,10 OK -0,11 0,10 --- 0,069166 
MAPK12 6300 SKV_09 F09 Hs_MAPK12_6 TGGAAGCGTGTTACTTACAAA 1,12 0,28 OK -0,11 0,29 --- 0,554144 
SRPK2 6733 SKV_09 G03 Hs_SRPK2_8 CAGCTCCTATGAACAATTCAA 0,59 0,37 OK -0,11 0,17 --- 0,319877 
PRKCZ 5590 SKV_03 C05 Hs_PRKCZ_6 GACCAAATTTACGCCATGAAA 0,60 0,13 OK -0,11 0,25 --- 0,480459 
TYK2 7297 SKV_22 B05 Hs_TYK2_5 CACCATCTGGTAATAAACTCA 0,67 0,11 OK -0,11 0,22 --- 0,425266 
ERBB2 2064 SKV_22 G04 Hs_ERBB2_15 CACGTTTGAGTCCATGCCCAA 0,18 0,17 TOXIC -0,12 1,37 --- 0,891169 
BMPR1A 657 SKV_22 C10 Hs_BMPR1A_5 CAGCTACGCCGGACAATAGAA 0,51 0,14 OK -0,12 0,15 --- 0,238735 
PDK1 5163 SKV_02 G03 Hs_PDK1_6 TCGGGTTTCTATAGGAAACTA 0,70 0,10 OK -0,12 0,45 --- 0,675323 
JAK1 3716 SKV_21 E04 Hs_JAK1_5 ACCGGATGAGGTTCTATTTCA 1,15 0,08 OK -0,12 0,15 --- 0,166523 
BCKDK 10295 SKV_25 G07 Hs_BCKDK_7 CACAATGGAGAGTCACCTAGA 0,61 0,24 OK -0,12 0,32 --- 0,556388 
PRKAG2 51422 SKV_25 F04 Hs_PRKAG2_6 AACATTTAAGCCTTTAGTGAA 0,88 0,14 OK -0,12 0,08 --- 0,056179 
PIK3CG 5294 SKV_15 F03 Hs_PIK3CG_6 CACCTTTACTCTATAACTCAA 0,98 0,21 OK -0,12 0,18 --- 0,161518 
KIT 3815 SKV_23 C08 Hs_KIT_6 CTCGCACCTTTCCAAAGTTAA 1,15 0,07 OK -0,12 0,14 --- 0,208062 
CDKN2B 1030 SKV_15 C04 Hs_CDKN2B_6 GAGAGCAATTGTAACGGTTAA 0,96 0,24 OK -0,12 0,10 --- 0,027783 
SH3KBP1 30011 SKV_16 D04 Hs_SH3KBP1_6 TAGCTTATATATGACGGTATA 1,06 0,12 OK -0,12 0,16 --- 0,119814 
CAMK4 814 SKV_04 D05 Hs_CAMK4_6 TTGCAAGTTAACACAACGTAA 1,20 0,32 OK -0,12 0,08 --- 0,046734 
ACVR1B 91 SKV_22 C06 Hs_ACVR1B_5 CTGTGATTACCTCTCAATCTA 0,73 0,03 OK -0,13 0,22 --- 0,378920 
EPHA7 2045 SKV_22 F05 Hs_EPHA7_5 ACCAGTCATGATAGTAATAGA 0,95 0,02 OK -0,13 0,08 --- 0,058216 
EPHB1 2047 SKV_21 B07 Hs_EPHB1_5 ATGGCCCTGGATTATCTACTA 0,99 0,10 OK -0,13 0,10 --- 0,044384 
PIP5K1C 23396 SKV_13 C06 Hs_PIP5K1C_11 CCCATGATAGAAGTCTGTAAA 1,26 0,34 OK -0,13 0,28 --- 0,323758 
PRKAR2B 5577 SKV_12 F08 Hs_PRKAR2B_6 CACGCCATTGGGACTGTCAAA 0,44 0,12 OK -0,13 0,15 --- 0,221562 
RIPK2 8767 SKV_24 D03 Hs_RIPK2_7 CAGGGACTTGATCATGAAAGA 1,19 0,32 OK -0,13 0,21 --- 0,359089 
TAOK2 9344 SKV_20 D09 Hs_TAOK2_5 GCCCAAGAGCCTCAAATCTAA 0,61 0,07 OK -0,13 0,24 --- 0,328153 
CSNK1G2 1455 SKV_07 C08 Hs_CSNK1G2_5 AAGAATCTCTATACAAATGAA 0,86 0,58 OK -0,13 0,23 --- 0,385559 
PIP4K2A 5305 SKV_12 F04 Hs_PIP5K2A_5 ATGGAATTAAGTGCCATGAAA 0,70 0,33 OK -0,13 0,22 --- 0,366969 
RIPK2 8767 SKV_25 G05 Hs_RIPK2_10 ATGCTCTTCAGCAATAATAAA 0,89 0,26 OK -0,13 0,41 --- 0,605932 
CIB2 10518 SKV_16 B05 Hs_CIB2_6 CTGCACCTTCTTCAATAAGAA 0,52 0,05 OK -0,13 0,21 --- 0,191232 
GSK3B 2932 SKV_09 D08 Hs_GSK3B_7 AACACTGGTCACGTTTGGAAA 0,99 0,25 OK -0,13 0,33 --- 0,530525 
EPHA8 2046 SKV_21 B06 Hs_EPHA8_10 GAGCGTGTGCTTATCCGTTAA 0,99 0,16 OK -0,13 0,08 --- 0,017551 
DGKQ 1609 SKV_08 G05 Hs_DGKQ_5 CAGCGACACCAGGTTTGAGAA 0,80 0,34 OK -0,13 0,07 --- 0,031356 
PRKAB2 5565 SKV_02 G06 Hs_PRKAB2_6 TCCAATATTAGTTGGAGTTAA 1,18 0,16 OK -0,13 0,23 --- 0,366174 
NME5 8382 SKV_11 C06 Hs_NME5_6 ATGATATTAGCTAGACATAAA 0,84 0,20 OK -0,14 0,39 --- 0,275855 
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HK2 3099 SKV_10 F04 Hs_HK2_6 CGGCCGTGCTACAATAGGTAA 0,46 0,29 OK -0,14 0,33 --- 0,505349 
VRK3 51231 SKV_07 D04 Hs_VRK3_7 CAGACCTTTGTCAATCCACAT 0,14 0,01 TOXIC -0,14 0,22 --- 0,342373 
CAMK2D 817 SKV_06 B06 Hs_CAMK2D_10 GTGCGACTTCATGATAGCATA 0,59 0,13 OK -0,14 0,14 --- 0,162016 
STK11 6794 SKV_04 F08 Hs_STK11_5 AACGTGAAGAAGGAAATTCAA 1,06 0,17 OK -0,14 0,08 --- 0,034762 
NLK 51701 SKV_10 B09 Hs_NLK_10 ATGGTGGAAGATAATGTACTA 0,61 0,28 OK -0,14 0,25 --- 0,377056 
ROS1 6098 SKV_23 E07 Hs_ROS1_6 ACCGAGAAGGGTTAAACTATA 0,93 0,10 OK -0,14 0,16 --- 0,193069 
CDC2L5 8621 SKV_09 G06 Hs_CDC2L5_6 TCAGAGTATTATCAATATGAA 0,93 0,37 OK -0,14 0,04 --- 0,002890 
PKLR 5313 SKV_11 B05 Hs_PKLR_2 GAGGCCTATCTGAGACTATAA 0,49 0,22 OK -0,14 0,39 --- 0,262751 
PXK 54899 SKV_19 G09 Hs_PXK_6 TAAGATCCCTACAAAGTTAAA 0,80 0,20 OK -0,14 0,21 --- 0,217379 
STK4 6789 SKV_20 D03 Hs_STK4_5 AGGATTCATAGCATCACTATA 0,83 0,17 OK -0,14 0,10 --- 0,033910 
ETNK1 55500 SKV_11 G04 Hs_ETNK1_5 CCGTATGTGGTGGATTAGAAA 1,15 0,43 OK -0,14 0,43 --- 0,260456 
PIP4K2B 8396 SKV_12 G09 Hs_PIP5K2B_9 CACGATCAATGAGCTGAGCAA 0,71 0,04 OK -0,14 0,43 --- 0,589921 
RAGE 5891 SKV_08 B08 Hs_RAGE_8 TTGCACTAATATGTGAACTTA 0,74 0,32 OK -0,15 0,17 --- 0,206205 
AURKA 6790 SKV_18 C07 Hs_STK6_5 CACCTTCGGCATCCTAATATT 0,12 0,07 TOXIC -0,15 0,24 --- 0,267705 
PANK1 53354 SKV_13 D06 Hs_PANK1_5 AACGCTGGTTAAATTGGTGTA 1,12 0,27 OK -0,15 0,27 --- 0,260981 
PBK 55872 SKV_19 E10 Hs_PBK_6 TCAGTAGTTATTAGACTCTAA 0,66 0,13 OK -0,15 0,31 --- 0,375539 
KDR 3791 SKV_21 E07 Hs_KDR_5 AACGCTGACATGTACGGTCTA 1,29 0,17 OK -0,15 0,09 --- 0,015812 
ABL2 27 SKV_20 F10 Hs_ABL2_9 CAGGTCTATGACCTACTAGAA 0,36 0,17 TOXIC -0,15 0,11 --- 0,032088 
CDC42SE2 56990 SKV_16 D10 Hs_CDC42SE2_3 CAGGAGACCTGTTCAGTGGAA 0,33 0,04 TOXIC -0,15 0,20 --- 0,126747 
RIPK2 8767 SKV_24 F03 Hs_RIPK2_16 AAGAAAGTTTGCCATATGATA 1,00 0,25 OK -0,15 0,42 --- 0,561157 
EPHB4 2050 SKV_21 B10 Hs_EPHB4_6 TCGGACAAACACGGACAGTAT 1,33 0,17 OK -0,15 0,12 --- 0,039751 
IRAK4 51135 SKV_24 D09 Hs_IRAK4_6 ATCCTATTAGTCATATATTTA 0,93 0,26 OK -0,15 0,45 --- 0,584450 
TK1 7083 SKV_11 B10 Hs_TK1_5 CGGGCCGATGTTCTCAGGAAA 0,23 0,07 TOXIC -0,16 0,37 --- 0,239117 
JAK1 3716 SKV_23 C04 Hs_JAK1_6 CACGGATAACATCAGCTTCAT 0,25 0,04 TOXIC -0,16 0,12 --- 0,092281 
CKS2 1164 SKV_16 G09 Hs_CKS2_8 TAGGTTACTGTAAGATGTTTA 1,17 0,29 OK -0,16 0,06 --- 0,000290 
PCTK3 5129 SKV_09 E04 Hs_PCTK3_11 CAGAGACAGATAATATATTTA 1,08 0,11 OK -0,16 0,29 --- 0,396289 
LYK5 92335 SKV_20 F07 Hs_LYK5_5 CTGGTTCTAGTTCTGGTTCTA 0,85 0,28 OK -0,16 0,15 --- 0,074333 
PIP4K2C 79837 SKV_12 B05 Hs_PIP5K2C_5 CCGGAGCAGTATGCTAAGCGA 0,61 0,14 OK -0,16 0,23 --- 0,295899 
DCLK1 9201 SKV_06 E06 Hs_DCAMKL1_6 CCGGAAGTGATAACACGCAAA 0,67 0,39 OK -0,16 0,11 --- 0,067985 
PRKCDBP 112464 SKV_16 E10 Hs_PRKCDBP_6 AAGGAGCGAATCCTACATCCA 0,47 0,13 OK -0,16 0,11 --- 0,011296 
ADCK4 79934 SKV_02 E08 Hs_ADCK4_5 CAGATGCTGAGAGTTCTTGAA 0,70 0,23 OK -0,16 0,08 --- 0,021473 
NME4 4833 SKV_09 C06 Hs_NME4_5 ACCAACTACCTCCGTCAGCAA 0,48 0,12 OK -0,16 0,08 --- 0,022952 
RFK 55312 SKV_13 D10 Hs_RFK_9 TAGGATGGAACCCATATTACA 1,10 0,37 OK -0,17 0,26 --- 0,184375 
PKIA 5569 SKV_14 B03 Hs_PKIA_10 TCACTTGATCATATGACGAAA 1,00 0,36 OK -0,17 0,17 --- 0,059923 
EPHB2 2048 SKV_21 B08 Hs_EPHB2_10 CCGAGAGGACCTCGTCTACAA 0,98 0,12 OK -0,17 0,09 --- 0,008138 
MYLK 4638 SKV_06 C07 Hs_MYLK_10 CAGCATCCATGGCTAATGAAA 0,71 0,71 OK -0,17 0,33 --- 0,424903 
JAK2 3717 SKV_21 E05 Hs_JAK2_7 AGCCATCATACGAGATCTTAA 1,09 0,10 OK -0,17 0,10 --- 0,016634 
XYLB 9942 SKV_11 D09 Hs_XYLB_5 CTGAAATTATTGGACGTCATA 0,75 0,36 OK -0,17 0,12 --- 0,213813 
IKBKAP 8518 SKV_17 E06 Hs_IKBKAP_6 GCGGTTTACTATAGACAAATA 0,79 0,25 OK -0,17 0,30 --- 0,292395 
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PRKY 5616 SKV_01 E08 Hs_PRKY_3 TACAGTGAGTTTGTTCTGAAA 0,84 0,14 OK -0,17 0,33 --- 0,410364 
CDK9 1025 SKV_07 E10 Hs_CDK9_6 TGGGCACAGTTTGGTCCGTTA 1,19 0,40 OK -0,18 0,12 --- 0,059840 
NEK4 6787 SKV_17 D08 Hs_NEK4_8 CTGGGTCTGTGAGCAGTTCAA 1,13 0,11 OK -0,18 0,19 --- 0,109226 
CDKL3 51265 SKV_08 D08 Hs_CDKL3_8 CTAAAGCAATTTCATCACGAA 0,74 0,14 OK -0,18 0,51 --- 0,579664 
MADD 8567 SKV_14 B07 Hs_MADD_1 CTCAACAAGTTCTATACTAAA 1,13 0,32 OK -0,18 0,26 --- 0,158538 
MAPK7 5598 SKV_09 E10 Hs_MAPK7_9 CAGACCCACCTTTCAGCCTTA 0,67 0,27 OK -0,18 0,37 --- 0,447686 
MAK 4117 SKV_07 F09 Hs_MAK_5 GCCCGATTCCTTCATGCTATA 0,78 0,33 OK -0,18 0,38 --- 0,454133 
PRKAA1 5562 SKV_04 F06 Hs_PRKAA1_5 CCCACGATATTCTGTACACAA 0,79 0,19 OK -0,18 0,11 --- 0,040458 
MAGI3 260425 SKV_12 C07 Hs_MAGI-3_6 CTGGATAGTCAGTGGTGTCAA 0,52 0,15 OK -0,18 0,60 --- 0,623140 
RPS6KA4 8986 SKV_03 D08 Hs_RPS6KA4_6 CGCCACCTTCATGGCATTCAA 0,46 0,16 OK -0,18 0,37 --- 0,441872 
DGUOK 1716 SKV_10 E07 Hs_DGUOK_10 CAGCACGATGGTCCTACACAT 0,39 0,18 TOXIC -0,19 0,04 --- 0,001092 
PICK1 9463 SKV_12 E03 Hs_PRKCABP_7 CACCTCGGCGGCCTTTATTTA 1,05 0,30 OK -0,19 0,08 --- 0,018192 
RPS6KA5 9252 SKV_03 D10 Hs_RPS6KA5_9 CTGGATCTCTTACGTAATTCA 0,55 0,37 OK -0,19 0,63 --- 0,633147 
RBKS 64080 SKV_11 G07 Hs_RBKS_6 CAGGTGGTAATCATTACCTTA 1,16 0,12 OK -0,19 0,19 --- 0,187154 
ETNK1 55500 SKV_13 E04 Hs_ETNK1_6 TCCGTATGTGGTGGATTAGAA 1,12 0,14 OK -0,19 0,34 --- 0,247351 
TAOK2 9344 SKV_18 F09 Hs_TAOK2_11 AACGGAAACCACCGCTCTTTA 0,77 0,11 OK -0,19 0,25 --- 0,170089 
MAP3K6 9064 SKV_18 F08 Hs_MAP3K6_6 TCAGAGGAGCTGAGTAATGAA 0,16 0,12 TOXIC -0,19 0,42 --- 0,399827 
PKN2 5586 SKV_01 E03 Hs_PKN2_5 AAAGTATGATATCTACGCAAA 0,60 0,21 OK -0,19 0,37 --- 0,423688 
PRKRA 8575 SKV_13 B04 Hs_PRKRA_5 ATGATTGATTGTTAAATTTCA 0,85 0,23 OK -0,19 0,22 --- 0,087456 
MATK 4145 SKV_21 F03 Hs_MATK_10 GACGGATTCTAAGGACTCTAA 0,57 0,14 OK -0,20 0,17 --- 0,064707 
CSNK2A1 1457 SKV_17 B03 Hs_CSNK2A1_10 CTGGTCGCTTACATCACTTTA 0,80 0,17 OK -0,20 0,08 --- 0,003271 
PIK3C2G 5288 SKV_17 C06 Hs_PIK3C2G_6 CCCGTAGAAATGATAACTCCA 1,04 0,28 OK -0,20 0,15 --- 0,041970 
MAP3K9 4293 SKV_22 E03 Hs_MAP3K9_5 CAGGAGCTCAGTCGTCCCAAA 0,93 0,22 OK -0,20 0,10 --- 0,022161 
STK35 140901 SKV_25 B10 Hs_STK35_7 CAAAGTTAGTTTCCAATACTA 0,58 0,16 OK -0,20 0,37 --- 0,400973 
MARK3 4140 SKV_04 E06 Hs_MARK3_7 CACGACGAAATACTTATGTTT 1,49 0,46 OK -0,20 0,08 --- 0,014190 
AKAP5 9495 SKV_12 E07 Hs_AKAP5_5 AGGGCTTTCATCAAGAAATTA 1,47 0,44 OK -0,20 0,11 --- 0,031129 
JAK3 3718 SKV_21 E06 Hs_JAK3_6 TCCGGGAGGCGCAGACACTTA 1,32 0,16 OK -0,20 0,18 --- 0,062577 
AKAP13 11214 SKV_16 B10 Hs_AKAP13_6 CTCGGTGTTTCAGGCACTAAA 0,67 0,15 OK -0,20 0,15 --- 0,016386 
EPHA3 2042 SKV_19 C10 Hs_EPHA3_6 TTGGATAGTTTCCTACGTAAA 1,21 0,30 OK -0,20 0,09 --- 0,005020 
ACVR2A 92 SKV_23 G07 Hs_ACVR2_4 ACCAATCAAACTGGTGTTGAA 0,96 0,19 OK -0,21 0,18 --- 0,116744 
TTK 7272 SKV_15 F10 Hs_TTK_6 CAGCAATACCTTGGATGATTA 0,44 0,18 OK -0,21 0,08 --- 0,000278 
AK7 122481 SKV_13 G04 Hs_AK7_7 GACGATCAATATATAATTAGA 1,28 0,25 OK -0,21 0,25 --- 0,098708 
ITK 3702 SKV_21 E03 Hs_ITK_5 CAGGACTTTAGTAGAGACTGA 1,20 0,14 OK -0,21 0,15 --- 0,031645 
MAST4 375449 SKV_20 F08 Hs_LOC375449_4 ATGAATTGCCACCACATTAAA 0,57 0,08 OK -0,21 0,16 --- 0,035679 
ZMYND8 23613 SKV_16 C08 Hs_PRKCBP1_8 CACCATTGAACAGTTATCCTA 0,59 0,13 OK -0,21 0,15 --- 0,014664 
KIDINS220 57498 SKV_16 E03 Hs_KIDINS220_6 TCGCAGATGCGCTATTATCTA 0,74 0,14 OK -0,21 0,18 --- 0,029178 
ERBB3 2065 SKV_22 G05 Hs_ERBB3_6 CTTCGTCATGTTGAACTATAA 0,41 0,09 OK -0,21 0,53 --- 0,524584 
CASK 8573 SKV_04 G04 Hs_CASK_5 AACCAATGGGAATCACTTTAA 0,22 0,02 TOXIC -0,21 0,26 --- 0,225718 
MAP3K11 4296 SKV_22 E05 Hs_MAP3K11_6 CCCGACGTCTGGAGGACTCAA 1,20 0,17 OK -0,21 0,06 --- 0,003274 
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CAMK2N1 55450 SKV_05 C08 Hs_CaMKIINalpha_5 AGCAAGCGGGTTGTTATTGAA 0,76 0,10 OK -0,21 0,34 --- 0,339517 
PRKRIR 5612 SKV_12 F09 Hs_PRKRIR_14 ATGGGAGTATCTGTTGCATTA 1,25 0,59 OK -0,21 0,23 --- 0,183096 
DAPK1 1612 SKV_04 D09 Hs_DAPK1_5 AAGCATGTAATGTTAATGTTA 1,14 0,26 OK -0,21 0,29 --- 0,266475 
PRKDC 5591 SKV_02 D04 Hs_PRKDC_6 TTCGGCTAACTCGCCAGTTTA 0,66 0,17 OK -0,21 0,24 --- 0,195856 
EPHB4 2050 SKV_22 F10 Hs_EPHB4_5 CCCAGCCAATAGCCACTCTAA 0,48 0,04 OK -0,22 0,16 --- 0,083402 
PKIG 11142 SKV_14 D09 Hs_PKIG_8 CCACAAGATGTTATTTATTGA 1,02 0,60 OK -0,22 0,45 --- 0,313328 
LOC161635 161635 SKV_07 D09 LOC161635 TTGGTCGTGTGAATTATTAAA 1,11 0,20 OK -0,22 0,40 --- 0,401997 
EPHB6 2051 SKV_21 C03 Hs_EPHB6_5 AACCGCCAATCTCTAGATCAA 0,61 0,15 OK -0,22 0,17 --- 0,039265 
CDKN2B 1030 SKV_16 G04 Hs_CDKN2B_5 CTGCTTACTTATGCCATAGAA 0,64 0,15 OK -0,22 0,29 --- 0,130103 
AURKAIP1 54998 SKV_16 D08 Hs_AKIP_6 CTGCTGTGATCCGTAGTAATA 0,33 0,13 TOXIC -0,22 0,18 --- 0,025935 
MAP3K7 6885 SKV_18 F05 Hs_MAP3K7_6 CCCGTGTGAACCATCCTAATA 0,56 0,11 OK -0,22 0,26 --- 0,140828 
UCK2 7371 SKV_11 C05 Hs_UCK2_6 TCAGTACATTACGTTCGTCAA 0,83 0,07 OK -0,22 0,08 --- 0,144424 
PRKG1 5592 SKV_25 E06 Hs_PRKG1_5 GAGGTTCGTTTGAAGATTCTA 0,63 0,06 OK -0,22 0,04 --- 0,000872 
CDKL3 51265 SKV_10 B08 Hs_CDKL3_7 AGCTCCCGAATTAGTATTAAA 0,73 0,21 OK -0,22 0,15 --- 0,058690 
ADK 132 SKV_10 C06 Hs_ADK_11 AAGAAAGATCATTATTTAATA 1,22 0,08 OK -0,22 0,31 --- 0,276367 
SGK3 23678 SKV_03 F04 Hs_SGKL_5 ACCAACTAACTTACATGCTTA 0,67 0,25 OK -0,23 0,35 --- 0,327573 
CALM3 808 SKV_10 D04 Hs_CALM3_5 CACCAATTGATTGACTGAGAA 0,76 0,25 OK -0,23 0,70 --- 0,608522 
RIPK4 54101 SKV_24 G03 Hs_RIPK4_5 AAGCCTGATGACGAAGTGAAA 0,42 0,06 OK -0,23 0,51 --- 0,482413 
ZAK 51776 SKV_24 F10 Hs_ZAK_15 AAGGAATGCATTATTTACATA 0,75 0,10 OK -0,23 0,06 --- 0,002442 
TGFBR1 7046 SKV_22 E08 Hs_TGFBR1_6 TCCATTGGTGGAATTCATGAA 1,17 0,20 OK -0,23 0,06 --- 0,002181 
GUK1 2987 SKV_10 E10 Hs_GUK1_6 CCCGGCGAGGAGAACGGCAAA 0,81 0,42 OK -0,23 0,09 --- 0,012658 
CDK7 1022 SKV_07 E09 Hs_CDK7_6 GAGGCTTTAAGGTAGCTTTAA 0,20 0,13 TOXIC -0,23 0,32 --- 0,277108 
PIK3CG 5294 SKV_17 D03 Hs_PIK3CG_5 ATCGAAGTTTGCAGAGACAAA 1,14 0,36 OK -0,23 0,13 --- 0,011150 
AKAP3 10566 SKV_14 D06 Hs_AKAP3_5 AGGGATCATGACCTATGCTAA 0,81 0,22 OK -0,23 0,33 --- 0,151064 
MARK2 2011 SKV_06 C03 Hs_MARK2_7 CCACCTCTAATTCTTACTCTA 0,89 0,08 OK -0,24 0,12 --- 0,023922 
PLK1 5347 SKV_17 D06 Hs_PLK1_7 CGCGGGCAAGATTGTGCCTAA 0,04 0,02 TOXIC -0,24 0,55 --- 0,413402 
NEK1 4750 SKV_17 B09 Hs_NEK1_8 AACCAGGAATACTATATCGAA 0,78 0,09 OK -0,24 0,26 --- 0,112877 
RAF1 5894 SKV_22 E06 Hs_RAF1_6 CAGATCTTAGTAAGCTATATA 1,24 0,19 OK -0,24 0,11 --- 0,019866 
PFKFB3 5209 SKV_10 G08 Hs_PFKFB3_6 CTCCAATATCATGGAAGTTAA 0,75 0,29 OK -0,24 0,23 --- 0,143387 
PFKFB2 5208 SKV_10 G07 Hs_PFKFB2_6 CCGTGACAAGCCAACTAACAA 0,30 0,20 TOXIC -0,24 0,77 --- 0,612343 
AK5 26289 SKV_13 C08 Hs_AK5_6 CAGCAATTATAAATTAATATA 0,97 0,35 OK -0,24 0,14 --- 0,006077 
EIF2AK2 5610 SKV_17 D07 Hs_EIF2AK2_5 ACGGAAAGACTTACGTTATTA 1,11 0,31 OK -0,24 0,16 --- 0,021318 
RPS6KA3 6197 SKV_01 F04 Hs_RPS6KA3_6 TCCAAACATTATCACTCTAAA 0,83 0,24 OK -0,25 0,19 --- 0,086321 
LTK 4058 SKV_21 E09 Hs_LTK_5 ACAGATCTTTGGAGTGCCTAA 1,28 0,24 OK -0,25 0,10 --- 0,002463 
PRKAA2 5563 SKV_25 B03 Hs_PRKAA2_6 CCGAAGTCAGAGCAAACCGTA 0,61 0,14 OK -0,25 0,42 --- 0,372001 
XYLB 9942 SKV_13 B09 Hs_XYLB_6 TCAGGACTCCAGCTAAATCAA 0,77 0,21 OK -0,25 0,26 --- 0,067877 
CSNK2A1 1457 SKV_15 D03 Hs_CSNK2A1_9 TCCATTGAAGCTGAAATGGTA 0,36 0,11 TOXIC -0,25 0,32 --- 0,122052 
HIPK3 10114 SKV_08 D04 Hs_HIPK3_5 CACGTTTGGCCAGGTAGTTAA 0,51 0,20 OK -0,25 0,65 --- 0,543394 
EPHB3 2049 SKV_21 B09 Hs_EPHB3_7 TCCCAGATTACACAACCTTCA 0,49 0,17 OK -0,25 0,23 --- 0,074882 
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PIK3R2 5296 SKV_17 D05 Hs_PIK3R2_5 CCGCGAGTATGACCAGCTTTA 1,13 0,20 OK -0,25 0,16 --- 0,022621 
PLK4 10733 SKV_17 F08 Hs_PLK4_6 CAGACATATAAGTTTAATAAA 0,89 0,14 OK -0,25 0,08 --- 0,000679 
MAP3K10 4294 SKV_22 E04 Hs_MAP3K10_5 CAGGATGTTCACTCTATTTAT 1,05 0,16 OK -0,25 0,01 --- 0,000004 
CDC2 983 SKV_05 F10 Hs_CDC2_13 TCGGGAAATTTCTCTATTAAA 0,49 0,54 OK -0,25 0,03 --- 0,000120 
SNF1LK2 23235 SKV_05 B09 Hs_SNF1LK2_6 CCGAAGGATGTTGGTCCTAGA 0,52 0,26 OK -0,26 0,17 --- 0,056432 
RIOK1 83732 SKV_02 E09 Hs_RIOK1_5 GCCCAACAAGATAATATTCTA 1,04 0,27 OK -0,26 0,30 --- 0,214518 
CDC42SE2 56990 SKV_14 F10 Hs_CDC42SE2_2 AAGGGAGGTTATGGAGGTGGA 0,37 0,47 TOXIC -0,26 0,34 --- 0,133390 
FLT3 2322 SKV_23 B06 Hs_FLT3_6 CCGGCTTGAGTGAATTGTGTA 0,67 0,08 OK -0,26 0,30 --- 0,211551 
AK2 204 SKV_08 E08 Hs_AK2_4 ATGGGTGGGAATGATAGGACA 0,63 0,31 OK -0,26 0,31 --- 0,228424 
PIK3CA 5290 SKV_17 C08 Hs_PIK3CA_13 AAGCTTTAGAATAATGCGCAA 1,24 0,12 OK -0,26 0,11 --- 0,004044 
PIK3CA 5290 SKV_15 E08 Hs_PIK3CA_5 CTGAGTCAGTATAAGTATATA 0,72 0,21 OK -0,26 0,27 --- 0,064427 
CMPK 51727 SKV_11 F05 Hs_UMP-CMPK_5 CGCGTATATATCCCTCTAGTA 0,79 0,17 OK -0,26 0,17 --- 0,105340 
MAP2K1IP1 8649 SKV_12 D08 Hs_MAP2K1IP1_6 TAGCATATAGATGTAATTTAT 0,90 0,09 OK -0,26 0,09 --- 0,007348 
MAP3K3 4215 SKV_20 B04 Hs_MAP3K3_6 CCACGTGTCTGTGCACCACAA 0,23 0,07 TOXIC -0,26 0,49 --- 0,328513 
PIK3C2A 5286 SKV_17 C04 Hs_PIK3C2A_6 TACCCACTAATTGCATTGGAA 1,00 0,21 OK -0,26 0,22 --- 0,056999 
PIP5K1B 8395 SKV_25 F09 Hs_PIP5K1B_7 AAGGGTTACCTTCCAGTTCAA 0,21 0,09 TOXIC -0,26 0,28 --- 0,186351 
PIK3C2B 5287 SKV_17 C05 Hs_PIK3C2B_5 GAGGGAGGAGCTAAACGGTTA 1,11 0,09 OK -0,26 0,14 --- 0,010727 
CDC42BPG 55561 SKV_02 C03 Hs_CDC42BPG_6 CTCGCCGCCTACCAACTTCAA 0,14 0,13 TOXIC -0,26 0,38 --- 0,292367 
NEK3 4752 SKV_17 C03 Hs_NEK3_9 ACGATAGAGGTGGTTCTGTAA 1,05 0,27 OK -0,26 0,18 --- 0,025151 
TWF2 11344 SKV_04 B10 Hs_PTK9L_6 TTGGGATGGTTGAATGCTGTA 0,05 0,05 TOXIC -0,27 0,92 --- 0,641519 
MAP2K5 5607 SKV_18 E05 Hs_MAP2K5_12 CAAGACGTATGTTGGAACAAA 0,32 0,12 TOXIC -0,27 0,45 --- 0,276900 
ILK 3611 SKV_24 B06 Hs_ILK_5 TAGCCGTAGTGTAATGATTGA 1,00 0,07 OK -0,27 0,17 --- 0,051571 
NUAK2 81788 SKV_07 B05 Hs_NUAK2_5 TACCTAATGGTCTCTACCTAA 0,72 0,38 OK -0,27 0,38 --- 0,287947 
DCLK1 9201 SKV_04 G06 Hs_DCAMKL1_5 CAGGTTTATAACTTCGACACA 0,63 0,05 OK -0,27 0,11 --- 0,014376 
CINP 51550 SKV_16 D06 Hs_CINP_6 GCGGCTGATTGGCACAATTTA 0,46 0,08 OK -0,27 0,14 --- 0,003023 
EPHB1 2047 SKV_22 F07 Hs_EPHB1_6 GCGGGATGATGTGACCTACAA 0,33 0,12 TOXIC -0,27 0,29 --- 0,187924 
AKAP5 9495 SKV_14 C07 Hs_AKAP5_6 ATCAGGTTGATCTTTAAATAA 0,84 0,16 OK -0,27 0,33 --- 0,104603 
MOS 4342 SKV_15 D08 Hs_MOS_6 CTCGGTGTACAAGGCGACTTA 0,70 0,27 OK -0,27 0,10 --- 0,000274 
EPHA1 2041 SKV_20 G09 Hs_EPHA1_5 CAGATGGGATCCCGTATCGAA 1,00 0,06 OK -0,27 0,20 --- 0,032253 
MARCKS 4082 SKV_12 C09 Hs_MARCKS_6 TTGAGTTTCTTTGTTGAAGAA 0,81 0,42 OK -0,27 0,27 --- 0,151934 
RPS6KA1 6195 SKV_01 E10 Hs_RPS6KA1_10 TGCCACGTACTCCGCACTCAA 0,44 0,35 OK -0,27 0,85 --- 0,608429 
SKIP 51763 SKV_25 C09 Hs_SKIP_12 CCCGGAGAAATACTTAAGATA 0,74 0,44 OK -0,27 1,19 --- 0,711802 
CIT 11113 SKV_03 E07 Hs_CIT_3 CAGGATATACCGTAACACGAA 0,58 0,12 OK -0,27 0,42 --- 0,325601 
NME5 8382 SKV_12 G06 Hs_NME5_7 CATGATATTAGCTAGACATAA 0,74 0,15 OK -0,27 0,20 --- 0,076895 
ZC3HC1 51530 SKV_16 D05 Hs_ZC3HC1_1 CCGCTTGAGGCTCTCTATGAA 0,29 0,07 TOXIC -0,27 0,10 --- 0,000223 
MARK4 57787 SKV_07 B03 Hs_MARK4_6 CTGCAGCCTGTTGCCCAATAA 0,42 0,25 OK -0,28 0,10 --- 0,008953 
MAPKAPK2 9261 SKV_06 E07 Hs_MAPKAPK2_5 CTACGAGCAGATCAAGATAAA 0,77 0,45 OK -0,28 0,02 --- 0,000024 
FGFR2 2263 SKV_21 D04 Hs_FGFR2_7 CAGCATATGTGTAAAGATTTA 1,00 0,21 OK -0,28 0,10 --- 0,001146 
ARAF 369 SKV_22 C09 Hs_ARAF_5 CCGACTCATCAAGGGACGAAA 1,08 0,11 OK -0,28 0,14 --- 0,023989 
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ACVR1 90 SKV_22 C05 Hs_ACVR1_6 CTGGTCTGTCTTTGGATAATA 0,40 0,03 OK -0,28 0,32 --- 0,203081 
KIAA1804 84451 SKV_24 E04 Hs_KIAA1804_5 ACGGACCATGTCTGATGGAAA 0,71 0,16 OK -0,28 0,29 --- 0,172515 
STK39 27347 SKV_18 G10 Hs_STK39_5 TGGAATAGTCTCAGATCTAAA 0,70 0,29 OK -0,28 0,24 --- 0,060305 
EPHB2 2048 SKV_22 F08 Hs_EPHB2_9 CACGCTTTCTAGAGGACGATA 0,87 0,10 OK -0,28 0,06 --- 0,001259 
PIK3R1 5295 SKV_17 D04 Hs_PIK3R1_6 TAGCTGGTTATGAACTAGTAA 1,14 0,22 OK -0,28 0,21 --- 0,037683 
PHKG1 5260 SKV_06 D03 Hs_PHKG1_6 CCGGGAGATCGTCATCCGAGA 0,46 0,36 OK -0,28 0,41 --- 0,294206 
TNNI3K 51086 SKV_24 D08 Hs_TNNI3K_7 GGAGCTAATGTCAATATTCAA 0,81 0,09 OK -0,28 0,08 --- 0,002867 
CSK 1445 SKV_20 G06 Hs_CSK_3 TACGCGCCTCATTAAACCAAA 1,06 0,29 OK -0,28 0,31 --- 0,116742 
PIK3C3 5289 SKV_17 C07 Hs_PIK3C3_6 TCGGTTGGTGCATCTAATGAA 1,01 0,18 OK -0,29 0,07 --- 0,000215 
BMPR1B 658 SKV_24 B03 Hs_BMPR1B_6 ACGGATATTGTTTCACGATGA 0,82 0,23 OK -0,29 0,54 --- 0,414692 
STK36 27148 SKV_25 C08 Hs_STK36_6 TGCCAGCTCTTTCTTATTCTA 0,70 0,02 OK -0,29 0,09 --- 0,006161 
PHKA1 5255 SKV_06 C08 Hs_PHKA1_6 CCCAATCGTCTGTACTATGAA 0,52 0,13 OK -0,29 0,24 --- 0,104087 
SH3KBP1 30011 SKV_14 F04 Hs_SH3KBP1_5 CTCTGAGATCTCAATGCGAAA 0,73 0,17 OK -0,29 0,12 --- 0,000707 
PKIG 11142 SKV_16 B09 Hs_PKIG_5 GAGCTCCATGTCCCAGATAAA 0,34 0,07 TOXIC -0,29 0,26 --- 0,038684 
AKAP7 9465 SKV_14 C04 Hs_AKAP7_5 AACGATGGGTCTGAAGTCCAA 0,63 0,39 OK -0,29 0,20 --- 0,014204 
TIE1 7075 SKV_25 D07 Hs_TIE1_5 CTGGAGCAACACAGTAGAAGA 0,72 0,06 OK -0,29 0,04 --- 0,000236 
STK31 56164 SKV_19 G10 Hs_STK31_8 AAGGAGATAATTTCAAATACA 0,66 0,27 OK -0,29 0,36 --- 0,158881 
PIK3R3 8503 SKV_25 F08 Hs_PIK3R3_7 AAGGGAGGCAATAATAAGTTA 0,86 0,13 OK -0,29 0,24 --- 0,108387 
HK3 3101 SKV_10 F05 Hs_HK3_6 CCGGAATGCGATGTCTCCTTA 0,93 0,22 OK -0,29 0,26 --- 0,125084 
GIT2 9815 SKV_14 C09 Hs_GIT2_6 CCCGTTGATTATGCAAGGCAA 0,44 0,40 OK -0,29 0,26 --- 0,035895 
STK16 8576 SKV_18 C08 Hs_STK16_9 CACATAGTGTTCTGACTCCAA 0,51 0,14 OK -0,29 0,28 --- 0,081442 
PFKFB3 5209 SKV_09 C08 Hs_PFKFB3_5 CAGGGACTTGTCGCTGATCAA 0,45 0,13 OK -0,29 0,18 --- 0,048351 
SYK 6850 SKV_21 G10 Hs_SYK_5 CCCGCTCTTAAAGATGAGTTA 0,96 0,22 OK -0,29 0,14 --- 0,004940 
MAP3K7IP1 10454 SKV_16 B04 Hs_MAP3K7IP1_10 ATGTAGTAAAGAAGTAATAAA 0,80 0,17 OK -0,29 0,18 --- 0,006626 
ZMYND8 23613 SKV_14 E08 Hs_PRKCBP1_7 AGCGAACTTGTCATAGATTTA 0,96 0,23 OK -0,29 0,18 --- 0,005911 
LIMK1 3984 SKV_22 D09 Hs_LIMK1_7 GAGCATCTAGGAAGTATTAAA 1,20 0,17 OK -0,29 0,14 --- 0,020215 
LIMK2 3985 SKV_24 B10 Hs_LIMK2_15 TTGATCAGACTAAATAAATTA 0,83 0,07 OK -0,30 0,50 --- 0,356568 
CDKN1A 1026 SKV_10 D05 Hs_CDKN1A_6 CAGTTTGTGTGTCTTAATTAT 0,95 0,09 OK -0,30 0,34 --- 0,205792 
PSKH2 85481 SKV_05 D09 Hs_PSKH2_5 AAGGACTTTATAGACAAACTA 0,94 0,15 OK -0,30 0,31 --- 0,174231 
EPHA3 2042 SKV_20 G10 Hs_EPHA3_5 TCGGATATGATTGTTTCTCAA 0,99 0,31 OK -0,30 0,11 --- 0,001308 
DDR2 4921 SKV_21 F09 Hs_DDR2_3 ACGCACTGTCAGTTACACCAA 0,47 0,06 OK -0,30 0,08 --- 0,000371 
PTK7 5754 SKV_21 G05 Hs_PTK7_3 CCGAGAGAAGCCCACTATTAA 0,54 0,09 OK -0,30 0,26 --- 0,061862 
TYK2 7297 SKV_23 F05 Hs_TYK2_7 CTGATGCTATATTTCCGCATA 0,83 0,09 OK -0,30 0,09 --- 0,005185 
GSK3A 2931 SKV_07 F07 Hs_GSK3A_5 CCGGGTGTAAATAGATTGTTA 1,06 0,32 OK -0,30 0,31 --- 0,163217 
EGFR 1956 SKV_20 G07 Hs_EGFR_6 CCCATCCAATTTATCAAGGAA 0,53 0,37 OK -0,30 0,45 --- 0,226283 
TGFBR2 7048 SKV_22 E09 Hs_TGFBR2_7 TCGGTTAATAACGACATGATA 1,15 0,13 OK -0,30 0,07 --- 0,001400 
MAPK6 5597 SKV_09 E09 Hs_MAPK6_5 CAAGTTCAATTTGAAAGGAAA 0,87 0,20 OK -0,31 0,13 --- 0,015018 
FRAP1 2475 SKV_25 D03 Hs_FRAP1_5 ACTCGCTGATCCAAATGACAA 0,56 0,12 OK -0,31 0,55 --- 0,384055 
RPS6KA6 27330 SKV_03 F07 Hs_RPS6KA6_6 GGCGAGGTAAATGGTCTTAAA 0,50 0,20 OK -0,31 0,33 --- 0,180906 
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MAPK15 225689 SKV_08 E05 Hs_MAPK15_1 CCACTGACTTCCTCCAATAAA 0,90 0,38 OK -0,31 0,26 --- 0,109504 
EIF2AK3 9451 SKV_15 G09 Hs_EIF2AK3_5 CACAAACTGTATAACGGTTTA 1,10 0,43 OK -0,31 0,19 --- 0,007674 
PCTK2 5128 SKV_07 G03 Hs_PCTK2_5 AGGCTTAATTCTTGCGTATAA 1,10 0,30 OK -0,31 0,21 --- 0,059781 
KIAA1804 84451 SKV_24 G04 Hs_KIAA1804_6 CGGGAACTTAACATTCTGATA 1,17 0,25 OK -0,31 0,21 --- 0,056849 
CDK5 1020 SKV_05 G07 Hs_CDK5_9 CCCTTTGTGGACTTTATTTAA 0,93 0,38 OK -0,32 0,08 --- 0,002059 
SPHK2 56848 SKV_13 E06 Hs_SPHK2_6 CCGAGGGTAGTGCCTGATCAA 0,35 0,20 TOXIC -0,32 0,29 --- 0,041121 
ITK 3702 SKV_23 C03 Hs_ITK_6 CTGGTGAGTTAAGTAAGATTA 0,81 0,08 OK -0,32 0,04 --- 0,000208 
DTYMK 1841 SKV_10 E08 Hs_DTYMK_6 TCCCGGAAAGATCAACTGAAA 0,81 0,27 OK -0,32 0,41 --- 0,253537 
RIPK1 8737 SKV_24 C10 Hs_RIPK1_5 TACCACTAGTCTGACGGATAA 0,70 0,21 OK -0,32 0,22 --- 0,063016 
LYN 4067 SKV_21 E10 Hs_LYN_13 CGGGAAATATGGGATGTATAA 1,29 0,18 OK -0,32 0,13 --- 0,003170 
DGKZ 8525 SKV_12 G10 Hs_DGKZ_5 CTGGAGCGAGTCAGCGACATA 1,29 0,25 OK -0,32 0,42 --- 0,260026 
PIP5K1C 23396 SKV_11 E06 Hs_PIP5K1C_5 CCGCGTCGTGGTCATGAACAA 0,26 0,08 TOXIC -0,32 0,39 --- 0,059910 
VRK2 7444 SKV_07 D03 Hs_VRK2_6 AGGGAAGAAGTTACAGATTTA 0,54 0,08 OK -0,32 0,19 --- 0,040973 
RPS6KC1 26750 SKV_26 B05 Hs_RPS6KC1_7 CCTGATCTTCTTGTAAATTTA 0,84 0,26 OK -0,32 0,14 --- 0,017940 
PAK2 5062 SKV_20 B08 Hs_PAK2_8 CCGCGACCGGATCATACGAAA 0,79 0,07 OK -0,33 0,08 --- 0,000150 
JAK2 3717 SKV_23 C05 Hs_JAK2_8 CTGCCTTACGATGACAGAAAT 0,94 0,12 OK -0,33 0,17 --- 0,030922 
CKS1B 1163 SKV_16 G08 Hs_CKS1B_5 AAGAAATCTGTTCATGTTAAA 1,13 0,45 OK -0,33 0,22 --- 0,010573 
GRK6 2870 SKV_01 B10 Hs_GRK6_9 AAGGATGTTCTGGACATTGAA 0,38 0,39 TOXIC -0,33 0,80 --- 0,512743 
ARAF 369 SKV_23 G09 Hs_ARAF_6 CCGGGATGGCATGAGTGTCTA 0,98 0,26 OK -0,33 0,08 --- 0,001555 
KHK 3795 SKV_10 F09 Hs_KHK_7 TAGGGTGGGTAAGGCCTTATA 0,66 0,31 OK -0,33 0,56 --- 0,360877 
CDKL5 6792 SKV_08 C04 Hs_CDKL5_5 AAGATAGACGCTTCATGTTAA 0,60 0,11 OK -0,34 0,46 --- 0,275570 
VRK1 7443 SKV_05 E10 Hs_VRK1_6 CCAGGTGTACTTGGTAGATTA 0,95 0,10 OK -0,34 0,33 --- 0,152004 
PRKG2 5593 SKV_03 C06 Hs_PRKG2_6 TTGAGTACTACTAACGTTTAA 0,57 0,14 OK -0,34 0,24 --- 0,073262 
EPHA1 2041 SKV_19 C09 Hs_EPHA1_6 TACCTCAGTAATCACAATTAT 0,97 0,12 OK -0,34 0,17 --- 0,006331 
AKAP14 158798 SKV_15 B06 Hs_AKAP14_6 CCCATTGTCGTTTCTTATGTA 0,61 0,16 OK -0,34 0,25 --- 0,014785 
STK38L 23012 SKV_01 G10 Hs_STK38L_5 AGGGAGATGTACTGTATTATA 0,76 0,17 OK -0,34 0,23 --- 0,062616 
NUCKS1 64710 SKV_25 F05 Hs_NUCKS_7 AAGAACCTACTTAAGATAGAA 0,53 0,25 OK -0,34 0,22 --- 0,057214 
CDK5R1 8851 SKV_11 D05 Hs_CDK5R1_5 CCGGAAGGCCACGCTGTTTGA 0,56 0,24 OK -0,34 0,40 --- 0,049359 
STYXL1 51657 SKV_14 F07 Hs_DUSP24_8 CAGGCTTGTCTGGAAGGAGAA 0,24 0,09 TOXIC -0,34 0,22 --- 0,007615 
PNKP 11284 SKV_13 C05 Hs_PNKP_4 CGGGAAGTCCACCTTTCTCAA 0,76 0,10 OK -0,34 0,22 --- 0,009145 
FGFR1 2260 SKV_22 G10 Hs_FGFR1_7 CCGGCCTCTATGCTTGCGTAA 1,07 0,10 OK -0,34 0,25 --- 0,076517 
MAPK1 5594 SKV_07 G06 Hs_MAPK1_12 AACACTTGTCAAGAAGCGTTA 0,62 0,32 OK -0,35 0,22 --- 0,053894 
IHPK3 117283 SKV_12 B10 Hs_IHPK3_5 AAGACTGGTGGACAAGTGTAA 0,27 0,16 TOXIC -0,35 0,74 --- 0,462180 
PDGFRB 5159 SKV_23 E03 Hs_PDGFRB_5 CCGAGCAACTTTGATCAACGA 0,67 0,12 OK -0,35 0,30 --- 0,119286 
IBTK 25998 SKV_17 G04 Hs_IBTK_5 CAGATTGAGGAGCATGCCATA 0,30 0,18 TOXIC -0,35 0,34 --- 0,088092 
RET 5979 SKV_21 G06 Hs_RET_10 TAGGCTGGTTCTCAACCGGAA 1,17 0,18 OK -0,35 0,34 --- 0,085683 
HK3 3101 SKV_09 B05 Hs_HK3_5 CACTCAGGTTAGCAATATATA 0,75 0,36 OK -0,35 0,34 --- 0,145950 
TESK1 7016 SKV_22 E07 Hs_TESK1_5 CAGGACCGCCCTGACACACAA 1,02 0,22 OK -0,35 0,08 --- 0,001636 
GIT1 28964 SKV_16 C10 Hs_GIT1_6 GCCGCTGAGGATGTCCCGAAA 0,50 0,17 OK -0,35 0,11 --- 0,000177 
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VRK1 7443 SKV_07 C10 Hs_VRK1_5 CAGGTTATACTCCTTAAGTTA 0,88 0,62 OK -0,35 0,25 --- 0,072639 
JAK3 3718 SKV_23 C06 Hs_JAK3_5 CGGGAGATTCAGATCCTCAAA 0,30 0,05 TOXIC -0,35 0,35 --- 0,151693 
MINK1 50488 SKV_25 D08 Hs_MINK1_6 CCGGAAGTACAAGAAGCGATT 0,56 0,05 OK -0,35 0,42 --- 0,221181 
CARKL 23729 SKV_11 E07 Hs_CARKL_5 ATGAAACATATTGTCTCTTTA 1,09 0,07 OK -0,36 0,16 --- 0,042269 
CDK3 1018 SKV_07 E05 Hs_CDK3_6 CAGACTGGATTTGGAGATGGA 0,31 0,25 TOXIC -0,36 0,18 --- 0,025387 
PRKAB1 5564 SKV_02 G05 Hs_PRKAB1_6 CTGGCTATGGAACTAAATACA 0,47 0,33 OK -0,36 0,49 --- 0,277178 
CAMK1D 57118 SKV_05 C09 Hs_CAMK1D_7 CTGAGAAAGATTAAGCATGAA 0,29 0,25 TOXIC -0,36 0,10 --- 0,003077 
DGUOK 1716 SKV_08 G07 Hs_DGUOK_9 CACCTTTGTAAAGAATCTGTA 0,67 0,59 OK -0,36 0,45 --- 0,234327 
RYK 6259 SKV_21 G08 Hs_RYK_9 CGGTCTTGATGCAGAACTTTA 0,83 0,14 OK -0,36 0,32 --- 0,065215 
AKAP1 8165 SKV_14 B06 Hs_AKAP1_9 AGCGCTGAACTTGATTGGGAA 0,98 0,38 OK -0,36 0,19 --- 0,003243 
RIPK1 8737 SKV_22 E10 Hs_RIPK1_6 CCGACATTTCCTGGCATTGAA 1,28 0,26 OK -0,36 0,19 --- 0,030138 
MAP3K9 4293 SKV_24 C03 Hs_MAP3K9_3 CACGACCATCTTTCACGAATA 1,10 0,27 OK -0,36 0,14 --- 0,011717 
MAST2 23139 SKV_03 F03 Hs_MAST2_5 CAGGAGTGTGCTGTCTGGCAA 0,32 0,13 TOXIC -0,37 0,15 --- 0,012327 
TTBK2 146057 SKV_05 F08 Hs_TTBK2_5 CACATTGGTCATGACATGTTA 0,86 0,24 OK -0,37 0,25 --- 0,062057 
PKN2 5586 SKV_03 C03 Hs_PKN2_6 CACGTCAAAGTATGATATCTA 0,24 0,19 TOXIC -0,37 0,41 --- 0,193906 
GNE 10020 SKV_11 D10 Hs_GNE_9 CTGCTTACTAATGTATTAATA 0,94 0,40 OK -0,37 0,16 --- 0,037741 
MAP2K5 5607 SKV_20 C05 Hs_MAP2K5_11 AAGACGTATGTTGGAACAAAT 0,38 0,11 TOXIC -0,37 0,37 --- 0,095201 
IKBKB 3551 SKV_25 E10 Hs_MAPKAP1_3 AAGATTAGAACGACTCCGAAA 0,67 0,14 OK -0,37 0,10 --- 0,002800 
CKS2 1164 SKV_15 C09 Hs_CKS2_5 CTGTAAGATGTTTAAGATAAA 0,47 0,24 OK -0,37 0,24 --- 0,010216 
HGS 9146 SKV_12 D10 Hs_HGS_5 CCGGAACGAGCCCAAGTACAA 0,21 0,10 TOXIC -0,38 0,83 --- 0,474753 
NME1 4830 SKV_09 C03 Hs_NME1_10 CCCTGAGGAACTGGTAGATTA 1,02 0,27 OK -0,38 0,08 --- 0,001484 
TEC 7006 SKV_22 B03 Hs_TEC_5 CAGTACAAAGTCGCAATCAAA 0,57 0,11 OK -0,38 0,17 --- 0,019313 
CSNK1A1 1452 SKV_05 E05 Hs_CSNK1A1_6 CAAGAGTAACATGAAAGGTTT 1,08 0,07 OK -0,38 0,48 --- 0,248314 
CHUK 1147 SKV_16 G07 Hs_CHUK_6 TTCCATAAGCTTGGTGACAAA 0,36 0,14 TOXIC -0,38 0,34 --- 0,035202 
RP6-213H19.1 51765 SKV_20 F04 Hs_MST4_6 CAGCAAGTCGTTGCTATTAAA 0,69 0,10 OK -0,38 0,34 --- 0,068292 
DYRK1B 9149 SKV_10 B03 Hs_DYRK1B_6 CCAGGATTCGAGCAACAAGAA 0,43 0,35 OK -0,38 0,48 --- 0,241272 
MAPK8 5599 SKV_09 F03 Hs_MAPK8_12 GTGGAAAGAATTGATATATAA 0,64 0,26 OK -0,38 0,11 --- 0,003444 
SRPK2 6733 SKV_08 C03 Hs_SRPK2_7 CAGAAAGTGATTACACATATA 0,94 0,17 OK -0,38 0,18 --- 0,019424 
TESK1 7016 SKV_24 C07 Hs_TESK1_6 CTGCGGTACCTGCACTCCAAA 0,52 0,08 OK -0,39 0,11 --- 0,003577 
MAST1 22983 SKV_03 E09 Hs_MAST1_5 CAACGAGATCGTGATGATGAA 0,43 0,11 OK -0,39 0,25 --- 0,055972 
OSR1 130497 SKV_25 B06 Hs_OXSR1_6 AAGGAGAAAGTGGCAATCAAA 0,46 0,03 OK -0,39 0,21 --- 0,034667 
PRKAB2 5565 SKV_01 C06 Hs_PRKAB2_5 ACCCAAAGTACTACTCATTTA 0,41 0,29 OK -0,39 0,33 --- 0,112578 
ROS1 6098 SKV_21 G07 Hs_ROS1_5 AAGGTAATTGCTCTAACTTTA 0,71 0,26 OK -0,39 0,33 --- 0,059024 
STK17B 9262 SKV_04 G08 Hs_STK17B_8 TGGTTAGACAATGTATATCAA 1,18 0,25 OK -0,39 0,15 --- 0,009869 
CDK4 1019 SKV_07 E06 Hs_CDK4_7 AAGGTAATCCGGAGTGAGCAA 0,34 0,12 TOXIC -0,40 0,45 --- 0,200754 
CSNK1G1 53944 SKV_26 C05 Hs_CSNK1G1_7 TTGGACCATGTGGGAAATATA 0,56 0,15 OK -0,40 0,43 --- 0,183411 
TTK 7272 SKV_17 D10 Hs_TTK_7 TCCGACTTTATGATTATGAAA 1,19 0,12 OK -0,40 0,22 --- 0,011782 
CSNK1E 1454 SKV_07 C07 Hs_CSNK1E_6 GTGGTTGTTAATTTGAAGTAA 0,29 0,17 TOXIC -0,40 0,38 --- 0,141434 
STK17A 9263 SKV_04 G09 Hs_STK17A_6 TCCATTGTAACCGAAGAGTTA 1,26 0,28 OK -0,40 0,23 --- 0,041031 
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PANK3 79646 SKV_13 F04 Hs_PANK3_3 TCCAAAGGTGATAGCACACAA 0,19 0,12 TOXIC -0,40 0,31 --- 0,018612 
PCTK2 5128 SKV_09 E03 Hs_PCTK2_6 TAGGCTTAATTCTTGCGTATA 1,06 0,24 OK -0,40 0,47 --- 0,208115 
STK10 6793 SKV_18 F04 Hs_STK10_5 CACGGAATTAGAGAACCTGGA 0,11 0,03 TOXIC -0,41 0,76 --- 0,324562 
DGKD 8527 SKV_11 D03 Hs_DGKD_5 CAGCAGATTCTCTTCTATGAA 0,58 0,33 OK -0,41 0,44 --- 0,025517 
MET 4233 SKV_23 D04 Hs_MET_8 ACCGAGGGAATCATCATGAAA 0,88 0,14 OK -0,41 0,23 --- 0,035936 
DTYMK 1841 SKV_08 G08 Hs_DTYMK_5 ATCAGTTGGAATTCTCCTAAA 0,75 0,23 OK -0,41 0,39 --- 0,143014 
NME2 4831 SKV_09 C04 Hs_NME2_3 TAGAGCATATTTGCCAATAAA 0,77 0,24 OK -0,41 0,27 --- 0,056727 
SKP2 6502 SKV_14 B05 Hs_SKP2_8 ACCCTTCAACTGTTAAAGGAA 0,64 0,48 OK -0,41 0,40 --- 0,052596 
DYRK3 8444 SKV_08 C05 Hs_DYRK3_9 AGCCAATAAGCTTAAAGCTAA 0,74 0,06 OK -0,41 0,20 --- 0,021475 
PAK1 5058 SKV_18 D07 Hs_PAK1_8 TCCACTGATTGCTGCAGCTAA 0,66 0,17 OK -0,41 0,11 --- 0,000243 
AK5 26289 SKV_11 E08 Hs_AK5_3 TAGAGGCATCAAGCAAGTAAA 1,08 0,37 OK -0,42 0,63 --- 0,024138 
RIOK3 8780 SKV_02 D06 Hs_RIOK3_5 ATGCGGCAGTTATATCATGAA 0,52 0,31 OK -0,42 0,20 --- 0,024080 
RPS6KA2 6196 SKV_01 F03 Hs_RPS6KA2_9 CCGAGTGAGATCGAAGATGGA 0,25 0,16 TOXIC -0,42 0,34 --- 0,101826 
PI4K2B 55300 SKV_11 F09 Hs_PI4K2B_6 ATGAACTTTGTGCAAGATTTA 0,97 0,11 OK -0,42 0,21 --- 0,021471 
NME3 4832 SKV_10 G05 Hs_NME3_2 ACGCACCTTCCTGGCCGTGAA 0,63 0,64 OK -0,42 0,17 --- 0,011866 
SKIP 51763 SKV_25 B09 Hs_SKIP_11 CTGGACAAAGAGAGAATTCAA 0,70 0,13 OK -0,42 0,13 --- 0,004341 
PKIB 5570 SKV_12 D04 Hs_PKIB_6 CCGGAATGCCTTACCAGACAT 0,21 0,12 TOXIC -0,43 0,40 --- 0,139222 
PIK3CB 5291 SKV_17 C09 Hs_PIK3CB_6 TCGGGAAGCTACCATTTCTTA 1,35 0,24 OK -0,43 0,25 --- 0,014222 
PSKH2 85481 SKV_07 B09 Hs_PSKH2_6 GAGGATCAAGTTTACATGGTA 0,77 0,32 OK -0,43 0,46 --- 0,181082 
MAK 4117 SKV_09 D09 Hs_MAK_9 AGCGTTCAAATTTATATTCAA 1,03 0,20 OK -0,43 0,39 --- 0,126212 
CDKN2D 1032 SKV_16 G06 Hs_CDKN2D_6 ATGAGTTATGAGTTATTCATA 0,88 0,17 OK -0,43 0,15 --- 0,000258 
ICK 22858 SKV_08 D05 Hs_ICK_7 AAGGACTATTATATTATATAA 0,65 0,20 OK -0,43 0,29 --- 0,061839 
TSSK6 83983 SKV_25 E09 Hs_SSTK_1 ATCGAGGTGTGCAACGGGAAA 0,71 0,19 OK -0,43 0,28 --- 0,057550 
GNE 10020 SKV_13 B10 Hs_GNE_8 ATGAAGGTTTCTACAACATAT 0,43 0,15 OK -0,43 0,28 --- 0,008677 
AURKAIP1 54998 SKV_14 F08 Hs_AKIP_5 ATCCGTAGTAATAAATTCTCA 0,79 0,41 OK -0,43 0,13 --- 0,000083 
CALM3 808 SKV_08 F04 Hs_CALM3_7 CCGCAGAGCTGCGTCACGTAA 0,87 0,08 OK -0,44 0,21 --- 0,022940 
TAOK3 51347 SKV_19 B03 Hs_TAOK3_5 CAAACAGTATAAAGCACTCAA 0,13 0,07 TOXIC -0,44 0,28 --- 0,020409 
PFTK1 5218 SKV_07 G05 Hs_PFTK1_6 CTGGGTCTTGTCAACATCTAA 0,65 0,07 OK -0,44 0,24 --- 0,034288 
BMP2K 55589 SKV_17 G09 Hs_BMP2K_6 TCCGATGTGCATTGAAGCGAA 0,62 0,13 OK -0,44 0,19 --- 0,003291 
ERN2 10595 SKV_19 D06 Hs_ERN2_6 CACCTGCATTCTTTACACATA 0,38 0,15 TOXIC -0,44 0,40 --- 0,067264 
KIT 3815 SKV_21 E08 Hs_KIT_5 CACGGTTGAATGTAAGGCTTA 0,88 0,06 OK -0,45 0,07 --- 0,000039 
KALRN 8997 SKV_06 F06 Hs_TRAD_5 CCCATTGAGTATCAACGGAAA 1,20 0,46 OK -0,45 0,29 --- 0,058256 
PRKG1 5592 SKV_25 D06 Hs_PRKG1_6 CCAGTCTTTCTTAGAACTTTA 0,73 0,26 OK -0,45 0,42 --- 0,140993 
PRKG2 5593 SKV_01 E06 Hs_PRKG2_5 GACCTACAATTTGATTCTCAA 0,59 0,05 OK -0,45 0,37 --- 0,105472 
ADRBK2 157 SKV_01 B04 Hs_ADRBK2_5 AAGATGTTCAGTGTTGGGTAA 0,26 0,18 TOXIC -0,45 0,12 --- 0,002658 
PHKB 5257 SKV_06 C10 Hs_PHKB_6 TCGATGGGTCTTTGAATAGAA 0,41 0,22 OK -0,45 0,28 --- 0,049401 
CRKRS 51755 SKV_08 D10 Hs_CRK7_5 ACCGGATATCGGGAAGTTCAA 0,57 0,31 OK -0,45 0,59 --- 0,252190 
STK11IP 114790 SKV_16 F03 Hs_STK11IP_5 CTCTGCGTTTCTTGAACCTAA 0,24 0,01 TOXIC -0,46 0,45 --- 0,053733 
AKAP4 8852 SKV_12 D09 Hs_AKAP4_7 GTCGGTGAACACATTCTCAAA 0,93 0,20 OK -0,46 0,26 --- 0,038707 
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CKS1B 1163 SKV_15 C08 Hs_CKS1B_4 AACATCTTTCTGATAACATTA 0,39 0,19 TOXIC -0,46 0,25 --- 0,004619 
PIK3R3 8503 SKV_15 G04 Hs_PIK3R3_5 GAGGATATCAATCGAGTACAA 0,12 0,08 TOXIC -0,46 0,29 --- 0,009437 
MAPK10 5602 SKV_08 B06 Hs_MAPK10_5 CCGCATGTGTCTGTATTCATA 0,91 0,19 OK -0,46 0,31 --- 0,063939 
ZAK 51776 SKV_24 D10 Hs_ZAK_6 CTATGATTACATTAACAGTAA 0,75 0,24 OK -0,46 0,49 --- 0,177406 
MADD 8567 SKV_12 D07 Hs_MADD_7 CACACCGTCCACTGAATTCAA 0,68 0,16 OK -0,46 0,31 --- 0,060569 
AKAP11 11215 SKV_14 E03 Hs_AKAP11_6 CTGACCGGTTATCTAAATCTA 0,54 0,11 OK -0,47 0,37 --- 0,022933 
UCKL1 54963 SKV_11 F07 Hs_UCKL1_5 ACCCAGGACTGTTGAATACAA 0,64 0,33 OK -0,47 0,29 --- 0,012616 
TEK 7010 SKV_22 B04 Hs_TEK_5 ACGGGCCAGATTGTAAGCTTA 0,62 0,14 OK -0,47 0,17 --- 0,008370 
PANK4 55229 SKV_11 F08 Hs_PANK4_5 CTGGGAGACGTTCATATTGGA 0,75 0,44 OK -0,47 0,66 --- 0,013107 
TLK1 9874 SKV_19 D04 Hs_TLK1_5 CAGAGAGTATAGAATACACAA 0,97 0,90 OK -0,47 0,39 --- 0,051177 
SNRK 54861 SKV_05 C07 Hs_SNRK_7 CACCACTGAATTGGAACGGAT 0,43 0,04 OK -0,47 0,27 --- 0,040039 
NEK9 91754 SKV_19 F10 Hs_NEK9_5 CACGAACCAGTGAAGTCTATA 0,55 0,20 OK -0,47 0,30 --- 0,018908 
HCK 3055 SKV_21 D10 Hs_HCK_7 CGGCAGGGAGATACCGTGAAA 0,99 0,17 OK -0,47 0,16 --- 0,001140 
DGKB 1607 SKV_10 E03 Hs_DGKB_10 CTCATTCTAGTCCAATGGTAA 0,32 0,09 TOXIC -0,48 0,44 --- 0,132362 
AURKC 6795 SKV_17 D09 Hs_AURKC_6 CCGGGTGTACCTGATTCTGGA 1,37 0,34 OK -0,48 0,30 --- 0,019130 
PRKRIR 5612 SKV_11 B09 Hs_PRKRIR_5 AAGGTGTATGTAGACCACTTA 0,44 0,07 OK -0,48 0,28 --- 0,011153 
CDKN1C 1028 SKV_15 B10 Hs_CDKN1C_5 AAGCTTTAAGAGTCATTTATA 1,06 0,09 OK -0,48 0,31 --- 0,008504 
PRKD3 23683 SKV_06 G04 Hs_PRKD3_6 CGGGAGAGTGTTACCATTGAA 0,25 0,11 TOXIC -0,48 0,31 --- 0,052528 
MAPK4 5596 SKV_09 E08 Hs_MAPK4_6 CGCCTTAAATCTAATCAGCAA 0,77 0,07 OK -0,49 0,27 --- 0,036823 
PCTK1 5127 SKV_07 F10 Hs_PCTK1_7 TCCGCAGAGGATGCCATGAAA 0,99 0,43 OK -0,49 0,19 --- 0,010802 
MAPK3 5595 SKV_09 E07 Hs_MAPK3_6 CCCGTCTAATATATAAATATA 1,14 0,23 OK -0,49 0,46 --- 0,137423 
AKAP12 9590 SKV_14 C08 Hs_AKAP12_6 CCCGAAATAATCGAACAGATT 0,70 0,35 OK -0,49 0,17 --- 0,000514 
PRKAG2 51422 SKV_03 F08 Hs_PRKAG2_14 TCGGTTGGTGGTGGTAAATGA 0,70 0,31 OK -0,49 0,14 --- 0,003475 
CDKN2A 1029 SKV_15 C03 Hs_CDKN2A_11 CAGGTGTGCCACATTCGCTAA 0,35 0,07 TOXIC -0,49 0,16 --- 0,000340 
RIPK1 8737 SKV_24 G07 Hs_RIPK1_5 TACCACTAGTCTGACGGATAA 1,20 0,02 OK -0,49 0,15 --- 0,004980 
AKAP6 9472 SKV_14 C05 Hs_AKAP6_5 CACGTTTGTCACTGCCGTTTA 0,74 0,14 OK -0,49 0,25 --- 0,003686 
CDKN1C 1028 SKV_16 F10 Hs_CDKN1C_6 TACACTGGTCCCAAAGTGTAA 0,47 0,10 OK -0,50 0,19 --- 0,000322 
NME1 4830 SKV_10 G03 Hs_NME1_9 CAAGTTGGCAGGAACATTATA 0,66 0,05 OK -0,50 0,66 --- 0,262237 
MLCK 91807 SKV_05 D10 Hs_LOC91807_7 GACCATGAATTTCATTGTAAA 0,98 0,43 OK -0,50 0,33 UP 0,060375 
IKBKAP 8518 SKV_15 G06 Hs_IKBKAP_5 CAGCGGTTTACTATAGACAAA 0,34 0,15 TOXIC -0,50 0,34 UP 0,012611 
ABL2 27 SKV_19 B10 Hs_ABL2_8 AACCCTGTCCTTAATAACTTA 0,77 0,21 OK -0,50 0,13 UP 0,000223 
CHKA 1119 SKV_10 D06 Hs_CHKA_5 AGCCGGCGATTAGATACTGAA 0,49 0,18 OK -0,50 0,53 UP 0,177383 
FGFR1 2260 SKV_21 C10 Hs_FGFR1_6 CAGAGATTTACCCATCGGGTA 0,73 0,13 OK -0,50 0,11 UP 0,000078 
BAIAP2L1 55971 SKV_14 F09 Hs_LOC55971_6 CTCAACGAGAGTCTTGATGAA 0,58 0,23 OK -0,50 0,33 UP 0,009750 
DDR1 780 SKV_19 C05 Hs_DDR1_9 ACGGTGTGAATCACACATCCA 0,40 0,09 OK -0,50 0,24 UP 0,005741 
BMP2K 55589 SKV_19 E09 Hs_BMP2K_5 AGGCATCACCTGAATATCTTA 0,88 0,14 OK -0,50 0,19 UP 0,001741 
DCK 1633 SKV_10 E06 Hs_DCK_6 TTGGTATAAATTAATTTGTTA 1,46 0,14 OK -0,51 0,41 UP 0,100737 
SPHK1 8877 SKV_25 F06 Hs_SPHK1_7 AAGGATGGGAAAGGTGTGTTT 0,61 0,29 OK -0,51 0,44 UP 0,113955 
TLK1 9874 SKV_17 F04 Hs_TLK1_6 CCGGAGAAGAAACAATCGGAA 0,56 0,09 OK -0,51 0,38 UP 0,035635 
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CHUK 1147 SKV_15 C07 Hs_CHUK_5 CAGGAGAAGTTCGGTTTAGTA 0,60 0,10 OK -0,51 0,13 UP 0,000035 
CDC42BPA 8476 SKV_03 D07 Hs_CDC42BPA_7 CAGATAATAGTCGGAAACAAA 0,31 0,11 TOXIC -0,51 0,58 UP 0,200737 
MET 4233 SKV_21 F04 Hs_MET_9 CGCGCCGTGATGAATATCGAA 0,82 0,08 OK -0,52 0,17 UP 0,000866 
MELK 9833 SKV_06 E10 Hs_MELK_5 CGGGTTGTCTTCCGTCAGATA 0,67 0,30 OK -0,52 0,29 UP 0,036460 
PNCK 139728 SKV_05 E03 Hs_PNCK_5 CTCGAAGATCATGGTCTCTGA 0,79 0,09 OK -0,52 0,26 UP 0,025342 
CSNK1G2 1455 SKV_05 E08 Hs_CSNK1G2_6 TAGGAAAGAATCTCTATACAA 0,41 0,19 OK -0,52 0,78 UP 0,311743 
SPHK2 56848 SKV_11 G06 Hs_SPHK2_5 CAGGATTGCGCTCGCTTTCAT 0,52 0,59 OK -0,52 0,61 UP 0,006973 
RPS6KA3 6197 SKV_03 D04 Hs_RPS6KA3_5 AGCGCTGAGAATGGACAGCAA 0,68 0,27 OK -0,52 0,24 UP 0,018454 
CSNK2B 1460 SKV_17 B05 Hs_CSNK2B_6 GTGGTGGGAATATGAAATAAA 0,57 0,10 OK -0,53 0,40 UP 0,037773 
KALRN 8997 SKV_05 B06 Hs_TRAD_7 CAGGACATCAATCAAGTCTTA 0,46 0,26 OK -0,53 0,53 UP 0,160826 
DGKZ 8525 SKV_11 C10 Hs_DGKZ_7 TCGCGTCAGCATGCACGACTA 0,70 0,37 OK -0,53 0,27 UP 0,006018 
NEK4 6787 SKV_15 F08 Hs_NEK4_7 CTCATCTAGGGTATATACAAA 0,44 0,17 OK -0,53 0,30 UP 0,005422 
PRKCI 5584 SKV_03 B09 Hs_PRKCI_8 ACGCCGCTGGAGAAAGCTTTA 0,49 0,41 OK -0,53 0,18 UP 0,006269 
PRKCI 5584 SKV_01 D09 Hs_PRKCI_10 CAGATTGTTCTTTGTTATAGA 0,77 0,24 OK -0,54 0,11 UP 0,001139 
CKMT1B 1159 SKV_08 F09 Hs_CKMT1_5 ACGGATCTAGATGCCAGTAAA 1,10 0,31 OK -0,54 0,20 UP 0,010002 
DCK 1633 SKV_08 G06 Hs_DCK_5 AAGTTGCAAAGTGGAATTAAA 0,88 0,09 OK -0,54 0,19 UP 0,007835 
PHKA2 5256 SKV_04 E09 Hs_PHKA2_6 CCGGATTCTTAGTCACATATA 0,99 0,28 OK -0,54 0,11 UP 0,000926 
LOC161635 161635 SKV_05 F09 LOC161635 TCCATCGATCTGGAATTTATA 1,12 0,09 OK -0,54 0,02 UP 0,000001 
PIK3C2B 5287 SKV_15 E05 Hs_PIK3C2B_6 CACTGTAGACTTGCTTATCTA 0,86 0,31 OK -0,54 0,26 UP 0,001733 
EGFR 1956 SKV_19 C07 Hs_EGFR_10 TACGAATATTAAACACTTCAA 0,37 0,13 TOXIC -0,54 0,56 UP 0,102076 
RPS6KB2 6199 SKV_03 D05 Hs_RPS6KB2_5 ACCGCAGAGAACCGGAAGAAA 0,15 0,05 TOXIC -0,54 0,23 UP 0,015234 
ADCK2 90956 SKV_02 E10 Hs_ADCK2_6 CAGATTGACCTGCGTTACGAA 0,73 0,22 OK -0,55 0,37 UP 0,061239 
IKBKG 8517 SKV_17 E05 Hs_IKBKG_6 TTCGGAAATGCCTCACATATA 0,95 0,09 OK -0,55 0,28 UP 0,010163 
PKM2 5315 SKV_11 B06 Hs_PKM2_8 AACATCAAGATTATCAGCAAA 0,49 0,17 OK -0,55 0,34 UP 0,004406 
PACSIN2 11252 SKV_16 C04 Hs_PACSIN2_6 GAAGCTTTACATAGAACCTTA 0,77 0,14 OK -0,56 0,25 UP 0,001348 
MARK3 4140 SKV_06 C06 Hs_MARK3_8 CTCGCATTGTGCAGAATTAAA 0,97 0,10 OK -0,56 0,56 UP 0,158541 
STK17B 9262 SKV_06 E08 Hs_STK17B_16 CACGAGATTGCTGTGCTTGAA 0,69 0,42 OK -0,56 0,46 UP 0,100365 
PKIA 5569 SKV_12 D03 Hs_PKIA_9 ATGATTATCATTAGAAGCTAA 0,43 0,18 OK -0,56 0,69 UP 0,234335 
MAP2K1 5604 SKV_20 B10 Hs_MAP2K1_7 CTGGAAGAATTCCTGAACAAA 0,47 0,10 OK -0,56 0,13 UP 0,000127 
PASK 23178 SKV_05 B08 Hs_PASK_6 CGCGCTGACACTGTTTGGTTA 0,86 0,11 OK -0,56 0,65 UP 0,207344 
CSNK1G3 1456 SKV_07 C09 Hs_CSNK1G3_5 CAACATATCTTCGTTATGTAA 0,96 0,06 OK -0,56 0,34 UP 0,046320 
DGKA 1606 SKV_10 D10 Hs_DGKA_6 CACGACCAGTGTGCCATGAAA 0,58 0,14 OK -0,57 0,43 UP 0,084532 
EIF2AK2 5610 SKV_15 F07 Hs_EIF2AK2_6 CGGAAAGACTTACGTTATTAA 0,81 0,28 OK -0,57 0,28 UP 0,002603 
ALPK2 115701 SKV_06 B03 Hs_ALPK2_1 CAGGATTTGCGACCAGGTTTA 0,30 0,18 TOXIC -0,58 1,05 UP 0,394014 
ROCK1 6093 SKV_03 C09 Hs_ROCK1_10 CAAGCTCGAATTACATCTTTA 0,56 0,15 OK -0,58 0,29 UP 0,026864 
IRAK4 51135 SKV_24 F09 Hs_IRAK4_7 TTGCAGGACAGTGGTTATTAA 0,49 0,21 OK -0,58 0,29 UP 0,027058 
PI4K2A 55361 SKV_13 E03 Hs_PI4KII_5 ACGCAAATGTATGAATAACAA 0,52 0,31 OK -0,58 0,60 UP 0,062083 
CDKL2 8999 SKV_08 C10 Hs_CDKL2_5 ATGATGTGTTTAGGTAATCTA 0,85 0,08 OK -0,58 0,58 UP 0,155480 
AKAP4 8852 SKV_14 B09 Hs_AKAP4_8 TACAGTGTCTATGCCGATCAA 0,75 0,36 OK -0,58 0,20 UP 0,000194 
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LATS1 9113 SKV_03 D09 Hs_LATS1_5 CCCATGAATCCTCCTAATCAA 0,82 0,11 OK -0,58 0,22 UP 0,009435 
ACVR1 90 SKV_23 G05 Hs_ACVR1_5 CGGATGGTGAGCAATGGTATA 1,11 0,16 OK -0,59 0,15 UP 0,002447 
DBF4 10926 SKV_16 B08 Hs_ASK_5 CAGTATCAAGTTGTTGATGAT 0,38 0,11 TOXIC -0,59 0,23 UP 0,000379 
NTRK3 4916 SKV_21 F06 Hs_NTRK3_9 CACGGATAACTTTATCTTGTT 0,79 0,14 OK -0,59 0,26 UP 0,003648 
CSNK1A1L 122011 SKV_07 D07 Hs_CSNK1A1L_11 AAGGACTAAAGGCTATGACAA 0,18 0,10 TOXIC -0,60 0,34 UP 0,037675 
GRK6 2870 SKV_02 F10 Hs_GRK6_10 AGGCATGTGGGCGGCACGTAA 0,65 0,15 OK -0,61 0,32 UP 0,029884 
CSNK2A2 1459 SKV_17 B04 Hs_CSNK2A2_6 CTGGGACAACATTCACGGAAA 0,43 0,18 OK -0,61 0,54 UP 0,066455 
PFTK1 5218 SKV_09 E05 Hs_PFTK1_5 AAGGGACACCTTTCACAGCTA 0,74 0,37 OK -0,61 0,88 UP 0,294492 
CDC42BPB 9578 SKV_01 G04 Hs_CDC42BPB_5 CGCCGAGATATTCCATGTATA 0,69 0,14 OK -0,62 0,13 UP 0,001235 
SRC 6714 SKV_21 G09 Hs_SRC_7 CGGCTTGTGGGTGATGTTTGA 0,70 0,11 OK -0,62 0,19 UP 0,000650 
PDGFRB 5159 SKV_21 G03 Hs_PDGFRB_6 CTGCCGAGCAACTTTGATCAA 0,83 0,23 OK -0,62 0,22 UP 0,001416 
STK39 27347 SKV_20 E10 Hs_STK39_6 TTGGAGTATTTGTAACTTCTA 0,38 0,11 TOXIC -0,62 0,13 UP 0,000076 
AKAP13 11214 SKV_14 D10 Hs_AKAP13_5 CCGCCTGTTTGGGTTAACAAA 0,70 0,18 OK -0,62 0,25 UP 0,000487 
PRKAR1A 5573 SKV_03 B03 Hs_PRKAR1A_7 CAGCTAGTGCCAAATAATTGA 0,59 0,09 OK -0,63 0,53 UP 0,111571 
PAK7 57144 SKV_20 F06 Hs_PAK7_5 ATGATCTGGATCCGTATTATA 0,87 0,18 OK -0,64 0,17 UP 0,000291 
LMTK2 22853 SKV_23 G04 Hs_LMTK2_6 CAGATCAGACTAAGTATAGTA 0,64 0,07 OK -0,65 0,08 UP 0,000126 
MARCKS 4082 SKV_13 G09 Hs_MARCKS_5 CTCCTTCAAGAAGAACAAGAA 0,53 0,21 OK -0,65 0,56 UP 0,031083 
MAPKBP1 23005 SKV_16 C05 Hs_MAPKBP1_6 CCCGTTTGTACTGATGTATGA 0,63 0,09 OK -0,65 0,26 UP 0,000787 
GK 2710 SKV_10 E09 Hs_GK_6 CTGAGGGTAGCCCATTTATAA 0,62 0,20 OK -0,66 0,55 UP 0,104633 
AKAP9 10142 SKV_12 E10 Hs_AKAP9_6 CAGCTTCAAAGGGATATACAA 0,48 0,19 OK -0,66 1,01 UP 0,318892 
RET 5979 SKV_23 E06 Hs_RET_9 CCGCTGGTGGACTGTAATAAT 0,97 0,01 OK -0,67 0,27 UP 0,013540 
TNK1 8711 SKV_22 B08 Hs_TNK1_6 ATCGGTCATGATGAACTTGGA 0,30 0,05 TOXIC -0,67 0,16 UP 0,001928 
PASK 23178 SKV_06 F08 Hs_PASK_5 ATCCTGGTTGCTAACGACAAA 0,87 0,09 OK -0,67 0,30 UP 0,017657 
PRKCH 5583 SKV_03 B08 Hs_PRKCH_6 GACCAGATTTGTGGCTTATAA 0,20 0,22 TOXIC -0,68 0,71 UP 0,170344 
NUCKS1 64710 SKV_16 E06 Hs_NUCKS1_5 TCGGGCCCTCCCACTAAGAAA 0,89 0,09 OK -0,69 0,19 UP 0,000034 
STK16 8576 SKV_19 G08 Hs_STK16_2 CAGGAGAATGTGTAACAAGAA 0,41 0,14 OK -0,69 0,27 UP 0,002231 
PHKA1 5255 SKV_04 E08 Hs_PHKA1_5 ATGGGAGTGCTTGGAACTTCA 0,80 0,22 OK -0,69 0,25 UP 0,008943 
NEK11 79858 SKV_18 B07 Hs_NEK11_7 TGAGATAAGCTTATAGATCAA 0,70 0,14 OK -0,69 0,09 UP 0,000006 
PHKG2 5261 SKV_04 F04 Hs_PHKG2_5 CTGCATGCACTGCATATGAAA 0,51 0,19 OK -0,70 0,25 UP 0,008437 
AAK1 22848 SKV_19 E03 Hs_AAK1_6 CCAGGTGGTAAACCTGATGAA 0,14 0,06 TOXIC -0,71 0,44 UP 0,018416 
AKAP8L 26993 SKV_16 C09 Hs_AKAP8L_6 CCTGTGATTATGGATATGGAA 0,72 0,12 OK -0,71 0,19 UP 0,000052 
ACVR2A 92 SKV_22 C07 Hs_ACVR2_1 GAGGTATTAGAGGGTGCTATA 0,44 0,07 OK -0,71 0,17 UP 0,001778 
MAP3K3 4215 SKV_18 D04 Hs_MAP3K3_5 CAGGAATACTCAGATCGGGAA 0,79 0,08 OK -0,71 0,10 UP 0,000007 
NEK7 140609 SKV_18 C04 Hs_NEK7_6 CCGGATATGGGCTATAATACA 0,65 0,13 OK -0,72 0,40 UP 0,011481 
ERBB3 2065 SKV_21 C05 Hs_ERBB3_5 ACCACGGTATCTGGTCATAAA 0,37 0,08 TOXIC -0,72 0,23 UP 0,000789 
CSNK2A2 1459 SKV_15 D04 Hs_CSNK2A2_5 CAGGAGTACAATGTTCGTGTA 0,88 0,30 OK -0,73 0,41 UP 0,003989 
STK17A 9263 SKV_06 E09 Hs_STK17A_5 AACCAGGATATTTAACAGGTA 0,91 0,36 OK -0,73 0,25 UP 0,007150 
MAP2K4 6416 SKV_20 C09 Hs_MAP2K4_8 AGGGTGTATAGTGTTCACAAA 0,96 0,26 OK -0,75 0,21 UP 0,000372 
DGKG 1608 SKV_10 E04 Hs_DGKG_5 ACCGCAAATGTGAATTATCAA 0,84 0,06 OK -0,75 0,61 UP 0,101038 
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HIPK2 28996 SKV_08 D07 Hs_HIPK2_5 AACCAGTACCCTTACATATAA 0,84 0,11 OK -0,76 0,68 UP 0,125579 
PIK3R2 5296 SKV_15 F05 Hs_PIK3R2_6 TTGGTACGTGGGCAAGATCAA 0,58 0,29 OK -0,76 0,25 UP 0,000133 
CALM1 801 SKV_08 E10 Hs_CALM1_5 CGGCAACTTACACACATTGAA 0,82 0,11 OK -0,77 0,44 UP 0,038799 
MAPK3 5595 SKV_07 G07 Hs_MAPK3_7 CTCCCTGACCCGTCTAATATA 0,87 0,38 OK -0,77 0,15 UP 0,000932 
TEK 7010 SKV_23 F04 Hs_TEK_6 TCGGTGCTACTTAACAACTTA 0,85 0,04 OK -0,78 0,21 UP 0,003004 
PKIB 5570 SKV_14 B04 Hs_PKIB_5 CAGCATGTGTATATTAGATAA 0,87 0,35 OK -0,78 0,49 UP 0,006984 
AATK 9625 SKV_23 F09 Hs_AATK_7 CTCCAACGTGTCAGCCAACAA 0,36 0,05 TOXIC -0,79 0,36 UP 0,019181 
MAST2 23139 SKV_02 B03 Hs_MAST2_6 CAGTGAAATAATAATGATGAA 0,40 0,21 TOXIC -0,79 0,59 UP 0,079700 
PINK1 65018 SKV_18 B03 Hs_PINK1_4 GACGCTGTTCCTCGTTATGAA 0,49 0,15 OK -0,81 0,23 UP 0,000422 
FYN 2534 SKV_21 D09 Hs_FYN_5 AAGACATGTGGTGTATATAAA 0,76 0,09 OK -0,81 0,13 UP 0,000015 
TBK1 29110 SKV_17 G06 Hs_TBK1_6 CAGAACGTAGATTAGCTTATA 0,22 0,12 TOXIC -0,81 0,56 UP 0,026754 
AK1 203 SKV_10 C07 Hs_AK1_6 GCGGCTGGAGACCTATTACAA 0,53 0,18 OK -0,81 0,47 UP 0,039848 
ALS2CR2 55437 SKV_20 F05 Hs_ALS2CR2_6 CCAGTGGAACTCACACAGTAA 0,48 0,17 OK -0,82 0,24 UP 0,000528 
PKLR 5313 SKV_26 B07 Hs_PKLR_9 CGGCAGCTGTTTGAGGAGCTA 0,44 0,09 OK -0,83 0,78 UP 0,140502 
NME4 4833 SKV_10 G06 Hs_NME4_6 CAGCACATGGGTGGTACACTA 0,64 0,13 OK -0,84 0,57 UP 0,063185 
PRKX 5613 SKV_01 E07 Hs_PRKX_5 CGGATGGGATTCACTTAAGAA 0,27 0,22 TOXIC -0,88 0,95 UP 0,186301 
NEK6 10783 SKV_17 F10 Hs_NEK6_7 AAGGGATAAAGTGGAAATCAT 0,28 0,06 TOXIC -0,93 0,20 UP 0,000086 
PTK2 5747 SKV_23 E04 Hs_PTK2_5 CACCTGGGTACTGGTATGGAA 0,79 0,03 OK -0,96 0,29 UP 0,004749 
PGK1 5230 SKV_10 G10 Hs_PGK1_5 CACAATTATAGATTAGATCAA 1,08 0,25 OK -0,96 0,33 UP 0,006993 
SNF1LK 150094 SKV_05 E04 Hs_SNF1LK_6 TCCACACATCATAAAGCTTTA 0,57 0,20 OK -0,96 0,51 UP 0,031523 
PAK2 5062 SKV_18 D08 Hs_PAK2_9 CCGGATCATACGAAATCAATT 0,72 0,12 OK -0,97 0,15 UP 0,000012 
PFKM 5213 SKV_10 G09 Hs_PFKM_5 AACAGATCAGTGCCAATATAA 0,23 0,07 TOXIC -0,97 0,56 UP 0,040689 
CERK 64781 SKV_13 E10 Hs_CERK_6 CGGCTTAAACTTTGATCTGTA 1,20 0,38 OK -1,00 0,29 UP 0,000052 
CSNK1G3 1456 SKV_05 E09 Hs_CSNK1G3_6 TACCGCAAACTTGATATGGAA 1,24 0,08 OK -1,00 0,30 UP 0,004468 
PRKCE 5581 SKV_01 D07 Hs_PRKCE_6 CACGGAAACACCCGTACCTTA 0,18 0,17 TOXIC -1,00 1,62 UP 0,343082 
ROR1 4919 SKV_23 D07 Hs_ROR1_6 CCGTACTGCGATGAAACTTCA 0,29 0,11 TOXIC -1,04 0,28 UP 0,003091 
MAP3K10 4294 SKV_25 G06 Hs_MAP3K10_7 CAAGCGCAAGGGCAACTTCAA 0,16 0,05 TOXIC -1,09 0,90 UP 0,104461 
MAP4K3 8491 SKV_20 D07 Hs_MAP4K3_6 TCGAGCTGTTGGATAAAGTAA 0,38 0,11 TOXIC -1,10 0,36 UP 0,000860 
NUAK1 9891 SKV_06 F03 Hs_ARK5_5 TAGGGATTTACTGGCATGGTA 0,48 0,17 OK -1,11 0,31 UP 0,003348 
MERTK 10461 SKV_23 G03 Hs_MERTK_14 CAGATGAATGTTGTTAAGTAA 0,80 0,14 OK -1,13 0,21 UP 0,000728 
SNF1LK2 23235 SKV_06 F09 Hs_SNF1LK2_11 CAGGATTACATCCGTTTATTA 0,97 0,31 OK -1,13 0,53 UP 0,020271 
AK2 204 SKV_10 C08 Hs_AK2_5 CCACATGTAAAGACTTGGTTA 0,85 0,21 OK -1,14 0,86 UP 0,083260 
ALS2CR7 65061 SKV_10 C03 Hs_ALS2CR7_5 CTGGACATAAACTAAGTCTAA 0,13 0,06 TOXIC -1,19 0,26 UP 0,001423 
CLK2 1196 SKV_07 F03 Hs_CLK2_5 CAGCTACAGACGCAACGATTA 0,47 0,14 OK -1,21 0,36 UP 0,004334 
PRKAR1A 5573 SKV_01 D03 Hs_PRKAR1A_8 CTGGACCGACCTAGATTTGAA 0,22 0,10 TOXIC -1,30 0,98 UP 0,083531 
AK3L1 205 SKV_08 E09 Hs_AK3_10 CCTGGTAACAGTGAAATTGAA 0,53 0,18 OK -1,39 0,79 UP 0,038371 
CDK6 1021 SKV_07 E08 Hs_CDK6_6 TCTGAAGTGTTTGACATTTAA 0,93 0,47 OK -1,51 0,35 UP 0,001673 
ULK2 9706 SKV_17 F03 Hs_ULK2_6 CAGCCTGAGATACGTGCCTTA 0,03 0,01 TOXIC -1,60 1,03 UP 0,020374 
 
pos.: position in plate inh.: inhibition Sign.: significance 
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Table S.2: List of SKV targets ordered for validation 
A: downregulating siRNAs           
Target gene Gene ID plate pos. sequence name SKV siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
ROCK2 9475 SKV_01 G03 Hs_ROCK2_6 ATGCACTTGTATAAAGCCATA 0,45 0,21 OK 1,59 0,45 DOWN 0,003730 
LATS2 26524 SKV_03 F05 Hs_LATS2_8 AAGGATGTCCTGAACCGGAAT 0,61 0,06 OK 1,26 0,13 DOWN 0,000080 
MKNK2 2872 SKV_06 C04 Hs_MKNK2_15 CAGCCAGGAGTACGCCGTCAA 0,54 0,49 OK 1,10 0,21 DOWN 0,000854 
ADCK2 90956 SKV_04 C10 Hs_ADCK2_5 CCGGAATGTGAAAGCCGTCAA 0,62 0,15 OK 1,05 0,15 DOWN 0,000237 
PRKCH 5583 SKV_01 D08 Hs_PRKCH_5 CGCCGTGTGCTCATCACTGAA 0,54 0,30 OK 1,02 0,25 DOWN 0,002166 
MAP2K7 5609 SKV_20 C07 Hs_MAP2K7_13 CTGCGCTGAGAAGCTCAAGAA 0,40 0,06 OK 0,94 0,04 DOWN 0,000000 
FGFR3 2261 SKV_23 B03 Hs_FGFR3_5 ACCCTACGTTACCGTGCTCAA 0,44 0,04 OK 0,91 0,05 DOWN 0,000007 
MARK4 57787 SKV_05 D03 Hs_MARK4_5 CCGCATCATGAAGGGCCTAAA 0,57 0,19 OK 0,87 0,07 DOWN 0,000027 
AKT2 208 SKV_02 F06 Hs_AKT2_8 CAAGCGTGGTGAATACATCAA 0,55 0,28 OK 0,83 0,15 DOWN 0,000699 
MAP3K7 6885 SKV_20 D05 Hs_MAP3K7_8 AAGACTTGACTGTAACTGGAA 0,66 0,11 OK 0,83 0,25 DOWN 0,000582 
CDC2L1 984 SKV_07 E03 Hs_CDC2L1_9 CACGTCGCTGAGGGAGATCAA 0,40 0,21 OK 0,83 0,18 DOWN 0,001436 
EIF2AK3 9451 SKV_17 E09 Hs_EIF2AK3_6 CGGCAGGTCATTAGTAATTAT 0,49 0,17 OK 0,83 0,32 DOWN 0,001943 
EPHA2 1969 SKV_20 G08 Hs_EPHA2_7 CAGCGCCAAGTAAACAGGGTA 0,42 0,12 OK 0,79 0,05 DOWN 0,000000 
STK38 11329 SKV_03 E08 Hs_STK38_5 AACCTTATCGCTCAACATGAA 0,48 0,07 OK 0,78 0,31 DOWN 0,011501 
PIP4K2C 79837 SKV_13 F05 Hs_PIP5K2C_6 TTGATGTGTGATAATCTCATA 0,86 0,25 OK 0,78 0,12 DOWN 0,000001 
BEGAIN 57596 SKV_16 E04 Hs_KIAA1446_5 CGGGCGGACCATGTCACCGTA 0,55 0,15 OK 0,76 0,10 DOWN 0,000000 
MAP3K7IP1 10454 SKV_14 D04 Hs_MAP3K7IP1_7 AACGGCTATGATGGCAACCGA 0,48 0,12 OK 0,73 0,19 DOWN 0,000029 
NRGN 4900 SKV_12 C10 Hs_NRGN_6 CACCCAAGCACACTCACTTAA 0,83 0,08 OK 0,72 0,31 DOWN 0,016160 
CSNK1D 1453 SKV_07 C06 Hs_CSNK1D_6 CTCCCTGACGATTCCACTGTA 0,62 0,15 OK 0,72 0,22 DOWN 0,005080 
PDPK1 5170 SKV_02 G04 Hs_PDPK1_9 CACGCCTAACAGGACGTATTA 0,79 0,29 OK 0,71 0,42 DOWN 0,041453 
             
B: upregulating siRNAs           
Target gene Gene ID plate pos. sequence name SKV siRNA sequence Mean cells SD cells phenotype Mean inh. SD inh. phenotype Sign. inh. 
CDK6 1021 SKV_07 E08 Hs_CDK6_6 TCTGAAGTGTTTGACATTTAA 0,93 0,47 OK -1,51 0,35 UP 0,001673 
AK3L1 205 SKV_08 E09 Hs_AK3_10 CCTGGTAACAGTGAAATTGAA 0,53 0,18 OK -1,39 0,79 UP 0,038371 
CLK2 1196 SKV_07 F03 Hs_CLK2_5 CAGCTACAGACGCAACGATTA 0,47 0,14 OK -1,21 0,36 UP 0,004334 
SNF1LK2 23235 SKV_06 F09 Hs_SNF1LK2_11 CAGGATTACATCCGTTTATTA 0,97 0,31 OK -1,13 0,53 UP 0,020271 
MERTK 10461 SKV_23 G03 Hs_MERTK_14 CAGATGAATGTTGTTAAGTAA 0,80 0,14 OK -1,13 0,21 UP 0,000728 
NUAK1 9891 SKV_06 F03 Hs_ARK5_5 TAGGGATTTACTGGCATGGTA 0,48 0,17 OK -1,11 0,31 UP 0,003348 
CSNK1G3 1456 SKV_05 E09 Hs_CSNK1G3_6 TACCGCAAACTTGATATGGAA 1,24 0,08 OK -1,00 0,30 UP 0,004468 
CERK 64781 SKV_13 E10 Hs_CERK_6 CGGCTTAAACTTTGATCTGTA 1,20 0,38 OK -1,00 0,29 UP 0,000052 
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PAK2 5062 SKV_18 D08 Hs_PAK2_9 CCGGATCATACGAAATCAATT 0,72 0,12 OK -0,97 0,15 UP 0,000012 
SNF1LK 150094 SKV_05 E04 Hs_SNF1LK_6 TCCACACATCATAAAGCTTTA 0,57 0,20 OK -0,96 0,51 UP 0,031523 
PGK1 5230 SKV_10 G10 Hs_PGK1_5 CACAATTATAGATTAGATCAA 1,08 0,25 OK -0,96 0,33 UP 0,006993 
PTK2 5747 SKV_23 E04 Hs_PTK2_5 CACCTGGGTACTGGTATGGAA 0,79 0,03 OK -0,96 0,29 UP 0,004749 
ALS2CR2 55437 SKV_20 F05 Hs_ALS2CR2_6 CCAGTGGAACTCACACAGTAA 0,48 0,17 OK -0,82 0,24 UP 0,000528 
AK1 203 SKV_10 C07 Hs_AK1_6 GCGGCTGGAGACCTATTACAA 0,53 0,18 OK -0,81 0,47 UP 0,039848 
FYN 2534 SKV_21 D09 Hs_FYN_5 AAGACATGTGGTGTATATAAA 0,76 0,09 OK -0,81 0,13 UP 0,000015 
PINK1 65018 SKV_18 B03 Hs_PINK1_4 GACGCTGTTCCTCGTTATGAA 0,49 0,15 OK -0,81 0,23 UP 0,000422 
PKIB 5570 SKV_14 B04 Hs_PKIB_5 CAGCATGTGTATATTAGATAA 0,87 0,35 OK -0,78 0,49 UP 0,006984 
TEK 7010 SKV_23 F04 Hs_TEK_6 TCGGTGCTACTTAACAACTTA 0,85 0,04 OK -0,78 0,21 UP 0,003004 
MAPK3 5595 SKV_07 G07 Hs_MAPK3_7 CTCCCTGACCCGTCTAATATA 0,87 0,38 OK -0,77 0,15 UP 0,000932 
CALM1 801 SKV_08 E10 Hs_CALM1_5 CGGCAACTTACACACATTGAA 0,82 0,11 OK -0,77 0,44 UP 0,038799 
PIK3R2 5296 SKV_15 F05 Hs_PIK3R2_6 TTGGTACGTGGGCAAGATCAA 0,58 0,29 OK -0,76 0,25 UP 0,000133 
MAP2K4 6416 SKV_20 C09 Hs_MAP2K4_8 AGGGTGTATAGTGTTCACAAA 0,96 0,26 OK -0,75 0,21 UP 0,000372 
STK17A 9263 SKV_06 E09 Hs_STK17A_5 AACCAGGATATTTAACAGGTA 0,91 0,36 OK -0,73 0,25 UP 0,007150 
CSNK2A2 1459 SKV_15 D04 Hs_CSNK2A2_5 CAGGAGTACAATGTTCGTGTA 0,88 0,30 OK -0,73 0,41 UP 0,003989 
NEK7 140609 SKV_18 C04 Hs_NEK7_6 CCGGATATGGGCTATAATACA 0,65 0,13 OK -0,72 0,40 UP 0,011481 
MAP3K3 4215 SKV_18 D04 Hs_MAP3K3_5 CAGGAATACTCAGATCGGGAA 0,79 0,08 OK -0,71 0,10 UP 0,000007 
ACVR2A 92 SKV_22 C07 Hs_ACVR2_1 GAGGTATTAGAGGGTGCTATA 0,44 0,07 OK -0,71 0,17 UP 0,001778 
AKAP8L 26993 SKV_16 C09 Hs_AKAP8L_6 CCTGTGATTATGGATATGGAA 0,72 0,12 OK -0,71 0,19 UP 0,000052 
 
 
 
 
 
 
 
 
pos.: position in plate inh.: inhibition Sign.: significance 
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Table S.3: Comparison of kinase knock down results 
target gene phenotype Kuijl et al., (2007) phenotype this work 
ABL1 down --- 
AKT1 down up (1/4) 
CALM3 down --- 
CAMK2B down --- 
CINP down --- 
FASTK down --- 
LYN down --- 
MAP3K14 down down (1/4) 
MAPK8IP2 down down (1/4) 
PAK4 down --- 
PCTK1 down up (1/4) 
PIK3C2G down --- 
PIK3CA down --- 
PRKD2 down up (1/4) 
 
Figure S.4: Principle of multi-paramteric flow cytometry 
Figure S.4: Principle of multi-parametric flow cytometry. 
The schematic illustration shows the principle of multi-parametric flow cytometry as 
implemented in the FACS Calibur. Particles delivered by the fluidics subsequently pass two laser 
beams and their characteristic light scattering and light emitting properties can be monitored 
and amplified by different detectors. The data for every parameter can be saved and analyzed 
on a single cell level. 
(Taken from: http://www.abdserotec.com/support/signal_processing-710.html) 
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